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Abstract 
Chapter 1. Part A: N-Heterocyclic Carbenes Catalyzed Enantioselective Boryl 
Conjugate Additions to α ,β-Unsaturated Ketones, Esters, Weinreb Amides and 
Aldehydes. The first broadly applicable enantioselective boryl conjugate addition 
reactions to a variety of α,β-unsaturated carbonyls are reported. Transformations are 
promoted by 5.0 mol % of a chiral Lewis basic N-heterocyclic carbene. The distinctive 
feature of the reactions in chemoselectivity of the method compared to the Cu-catalyzed 
variants has been illustrated.  
Part B: Enantioselective Synthesis of Boron-Substituted Quaternary Carbon 
Stereogenic Centers through N-Heterocyclic Carbenes Catalyzed Boryl Conjugate 
Additions to Cyclic and Acyclic Enones The first examples of Lewis base catalyzed 
enantioselective boryl conjugate additions that afford products containing boron-
substituted quaternary carbon stereogenic centers are presented. The carbon–boron bond 
forming reactions are promoted by 1.0–5.0 mol % of a chiral N–hererocyclic carbene. 
Cyclic or linear α,β–unsaturated ketones can be used as suitable substrates and the 
desired products are obtained in 63–95% yield and 91:9 to >99:1 enantiomeric ratio. The 
utility of the Lewis base-catalyzed approach is demonstrated in the context of an 
enantioselective formal synthesis of antifungal natural product crassinervic acid. 
 ii 
Chapter 2.	   Enantioselectivity Fluctuations in Phosphine–Cu-Catalyzed 
Enantioselective Boron-Allyl Addition to Aryl-Substituted Olefins. Catalytic 
enantioselective multicomponent processes involving B2(pin)2, aryl or heteroaryl 
monosubstituted olefins, and allylic phosphates or carbonates are disclosed. 
Transformations promoted by a chiral Cu–phosphine complex afford products that 
contain a primary C–B(pin) bond and an allyl-substituted tertiary carbon stereogenic 
center in up to 84% yield and 98:2 enantiomeric ratio. The utility of the approach is 
showcased in the enantioselective formal synthesis of biologically active heliespirones A 
and C. Based on mechanistic and computational studies, we show that enantioselectivities 
variations can depend on electronic and/or steric factors of the alkene substrate and the 
allyl electrophile as well as their concentration. In most cases, selectivity loss can be 
minimized and that the resulting insights are also applicable to reactions involving Cu–H 
species. 
Chapter 3.	   Synthesis of Vicinal Diboronate Compounds through Practical 
Phosphine–Copper Catalyzed Three-Component Processes. The phosphine–Cu-
catalyzed multicomponent processes have been developed for a practical and direct 
synthesis of vicinal diboronate compounds. Reactions of alkenyl–boronates, allylic 
phosphates, and diboron reagents are promoted by 2.5–10 mol % of a Cy3P–Cu complex 
affording a wide range of desirable vicinal diboronate products. The ability for easy 
access to either regioisomers of the products with a C–B(pin) and an adjacent C–B(dan) 
bond that can be site-selectively functionalized is a noteworthy feature of the method. 
 i 
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Chapter 1 
Part A: N-Heterocyclic Carbenes Catalyzed Enantioselective 
Boryl Conjugate Additions to α ,β-Unsaturated Ketones, 
Esters, Weinreb Amides and Aldehydes 
 
1A.1. Introduction 
 Organoboron compounds are versatile intermediates in organic synthesis. 1 
Development of catalytic methods to efficiently and selectively access these entities are 
thus of considerable interest especially in the pharmaceutical industry; for example, the 
antidepressant Prozac® (fluoxetine) 2  and the cholesterol-lowering drug Lipitor® 
(atorvastatin). 3  In addition, Velcade® (bortezomib) 4  and Kerydin® (tavaborole) 5  are 
examples of boron-containing pharmaceuticals approved by FDA for treatment of people 
with multiple myeloma (a cancer of the plasma cells) and onychomycosis of the toenails 
(a fungal infection), respectively.  
 One important approach to obtain boron-containing compounds is catalytic 
enantioselective boryl conjugate additions (BCAs) to α,β-unsaturated carbonyls.  The 
product of such method contains a boron-substituted carbon stereogenic center at the β-	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(1) For representative reviews on organoboron chemistry, see: (a) Lappert, M. F. Chem. Rev. 1956, 56, 
959–1064. (b) Thomas, S. E. Organic Synthesis: The Roles of Boron and Silicon (Oxford Chemistry 
(2) Robertson, D. W.; Krushinski J. H.; Fuller R. W.; Leander J. D. J. Med. Chem. 1988, 31, 1412–1417.  
(3) Roth, B. D. Progress in Medicinal Chemistry 2002, 40, 1–22.  
(4) Curran, M. P.; McKeage, K. Drugs 2009, 69, 859–888.  
(5) Elewski, B. E.; Aly, R.; Baldwin, S. L.; González Soto, R. F.; Rich, P.; Weisfeld, M.; Wiltz, H.; Zane, L. 
T.; Pollak, R. J. Am. Acad. Dermatol. 2015, 73, 62–69.  
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position of the carbonyl group. The corresponding C–B bond can be readily converted 
into C–O6, C–N7, C–C8 as well as C–F bond.9 Catalytic BCAs have only been reported 
with a catalyst derived from a transition-metal complex until our report in 2009, in which 
the reaction is catalyzed by a N-heterocyclic carbene (NHC).10 This method not only 
offers complementary reactivities and selectivities to the metal-catalyzed variants, but 
proceeds through a different pathway that relates to other Lewis base-catalyzed 
transformations. 
 In this chapter, development of Lewis base promoted BCAs will be outlined 
including our disclosures on enantioselective BCAs catalyzed by a chiral NHC to access 
products containing B-substituted tertiary (Part A) and quaternary (Part B) carbon 
stereogenic centers.  
1A.2. Background 
1A.2.1. Initial Evidence of B–B Bonds Activation by a Lewis Base 
 Activation of B–B bond by a Lewis base has been shown in the reaction of NHC- 
or phosphine-Cu-alkoxide with bis(pinacolato)diboron [B2(pin)2] affording the 
corresponding Cu–B(pin) complex 1.3 (Scheme 1.1). 11  The oxygen of the copper 
alkoxide complex interacts with one of the boron atoms in B2(pin)2. The B–B bond is 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(6) Carboni, B.; Ollivault, M.; Bouguenec, F. L.; Carrié, R.; Jazouli, M. Tetrahedron Lett. 1997, 38, 6665–
6668.  
(7) (a) Moran, W. J.; Morken, J. P. Org. Lett. 2006, 8, 2413–2415. (b) Mlynarski, S. N.; Karns, A. S.; 
Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449–16451.  
(8) (a) Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M. J. Am. Chem. Soc. 2009, 131, 5024–
5025. (b) Ohmura, T.; Awano, T.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 13191–13193. (c) Sandrock, 
D.; Jean-Gérard, L.; Chen, C. Y.; Dreher, S. D.; Molander, G. A. J. Am. Chem. Soc. 2010, 132, 17108–
17110. 
(9) Li, Z.; Wang, Z.; Zhu, L.; Tan, X.; Li, C. J. Am. Chem. Soc. 2014, 136, 16439–16443.  
(10) (a) Lee, K.-S.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 7253–7255. (b) Lee, 
K.-S.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 12766. 
(11) Laitar, D.S.; Müller, P.; Sadighi, J. P. J. Am. Chem. Soc. 2005, 127, 17196–17197.  
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polarized/weaken and the Cu–B(pin) complex is generated upon formation of RO–B(pin) 
through σ–bond metathesis. A Lewis basic ligand on Cu plays a crucial role in donating 
its electron density to the metal center, rendering Cu more Lewis acidic and the alkoxide 
oxygen more Lewis basic based on the principle of Lewis base activation of Lewis acid.12 
 
 X-ray crystallographic data shown in Scheme 1.2 support the idea that the B–B 
bond can be elongated and weakened by donation of electron density by a Lewis base. 
Complex 1.4 formed from binding of 4-methylpyridine with bis(catecholato)diboron, 
disclosed in 1995 by Marder and Norman shows significant lengthening of the B–B 
bond.13 Later in 1997, they also showed that a phosphine can donate a pair of electrons to 
cause the stretching of a B–B bond from 1.673 to 1.689 Å (1.5, Scheme 1.2). 14 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(12) For discussions on Lewis base activations of Lewis acids, see: (a) Guttmann, V. The Donor–Acceptor 
Approach to Molecular Interactions; Plenum Press, New York, 1978. (b) Denmark, S. E.; Beutner, G. L. 
Angew. Chem., Int. Ed. 2008, 47, 1560–1638.  
(13) Nguyen, P.; Dai, C.; Taylor, N. J.; Power, W. P.; Marder, T. B. Inorg. Chem. 1995, 34, 4290–4291. 
(14) Clegg, W.; Dai, C.; Lawlor, F. J.; Marder, T. B.; Nguyen, P.; Norman, N. C.; Pickett, N. L.; Power, W. 
































1A.2.2. Boryl Conjugate Additions Catalyzed by Achiral NHCs 
 In 2009, our laboratories investigated a possibility for an NHC to activate a 
diboron reagent. We selected an NHC as a representative for a Lewis base due to its 
unique electronic nature: a strong σ-donor and weak π-acceptor. We found that when 
B2(pin)2 is treated with 1,3-biscyclohexylimidazolylidene 1.6 in thf-d8 at –10 ºC, within 5 
min, an NHC•B2(pin)2 complex 1.7 is formed and characterized by 11B NMR spectra 
(Scheme 1.3).10 The 11B NMR signal of B2(pin)2 (30.1 ppm) disappears [>98% conv of 
B2(pin)2], and two signals at 1.8 and 36.3 ppm appear instead. The signal at 1.8 ppm 
likely corresponds to an sp3-hybridized boron indicating the coordination of the NHC 1.6. 
Interestingly, the sp2-hybridized boron shows a more downfield signal at 36.3 ppm 
compared to a signal of B2(pin)2 at 30.1 ppm. As the NHC coordinates to B2(pin)2, it 
polarizes the B–B bond and the net accumulation of electron density resides on the two 
more electronegative oxygen atoms. Because of this Lewis base activation of Lewis acid 
scenario, the sp2-hybridized boron becomes more electrophilic and results in a downfield 
shift in 11B NMR spectra.  




































 DFT calculations were performed and an increased bond length was observed 
from B2(pin)2 (1.703 Å) to NHC•diboron complex 1.7 (1.749 Å). This is consistent with a 
report in 2012 by Marder and co-workers on the X-ray crystal structure of complex 1.7. 
The B–B length in the crystal structure is 1.743(2) Å, very similar to our calculated value 
(1.749 Å). 
 
 We then began to investigate whether the BCA process can occur in the presence 
of NHC as a Lewis base. Cyclohexenone 1.8a was used as a representative substrate and 
treated with a mixture of 1.1 equiv B2(pin)2 and 10 mol % of an NHC (generated in situ 
from deprotonation of the corresponding imidazolium/imidazolinium salt) (Scheme 
1.4).10 When an NHC derived from imidazolium salt im-1 was used, there was 66% conv 
to the desired product (1.9a) at room temperature after 12 h. With im-2, the efficiency 
improved (92% conv). However, reactivity suffered when a more sizable NHC precursor 
(im-3) was used (45% conv). With the more electron-donating bis-cyclohexyl 
imidazolium salt im-4, the reaction proceeded to >98% conv to afford 1.9a. The BCA 
reaction does not proceed in the absence of an N-heterocyclic salt, or with less Lewis 
basic PPh3 or PCy3. However, 50% conv was observed with OPPh3 present indicating it 
as a potential catalyst for Lewis base catalyzed transformations as well. 













1.8 ppm 36.3 ppm
1.749 Å (calculated)
11B NMR: 30.1 ppm
B–B length: 1.703 Å (calculated)
1.7
1.7
Marder et al. 2012
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 As shown in Scheme 1.5, the NHC-catalyzed boryl conjugate additions to α,β-
unsaturated carbonyls proved to be efficient and general. A variety of cyclic and acyclic 
enones and enoates are suitable substrates. Cyclic enones with different ring sizes are 
generally effective (1.9b, 1.9c and 1.9d). Cyclic or acyclic enoates are also suitable 
substrates, although a slightly higher catalyst loading (5 mol %) and longer reaction time 
(24 h) are required for a complete transformation (1.9e and 1.12). Reaction to produce 
1.9f indicates that the NHC-catalyzed protocol can be scalable. 
 In NHC-catalyzed BCAs, boryl enolate 1.13 can be isolated without aqueous 
workup (Scheme 1.6). Moreover, the reaction proceeds with high efficiency in the 
presence of 1-hexyne (Scheme 1.6). This is in contrast to the Cu-catalyzed reaction. 
There is <2% conv when 2.5 mol % CuOt-Bu is present. In another example, when 
benzaldehyde is added, the NHC-catalyzed BCA proceeds to afford the β-boryl aldol 
product 1.14 cleanly with high diastereoselectivity (85% yield, >98:2 dr). The Cu-
O
10 mol % Lewis Base






















NaOt-Bu PPh3 PCy3 OPPh3
<2% conv. <2% conv. <2% conv. 50% conv.
Scheme 1.4. Examination of different Lewis bases as catalysts for metal-free BCA reactions
1.8a 1.9a
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catalyzed reaction; however, results in only 31% of the desired product with 19% conv to 
benzaldehyde diboration. 
 
 Our initial proposed mechanism was based on the formation of NHC•diboron 
complex i (Scheme 1.7). The B–B bond in i is polarized and the electron density is 
accumulated at the uncoordinated B(pin) unit enhancing its nucleophilicity. The B(pin) 
group transfers to the β-carbon of the enone, resulting in formation of iii and iv which 
probably are in equilibrium favoring of iv due to a stronger B–O bond. Upon release of 
the NHC, product v is generated.  
Scheme 1.5. Efficient BCA reactions catalyzed by achiral NHC
O 2.5 mol %
2.5 mol % NaOt-Bu



















78% yield, >98:2 dr














70% yield, 88:12 dr





















(6.0 h; 0.5 g scale)
Me
1.9d




 The NHC-catalyzed boryl conjugate addition to a variety of α,β-unsaturated 
carbonyls unveils an entirely new avenue in the realm of catalysis. It is the first transition 
metal-free catalytic transformation to form C–B bonds. A number of Lewis base 
catalyzed protocols to construct C–B, C–Si and C–C bonds were discovered after this 
report. In the next section, focus will be placed on the development of an enantioselective 
version of this transformation and illustrate the knowledge we learned during our studies. 
Scheme 1.6. High efficiency and chemoselectivity in NHC catalyzed BCA reactions
O 2.5 mol %











with 2.5 mol % CuOt-Bu: <2% conv
O
2.5 mol % im-4










X-ray structure of 1.14
with 2.5 mol % CuOt-Bu: 31% yield, >98:2 dr of 1.14
and 19% conv to benzaldehyde diboration
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1A.2.3. Boryl Conjugate Additions Catalyzed by Phosphine/alkoxide 	   In 2010, Fernández and co-workers reported the first phosphine-promoted boron 
conjugate additions to α,β-unsaturated ketones and esters.15  As shown in Scheme 1.8, 
PPh3 or dppf is used to promote the reaction at 70 ºC. Excess methanol and base 
(Cs2CO3) prove to be essential for high efficiency similar to the report from our group.10 
PPh3 is more effective than the more sizable dppf. Cyclohexenone, a single case of a 
cyclic enone, requires a longer reaction time (16 h) for high conversion (1.9a, Scheme 
1.8). 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
























































Scheme 1.8. Boryl conjugate additions performed with achiral phosphines
1.1 equiv. B2(pin)2, 15 mol % Cs2CO3,
5.0 equiv. MeOH, thf, 70 °C, 6 h
4.0 mol % PPh3 or dppf
with PPh3: >98% conv, 86% yield
with dppf: 70% conv, yield nr
with PPh3: 54% conv, yield nr
with dppf: 55% conv, yield nr
with PPh3: >98% conv, 81% yield
with dppf: 69% conv, yield nr










	   In	  the	  same	  study,	  a variety of chiral phosphines were examined and (R)-binap or 
(R)-(S)-josiphos 1.20 was found to be optimal. However, the method usually delivered 
products with low enantioselectivity (Scheme 1.9). 
 
A mechanistic study by the same group showed that ion pair 1.21 derived from 
addition of a methoxy group to B2(pin)2 and conjugate addition of PMe3 to an enone can 
be detected spectroscopically (Scheme 1.10).16 DFT calculations of the reaction were 
carried out subsequently. As shown in Scheme 1.10, a transition structure was proposed, 
in which an α-carbonyl proton serves as a connector for a four-component ensemble. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(16) Pubill-Ulldemolins, C.; Bonet, A.; Gulyás, H.; Bo, C.; Fernández, E. Org. Biomol. Chem. 2012, 10, 
9677–9682. 
1.1 equiv. B2(pin)2, 15 mol % Cs2CO3,
5.0 equiv. MeOH, thf, 70 °C, 6 h
4.0 mol % R-binap or R,S-josiphos
with R-binap: >98% conv, 80% yield, 81.5:18.5 er






with R-binap: >98% conv, 89% yield, 76:24 er
with 1.20: 61% conv, yield nr, 91:9 er
with R-binap: 63% conv, yield nr, 77:23 er
with 1.20: 42% conv, yield nr, 76:24 er
MePh
O B(pin)
with R-binap: 75% conv (16 h), yield nr, 77:23 er
with 1.20: 62% conv (16 h), yield nr, 68:32 er
O
B(pin)















Based on the proposed mechanism, Fernández and co-workers in the same report 
developed phosphine promoted base-free BCAs to α,β-unsaturated carbonyls (Scheme 
1.11). In the presence of PCy3 and MeOH without any additional base such as Cs2CO3, 
the BCA reactions are efficient delivering β-boryl ketones and esters in high yields, 
except the acyclic one bearing a quaternary carbon center (1.23). 
 

















11B NMR: 1.3  35.0 ppm 31P NMR: 30.4 ppm




















MeOH, 70 ºC, 6 h




















1.17 1.9e 1.9f 1.23
Scheme 1.11. Phosphine-catalyzed boryl conjugate additions performed in methanol
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methoxide catalyzed BCA. Verkade’s base was employed instead of phosphine, as shown 
in Scheme 1.12.17 The reactions, however, require 15 mol % catalyst loading (vs 5 mol % 
PCy3) and longer reaction time (24 h vs 6 h). In addition to B2(pin)2, B2(cat)2 (cat = 
catechol) can be used as a diboron reagent delivering the corresponding product in high 
conversion (1.24, Scheme 1.12). This report shows that the Lewis base catalyst in the 
phosphine assisted BCAs mentioned above is the methoxide anion rather than the 
phosphine itself. 
 
Fernández and co-workers have shown that methoxide can promote diboron 
additions to unactivated alkyl-substituted alkenes. 18  As shown in Scheme 1.13, in 
addition to monosubstituted alkenes, disubstituted alkenes (E and Z isomers) as well as an 
allene are suitable substrates. When styrene was employed, the reaction suffered from 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(17) Pubill-Ulldemolins, C.; Bonet, A.; Bo, C.; Gulyás, H.; Fernández, E. Chem. Eur. J. 2012, 18, 1121–
1126. 
(18) Bonet, A., Pubill-Ulldemolins, C.; Bo, C.; Gulyás, H.; Fernández, E. Angew. Chem., Int. Ed. 2011, 50, 


































Scheme 1.12. Verkade base-promoted boryl conjugate additions
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competitive protoboration reaction. 
 
In addition to reactions of diboron reagent with unsaturated carbonyls and 
alkenes, Fernández and co-workers reported that phosphine can catalyze the reaction of 
B2(pin)2 with aryl- and alkyl-substituted N-tosylimines to produce α-amino boronic 
esters, as shown in Scheme 1.14.19 Reactions with PPh3 were carried out at 70 ºC, while 
(R)-(R)-Walphos (CF3) can be used to deliver products with 62:38 er to 95:5 er (at 45 ºC). 
Both Cs2CO3 and MeOH were required for high efficiency of reactions as well as the 
phosphine (the reaction proceeds to 70% conv without PPh3). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(19) Solé, C.; Gulyás, H.; Fernández, E. Chem. Commun. 2012, 48, 3769–3771. 
1.26 1.27
Scheme 1.13. Alkoxide-catalyzed diboration reactions with non-activated olefins and an allene
5.0 equiv. MeOH, thf, 70 °C, 6 h n-Hex
B(pin)
98% conv, >98% diboron addition,
71% yield
n-Hex




85% conv, >98% diboron addition,




74% conv, 96% diboron addition,






92% conv, 95% diboron addition,
syn:anti = 5:95, 69% yield
Me
B(pin)
5.0 equiv. MeOH, thf, 45 °C, 20 h
B(pin)
95% conv, 92% diboron addition,
76% yield
Cy •






1A.2.4. Reactions Promoted by Other Lewis Bases 
 Ohmura, Suginome and co-workers reported in 2012 a method for 1,4-diboron 
additions of pyrazines, as shown in Scheme 1.15.20 The reactions proceed without any 
additional base and products were isolated in 77–96% yield. The mechanism begins with 
a pyrazine nitrogen coordinating to one of the boron atoms in B2(pin)2. Subsequent 
nucleophilic addition of the uncoordinated B(pin) unit to the C2 carbon of pyrazine 
followed by an intramolecular rearrangement produces the 1,4-diboron pyrazine. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(20) Oshima, K.; Ohmura, T.; Suginome, M. Chem. Commun. 2012, 48, 8571–8573.  
Scheme 1.14. Alkoxide catalyzed boron additions to tosylimines
1.2 equiv B2(pin)2, 15 mol % Cs2CO3,
2.5 equiv MeOH, thf, 45 or 70 °C, 15 h





with PPh3 (70 °C): 91% conv, 78% yield







with PPh3 (70 °C): 84% conv, 62% yield




with PPh3 (70 °C): >98% conv, 82% yield








In 2013, Zhang and co-workers used a Lewis base activation of a B–B bond 
strategy to effect borylation of aryl iodides (Scheme 1.16).21 In the presence of 2.0 equiv 
of Cs2CO3 in refluxing methanol after 20–48 h, the desired aryl-B(pin) compounds with 
an electron-withdrawing or donating can be isolated in moderate to good yields. The 
mechanism of the reaction is unclear; however, preliminary mechanistic study shows that 
the reaction is not copper-catalyzed or proceeds through a radical pathway. 
Morken and co-workers reported an alkoxide-catalyzed directed diboron addition 
to homoallylic alcohols (Scheme 1.17a).22 In the presence of Cs2CO3 and methanol, the 
reactions are efficient delivering a variety of triol products (products after oxidation) after 
6–12 hours at 70 ºC and with high diastereoselectivity. The diborylation reaction is 
scalable. For example, compound 1.46 can be isolated with similarly high efficiency and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(21) Zhang, J.; Wu, H.-H.; Zhang, J. Eur. J. Org. Chem. 2013, 6263–6266.   
(22) Blaisdell, T. P.; Caya, T. C.; Zhang, L.; Sanz-Marco, A.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 
9264–9267.   
N N + B B
O
O O
O thf, 22 ºC, 2 h N N(pin)B B(pin)
1.36 1.37
93% yield(1.1 equiv)







Scheme 1.15. 1,4-Diboration of pyrazine
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stereoselectivity on a 5 gram scale. Low diastereoselectivity when a trishomoallylic 
alcohol (1.52, 1:1 dr) was used suggests that the hydroxyl unit is too far to be able to 
direct diboron addition effectively. 
A mechanism was proposed based on several experimental supports that the 
alkoxide in the substrate activates B2(pin)2 to initiate diboron addition. A stereochemical 
model also explains the observed syn selectivity of the diborylation (Scheme 1.17b). 
 
Hirano, Uchiyama, and co-workers disclosed trans-diboryl additions to 
propargylic alcohols (Scheme 1.18). 23 Treatment of a propargylic alcohol with one 
equivalent of n-BuLi followed by the addition of B2(pin)2 allows the formation of the 
corresponding trans-diborylated products after 24 h at 75 °C. A range of propargylic 
alcohols can be used as substrates. In addition, a dissymmetrical diboron [(pin)B–B(dan), 
(dan) = naphthalene-1,8-diaminato] could be employed in the reaction as well, delivering 
the product bearing the B(dan) unit selectively (Scheme 1.18a). 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  





O 2.0 equiv Cs2CO3


























DFT calculations were performed to provide insight into mechanism of the 
reaction (Scheme 1.18b). The initial complexation of diboron reagent and lithium 
propargylic alkoxide is likely to occur prior to the first C–B bond formation (activation 
energy = +23.2 kcal/mol). The second C–B bond formation is proposed to be more 
energetically favored (activation barrier = +2.1 kcal/mol) leading to the observed trans 
diboron addition product. 
Scheme 1.17. Hydroxyl-directed diastereoselective diboron additions to alkenes
30 mol % Cs2CO3, 2.0 equiv B2(pin)2
17 equiv MeOH, thf, 70 °C, 6–12 h
84% yield, 17:1 dr
 (5 g scale)
a) Hydroxyl-directed stereoselective diboron additions to alkenes






























70% yield, 6:1 dr
OH
OH































Another set of transformations involves the activation of a B–B bond by a diazo 
intermediate reported by Wang and co-workers (Scheme 1.19).24 Tosylhydrazones can be 
converted to alkyl–B(pin) through reactions with B2(pin)2. Aryl-substituted 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(24) Li, H.; Wang, L.; Zhang, Y.; Wang, J. Angew. Chem., Int. Ed. 2012, 51, 2943–2946.   
Scheme 1.18. Alkoxide-activated trans-diboron additions to propargylic alcohols
1) 1.0 equiv n-BuLi,thf, –78 ! 22 °C, 30 min
77% yield
a) trans-Diborylation of propargylic alcohols















































































"G = –8.5 kcal/mol
"G = –2.4 kcal/mol
"G  = +23.2 kcal/mol
First C–B bond formation










"G = –32.6 kcal/mol
"G  = +2.1 kcal/mol















tosylhydrazones, including those with an electron-rich, electron-poor or B(pin) 
substituent, as well as alkyl tosylhydrazones can serve as suitable substrates (Scheme 
1.19a). There is, however, minimal conversion to the desired products with the ketone-
derived substrates under the same conditions. Based on the hypothesis that the lower 
reactivity of ketones might be due to the sizeable B2(pin)2, reactions with the smaller 
HB(pin) were examined and indeed proceeded to generate products with a secondary C–
B bond more efficiently.  It was proposed that the transformation starts with in situ 
generation of a diazo compound, which then coordinates to B2(pin)2 followed by a 1,2-
migration (Scheme 1.19b). The diboron intermediate would then be converted to the 
alkyl–B(pin) product by a proto-deboration process in the presence of NaOMe and 




1A.3. NHC-catalyzed Enantioselective Boryl Conjugate Additions to 
Generate Boron Substituted Tertiary Carbon Stereogenic Centers 
1A.3.1. Initial Studies 
 We began by employing similar conditions used for non-enantioselective BCAs 
with enone 1.76 except a chiral imidazolinium salt (im-5) was used.10 There was hardly 
any product formation after 14 h (Scheme 1.20a). We reasoned that it might be because 
the sterically hindered chiral NHC cannot coordinate effectively with B2(pin)2. As shown 
in Scheme 1.20b, we proposed that if one of the sizable pinacol units is replaced to a 
Scheme 1.19. Alkoxide-promoted reactions of tosylhydrazones and B2(pin)2 or HB(pin)
1.70
NNHTs
2.0 equiv NaOMe, 2.0 equiv MeOH
1.2 equiv B2(pin)2, toluene, 90 °C, 3–12 h
B(pin)
63% (GC) yield
















































1.72 1.73 1.74 1.75
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smaller alkoxide group such as methoxide, the boron center would become more 
accessible and allow effective association of the chiral NHC. We then added 20 equiv of 
MeOH into the reaction mixture (Scheme 1.20c). Indeed, there was 24% conv to the 
desired product, which was formed with appreciable enantioselectivity (87:13 er). When 
we switched the base to dbu (1,8-diazabicyclo[5.4.0]-undec-7-ene), higher conversion 
was observed with slightly increased er value (47% conv, 92:8 er) indicating that in the 
reaction with NaOt-Bu, there was some catalysis by an achiral Lewis base (likely the 
methoxide) causing lower enantioselectivity. We found that increasing the amount of 
MeOH to 60 equiv gave 82% yield of the product with 92:8 er. 25 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(25) Wu, H.; Radomkit, S.; O’Brien, J. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 8277–8285.  
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1A.3.2. NHC Screening for Catalytic Enantioselective BCA Reactions 
 With similar reaction conditions (use of dbu and MeOH), we have tried a variety 
of chiral imidazolinium salts, the results are summarized in Table 1.1. The sulfonate-
containing NHC (derived from im-6, entry 1) promotes the BCA reaction generating the 
product in 48% conv, but with low enantioselectivity (47:53 er).  We turned our attention 
to using a monodentate NHC as a catalyst. With the monophenyl backbone NHC derived 
from im-7, only 30% conv is observed with 31:69 er. When we switched to monodentate 
NHCs that contain a biphenyl backbone, there was dramatic improvement in 






















with 7.5 mol % NaOt-Bu + 20 equiv. MeOH:  24% conv, 87:13 er
with 20 mol % dbu + 20 equiv. MeOH: 47% conv, 92:8 er
with 20 mol % dbu + 60 equiv. MeOH: 87% conv, 82% yield, 92:8 er




c) Validation of hypothesis
1.1 equiv B2(pin)2,
weak Lewis base, MeOH,
























enantioselectivity (up to 81:19 er, entries 4–5) although the conversions are still low. A 
methyl substituent at the ortho position of the unsymmetric N-aryl motif (im-11, entry 6) 
diminishes both efficiency and selectivity. However, reactions with NHCs that contain a 
meta-substituent proceed with higher conversion (82% and 78% conv, entries 7 and 8, 
respectively). After modifications of the NHCs structure, we found that the NHC-derived 
from im-16 promotes the BCA reaction efficiently and selectively (81% conv and 95:5 
er, entry 11). Again, increasing the amount of MeOH (60 equiv) improves reaction 




entry imidazolinium salt conv (%)b erc
5.0 mol % imidazolinium salt
20 mol % dbu, 1.1 equiv B2(pin)2,
20 equiv MeOH, thf, 22 ºC, 14 h;
NH4Cl (aq) workup
Table 1.1. Examination on various chiral NHC catalystsa
a Reactions were performed under N2 atmosphere. b Conversions to the desired product were 
determined by analysis of 400 MHz 1H NMR spectra of unpurified mixtures. c Determined by HPLC 













im-17 R = H, G = Ph
im-5 R = Me, G = Ph






im-12 R = Me, G = Ph
im-13 R = i-Pr, G = Ph
im-14 R = H, G = Cy
im-15 R = H, G = Mes






im-8 R = H, Ar = Mes 
im-9 R = H, Ar = 2,6-(Et)2C6H3











































































im-11 Ar = 2,6-(Et)2C6H3
Me
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1A.3.3. Catalytic Enantioselective BCA Reactions to α ,β-Unsaturated Acyclic Ketones 
 With the optimized reaction conditions in hand, various acyclic α,β-unsaturated 
ketones were examined (Scheme 1.21). The BCA reactions are quite general delivering 
good yield and enantioselectivity of products containing electron-donating or electron-
withdrawing groups on the aryl substituent as well as a hetero-aryl substituent. Reaction 
with a substrate bearing an ortho-methyl phenyl substituent requires higher temperature 
(50 ºC) to proceed to 95% conv (~15% conv at 22 ºC), but with diminished 
enantioselectivity (1.81, 90% yield, 85.5:14.5 er). The NHC-catalyzed enantioselective 
BCA reaction accommodates enones with alkyl substituents with high efficiencies (1.82–
1.83) and enantioselectivities (up to 94.5:5.5 er). The reaction with trans-chalcone is 
slightly slower; however, with a higher amount of dbu, the reaction proceeds to complete 
conversion (vs 82% conv with 20 mol% dbu). The reason why increasing the amount of 
dbu facilitate BCA processes is that deprotonation of the imidazolinium salt as well as 
MeOH hydrolysis of B2(pin)2 requires an excess amount of base, therefore more dbu 
means higher efficiency of the processes that will result in higher conversion. 
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 The strategy of using higher amount of dbu can be applied to other substrates that 
are not effective. As shown in Scheme 1.22, with 1.0 equiv of dbu, the desired products 
are generated in much higher yields and in some cases, with higher enantioselectivity. 
The enhancement in selectivity suggests that at a lower concentration of dbu, there is 
probably incomplete deprotonation of imidazolinium salt to form NHC as well as a lower 
concentration of a partially methanolyzed diboron species [(MeO)2B–B(pin)]. The 
background reaction promoted by a methoxide is then more competitive causing lower 
enantioselectivity of the products. 
Scheme 1.21. NHC-catalyzed enantioselective BCA to acyclic enones
1.1 equiv. B2(pin)2, 20 mol % dbu,
60 equiv. MeOH, thf, 22 °C, 14 h
5.0 mol %
>98% conv, 92% yield,
96:4 er





75% conv, 73% yield,
92:8 er
Me
>98% conv, 80% yield,
93.5:6.5 er



































>98% conv, 93% yield,
94:6 er
1.83





94% conv, 90% yield,
90:10 er









1A.3.4. Catalytic Enantioselective BCA Reactions to α ,β-Unsaturated Acyclic Esters 
 α,β-Unsaturated esters or enoates are as well suitable substrates in the NHC-
catalyzed enantioselective BCA reactions. As shown in Scheme 1.23, methyl esters 
(1.90–1.92) as well as a more sizable tert-butyl ester (1.93) proceed to generate β-boryl 
esters in 62–87% yield and 94:6 to 98:2 er. Although, in some cases (1.91 and 1.93), a 
higher temperature is required for high reactivity. For 1.91, we used 7.5 mol % of im-16 
and quenched the reaction after 10 h to minimize the proto-deboration of the product. 
1.1 equiv B2(pin)2, 60 equiv MeOH





O B(pin)5.0 mol % im-16
20 or 100 mol % dbu




with 20 mol % dbu:
27% conv, 18% yield, 98:2 er
with 100 mol % dbu:




with 20 mol % dbu:
34% conv, 19% yield, 91:9 er
with 100 mol % dbu:




with 20 mol % dbu:
60% conv, 43% yield, 92:8 er
with 100 mol % dbu:
90% conv, 62% yield, 93:7 er
Me
O B(pin) with 20 mol % dbu:
75% conv, 73% yield, 92:8 er
with 100 mol % dbu:
>98% conv, 82% yield, 94:6 erO
O B(pin) with 20 mol % dbu:
82% conv, 72% yield, 93.5:6.5 er, 18 h
with 100 mol % dbu:






1A.3.5. Catalytic Enantioselective BCA Reactions to α ,β-Unsaturated Weinreb Amides 
 We examined our BCA reactions with α,β-unsaturated Weinreb amides26 to 
obtain synthetically useful β-boryl amides. Weinreb amides are generally less effective 
substrates. Thus, higher reaction temperatures and/or longer reaction times are required. 
The scope of the reactions is shown in Scheme 1.24. Substrates bearing aryl- or alkyl-
substituent are both effective and proceed to afford the desired products in 60–92% yield 
and 86.5:13.5–95:5 er. In certain cases, less MeOH (30 equiv) was used to minimize 
proto-deboration and/or formation of β-boryl methyl esters (1.95–1.96). 
To the best of our knowledge, there is only one example of enantioselective BCA 
reaction to a Weinreb amide. 27 However, this method is Cu-catalyzed rendering our 
metal-free protocol an attractive strategy to access these versatile entities. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(26) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815–3818.  
(27) Hirsch-Weil, D.; Abboud, K. A.; Hong, S. Chem. Commun. 2010, 46, 7525–7527. 
Scheme 1.23. NHC-catalyzed enantioselective BCA reactions to enoates
MeO n-pentyl
O B(pin)
5.0 mol % im-16, 20 mol % dbu

















>98% conv, 62% yield,
94:6 er
(7.5 mol % im-16, 50 ºC, 10 h)
MeO Ph
O
1.1 equiv B2(pin)2, 60 equiv MeOH




1A.3.6. Catalytic Enantioselective BCA Reactions to α ,β-Unsaturated Aldehydes 
 As discussed earlier in the context of reactions with achiral NHC, 
chemoselectivity is problematic with Cu-catalyzed variants in the presence of aldehydes 
(1,2- vs 1,4-addition). However, there has been a single example on an enantioselective 
NHC–Cu-catalyzed BCA reaction of cinnamaldehyde although the desired product was 
obtained in low enantioselectivity (86% conv, yield not reported, 70:30 er).28 In addition, 
a report by Ibrahem and co-workers on a Cu-catalyzed protocol to in situ generated 
unsaturated iminiums, an important strategy to access β-boryl aldehyde 
enantioselectively appeared in 2011.29 However, the use of an air- and moisture-sensitive 
Cu(OTf)2 and a Brønsted acid (o-FC6H4CO2H) is required. With these limitations, we 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(28) Lillo, V.; Prieto, A.; Bonet, A.; Díaz-Requejo, M. M.; Ramírez, J.; Pérez, P. J.; Fernández, E. 
Organometallics, 2009, 28, 659–662.  
(29) Ibrahem, I.; Breistein, P.; Córdova, A. Angew. Chem., Int. Ed. 2011, 50, 12036–12041. 
Scheme 1.24. NHC-catalyzed enantioselective BCA reactions to unsaturated Weinreb amides
N n-pentyl
O B(pin)
77% conv, 74% yield,
95:5 er





67% conv, 60% yield,
95:5 er






>98% conv, 70% yield,
94:6 er







96% conv, 92% yield,
93:7 er










7.5 mol % im-16, 30 mol % dbu
1.1 equiv B2(pin)2, MeOH, thf
50 or 66 ºC, 10–36 h
1.94 1.95
86% conv, 61% yield
86.5:13.5 er





78% conv, 73% yield,
95:5 er





then pursued our NHC-catalyzed enantioselective BCA reactions with α,β-unsaturated 
aldehydes.  
 
 As shown in Scheme 1.25, the BCA reactions with alkyl-substituted enals are 
highly efficient (≥95% conv) and enantioselective (94:6–95:5 er). Due to the instability 
of β-boryl aldehydes on silica gel, there was discrepancy between conversions and yields 
after isolation (63–72% yield). Reaction with aryl-substituted unsaturated aldehydes (for 
example, cinnamaldehyde) results in a complex mixture probably due to reaction of an 
NHC with carbonyl unit forming a Breslow intermediate, as well as methoxide conjugate 
additions to unsaturated aldehydes (a byproduct also observed in the BCA reactions to 
alkyl-substituted enals). 
1A.3.7. Functional Group Compatibilities of NHC-catalyzed Enantioselective BCA 
Reactions 
Scheme 1.25. NHC-catalyzed enantioselective BCA reactions to enals
5.0 mol % im-16, 20 mol % dbu







1.1 equiv B2(pin)2, 60 equiv MeOH
thf, 22 ºC, 14 h; 
NH4Cl (aq) workup
>98% conv, 65% yield
95:5 er




















 In the Scheme 1.26, NHC-catalyzed enantioselective BCA reactions and the 
previously reported phosphine–Cu-catalyzed protocols30 were tested in comparison in the 
presence of an equivalent of an additive. For the reaction with 1.76 without any additive, 
both methods are equally effective (>98% conv, 92–93% yield), although the 
enantioselectivity of the Cu-catalyzed reaction is slightly lower (85:15 er) likely because 
the optimal ligand is not Josiphos for this particular substrate. Addition of phenol does 
not affect the NHC-catalyzed protocol; however, the reaction is significantly slower in 
the phosphine–Cu-catalyzed reaction. This is probably due to inefficient reaction of 
phosphine–Cu-OPh with B2(pin)2 compared to phosphine-Cu-Ot-Bu complex.  
 
 In the presence of benzaldehyde, both protocols proceeded with diminished 
efficiency. However, the NHC-catalyzed one proceeded to 54% conv (65% conv with 
higher catalyst loading and temperature), while the Cu-catalyzed alternative suffered 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(30) (a) Lee, J.-E.; Yun, J. Angew. Chem., Int. Ed. 2008, 47, 145−147. (b) Sim, H.-S.; Feng, X.; Yun, J. 










1.1 equiv B2(pin)2, 20 mol % dbu, 





















3.0 mol % (R,S)-Josiphos
3.0 mol % CuCl, 3 mol % NaOt-Bu
1.1 equiv B2(pin)2, 1.0 equiv MeOH 












Method A Method B










(7.5 mol %, 50 ºC)
•




much more (only 16% conv). As mentioned before, NHC may reversibly react with 
benzaldehyde, forming a Breslow-type intermediate, but the Cu–B(pin) addition to the 
carbonyl moiety of the aldehyde is very efficient. Perhaps the most obvious example of 
chemoselectivity obtained from the NHC-catalyzed BCAs is when an equivalent of allene 
1.107 was added. The reaction promoted by a chiral NHC proceeded to afford the desired 
product (74% yield, 93:7 er with 7.5 mol % catalyst at 50 °C). In contrast, the Cu-
catalyzed reaction led to a complex mixture without any detectable product formation. 
This is probably because the Cu–B(pin) reacts efficiently with an allene.31 
 
 Another set of examples for demonstration of the functional group compatibility, 
we prepared substrates bearing an alkyne group. The NHC-catalyzed reactions proceed 
with high efficiency and enantioselectivity (71–80% yield, 94:6–95:5 er). While in the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(31) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 1490−1493. 














1.1 equiv B2(pin)2, 20 mol % dbu, 




3.0 mol % (R,S)-Josiphos
3.0 mol % CuCl, 3 mol % NaOt-Bu
1.1 equiv B2(pin)2, 1.0 equiv MeOH 
thf, 22 ºC, 24 h

















Cu-catalyzed protocol again suffers from reaction of the Cu–B(pin) with alkyne or 
aldehyde moiety.32 
1A.4. Conclusions 
 The enantioselective NHC-catalyzed boryl conjugate addition reactions can be 
used to access a range of β-boryl carbonyls including ketones, esters, Weinreb amides 
and aldehydes. The metal-free strategy offers complementary reactivity and selectivity 
profiles to the previously reported Cu-catalyzed alternatives and thus rendering its 
potential utility in chemical synthesis. In addition, the finding relates to the critical role of 
methanol in the enantioselective BCAs (vs reactions with achiral NHCs) will be 
beneficial for other methods involving diboron reagents and sterically hindered chiral 
catalysts. 
1A.5. Experimental Section 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm-1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: 7.26 ppm). Data are reported 
as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet), and coupling constants (Hz). 13C NMR spectra were recorded 
on a Varian Unity INOVA 400 (100 MHz) spectrometer with complete proton 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(32) For catalytic hydroborations of alkynes, which involve Cu−B additions, see: (a) Takahashi, K.; 
Ishiyama, T.; Miayura, N. J. Organomet. Chem. 2001, 625, 47−52. (b) Lee, J.-E.; Kwon, J.; Yun, J. Chem. 
Commun. 2008, 44, 733−734. (c) Kim, H. R.; Jung, I. G.; Yoo, K.; Jang, K.; Lee, E. S.; Yun, J.; Son, S. U. 
Chem. Commun. 2010, 46, 758−760. (d) Kim, H. R.; Yun, J. Chem. Commun. 2011, 47, 2943− 2945. (e) 
Jang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7859−7871. 
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decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance as the internal standard (CDCl3: 77.16 ppm). 11B NMR were recorded on a 
Varian Unity INOVA 500 (128 MHz) with BF3•OEt2 resonance as the external reference 
(d8-thf: 0.0 ppm). High-resolution mass spectrometry was performed on a Micromass 
LCT ESI-MS (positive mode) at the Mass Spectrometry Facility, Boston College. 
Enantiomeric ratios were determined by GLC analysis (Alltech Associated Chiraldex 
GTA column (30 m x 0.25 mm), Chiraldex B-DM (30 m x 0.25 mm) and Chiraldex aTA 
(30 m x 0.25 mm)) and HPLC analysis (high-performance liquid chromatography) with a 
Shimadzu chromatograph (Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral 
Technologies Chiralcel OD-H (4.6 x 250 mm), Chiral Technologies Chiralpak AS-H (4.6 
x 250 mm) or Chiral Technologies Chiralpak AD-H (4.6 x 250 mm)) in comparison with 
authentic racemic materials. Specific rotations were measured on a Rudolph Research 
Analytical Autopol IV Polarimeter.  
 Unless otherwise noted, reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 ºC) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Tetrahydrofuran (Aldrich Chemical Co.) 
was purified by distillation from sodium benzophenone ketyl immediately prior to use. 
Methanol (Acros Organics 99.9% Extra Dry, AcroSeal@) was used as received. All work-
up and purification procedures were carried out with reagent grade solvents (purchased 
from Fisher Scientific) under air.  
n  Reagents: 
Bis(pinacolato)diboron [B2(pin)2]: gifts from Frontier Scientific Inc., recrystallized 
from pentane and dried under vacuum prior to use.  
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1,8-Diazabicyclo[5.4.0]undec-7-ene (dbu): purchased from Aldrich Chemical Co. and 
purified by distillation from CaH2 prior to use.  
(E)-4-Phenylbut-3-en-2-one (1.76): purchased from Aldrich Chemical Co., purified by 
recrystallization in pentane and dried under vacuum prior to use.  
(E)-4-(4-Methoxyphenyl)but-3-en-2-one (substrate for 1.78): purchased from Aldrich 
Chemical Co. and used as received.  
(E)-4-(Furan-2-yl)but-3-en-2-one (substrate for 1.80): purchased from Aldrich 
Chemical Co., purified by chromatography and dried under vacuum prior to use. 
(E)-Non-3-en-2-one (substrate for 1.82): purchased from Aldrich Chemical Co. and 
purified by distillation from CaH2 prior to use.  
(E)-5-Methylhex-3-en-2-one (substrate for 1.83): purchased from Aldrich Chemical 
Co. and purified by distillation from CaH2 prior to use.  
(E)-Chalcone (substrate for 1.86): purchased from Aldrich Chemical Co., purified by 
chromatography and dried under vacuum prior to use.  
Methyl cinnamate (1.89): purchased from Aldrich Chemical Co., purified by 
chromatography and dried under vacuum prior to use.  
(E)-Methyl 3-(4-bromophenyl)acrylate (substrate for 1.91): purchased from Aldrich 
Chemical Co., purified by chromatography and dried under vacuum prior to use.  
(E)-Methyl oct-2-enoate (substrate for 1.92): purchased from Aldrich Chemical Co. 
and purified by distillation from CaH2 prior to use.  
tert-Butyl cinnamate (1.82d): purchased from Aldrich Chemical Co., purified by 
chromatography and dried under vacuum prior to use. 
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(E)-Hex-2-enal (1.101): purchased from Aldrich Chemical Co. and purified by 
distillation from CaH2 prior to use.  
(E)-4-Methylpent-2-enal (substrate for 1.105): purchased from Acros Organics and 
purified by distillation from CaH2 prior to use.  
Other α ,β-unsaturated carbonyls: prepared according to Wittig olefinations of the 
corresponding aldehydes, which were purchased from Aldrich Chemical Co. and used as 
received. 
n  Representative Experimental Procedure for NHC–Catalyzed Enantioselective 
(Pinacolato)boron Conjugate Addition:	   In a glovebox, an oven-dried vial (8 x 1 cm) 
equipped with a stir bar was charged with a solution of NHC, which was prepared from  
im-16 (11 mg, 0.017 mmol), dbu (10 mg, 0.066 mmol), and thf (0.47 mL, 0.036 M 
solution of catalyst) for 30 min at 22 °C under a dry N2 atmosphere. 
Bis(pinacolato)diboron (93 mg, 0.37 mmol), (E)-4-phenylbut-3-en-2-one (1.76) (49 mg, 
0.33 mmol) and methanol (0.80 mL) were added to the vial (0.26 M solution of 
substrate), which was sealed with a cap before removal from the glovebox. The mixture 
was allowed to stir at 22 °C for 14 h, after which the reaction was quenched by the 
addition of an aqueous solution of NH4Cl (1.0 mL, 0.7 M) and the mixture was allowed 
to stir for an additional 20 min. The aqueous layer was washed with diethyl ether (3 x 5 
mL). The combined organic layers were dried over anhydrous MgSO4 and filtered. The 
volatiles were removed under vacuum and the resulting light yellow oil was purified by 
silica gel chromatography (hexanes:Et2O = 10:1) to afford 84 mg (0.31 mmol, 92% yield) 
of (R)-4-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one (1.77) as a 
colorless oil. (R)-4-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-
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one (1.77): The spectroscopic data match those reported previously.33 1H NMR (400 
MHz, CDCl3): δ 7.26–7.18 (4H, m), 7.14–7.10 (1H, m), 3.02 (1H, dd, J = 18.4, 10.8 Hz), 
2.82 (1H, dd, J = 18.4, 5.6 Hz), 2.62 (1H, dd, J = 10.8, 5.6 Hz), 2.12 (3H, s), 1.20 (6H, s), 
1.14 (6H, s); Specific Rotation: [α]D20 –34.2 (c 1.06, CHCl3) for an enantiomerically 
enriched sample of 96:4 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (96:4 er shown; Chiralpak AS-H column, 
98/2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.689 50.213 1 15.632 95.776 
2 16.972 49.787 2 16.899 4.224 
Proof of Stereochemistry: The corresponding (R)-4-hydroxy-4-phenylbutan-2-one was 
obtained after oxidation of 1.77, the spectroscopic data match those reported previously.33 
Specific Rotation of (R)-4-hydroxy-4-phenylbutan-2-one: [α]D20 +64.3 (c 0.83, CHCl3). 
Literature value ([α]D20 –49.0 (c 0.52, CHCl3), 89.5:10.5 er) is assigned to the (S) 
enantiomer.33 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(33) Sim, H.-S.; Feng, X.; Yun, J. Chem. Eur. J. 2009, 15, 1939–1943 
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(E)-4-(o-Tolyl)but-3-en-2-one (substrate for 1.81): The spectroscopic data match those 
reported previously.34 1H NMR (400 MHz, CDCl3): δ 7.79 (1H, d, J = 16.4 Hz), 7.55–
7.53 (1H, m), 7.28–7.17 (3H, m), 6.62 (1H, d, J = 16.4 Hz), 2.42 (3H, s), 2.36 (3H, s).  
(R)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(o-tolyl)butan-2-one (1.81): IR 
(neat): 2976 (m), 1713 (s), 1356 (s), 1318 (s), 1259 (m), 1214 (m), 1165 (m), 1140 (s), 
1012 (w), 966 (m), 852 (m), 771 (m), 754 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.17–7.00 (4H, m), 3.00 (1H, dd, J = 17.6, 10.4 Hz), 2.85 (1H, dd, J = 10.4, 4.8 Hz), 2.74 
(1H, dd, J = 17.6, 4.8 Hz), 2.33 (3H, s), 2.12 (3H, s), 1.20 (6H, s), 1.14 (6H, s); 13C NMR 
(100 MHz, CDCl3): δ 208.5, 140.1, 136.2, 130.4, 127.6, 126.0, 125.4, 83.3, 46.9, 29.6, 
24.5, 24.5, 20.0; HRMS (ESI+): Calcd for C17H26B1O3 [M+H]+: 289.1975, Found: 
289.1977. Specific Rotation: [α]D20 –18.7 (c 1.07, CHCl3) for an enantiomerically 
enriched sample of 85.5:14.5 er. Enantiomeric purity was determined by HPLC analysis 
in comparison with authentic racemic material (85.5:14.5 er shown; Chiralcel OD-H 
column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 25.820 48.956 1 25.791 85.556 
2 29.986 51.044 2 30.010 14.444 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(34) Cá, N. D.; Motti, E.; Mega, A.; Catellani, M. Adv. Synth. Catal. 2010, 352, 1451–1454. 
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(R)-4-(4-Methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-
one (1.78): The spectroscopic data match those reported previously.35 1H NMR (400 
MHz, CDCl3): δ 7.13–7.09 (2H, m), 6.80–6.76 (2H, m), 3.75 (3H, s), 2.96 (1H, dd, J = 
18.2, 10.6 Hz), 2.78 (1H, dd, J = 18.2, 5.6 Hz), 2.56 (1H, dd, J = 10.6, 5.6 Hz), 2.11 (3H, 
s), 1.20 (6H, s), 1.15 (6H, s); Specific Rotation: [α]D20 –29.1 (c 1.07, CHCl3) for an 
enantiomerically enriched sample of 94:6 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (94:6 er shown; Chiralcel 
OD-H column, 98/2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 23.666 50.215 1 24.058 94.084 
2 25.844 49.785 2 26.278 5.916 
(E)-4-(4-Bromophenyl)but-3-en-2-one (substrate for 1.79): The spectroscopic data 
match those reported previously.36 1H NMR (400 MHz, CDCl3): δ 7.52 (2H, d, J = 8.4 
Hz), 7.43 (1H, d, J = 16.4 Hz), 7.39 (2H, d, J = 8.4 Hz), 6.68 (1H, d, J = 16.4 Hz), 2.36 
(3H, s). 
(R)-4-(4-Bromophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one 
(1.79): IR (neat): 2957 (m), 2922 (s), 2853 (m), 1707 (m), 1362 (m), 1327 (m), 1142 (m) 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(35) Shiomi, T.; Adachi, T.; Toribatake, K.; Zhou, L.; Nishiyama, H. Chem. Commun. 2009, 5987–5989. 
(36) Stern, T.; Rückbrod, S.; Czekelius, C.; Donner, C.; Brunner, H. Adv. Synth. Catal. 2010, 352, 1983–
1992. 
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cm–1; 1H NMR (400 MHz, CDCl3): δ 7.36 (2H, d, J = 8.4 Hz), 7.09 (2H, d, J = 8.4 Hz), 
2.99 (1H, dd, J = 18.4, 10.4 Hz), 2.81 (1H, dd, J = 18.4, 5.6 Hz), 2.60 (1H, dd, J = 10.4, 
5.6 Hz), 2.14 (3H, s), 1.21 (6H, s), 1.16 (6H, s); 13C NMR (100 MHz, CDCl3): δ 208.1, 
141.0, 131.6, 130.1, 119.5, 83.7, 47.4, 29.8, 24.7; HRMS (ESI+): Calcd for 
C16H23B1Br1O3 [M+H]+: 353.0924, Found: 353.0908. Specific Rotation: [α]D20 –7.2 (c 
0.33, CHCl3) for an enantiomerically enriched sample of 92:8 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (92:8 
er shown; Chiralpak AS-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 18.460 50.801 1 17.310 91.628 
2 20.013 49.199 2 18.669 8.372 
(R)-4-(Furan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one 
(1.80): IR (neat): 2978 (m), 2928 (m), 1714 (s), 1359 (s), 1324 (s), 1165 (s), 1124 (s), 
1008 (m), 850 (m), 727 (m), 799 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.21–7.19 (1H, 
m), 6.19–6.18 (1H, m), 5.95–5.94 (1H, m), 2.95–2.81 (2H, m), 2.70–2.66 (1H, m), 2.08 
(3H, s), 1.19 (6H, s), 1.16 (6H, s); 13C NMR (100 MHz, CDCl3): δ 207.8, 155.1, 140.9, 
110.2, 104.9, 83.7, 44.5, 29.5, 24.6, 24.5; HRMS (ESI+): Calcd for C14H22B1O4 [M+H]+: 
265.1611, Found: 265.1616. Specific Rotation: [α]D20 –2.7 (c 1.10, CHCl3) for an 
enantiomerically enriched sample of 92:8 er. Enantiomeric purity was determined by 
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HPLC analysis in comparison with authentic racemic material (92:8 er shown; Chiralpak 
AS-H column, 99.5/0.5 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 21.709 46.698 1 21.842 7.711 
2 23.101 53.302 2 23.223 92.289 
(S)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)nonan-2-one (1.82): IR (neat): 
2976 (w), 2958 (m), 2925 (m), 1715 (s), 1410 (s), 1379 (s), 1312 (s), 1266 (w), 1244 (w), 
1214 (w), 1143 (s), 968 (m), 857 (m), 670 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 2.53 
(2H, apparent d), 2.08 (3H, s), 1.40–1.34 (1H m), 1.29–1.19 (20H, m), 0.83 (3H, apparent 
t); 13C NMR (100 MHz, CDCl3): δ 209.2, 82.9, 45.8, 31.9, 30.3, 29.6, 28.5, 24.7, 24.6, 
22.5, 14.0; HRMS (ESI+): Calcd for C15H30B1O3 [M+H]+: 269.2288, Found: 269.2279. 
Specific Rotation: [α]D20 +0.8 (c 1.00, CHCl3) for an enantiomerically enriched sample of 
94:6 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (94:6 er shown; Chiralpak AD-H column, 99.8/0.2 hexanes/i-
PrOH, 0.3 mL/min, 300 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.943 49.343 1 15.279 5.619 
2 16.933 50.635 2 15.833 94.387 
(R)-5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-one (1.83): IR 
(neat): 2976 (m), 2958 (m), 1715 (s), 1412 (w), 1371 (s), 1310 (s), 1279 (s), 1214 (m), 
1165 (m), 1142 (s), 1123 (s), 969 (w), 850 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 2.59 
(1H, dd, J = 18.4, 11.2 Hz), 2.48 (1H, dd, J = 18.4, 4.8 Hz), 2.09 (3H, s), 1.71–1.63 (1H, 
m), 1.23–1.13 (13H, m), 0.91–0.88 (6H, m); 13C NMR (100 MHz, CDCl3): δ 209.5, 82.9, 
43.8, 29.7, 28.9, 25.0, 24.9, 24.7, 22.1, 21.6; HRMS (ESI+): Calcd for C13H26B1O3 
[M+H]+: 241.1975, Found: 241.1984. Specific Rotation: [α]D20 +1.2 (c 1.80, CHCl3) for 
an enantiomerically enriched sample of 94:6 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (94:6 er shown; Chiralcel 
OD-H column, 99.9/0.1 hexanes/i-PrOH, 0.3 mL/min, 300 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 17.999 50.558 1 18.647 6.344 
2 19.403 49.442 2 19.442 93.656 
(E)-1-Phenylhept-1-en-3-one (substrate for 1.84): The spectroscopic data match those 
reported previously.37 1H NMR (400 MHz, CDCl3): δ 7.55–7.51 (3H, m), 7.39–7.37 (3H, 
m), 6.73 (1H, d, J = 16.4 Hz), 2.65 (2H, t, J = 7.2 Hz), 1.69–1.61 (2H, m), 1.42–1.33 (2H, 
m), 0.93 (3H, t, J = 7.2 Hz). 
(R)-1-Phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptan-3-one (1.84): IR 
(neat): 2976 (m), 2931 (m), 1709 (s), 1369 (s), 1319 (s), 1280 (m), 1261 (w), 1214 (w), 
1141 (s), 1124 (s), 968 (m), 850 (m), 701 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.25–
7.18 (4H, m), 7.14–7.10 (1H, m), 2.99 (1H, dd, J = 18.2, 10.8 Hz), 2.78 (1H, dd, J = 18.2, 
5.2 Hz), 2.63 (1H, dd, J = 10.8, 5.2 Hz), 2.44–2.25 (2H, m), 1.58–1.50 (2H, m), 1.33–
1.24 (2H, m), 1.20 (6H, s), 1.14 (6H, s), 0.87 (3H, apparent t); 13C NMR (100 MHz, 
CDCl3): δ 210.8, 141.8, 128.4, 128.2, 125.5, 83.3, 46.6, 42.2, 26.2, 24.5, 24.5, 22.3, 13.8; 
HRMS (ESI+): Calcd for C19H30B1O3 [M+H]+: 317.2288, Found: 317.2297. Specific 
Rotation: [α]D20 –21.0 (c 1.34, CHCl3) for an enantiomerically enriched sample of 91:9 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (91:9 er shown; Chiralcel OJ-H column, 98/2 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.323 49.918 1 15.278 8.601 
2 19.806 50.082 2 19.556 91.399 
(E)-4-Methyl-1-phenylpent-1-en-3-one (substrate for 1.85): The spectroscopic data 
match those reported previously.38 1H NMR (400 MHz, CDCl3): δ 7.60 (1H, d, J = 16.0 
Hz), 7.56–7.53 (2H, m), 7.40–7.36 (3H, m), 6.80 (1H, d, J = 16.4 Hz), 2.97–2.87 (1H, m), 
1.18 (3H, s), 1.16 (3H, s). 
(R)-4-Methyl-1-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one 
(1.85): The spectroscopic data match those reported previously.33 1H NMR (400 MHz, 
CDCl3): δ 7.25–7.19 (4H, m), 7.14–7.10 (1H, m), 3.03 (1H, dd, J = 18.2, 11.2 Hz), 2.82 
(1H, dd, J = 18.2, 4.8 Hz), 2.63 (1H, dd, J = 11.2, 4.8 Hz), 2.59–2.53 (1H, m), 1.20 (6H, 
s), 1.13 (6H, s), 1.09–1.04 (6H, m); Specific Rotation: [α]D20 –20.3 (c 1.07, CHCl3) for an 
enantiomerically enriched sample of 90:10 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (90:10 er shown; 
Chiralpak AS-H column, 98/2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(38) Gillmore, A.; Lauret, C.; Roberts, S. M. Tetrahedron, 2003, 59, 4363–4375. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 12.855 49.099 1 12.519 89.879 
2 13.333 50.901 2 13.054 10.121 
(R)-1,3-Diphenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-one 
(1.86): The spectroscopic data match those reported previously.36 1H NMR (400 MHz, 
CDCl3): δ 7.97–7.94 (2H, m), 7.55–7.50 (1H, m), 7.44–7.40 (2H, m), 7.31–7.24 (4H, m), 
7.17–7.13 (1H, m), 3.54 (1H, dd, J = 18.4, 10.8 Hz), 3.41 (1H, dd, J = 18.4, 5.2 Hz), 2.79 
(1H, dd, J = 10.8, 5.2 Hz), 1.23 (6H, s), 1.15 (6H, s); Specific Rotation: [α]D20 –18.7 (c 
1.10, CHCl3) for an enantiomerically enriched sample of 94:6 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (94:6 
er shown; Chiralcel OJ-H column, 98/2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 28.04 52.650 1 28.06 93.561 
2 36.53 47.350 2 36.81 6.439 
 46	  
(E)-4-(4-Fluorophenyl)but-3-en-2-one (substrate for 1.87): The compound has been 
previously reported and spectra data match those previously described.38 1H NMR (400 
MHz, CDCl3): δ 7.56–7.50 (2H, m), 7.48 (1H, d, J = 16.4 Hz), 7.12–7.06 (2H, m), 6.65 
(1H, d, J = 16.4 Hz), 2.37 (3H, s). 
(R)-4-(4-Fluorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one 
(1.87): IR (neat): 2977 (m), 2926 (m), 2854 (w), 1714 (m), 1508 (s), 1362 (s), 1322 (s), 
1261 (m), 1220 (m), 1166 (m), 1142 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.19–7.14 
(2H, m), 7.98–6.91 (2H, m), 2.99 (1H, dd, J = 18.4, 10.4 Hz), 2.81 (1H, dd, J = 18.2, 5.4 
Hz), 2.61 (1H, dd, J = 10.4, 5.2 Hz), 2.13 (3H, s), 1.22 (6H, s), 1.16 (6H, s); 13C NMR 
(100 MHz, CDCl3): δ 208.3, 161.2 (d, J = 241.8 Hz), 137.4 (d, J = 3 Hz), 129.7 (d, J = 
8.2 Hz), 115.3 (d, J = 20.9 Hz), 83.6, 47.7, 29.8, 29.7, 24.7; HRMS (ESI+): Calcd for 
C16H23B1F1O3 [M+H]+: 293.1724, Found: 293.1719. Specific Rotation: [α]D20 –26.5 (c 
0.25, CHCl3) for an enantiomerically enriched sample of >99:1 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (>99:1 
er shown; Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 23.83 48.906 1 23.73 99.759 
2 25.82 51.094 2 25.45 0.241 
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(E)-4-(4-Chlorophenyl)but-3-en-2-one (substrate for 1.88): The compound has been 
previously reported and spectra data match those previously described.36 1H NMR (400 
MHz, CDCl3): δ 7.50–7.44 (3H, m), 7.39–7.36 (2H, m), 6.69 (1H, d, J = 16.4 Hz), 2.38 
(3H, s). 
(R)-4-(4-Chlorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one 
(1.88): IR (neat): 2975 (m), 2925 (m), 2851 (w), 1707 (s), 1491 (w), 1418 (w), 1359 (s), 
1325 (s), 1312 (m), 1141 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.22 (2H, d, J = 8.4 
Hz), 7.14 (2H, d, J = 8.4 Hz), 2.99 (1H, dd, J = 18.4, 10.4 Hz), 2.82 (1H, dd, J = 18.4, 5.6 
Hz), 2.61 (1H, dd, J = 10.2, 5.4 Hz), 2.14 (3H, s), 1.21 (6H, s), 1.16 (6H, s); 13C NMR 
(100 MHz, CDCl3): δ 208.2, 140.4, 131.4, 129.7, 128.7, 83.7, 47.4, 29.9, 29.7, 24.7; 
HRMS (ESI+): Calcd for C16H23B1Cl1O3 [M+H]+: 309.1429, Found: 309.1429. Specific 
Rotation: [α]D20 –12.0 (c 0.12, CHCl3) for an enantiomerically enriched sample of 95:5 er.  
Enantiomeric purity is determined by HPLC analysis in comparison with authentic 
racemic material (95:5 er shown; Chiralpak AS-H column, 99.5/0.5 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 24.62 50.039 1 24.77 94.768 
2 26.93 49.961 2 27.20 5.232 
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(R)-Methyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate 
(1.90): The spectroscopic data match those reported previously.39 1H NMR (400 MHz, 
CDCl3): δ 7.26–7.18 (4H, m), 7.15–7.11 (1H, m), 3.63 (3H, s), 2.88 (1H, dd, J = 15.8, 9.6 
Hz), 2.74–2.61 (2H, m), 1.24 (6H, s), 1.15 (6H, s); Specific Rotation: [α]D20 –20.3 (c 1.05, 
CHCl3) for an enantiomerically enriched sample of 98:2 er. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (98:2 er 




Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 24.21 49.602 1 24.30 98.337 
2 29.09 50.399 2 29.38 1.663 
(R)-Methyl-3-(4-bromophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propanoate (1.91): IR (neat): 2976 (m), 2953 (m), 2924 (m), 2853 (w), 1736 (s), 1487 
(m), 1437 (m), 1370 (s), 1327 (s), 1169 (m), 1141 (s), 1011 (m), 847 (m) cm–1; 1H NMR 
(400 MHz, CDCl3): δ 7.37 (2H, d, J = 8.4 Hz), 7.09 (2H, d, J = 8.4 Hz), 3.64 (3H, s), 
2.85 (1H, dd, J = 15.4, 8.6 Hz), 2.71–2.61 (2H, m), 1.21 (6H, s), 1.17 (6H, s);  13C NMR 
(100 MHz, CDCl3): δ 173.9, 140.8, 131.9, 130.3, 119.9, 84.1, 52.0, 37.2, 30.1, 30.5, 24.9, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(39) Park, J. K.; Lackey, H. H.; Rexford, M. D.; Kovnir, K.; Shatruk, M.; McQuade, D. T. Org. Lett. 2010, 
12, 5008–5011. 
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24.8; HRMS (ESI+): Calcd for C16H23B1Br1O4 [M+H]+: 369.0873, Found: 369.0872. 
Specific Rotation: [α]D20 –10.2 (c 0.32, CHCl3) for an enantiomerically enriched sample 
of 94:6 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (94:6 er shown; Chiralcel OJ-H column, 99/1 hexanes/i-PrOH, 
0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 22.676 49.825 1 23.305 5.785 
2 26.292 50.175 2 26.966 94.215 
(S)-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octanoate (1.92): IR (neat): 
2978 (m), 2927 (m), 2857 (w), 1737 (s), 1371 (m), 1318 (m), 1280 (s), 1168 (m), 1143 
(s), 1124 (s), 850 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 3.61 (3H, s), 2.44–2.32 (2H, 
m), 1.44–1.37 (1H, m), 1.32–1.20 (20H, m), 0.84 (3H, apparent t); 13C NMR (100 MHz, 
CDCl3): δ 174.4, 83.1, 51.3, 35.6, 31.9, 30.5, 28.3, 24.7, 24.6, 22.5, 14.0; HRMS (ESI+): 
Calcd for C15H30B1O4 [M+H]+: 285.2237, Found: 285.2236. Specific Rotation: [α]D20 
+2.5 (c 0.85, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric 
purity was determined by GLC analysis in comparison with authentic racemic material 
(95:5 er shown; Chiraldex B-DM column, 15 psi, 90 ºC).  
 50	  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 305.910 49.911 1 305.394 4.650 
2 313.884 50.089 2 313.624 95.350 
(R)-tert-Butyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate 
(1.93): The spectroscopic data match those reported previously.35 1H NMR (400 MHz, 
CDCl3): δ 7.25–7.18 (4H, m), 7.14–7.09 (1H, m), 2.78 (1H, dd, J = 15.6, 10.0 Hz), 2.68 
(1H, dd, J = 10.0, 5.6 Hz), 2.56 (1H, dd, J = 15.6, 5.6 Hz), 1.39 (9H, s), 1.20 (6H, s), 1.15 
(6H, s); Specific Rotation: [α]D20 –19.6 (c 1.20, CHCl3) for an enantiomerically enriched 
sample of 98:2 er. Enantiomeric purity was determined by HPLC analysis in comparison 
with authentic racemic material (98:2 er shown; Chiralcel OD-H column, 99.9/0.1 
hexanes/i-PrOH, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 18.936 50.176 1 20.612 97.903 
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2 22.250 49.824 2 25.031 2.097 
N-Methoxy-N-methylcinnamamide (1.94): The spectroscopic data match those reported 
previously.40 1H NMR (400 MHz, CDCl3): δ 7.72 (1H, d, J = 15.6 Hz), 7.57–7.54 (2H, 
m), 7.40–7.24 (3H, m), 7.02 (1H, d, J = 15.6 Hz), 3.75 (3H, s), 3.30 (3H, s). 
(R)-N-Methoxy-N-methyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propanamide (1.95): IR (neat): 2975 (w), 2931 (w), 1657 (s), 1359 (s), 1319 (s), 1248 
(m), 1140 (s), 1109 (m), 996 (m), 969 (w), 701 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.27–7.21 (4H, m), 7.16–7.10 (1H, m), 3.61 (3H, s), 3.14 (3H, s), 2.98–2.81 (2H, m), 
2.69 (1H, dd, J = 11.2, 5.6 Hz), 1.20 (6H, s), 1.15 (6H, s);  13C NMR (100 MHz, CDCl3): 
δ 174.3, 142.1, 128.4, 128.4, 125.5, 83.2, 61.1, 35.9, 32.3, 24.6, 24.5; HRMS (ESI+): 
Calcd for C16H33B1N1O4 [M+H]+: 320.2033, Found: 320.2032. Specific Rotation: [α]D20 –
65.3 (c 0.73, CHCl3) for an enantiomerically enriched sample of 86.5:13.5 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (86.5:13.5 er shown; Chiralcel OJ-H column, 99/1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
 
Peak # Time (mins) Area (%) Peak # Time (mins) Area (%) 
1 25.141 49.901 1 26.044 86.472 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(40) Murphy, J. A.; Commeureuc, A. G. J.; Snaddon, T. N.; McGuire, T. M.; Khan, T. A.; Hisler, K.; 
Dewis, M. L.; Carling, R. Org. Lett. 2005, 7, 1427–1429.  
 52	  
2 28.704 50.099 2 30.000 13.528 
(E)-3-(4-Bromophenyl)-N-methoxy-N-methylacrylamide (substrate for 1.96): IR 
(neat): 2964 (w), 2935 (w), 1656 (s), 1619 (s), 1488 (s), 1461 (s), 1379 (s), 1199 (m), 
1071 (s), 1008 (s), 815 (s), 789 (m), cm–1; 1H NMR (400 MHz, CDCl3): δ 7.65 (1H, d, J 
= 16.0 Hz), 7.50 (2H, d, J = 6.8 Hz), 7.42 (2H, d, J = 6.8 Hz), 7.01 (1H, d, J = 16.0 Hz), 
3.76 (3H, s), 3.30 (3H, s); 13C NMR (100 MHz, CDCl3): δ 166.7, 142.2, 134.2, 132.1, 
129.6, 124.1, 116.6, 62.0, 32.6; HRMS (ESI+): Calcd for C11H13Br1N1O2 [M+H]+: 
272.0109, Found: 272.0114. 
(R)-3-(4-Bromophenyl)-N-methoxy-N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propanamide (1.96): IR (neat): 2973 (w), 2922 (m), 2852 (w), 1725 
(w), 1659 (s), 1486 (m), 1361 (s), 1324 (s), 1108 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.37 (2H, d, J = 8.4 Hz), 7.15 (2H, d, J = 8.4 Hz), 3.64 (3H, s), 3.15 (3H, s), 2.98–2.82 
(2H, m), 2.66 (1H, dd, J = 10.0, 6.0 Hz), 1.21 (6H, s), 1.17 (6H, s); 13C NMR (100 MHz, 
CDCl3): δ 174.0, 141.4, 131.5, 130.3, 119.4, 83.5, 61.3, 35.8, 32.5, 29.8, 24.7, 24.7; 
HRMS (ESI+): Calcd for C17H26B1Br1N1O4 [M+H]+: 398.1138, Found: 398.1139. 
Specific Rotation: [α]D20 –15.6 (c 0.81, CHCl3) for an enantiomerically enriched sample 
of 94:6 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (94:6 er shown; Chiralcel OD-H column, 99/1 hexanes/i-
PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 32.987 50.132 1 31.973 94.229 
2 36.584 49.868 2 35.942 5.771 
(E)-N-Methoxy-N-methyloct-2-enamide (substrate for 1.97): IR (neat): 2957 (m), 
2928 (m), 2858 (w), 1665 (s), 1635 (s), 1462 (m), 1442 (m), 1411 (m), 1378 (s), 1177 (w), 
993 (m), 967 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 6.96 (1H, dt, J = 15.6, 6.8 Hz), 
6.37 (1H, dt, J = 14.0, 1.2 Hz), 3.68 (3H, s), 3.22 (3H, s), 2.24–2.18 (2H, m), 1.49–1.41 
(2H, m), 1.32–1.25 (4H, m), 0.89–0.84 (3H, m); 13C NMR (100 MHz, CDCl3): δ 166.9, 
147.7, 118.5, 61.5, 32.3, 32.1, 31.2, 27.9, 22.3, 13.8; HRMS (ESI+): Calcd for 
C10H20N1O2 [M+H]+:186.1494, Found: 186.1480.  
(S)-N-Methoxy-N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octanamide 
(1.97): IR (neat): 2958 (w), 2925 (m), 2856 (w), 1664 (s), 1462 (w), 1414 (m), 1379 (s), 
1315 (s), 1242 (w), 1215 (w), 1145 (s), 1003 (m), 968 (w), 867 (w) cm–1; 1H NMR (400 
MHz, CDCl3): δ 3.64 (3H, s), 3.12 (3H, s), 2.55–2.43 (2H, m), 1.45–1.20 (21H, m), 0.83 
(3H, apparent t); 13C NMR (100 MHz, CDCl3): δ 174.9, 82.7, 61.1, 33.7, 32.3, 32.0, 30.7, 
28.6, 24.8, 24.7, 22.5, 14.0; HRMS (ESI+): Calcd for C16H33B1N1O4 [M+H]+: 314.2503, 
Found: 314.2509. Specific Rotation: [α]D20 –1.1 (c 1.08, CHCl3) for an enantiomerically 
enriched sample of 95:5 er. Enantiomeric purity was determined by HPLC analysis in 
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comparison with authentic racemic material (95:5 er shown; Chiralcel OD-H column, 
99.9/0.1 hexanes/i-PrOH, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 34.571 50.634 1 31.714 94.796 
2 39.849 49.366 2 38.441 5.204 
(E)-N-Methoxy-N,4-dimethylpent-2-enamide (substrate 1.98): The spectroscopic data 
match those reported previously.41 1H NMR (400 MHz, CDCl3): δ 6.95 (1H, dd, J = 15.6, 
6.8 Hz), 6.34 (1H, d, J = 15.8 Hz), 3.70 (3H, s), 3.24 (3H, s), 2.52–2.47 (1H, m), 1.07 
(6H, overlapping d, J = 8.0 Hz). 
(R)-N-Methoxy-N,4-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentanamide (1.98): IR (neat): 2957 (m), 2872 (w), 1662 (s), 1464 (w), 1444 (m), 
1378 (s), 1317 (s), 1255 (m), 1215 (m), 1165 (m), 1144 (s), 1112 (w), 1099 (w), 1002 (m), 
976 (m), 870 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 3.66 (3H, s), 3.12 (3H, s), 2.52–
2.50 (2H, m), 1.78–1.66 (1H, m), 1.26–1.23 (7H, m), 1.20 (6H, s), 0.95–0.92 (6H, m); 
13C NMR (100 MHz, CDCl3): δ 175.3, 82.8, 61.1, 32.2, 31.7, 29.2, 25.0, 24.8, 22.2, 21.7; 
HRMS (ESI+): Calcd for C14H29B1N1O4 [M+H]+: 286.2190, Found: 286.2187. Specific 
Rotation: [α]D20 –2.0 (c 1.30, CHCl3) for an enantiomerically enriched sample of 95:5 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(41) Shintani, R.; Kimura, T.; Hayashi, T. Chem. Commun. 2005, 41, 3213–3214. 
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racemic material (95:5 er shown; Chiralcel OD-H column, 99.9/0.1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm).  
 
Peak # Time (mins) Area (%) Peak # Time (mins) Area (%) 
1 44.542 50.003 1 42.734 94.812 
2 49.925 49.997 2 46.866 5.188 
 (E)-N-Methoxy-N,5-dimethylhex-2-enamide (substrate for 1.99): IR (neat): 2956 (m), 
2925 (m), 2871 (w), 1664 (s), 1634 (s), 1464 (m), 1411 (m), 1378 (s), 1176 (m), 1152 (w), 
1114 (w), 1095 (w), 996 (s), 984 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 6.93 (1H, dt, J 
= 12.0, 6.0 Hz), 6.36 (1H, d, J = 12.0 Hz), 3.67 (3H, s), 3.21 (3H, s), 2.10 (2H, td, J = 5.2, 
1.2 Hz), 1.78–1.70 (1H, m), 0.90 (6H, overlapping d, J = 5.6 Hz); 13C NMR (100 MHz, 
CDCl3): δ 167.3, 147.0, 120.0, 61.9, 42.1, 32.6, 28.2, 22.6; HRMS (ESI+): Calcd for 
C9H18N1O2 [M+H]+: 172.1338, Found: 172.1342. 
(S)-N-Methoxy-N,5-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexanamide (1.99): IR (neat): 2955 (m), 2921 (s), 2852 (m), 1666 (m), 1463 (m), 
1378 (s), 1319 (m), 1146 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 3.67 (3H, s), 3.15 (3H, 
s), 2.57–2.43 (2H, m), 1.67–1.57 (1H, m), 1.41–1.32 (2H, m), 1.24–1.14 (13H, m), 0.89 
(3H, d, J = 6.8 Hz), 0.86 (3H, d, J = 6.8 Hz);  13C NMR (100 MHz, CDCl3): δ 174.9, 82.7, 
61.1, 39.9, 33.8, 30.3, 26.7, 24.8, 24.7, 22.8, 22.6; HRMS (ESI+): Calcd for 
C15H31B1N1O4 [M+H]+: 300.2346, Found: 300.2362. Specific Rotation: [α]D20 +2.8 (c 
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0.67, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (95:5 
er shown; Chiralpak AS-H column, 99.8/0.2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 18.899 50.664 1 18.847 94.706 
2 20.558 49.336 2 20.688 5.294 
 (E)-5-[(tert-Butyldimethylsilyl)oxy]-N-methoxy-N-methylpent-2-enamide (substrate 
for 1.100): IR (neat): 2954 (m), 2930 (m), 2857 (m), 1667 (s), 1637 (s), 1463 (w), 1411 
(w), 1379 (s), 1254 (m), 1098 (s), 998 (m), 981 (m), 836 (s), 776 (s) cm–1; 1H NMR (400 
MHz, CDCl3): δ 6.95 (1H, dt, J = 15.6, 7.2 Hz), 6.46 (1H, dt, J = 15.6, 1.2 Hz), 3.73 (2H, 
t, J = 6.8 Hz), 3.69 (3H, s), 3.23 (3H, s), 2.48–2.45 (2H, m), 0.88 (9H, s), 0.05 (6H, s); 
13C NMR (100 MHz, CDCl3): δ 167.1, 144.5, 120.7, 62.0, 61.9, 36.3, 32.6, 26.2, 18.6, –
5.0; HRMS (ESI+): Calcd for C13H28N1O3Si1 [M+H]+: 274.1838, Found: 274.1848. 
(S)-5-[(tert-Butyldimethylsilyl)oxy]-N-methoxy-N-methyl-3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pentanamide (1.100): IR (neat): 2956 (m), 2926 (s), 2855 (m), 
1665 (s), 1463 (w), 1414 (m), 1378 (s), 1316 (m), 1252 (m), 1146 (s), 1097 (s), 1006 (w), 
835 (s), 775 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 3.60–3.70 (5H, m), 3.15 (3H, s), 
2.67–2.52 (2H, m), 1.79–1.70 (1H, m), 1.58–1.50 (1H, m), 1.38–1.31 (1H, m), 1.24 (6H, 
s), 1.23 (6H, s), 0.88 (9H, s), 0.04 (6H, s); 13C NMR (100 MHz, CDCl3): δ 174.9, 82.8, 
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62.8, 61.1, 33.7, 30.3, 26.0, 25.0, 24.8, 24.8, 18.3, –5.3; HRMS (ESI+): Calcd for 
C19H41B1N1O5Si1 [M+H]+: 402.2847, Found: 402.2862. Specific Rotation: [α]D20 –1.8 (c 
1.28, CHCl3) for an enantiomerically enriched sample of 93:7 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (93:7 
er shown; Chiralpak AS-H column, 99.8/0.2 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 14.368 50.267 1 14.369 93.197 
2 15.712 49.733 2 15.829 6.803 
(S)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)hexanal (1.102): The 
spectroscopic data match those reported previously.42 1H NMR (400 MHz, CDCl3): δ 
9.74–9.74 (1H, m), 2.59–2.39 (2H, m), 1.47–1.40 (1H, m), 1.36–1.26 (4H, m), 1.22 (6H, 
s), 1.21 (6H, s), 0.87 (3H, t, J = 7.2 Hz); Specific Rotation: [α]D20 +3.6 (c 1.11, CHCl3) 
for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity was determined 
by GLC analysis in comparison with authentic racemic material (95:5 er shown; 
Chiraldex GTA column, 15 psi, 70 ºC). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 173.970 50.14852 1 172.646 94.97705 
2 180.768 49.85148 2 181.338 5.02295 
(E)-5-Phenylpent-2-enal (substrate for 1.103): The spectroscopic data match those 
reported previously.43 1H NMR (400 MHz, CDCl3): δ 9.50 (1H, d, J = 8.0 Hz), 7.33–7.29 
(2H, m), 7.24–7.18 (3H, m), 6.86 (1H, dt, J = 16.0, 6.6 Hz), 6.17–6.11 (1H, m), 2.84 (2H, 
t, J = 7.6 Hz), 2.70–2.64 (2H, m).  
(S)-5-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanal (1.103): IR 
(neat): 2976 (m), 2924 (m), 2855 (w), 2713 (w), 1723 (s), 1380 (s), 1318 (s), 1144 (s), 
701 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 9.74 (1H, t, J = 1.0 Hz), 7.26–7.23 (2H, m), 
7.16–7.14 (3H, m), 2.67–2.53 (4H, m), 1.83–1.75 (1H, m), 1.65–1.58 (1H, m), 1.40–1.35 
(1H, m), 1.24 (6H, s), 1.23 (6H, s);  13C NMR (100 MHz, CDCl3): δ 202.7, 142.5, 128.5, 
128.47, 125.9, 83.5, 46.0, 35.3, 32.7, 30.5, 25.0, 24.9; HRMS (ESI+): Calcd for 
C17H26B1O3 [M+H]+: 289.1975, Found: 289.2002. Specific Rotation: [α]D20 –9.6 (c 0.37, 
CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity was 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(43) Palais, L.; Babel, L.; Quintard, A.; Belot, S.; Alexakis, A. Org. Lett. 2010, 12, 1988–1991. 
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determined by HPLC analysis in comparison with authentic racemic material (95:5 er 
shown; Chiralcel OJ-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 30.557 49.690 1 30.903 95.192 
2 38.784 50.310 2 39.780 4.808 
(E)-5-Methylhex-2-enal (substrate for 1.104): IR (neat): 2930 (m), 2871 (w), 2811 (w), 
1686 (s), 1638 (m), 1466 (w), 1153 (m), 1112 (m), 1091 (m), 1012 (w), 977 (m), 885 (w) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 9.49 (1H, d, J = 8.0 Hz), 6.80 (1H, dt, J = 15.6, 7.2 
Hz), 6.12–6.05 (1H, m), 2.23–2.18 (2H, m), 1.85–1.75 (1H, m), 0.93 (6H, overlapping d, 
J = 7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 194.1, 157.7, 134.1, 41.9, 27.8, 22.3; HRMS 
(ESI+): Calcd for C7H13O1 [M+H]+: 113.0966, Found: 113.0961. 
(S)-5-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanal (1.104): IR 
(neat): 2977 (m), 2956 (m), 2926 (m), 2869 (w), 2716 (w), 1725 (s), 1467 (w), 1379 (s), 
1372 (s), 1317 (m), 1280 (m), 1168 (w), 1145 (s), 1125 (s), 850 (m) cm–1; 1H NMR (400 
MHz, CDCl3): δ 9.75 (1H, m), 2.53–2.51 (2H, m), 1.62–1.55 (1H, m), 1.40–1.33 (2H, m), 
1.23–1.14 (13H, m), 0.88 (3H, d, J = 6.4 Hz), 0.85 (3H, d, J = 6.4 Hz); 13C NMR (100 
MHz, CDCl3): δ 202.9, 83.3, 46.0, 39.6, 26.7, 25.1, 24.8, 22.7, 22.5; HRMS (ESI+): 
Calcd for C13H26B1O3 [M+H]+: 241.1975, Found: 241.1964. Specific Rotation: [α]D20 –
3.8 (c 0.94, CHCl3) for an enantiomerically enriched sample of 94:6 er. Enantiomeric 
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purity was determined by GLC analysis in comparison with authentic racemic material 
(94:6 er shown; Chiraldex GTA column, 15 psi, 70 ºC). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 216.030 49.95908 1 211.952 94.19974 
2 229.124 50.04902 2 229.041 5.80026 
(S)-4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanal (1.105): IR 
(neat): 2977 (m), 2931 (m), 2873 (w), 2716 (w), 1721 (s), 1372 (s), 1310 (s), 1279 (s), 
1214 (w), 1143 (s), 1124 (s), 967 (w), 849 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 9.72 
(1H, m), 2.56 (1H, dd, J = 18.2, 10.0 Hz), 2.43 (1H, dd, J = 18.2, 4.2 Hz), 1.74–1.66 (1H, 
m), 1.24–1.14 (13H, m), 0.89–0.83 (6H, m); 13C NMR (100 MHz, CDCl3): δ 203.1, 83.2, 
43.9, 28.9, 24.9, 24.7, 21.9, 21.5; HRMS (ESI+): Calcd for C12H24B1O3 [M+H]+: 
227.1819, Found: 227.1829. Specific Rotation: [α]D20 +2.4 (c 1.43, CHCl3) for an 
enantiomerically enriched sample of 91:9 er. Enantiomeric purity was determined by 
GLC analysis in comparison with authentic racemic material (91:9 er shown; Chiraldex 
GTA column, 15 psi, 70 ºC). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 190.395 48.01977 1 193.797 90.71579 
2 197.781 51.98023 2 201.452 9.28421 
 (E)-Oct-3-en-7-yn-2-one (substrate for 1.108): IR (neat): 3291 (br), 2962 (m), 2919 
(m), 2850 (m), 1697 (m), 1672 (s), 1627 (m), 1432 (m), 1361 (m), 1255 (s), 1018 (m), 
972 (m), 798 (m) 638 (br) cm–1; 1H NMR (400 MHz, CDCl3): δ 6.82 (1H, dt, J = 16.0, 
6.8 Hz), 6.13 (1H, d, J = 16.0 Hz), 2.48–2.43 (2H, m), 2.39–2.35 (2H, m), 2.26 (3H, s), 
2.01 (1H, t, J = 2.4 Hz); 13C NMR (100 MHz, CDCl3): δ 198.4, 145.3, 132.2, 82.6, 69.6, 
31.2, 27.0, 17.5; HRMS (ESI+): Calcd for C8H11O1 [M+H]+: 123.0810, Found: 123.0790. 
(S)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)oct-7-yn-2-one (1.108): IR (neat): 
3291 (br), 2977 (m), 2922 (m), 2852 (m), 1714 (m), 1380 (s), 1372 (s), 1315 (s), 1166 (s), 
1143 (s), 1125 (s), 967 (m), 851 (m), 671 (m), 632 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 2.66–2.54 (2H, m), 2.24–2.19 (2H, m), 2.11 (3H, s), 1.93–1.92 (1H, m), 1.76–
1.67 (1H, m), 1.55–1.46 (1H, m), 1.39–1.30 (1H, m), 1.23 (6H, s), 1.22 (6H, s); 13C NMR 
(100 MHz, CDCl3): δ 208.8, 84.6, 83.3, 68.5, 45.3, 29.8, 29.3, 24.9, 24.8, 17.9; HRMS 
(ESI+): Calcd for C14H24B1O3 [M+H]+: 251.1819, Found: 251.1813. Specific Rotation: 
[α]D20 –3.0 (c 0.87, CHCl3) for an enantiomerically enriched sample of 94:6 er.  
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Enantiomeric purity was determined by GLC analysis in comparison with authentic 
racemic material (94:6 er shown; Chiraldex aTA column, 15 psi, 90 ºC). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 399.751 52.13187 1 401.614 93.91151 
2 440.312 47.86813 2 445.617 6.08849 
(E)-Non-2-en-7-ynal (substrate for 1.110): IR (neat): 2939 (m), 2918 (m), 2712 (m), 
1691 (s), 1638 (m), 1434 (m), 1167 (m), 1124 (m), 975 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 9.50 (1H, d, J = 8.0 Hz), 6.84 (1H, dt, J = 15.6, 6.8 Hz), 6.14 (1H, dd, J = 15.6, 
8 Hz), 2.47–2.42 (2H, m), 2.22–2.17 (2H, m), 1.78–1.76 (3H, m), 1.76–1.64 (2H, m); 13C 
NMR (100 MHz, CDCl3): δ 194.1, 157.9, 133.4, 78.0, 76.7, 31.8, 27.2, 18.3, 3.5; HRMS 
(ESI+): Calcd for C9H13O2 [M+OH]+: 153.0916, Found: 153.0922. 
(S)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)non-7-ynal (1.110): IR (neat): 
2977 (m), 2924 (s), 2857 (m), 2712 (m), 1723 (m), 1458 (m), 1380 (s), 1372 (s), 1318 (s), 
1280 (m), 1166 (m), 1144 (s), 1125 (s), 967 (m), 850 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 9.76 (1H, s), 2.64–2.51 (2H, m), 2.13–2.09 (2H, m), 1.77–1.76 (3H, m), 1.56–
1.40 (4H, m), 1.36–1.30 (1H, m), 1.24 (6H, s), 1.23 (6H, s); 13C NMR (100 MHz, 
CDCl3): δ 202.8, 83.5, 79.2, 75.7, 46.0, 29.9, 28.5, 24.9, 24.8, 19.0, 3.6; HRMS (ESI+): 
Calcd for C15H26B1O3 [M+H]+: 265.1975, Found: 265.1975. Specific Rotation: [α]D20  
+11.0 (c 0.25, CHCl3) for an enantiomerically enriched sample of 95:5 er.  
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Enantiomeric purity was determined by GLC analysis in comparison with authentic 
racemic material (95:5 er shown; Chiraldex GTA column, 15 psi, 90 ºC). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 684.674 50.10745 1 677.946 94.95923 
2 703.621 49.89255 2 699.693 5.04077 
Imidazolinium Tetrafluoroborate Salt (im-16): Prepared according to a reported 
procedure and the spectroscopic data match those reported previously.44 1H NMR (400 
MHz, CDCl3): δ 8.76 (1H, s), 7.89 (1H, d, J = 1.6 Hz), 7.46–7.25 (7H, m), 7.19–7.02 (4H, 
m), 7.01 (1H, d, J = 8.0 Hz), 6.91 (1H, s), 6.59 (1H, s), 6.43–6.41 (2H, m), 5.35 (1H, d, J 
= 7.6 Hz), 5.21 (1H, d, J = 7.6 Hz), 3.08–3.01 (1H, m), 2.52 (3H, s), 2.50 (3H, s), 2.17 
(3H, s), 2.05 (3H, s), 1.93 (3H, s), 1.58 (3H, s), 1.25 (6H, d, J = 8.4 Hz). 






 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  































































































































































































































Part B: Enantioselective Synthesis of Boron-Substituted 
Quaternary Carbon Stereogenic Centers through 
N-Heterocyclic Carbenes Catalyzed Boryl Conjugate Additions 
to Cyclic and Acyclic Enones 
 
1B.1. Introduction 
 In recent years, development of an efficient and enantioselective synthesis of 
boron-containing molecules, which are versatile intermediates in chemical synthesis,45 
has exceedingly become the subject of current research interest. Despite several reports 
on the utility of C–B bonds,46 an efficient and selective synthetic strategy to furnish 
enantiomerically enriched boron-substituted quaternary stereogenic centers remains 
scarce. Two existing catalytic enantioselective approaches to those tertiary boronic esters 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(45) For representative reviews and articles regarding organoboron in synthesis, see: (a) Miyaura, N.; 
Suzuki, A. Chem. Rev. 1995, 95, 2457–2483. (b) Miyaura, N. Cross-Coupling Reactions; Springer-Verlag 
Berlin; Berlin, Germany, 2002; Vol. 219, pp 11–59. (c) Suzuki, A. J. Organomet. Chem. 1999, 576, 147–
168. (d) Darses, S.; Genet, J. P. Eur. J. Org. Chem. 2003, 4313–4327. (e) Sato, M.; Miyaura, N.; Suzuki, A.; 
Chem. Lett. 1989, 1405–1408. (f) Lee, J.-E.; Yun, J. Angew. Chem., Int. Ed. 2008, 47, 145–147. (g) 
Ohmura, T.; Taniguchi, H.; Kondo, Y.; Suginome, M. J. Am. Chem. Soc. 2007, 129, 3518–3519. (h) 
Morrill, C.; Funk, T. W.; Grubbs, R. H. Tetrahedron Lett. 2004, 45, 7733–7736. (i) Hall, D. G. Boronic 
Acids. Preparation, Applications in Organic Synthesis and Medicine, Wiley-VCH, Weinheim, 2005. 
(46) For representative examples of converting C–B to C–O, see: (a) Tortosa, M. Angew. Chem., Int. Ed. 
2011, 50, 3950–3953. (b) Stymiest, J. L.; Bagutski, V.; French, R. M.; Aggarwal, V. K. Nature 2008, 456, 
778–782. For C–B to C–C, see: (c) Imao, D.; Glasspoole, B.W.; Laberge, V. S.; Crudden, C. M. J. Am. 
Chem. Soc. 2009, 131, 5024–5025. (d) Hupe, E.; Marek, I.; Knochel, P. Org. Lett. 2002, 4, 2861–2863. For 
C–B to C–N, see: (e) Moran, W. J.; Morken, J. P. Org. Lett. 2006, 8, 2413–2415. (f) Mlynarski, S. N.; 
Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449–16451. For C–B to C–halogen, see: (g) 
Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794–16797. For C–
B to C–H, see: (h) Nave, S.; Sonawane, R. P.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 132, 
17096–17098. 
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are outlined in Scheme 1.28: conjugate addition 47  and allylic substitution. 48 , 49 
Enantioselective BCA reactions to α,β-unsaturated carbonyls provide access to 
invaluable β-boryl carbonyls.50,51, 52 However, the reported procedures are promoted by 
organocopper complexes that are known to promote Cu–B addition reactions to other 
functional groups (i.e. alkyne,53 allene,54 and aldehyde55) besides unsaturated carbonyls, 
thus the reaction could suffer from chemoselectivity issues in cases where substrates 
contain the aforementioned functional groups. In addition, use of transition-metal salts 
could cause complication in pharmaceutical industry; for example, removal of metal 
impurities from therapeutic agents as well as waste stream and toxicity issues associated 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(47) For a single report on Cu-catalyzed enantioselective BCAs to β-substituted cyclic enones, see: (a) 
Chen, I.-H.; Yin, L.; Itano, W.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 11664–11665. For 
Cu-catalyzed enantioselective BCAs to β-substituted acyclic enoates and enones, see:  (b) O’Brien, J. M.; 
Lee, K.-s.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10630–10633. (c) Feng, X.; Yun, J. Chem. Eur. J. 
2010, 16, 13609–13612. (d) Chen, I.-H.; Kanai, M.; Shibasaki, M. Org. Lett. 2010, 12, 4098–4101. (e) 
Kobayashi, S.; Xu, P.; Endo, T.; Ueno, M.; Kitanosono, T. Angew. Chem., Int. Ed. 2012, 51, 12763–12766. 
(48) For a report on Cu-catalyzed enantioselective (pinacolato)boron allylic substitution, see: A. Guzman-
Martinez, A. H. Hoveyda, J. Am. Chem. Soc. 2010, 132, 10634–10637. 
(49) For a non-catalytic enantioselective synthesis of boron-substituted quaternary carbons, see: (a) ref. 34b. 
(b) Bagutski, V.; French, R. M.; Aggarwal, V. K. Angew. Chem., Int. Ed. 2010, 49, 5142–5145. (c) 
Sonawane, R. P.; Jheengut, V.; Rabalakos, C.; Larouche-Gauthier, R.; Scott, H. K.; Aggarwal, V. K. 
Angew. Chem., Int. Ed. 2011, 50, 3760–3763.  
(50) For a review regarding the significance of enantioselective conjugate additions with B- and Si-based 
nucleophiles, see: Hartmann, E.; Vyas, D. J.; Oestreich, M. Chem. Commun. 2011, 47, 7917–7932. 
(51) For an application of enantioselective Cu-catalyzed BCA to synthesis of a biologically active molecule, 
see: (a) Chea, H.; Sim, H.-S.; Yun, J. Adv. Synth. Catal. 2009, 351, 855–858. (b) Stavber, G.; Časar, Z. 
Appl. Organometal. Chem. 2013, 27, 159–165. For a related non-enantioselective example, see: (c) Marcus, 
A. P.; Sarpong, R. Org. Lett. 2010, 12, 4560–4563. 
(52) For an application of enantioselective NHC-catalyzed BCA to synthesis of neopeltolide, see; Yu, M.; 
Hoveyda, A.H. Angew. Chem., Int. Ed. 2015, 54, 215–220. 
(53) For representative Cu–B additions to alkynes, see: (a) Lee, Y.; Jang, H.; Hoveyda, A. H. J. Am. Chem. 
Soc. 2009, 131, 18234–18235. (b) Jang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 
2011, 133, 7859–7871. (c) Liu, P.; Fukui, Y.; Tian, P.; He, Z.-T.; Sun, C.-Y.; Wu, N.-Y.; Lin, G.-Q. J. Am. 
Chem. Soc. 2013, 135, 11700–11703. (d) Moure, A. L.; Mauleon, P.; Arrayas, R. G.; Carretero, J. C. Org. 
Lett. 2013, 15, 2054–2057. 
(54) For representative Cu–B additions to allenes, see: (a) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 
2012, 134, 1490–1493. (b) Yuan, W.; Ma, S. Adv. Synth. Catal. 2012, 354, 1867–1872. (c) Meng, F.; Jung, 
B.; Haeffner, F.; Hoveyda, A. H. Org. Lett. 2013, 15, 1414–1417; d) Meng, F.; Jang, H.; Jung, B.; Hoveyda, 
A. H. Angew. Chem., Int. Ed. 2013, 52, 5046–5051. (e) Semba, K.; Shinomiya, M.; Fujihara, T.; Terao, J.; 
Tsuji, Y. Chem. Eur. J. 2013, 19, 7125–7132.  
(55) Laitar, D. S.; Tsui, E. Y.; Sadighi, J. P. J. Am. Chem. Soc. 2006, 128, 11036–11037. 
 110	  
with metal complexes.56 A metal-free alternative that is complementary to Cu-catalyzed 
variants and offers chemoselective BCA reactions is thus compelling. 
 
1B.2. NHC-catalyzed Enantioselective Boryl Conjugate Additions to 
Generate Boron-Substituted Quaternary Carbon Stereogenic Centers 
1B.2.1. Reaction conditions optimization and catalyst screening 
  We began our investigation with a representative enone 1.111 and imidazolinium 
salt im-5. Based on reaction conditions identified for NHC-catalyzed enantioselective 
BCA reactions (Chapter 1, Part A), we chose dbu as a base and MeOH as an additive. As 
data in Table 1.2 indicate, use of 20 mol % dbu and 60 equiv of MeOH results in high 
conversion and appreciable enantioselectivity (96% conv, 85% yield, 84:16 er, entry 2). 
The results improve slightly with higher amount of dbu (>98% conv, 92% yield, 86:14 er, 
entry 4). Use of other amine bases such as Et3N gives only 12% yield of the desired 
product suggesting Et3N being an inefficient base to deprotonate im-5 to generate an 
NHC (entry 5). With a sizable alcohol additive isopropanol, the BCA reaction proceeds 
to only 16% conv (entry 7). This is in agreement with the previously discussed role of 
alcohol to generate a more accessible diboron reagent. Reactions in the presence of polar 
aprotic additive did not give any product 1.112 (<2% conv, entries 8–9). In the presence 
of H2O as an additive, although the reaction is very efficient, the product is formed with 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(56) For selected reports on the significance of non-metal catalysis, see: (a) Gaunt, M. J.; Johansson, C. C. 














Scheme 1.28. Catalytic enantioselective synthesis of boron-substituted quaternary carbons
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much lower er value (85% yield, 68:32 er, entry 10). This can be contributed to more 
background reaction (a hydroxide catalyzed BCA reaction) compared to when MeOH is 
used.  
Without an alcohol additive, there is no product formation (<2% conv, entry 11). 
Results in entries 13–14 suggest that the NHC-catalyzed reaction proceeds with a distinct 
mechanism and without the presence of Cu salt because much lower er values were 
obtained from addition of CuCl (65:35 er, entry 13 and 64:36 er, entry 14 vs 84:16 er 
without CuCl, entry 2). 
 
Table 1.2. Optimization of reaction conditions with im-5 as the chiral NHC precursora
20–100 mol % base, 1.1 equiv B2(pin)2,





5.0 mol % im-5
a All reactions were performed under N2 atm. b Determined by analysis of 400 MHz 1H NMR
spectra of unpurified mixtures. c Yields of purified products. d Determined by HPLC analysis.
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 After having identified suitable reaction conditions, we turned to search for the 
most selective chiral NHC. As shown in Table 1.3, we started with C2-symmetric 
imidazolinium salts because im-5 gave promising results. Removing methyl substituents 
on the meta positions of the N-aryl motifs did not improve enantioselectivity (84:16 er, 
entry 1). While increasing the size of the substituents to i-Pr and t-Bu groups, the 
enantioselectivities decrease (79:21 er and 69:31 er, entries 2–3, respectively). 
We then examined the BCA reaction with C1-symmetric imidazolinium salts as 
NHC precursors. Reaction with im-8 proceeds with low efficiency although the 
enantioselectivity is similar to im-5 (21% yield, and 82:18 er, entry 4). Modification of 
its structure by changing the substituent at the meta position did not improve 
enantioselectivity, on the other hand the er values decrease with larger group (entries 5–
7). A very promising result was obtained when im-22 was employed. The BCA product 
was formed in 74% yield and 91.5:8.5 er (entry 10). Further modification of the 
imidazolinium salts’ structure gave im-25 as the optimal NHC precursor for reactions 
with cyclic enones (90% yield, and 96:4 er, entry 13).  
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Table 1.3. Examination on various chiral NHC catalystsa
20 mol % dbu, 1.1 equiv B2(pin)2,














im-17 R = H
im-19 R = i-Pr
im-20 R = t-Bu
entry conv (%)a
a See Table 1.2. Mes = 2,4,6-(Me)3C6H2.






im-8 R = H
im-12 R = Me
im-13 R = i-Pr






im-15 R = H






im-22 R1,R2 = Et
im-23 R1,R2 = n-Pr








































































im-25 R1 = i-Pr,R2 = Me
im-26 R1 = Ph,R2 = Me
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1B.2.2. NHC-catalyzed enantioselective BCAs to β-substituted cyclic enones 
We probe the generality of the NHC-catalyzed enantioselective BCA reaction. A 
variety of cyclic enones, ranging from five-, six-, seven-, and eight-membered rings, are 
suitable substrates and proceed to generate β-boryl ketones in 63–95% yield and in 92:8–
>98:2 er (Table 1.4). The transformations to produce boron-substituted cyclopentanone 
1.113–1.116 are usually efficient (>98% conv in all cases, entries 1–4). Reaction to 
afford product 1.113 is exceedingly enantioselective (entry 1, >98:2 er). Reactions with 
relatively larger aryl-substituted cyclopentenones are also efficient; however, somewhat 
lower enantioselectivities are obtained (entries 2–4, 92:8–95:5 er).   
 Catalytic BCAs with cyclohexenones tolerate towards substituents bearing 
electron-donating (entries 6 and 9) and electron-withdrawing groups (entries 7–8) and 
proceed efficiently and enantioselectively to deliver the corresponding products in 63–
93% yield and 92.5:7.5–97:3 er. In case of the strongly electron-withdrawing p-CF3 
substituted substrate, there is formation of proto-deboration product resulting in the 
diminished yield of 1.120 after isolation; however, the enantioselectivity remains high 
(>98% conv, 63% yield, 96:4 er, entry 8). Notably, the sterically-demanding naphthyl-
substituted cyclohexenone proceeds in BCA efficiently and enantioselectively at 4 °C 
after 14 h affording compound 1.122 in 93% yield and 96:4 er (entry 10). In addition to 
reactions with aryl-substituted cyclohexenones, BCA reactions of alkyl-substituted 
cyclohexenones afford a range of β-boryl products bearing a substituent ranging from n-
Bu 1.123, phenethyl 1.124, and silylprotected alkyne 1.125 in 80–91% yield and 94:6–
96:4 er. Large ring sizes including 7- and 8-membered substrates are effective in metal-
free BCA affording the products in 77–78% yield and 95:5 er (entries 14–15); it is worth 
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to mention that this is the first example of enantioselective BCA to a large ring-size 
substrate such as cyclooctenone.  
 
As shown in Scheme 1.29, facile enantioselective BCAs of relatively reactive 
substrates proceed efficiently with only 1.0 mol % of NHC precursor im-25 to afford the 
corresponding products without loss of efficiency and enantioselectivity compared to 
results obtained with higher loading (78–95% yield and 95:5–97:3 er). 
 
 
1.0 equiv dbu, thf, 60 equiv MeOH
5.0 mol % im-25,  1.1 equiv. B2(pin)2,
entry conv (%)
a See Table 1.2. b ~30% proto-deboration product is formed (determined by analysis of 400 MHz 1H NMR 


















































































































Table 1.4. NHC-catalyzed enantioselective BCAs to !-substituted cyclic enonesa
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1B.2.3. NHC-catalyzed enantioselective BCAs to β ,β-disubstituted acyclic enones 
We began searching for an optimal NHC catalyst for enantioselective BCAs of 
acyclic enones with im-25, the optimal NHC precursor in reactions with cyclic enones 
(Scheme 1.30). Reaction of acyclic enone 1.128 proceeds to give the desired product in 
69% yield and 89:11 er. Removing the ortho methyl substituent of the NHC derived from 
im-24 results in higher efficiency, but lower selectivity (89% yield, 79:21 er). Increasing 
the size to i-Pr group almost inhibits the reaction (im-27, 5% conv, 54:46 er). However, 
putting t-Bu substituents at the meta positions does not improve the result (im-28, 59% 
yield, 72:28 er). Imidazolinium salt im-15 bearing a N–Mes unit proves to be optimal 
generating the desired product in 90% yield and 91:9 er. 
 
 
1.1 equiv B2(pin)2, thf, 





1 mol % im-25,  5.0 mol % dbu





22 ºC, 3 h




–15 ºC, 14 h






4 ºC, 14 h




4 ºC, 14 h
>98% conv, 95% yield
96:4 er
Scheme 1.29. NHC-catalyzed enantioselective BCAs to !-substituted cyclic enones on low catalyst loading
1.114
1.122 1.118 1.113 1.127
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As the results in Scheme 1.31 illustrate, an array of β-substituted acyclic enones 
can be used as substrates. A range of products bearing aryl- or alkyl-substituted enones 
are suitable substrates in BCA affording the corresponding β-boryl compounds in 69–
94% yield and 91:9–98:2 er. It is worth mentioning that in certain cases, due to 
crystallinity gained from addition of the B(pin) unit, products can be recrystallized to 
obtain a higher enantiopurity. For example, compound 1.129–1.130 and 1.132 are 
obtained after recrystallization in 56–70% yield and >98:2 er (vs 90:10–92:8 er before 
recrystallization). Phenyl ketones, which prove to be difficult and less explored in Cu-
catalyzed variants,35b–e are shown to be effective in the NHC-catalyzed BCA; β-boryl 
ketone 1.138 and 1.139 are generated in 90–92% yield and 97:3–98:2 er. The reaction 






1 equiv. dbu, 1.1 equiv. B2(pin)2, 






75% conv, 69% yield
89:11 er
>98% conv, 89% yield
79:21 er
29% conv, 18% yield
92:8 er
64% conv, 59% yield
72:28 er

























Scheme 1.30. Examination on different chiral NHCs for acyclic substrates





























(69% yield and 91:9 er) presumably due to lack of conjugation to lower the LUMO of the 
enone.  
In terms of practicality of the method, catalytic enantioselective BCA reactions 
can be performed without strictly-inert atmosphere conditions. For example, ketone 1.112 
was obtained in 92% yield, 95:5 er when the reaction was performed outside of the 
glovebox (vs 90% yield, 96:4 er with glovebox techniques, entry 13, Table 1.2). One 
limitation of our metal-free method is that unsaturated esters as well as Weinreb amides 
are not suitable substrates and did not proceed in the BCA reactions. 
 
Transformations in Scheme 1.32 illustrate the utility of the resulting BCA 
product; β-hydroxy carbonyl 1.141 can be efficiently obtained from oxidation by bleach 
Scheme 1.31. NHC-Catalyzed enantioselective BCAs to !-substituted acyclic enones
>98% conv, 90% yield, 91:9 er
after recrystallization (hexanes):









87% conv, 83% yield, 92:8 er
after recrystallization (hexanes):

























>98% conv, 92% yield
97:3 er


























75% conv, 69% yield
91:9 er
1.140
1.0 equiv dbu, 60 equiv MeOH,
 thf, 22 ºC, 14 h





85% conv, 79% yield, 90:10 er
after recrystallization (hexanes):













at ambient temperature in two hours and with complete enantiospecificity (es) (95% 
yield, >98% es).39b Notably, at elevated temperature (70 °C), double-oxidation of boron-
containing compound 1.130 delivers β-hydroxy carboxylic acid 1.142 in 63% yield and 
>98% es.57,58  
 
Additionally, the absolute stereochemistry of the β-boryl products was 
unambiguously confirmed by X-ray structures of 1.124 (for cyclic) and 1.129 (for 
acyclic) as depicted in Scheme 1.33. 
 
1B.2.4. Functional group compatibilities and application in natural product 
synthesis 
The next phase of our studies is to illustrate the utility of the metal-free approach 
in comparison to Cu catalysis. As shown in Scheme 1.34, whereas NHC-catalyzed BCA 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(57) Liskin, D. V.; Valente, E. J. J. Mol. Struct. 2008, 878, 149–159. 
(58) There is ~30% conversion to benzoic acid presumably through retro-aldol of the resulting β-hydroxy 
ketone (determined by analysis of 1H NMR of the unpurified mixture). For a recent example of oxidation of 
ketone to carboxylic acid, see: Dabrowski, J. A.; Villaume, M. T.; Hoveyda, A. H. Angew. Chem., Int. Ed. 




Me Bpin aq. NaOCl 





>98% conv, 63% yield





>98% conv, 95% yield




EtOAc, 22 ºC, 2 h
99:1 er








Scheme 1.33. Absolute configurations confirmed by X-ray crystallography
X-ray structure of 1.124 X-ray structure of 1.129
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to alkyne-containing cyclohexenone 1.143 proceeds with high chemoselectivity to obtain 
product 1.144 in 75% yield and 94.5:5.5 er, under Cu-catalyzed conditions, compound 
1.144 is isolated in 45% yield and approximately 40% of Cu–B addition to alkyne is 
observed in the 1H NMR of the unpurified mixture. A more distinct example of 
chemoselectivity obtained from the NHC-catalyzed reaction is illustrated by reaction to 
generate allene-substituted 1.145. The reaction promoted by NHC offers a higher degree 
of chemoselectivity and delivers the product in 71% yield and 95:5 er although ~10% 
protoboration is detected. The Cu-catalyzed reaction significantly suffers from the Cu–B 
addition to allene (>98% reaction with allene moiety); allylcopper species formed in situ 
can further react with ketone moiety resulting in a complex mixture.  
 
Finally, as shown in Scheme 1.35, we demonstrate the utility of the NHC-
catalyzed BCA through the enantioselective formal synthesis of natural product (–)-
crassinervic acid, an antifungal agent, that contains a hydroxyl-substituted quaternary 
carbon at the β postion of the carbonyl.59  Highly functionalized ketone 1.146 proceeds 
efficiently and selectively in the NHC-catalyzed BCA reaction affording   β-boryl ketone 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(59) Lago, J. H. G.; Ramos, C. S.; Casanova, D. C. C.; Morandim, A. A.; Bergamo, D. C. B.; Cavalheiro, A. 
J.; Bolzani, V. S.; Furlan, M.; Guimaraes, E. F.; Young, M. C. M.; Kato, M. J. J. Nat. Prod. 2004, 67, 
1783–1788. 
5.0 mol % im-25,  1.0 equiv. dbu
1.1 equiv. B2(pin)2, thf, 
60 equiv. MeOH, 22 ºC, 14 h
O













>98% conv to complex mixture
Cu-Catalyzed BCA[Ref. 16]
>98% conv, 45% yield
88:12 er
(~40% reaction with alkyne)
1.143
Scheme 1.34. NHC-Catalyzed enantioselective BCAa to polyfunctional substrates
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1.147 in 72% yield and 95:5 er; however, less dbu (40 mol % vs 100 mol %) is used to 
minimize the reversible intramolecular cyclization of phenol to enone and the reaction 
was performed at slightly elevated temperature (35 °C) to regenerate the substrate for 
BCA from the cyclized byproduct. Oxidation of the C–B bond in 1.147 cleanly affords β-
hydroxy derivative in 93% yield, which can be converted to natural product (–)-
crassinervic acid, in one step by Pinnick oxidation.60 
 
1B.3. Conclusions 
We have demonstrated the first NHC-catalyzed enantioselective BCAs to β-
substituted cyclic and acyclic enones. 61  A wide range of B-substituted quaternary 
stereogenic centers are produced in up to 95% yield and >98:2 er. The described method 
is complementary to the more examined Cu-catalyzed alternatives. Moreover, the unique 
profiles in chemoselectivity of the metal-free approach are illustrated through cases 
involving polyfunctional molecules and in the formal synthesis of natural product (–)-
crassinervic acid. All above attributes from the NHC-catalyzed BCA should render the 
present study of useful in chemical synthesis.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(60) Chakor, J. N.; Merlini, L.; Dallavalle, S. Tetrahedron 2011, 67, 6300–6307. 
(61) Radomkit, S.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2014, 53, 3387–3391. 




>98% conv, 72 % yield
95:5 er
(–)-crassinervic acid
2) NaClO2, NaH2PO4.H2O, t-BuOH,
2-methyl-2-butene, 22 ºC, 3 h; 75% yieldref
1) NaBO3.4H2O, thf:H2O (1:1),
22 °C, 12 h, 93 %
Cu-Catalyzed BCA[Ref. 17]
>98% conv, 19% yield








Me 5.0 mol % im-15,  40 mol % dbu
1.1 equiv. B2(pin)2, thf, 
60 equiv MeOH, 35 ºC, 8 h1.146
Scheme 1.35. Application in the synthesis of (–)-crassinervic acid
1.147
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1B.4. Experimental Section 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm–1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, quint = quintet, sept = septet, m = multiplet), and coupling constants 
(Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 400 (100 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 
ppm). High-resolution mass spectrometry was performed on a Micromass LCT ESI-MS 
(positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomeric ratios 
were determined by GC analysis (Alltech Associated Chiraldex B-DM (30 m x 0.25 
mm)) and HPLC analysis (high-performance liquid chromatography) with a Shimadzu 
chromatograph [Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral 
Technologies Chiralcel OD-H (4.6 x 250 mm), Chiral Technologies Chiralpak AS-H (4.6 
x 250 mm) or Chiral Technologies Chiralpak AD-H (4.6 x 250 mm)] in comparison with 
authentic racemic materials. Specific rotations were measured on a Rudolph Research 
Analytical Autopol IV Polarimeter. Melting points were measured on a Thomas Hoover 
capillary melting point apparatus and are uncorrected. X-ray structures were obtained 
with a Microfocus sealed Cu tube from Incote. It is well established that that 
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aforementioned detector allows for the determination of absolute configuration of 
molecules that do not have a heavy atom. 
 Unless otherwise noted, reactions were carried out with distilled and degassed solvents 
under an atmosphere of dry N2 in oven- (135 ºC) or flame-dried glassware with standard 
dry box or vacuum-line techniques. Tetrahydrofuran (Aldrich Chemical Co.) was purified 
by distillation from sodium benzophenone ketyl immediately prior to use. Methanol 
(Acros Organics 99.9% Extra Dry, AcroSeal@) was used as received. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific) under an atmosphere of air.  
n  Reagents: 
Acetyl chloride: purchased from Aldrich and used as received. 
Alkyne substrates for preparation of acyclic enones: purchased from Aldrich and 
distilled over CaH2 prior to use, except 4’-bromophenylacetylene, which was used as 
received. 
Bis(pinacolato)diboron [B2(pin)2]: gifts/purchased from Frontier Scientific, Inc., 
recrystallized from pentane and dried under vacuum prior to use. 
3-Bromo-4-hydroxybenzaldehyde (S1): purchased from Aldrich and used as received. 
tert-Buthanol: purchased from Aldrich and used as received. 
tert-Butyllithium: purchased from Aldrich and titrated before use. 
Tetrakis(acetonitrile)copper (I) hexafluorophosphate: purchased from Aldrich and 
used as received. 
Copper (II) chloride: purchased from Strem and used as received. 
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bis-(Cyclopentadienyl)zirconium dichloride: purchased from Strem and recrystallized 
from toluene prior to use. 
1,8-Diazabicyclo[5.4.0]undec-7-ene (dbu): purchased from Aldrich and purified by 
distillation from CaH2 prior to use. 
Dimethyl sulfoxide: purchased from Aldrich and purified by distillation from CaH2 prior 
to use. 
Dimethoxyethane: purchased from Aldrich and purified by distillation from Na prior to 
use. 
Ethylene glycol: purchased from Aldrich and used as received. 
Geranial: prepared from oxidation of geraniol according to a previously reported 
procedure.62 
Geraniol: purchased from Aldrich and used as received. 
Imidazolinium salt im-15: prepared according to a previously reported procedure.63 
Imidazolinium salt im-25: prepared according to a previously reported procedure.64 
Isopropanol: purchased from Fisher Scientific and and purified by distillation from Mg 
prior to use. 
Lithium tert-butoxide: purchased from Strem and used as received. 
2-Methyl-2-butene: purchased from TCI and used as received. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(62) Fontán, N.; Vaz, B.; Álvarez, R.; de Lera, A. R. Chem. Commun. 2013, 49, 2694–2696. 
(63) Lee, K.-s.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455–4462. 
(64) Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. 
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3-Methyl-2-cyclohexen-1-one: purchased from Aldrich and purified by distillation from 
CaH2 prior to use. 
3-Methyl-2-cyclopenten-1-one: purchased from Aldrich and purified by distillation from 
CaH2 prior to use. 
N-Methylmorpholine N-oxide: purchased from Aldrich and used as received. 
(R,R)-QuinoxP*: purchased from Aldrich and used as received. 
Tetrapropylammonium perruthenate: purchased from TCI and used as received. 
p-Toluenesulfonic acid monohydrate: purchased from Aldrich and used as received. 
Trimethylaluminum: purchased from Aldrich (neat) and used as received. 
Triethylaluminum: purchased from Aldrich (neat) and used as received. 
Sodium chlorite: purchased from Alfa Aesar and used as received. 
Sodium hypochlorite (10–15%): purchased from Aldrich and used as received. 
Sodium phosphate monobasic monohydrate: purchased from Alfa Aesar and used as 
received. 
Sodium tert-butoxide: purchased from Strem and used as received. 
n  Representative Experimental Procedure for the Synthesis of Enone Substrates 
Cyclic enones were prepared according to a reported protocol.65 Acyclic enone substrates 
were synthesized according to a modified reported precedure66 for zirconocene-catalyzed 
carboalumination reactions. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(65) Moritani, Y.; Appella, D. H.; Jurkauskas, V.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 6797–
6798. 
(66) Wipf, P.; Lim, S. Angew. Chem., Int. Ed. 1993, 32, 1068–1071. 
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To a flame-dried round bottom flask equipped with a stir bar was added Cp2ZrCl2 
(643 mg, 2.20 mmol) and CH2Cl2 (50 mL) under N2 after which Me3Al (2.9 mL, 30 
mmol, USE CAUTION, PYROPHORIC) was added by syringe. The resulting mixture 
was allowed to cool to –22 °C (dry ice/acetone bath) and H2O (0.27 ml, 15 mmol) was 
added by syringe drop-wise (reaction is extremely vigorous, use vent needle). After 
allowing the mixture to stir for 10 min, phenylacetylene (1.1 ml, 10 mmol) was added by 
syringe. The mixture was allowed to stir for an additional 10 minutes, after which, acetyl 
chloride (0.85 ml, 12 mmol) was added. The mixture was allowed to stir for 10 min at –
22 ºC and then warm to 22 ºC and stir for an additional 10 min. The reaction was 
quenched upon drop-wise addition of a saturated aqueous solution of K2CO3 (1.0 mL, 
reaction is vigorous, use of a vent needle is recommended) until evolution of gas ceases. 
The mixture was transferred to a separatory funnel, Rochelle’s salt was added (20 mL) 
and the layers separated. The aqueous layer was washed with Et2O (3 x 20 mL). The 
combined organic layers were dried over MgSO4 and concentrated. The resulting yellow 
oil was purified by silica gel chromatography (100% hexanes → 20:1 Hexanes/Et2O) to 
afford (E)-4-phenylpent-3-en-2-one (substrate for 1.130) as a light yellow solid (1.3 g, 
8.0 mmol, 80%). 
(E)-4-(4-Fluorophenyl)pent-3-en-2-one (substrate for 1.131): IR (neat): 3051 (w), 
2919 (w), 1680 (s), 1598 (s), 1584 (s), 1507 (s), 1234 (m), 1178 (s), 1162 (s), 824 (m) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 7.42–7.39 (2H, m), 7.02–6.97 (2H, m), 6.41 (1H, s), 
2.45 (3H, s), 2.22 (3H, s); 13C NMR (100 MHz, CDCl3): δ 198.8, 163.4, (d, J = 248.1 
Hz), 162.1, 152.6, 138.6 (d, J = 3.1 Hz), 128.4 (d, J = 8.4 Hz), 124.4, 115.6 (d, J = 21.3 
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Hz), 32.3, 18.4; HRMS (ESI+): Calcd for C11H12F1O1 [M+H]+: 179.0872, Found: 
179.0877. 
(E)-8-Hydroxy-4-methyloct-3-en-2-one (substrate for 1.137): IR (neat): 3425 (br), 
2938 (m), 2866 (m), 1685 (s), 1612 (s), 1423 (m), 1357 (m), 1217 (m), 1064 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 6.06 (1H, s), 3.67–3.63 (2H, m), 2.16–2.11 (8H, m), 1.58–
1.53 (5H, m); 13C NMR (100 MHz, CDCl3): δ 199.1, 158.6, 123.7, 62.5, 40.9, 32.3, 31.8, 
23.8, 19.3; HRMS (ESI+): Calcd for C9H17O2 [M+H]+: 157.1229, Found: 157.1231. 
(E)-5-(2-Methoxyphenyl)-4-methylpent-3-en-2-one (substrate for 1.136): IR (neat): 
3002 (m), 2938 (m), 2837 (m), 1686 (s), 1616 (s), 1493 (s), 1245 (s), 754 (s) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.26–7.22 (1H, m), 7.08 (1H, d, J = 7.6, 2.0 Hz), 6.93–6.87 
(2H, m), 5.98 (1H, s), 3.81 (3H, s), 3.44 (2H, s), 2.14 (3H, s), 2.13 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 199.1, 157.7, 157.3, 130.8, 128.2, 126.4, 124.5, 120.6, 110.7, 55.5, 
40.9, 32.0, 19.6; HRMS (ESI+): Calcd for C13H17O2 [M+H]+: 205.1229, Found: 
205.1226.  
(E)-3-(4-Methoxyphenyl)-1-phenylbut-2-en-1-one (substrate for 1.138): IR (neat): 
3056 (m), 3002 (m), 2956 (m), 2837 (m), 1650 (s), 1585 (s), 1566 (s), 1447 (m), 1250 
(m), 1211 (s), 1177 (s), 1026 (s), 828 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 8.01–7.98 
(2H, m), 7.58–7.45 (5H, m), 7.17 (1H, s), 6.97–6.93 (2H, m), 3.85 (3H, s), 2.61 (3H, s); 
13C NMR (100 MHz, CDCl3): δ 191.9, 160.7, 154.9, 139.8, 135.0, 132.5, 128.6, 128.3, 
128.0, 120.5, 114.1, 55.5, 18.8; HRMS (ESI+): Calcd for C17H17O2 [M+H]+: 253.1229, 
Found: 253.1229.  
(E)-6-Methyl-2-phenylhept-2-en-4-one (substrate for 1.135): IR (neat): 2955 (m), 
2870 (m), 1678 (s), 1598 (s), 1446 (m), 1364 (m), 1174 (m), 1064 (m), 756 (s), 695 (s) 
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cm–1; 1H NMR (400 MHz, CDCl3): δ 7.49–7.45 (2H, m), 7.39–7.34 (3H, m), 6.48 (1H, s), 
2.54 (3H, s), 2.41 (2H, d, J = 7.2 Hz), 2.21 (1H, sept, J = 5.8 Hz), 0.97 (6H, d, J = 6.8 
Hz); 13C NMR (100 MHz, CDCl3): δ 201.3, 153.4, 142.7, 129.0, 128.5, 126.5, 124.6, 
54.0, 25.3, 25.3, 22.7, 18.3; HRMS (ESI+): Calcd for C14H19O1 [M+H]+: 203.1436, 
Found: 203.1436. 
n  Experimental Procedure for the Synthesis of 1.146 
 
(E)-1-(5-(1,3-Dioxolan-2-yl)-2-hydroxyphenyl)-3,7-dimethylocta-2,6-dien-1-one (S2): 
A flame-dried 100 mL round-bottom flask equipped with a Dean-Stark trap, reflux 
condenser, and a stir bar was charged with benzaldehyde S1 (2.00 g, 9.95 mmol), 
ethylene glycol (2.20 mL, 39.8 mmol), p-TsOH (189 mg, 0.995 mmol) and toluene (50 
mL). The mixture was allowed to reflux for 12 h. After allowing the solution to cool to 
22 °C, toluene was removed in vacuo. The resulting residue was passed through a short 
plug of neutralized silica gel with Et2O as eluent. All volatiles were removed under 
reduced pressure to afford 2.19 g (8.95 mmol, 90%) of S2, which was used in the next 

















10 mol % p-TsOH
toluene, reflux (Dean-Stark)
12 h
1) t-BuLi, thf, –78 ºC; then 
geranial,  –78 ºC, 2 h
2) 1.0 mol % TPAP, NMO
CH2Cl2, 22 °C, 2 h
10 mol % p-TsOH









To a solution of S2 (1.00 g, 4.08 mmol) in thf (20 mL) was added 1.7 M t-BuLi (7.20 
mL, 12.2 mmol) at –78 °C under an N2 atmosphere. After 10 min, geranial (1.05 mL, 
6.12 mmol) was added and the reaction mixture was allowed to stir for 2 h at –78 °C. 
After allowing the solution to warm to 22 ºC, water (10 mL) was added. The layers were 
separated and the aqueous segment was washed with Et2O (3 x 15 mL). The combined 
organic layer was dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
residue was dissolved in CH2Cl2 and N-methylmorpholine N-oxide (718 mg, 6.12 mmol) 
and tetrapropylammonium perruthenate (14.0 mg, 0.0408 mmol) were added. The 
solution was allowed to stir at 22 ºC for 2 h, after which it was filtered through a short 
plug of neutralized (flushed with 2 % Et3N in Et2O) silica gel with Et2O as eluent. All 
volatiles were removed in vacuo and the resulting brown oil was purified by neutralized 
(flushed with 2 % Et3N in 10:1 hexanes: Et2O) silica gel chromatography (10:1 hexanes: 
Et2O) to afford 839 mg (2.65 mmol, 65%) of S3 as light yellow solid. Melting point: 56–
58 °C.  IR (neat): 2963 (m), 2922 (m), 2887 (m), 1638 (s), 1583 (s), 1490 (m), 1364 (m), 
1289 (m), 1206 (m), 1088 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 12.9 (1H, s), 7.86 
(1H, d, J = 2.0 Hz), 7.56 (1H, dd, J = 2.0, 8.4 Hz), 6.99 (1H, d, J = 8.8 Hz), 6.78 (1H, s), 
5.74 (1H, s), 5.15–5.12 (1H, m), 4.16–4.02 (4H, m), 2.34–2.23 (4H, m), 2.20 (3H, s), 
1.72 (3H, s), 1.64 (3H, s). 13C NMR (100 MHz, CDCl3): δ 196.4, 164.2, 161.8, 134.1, 
133.0, 128.3, 128.1, 123.0, 120.4, 119.6, 118.8, 103.4, 65.4, 41.8, 26.3, 25.8, 20.2, 17.9; 
HRMS (ESI+): Calcd for C19H25O4 [M+H]+: 317.1753, Found: 317.1762. 
(E)-3-(3,7-Dimethylocta-2,6-dienoyl)-4-hydroxybenzaldehyde (1.146). To a solution 
of S3 (500 mg, 1.58 mmol) in acetone (5 mL) was added p-TsOH•H2O (30.1 mg, 0.158 
mmol). The mixture was allowed to stir at 22 ºC for 10 min. Water (5 mL) and Et2O (5 
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mL) were added. The organic layer was separated and the aqueous layer was washed with 
Et2O (3 x 10 mL). The combined organic layer was dried over Na2SO4, filtered, and 
concentrated in vacuo. The resulting yellow oil was purified by silica gel chromatography 
(10:1 hexanes: Et2O) to afford 417 mg (1.53 mmol, 97%) of 1.146 as light yellow oil. IR 
(neat): 2966 (m), 2918 (m), 2856 (m), 2732 (w), 1693 (s), 1634 (s), 1577 (s), 1485 (m), 
1297 (m), 1214 (m), 838 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 13.5 (1H, s), 9.89 
(1H, s), 8.31 (1H, d, J = 2.0 Hz), 7.96 (1H, dd, J = 6.8, 1.6 Hz), 7.09 (1H, d, J = 7.2 Hz), 
6.86 (1H, s), 5.15–5.12 (1H, m), 2.37–2.16 (7H, m), 1.72 (3H, s), 1.60 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 195.8, 190.1, 168.6, 164.5, 136.4, 133.2, 132.9, 128.1, 122.8, 
120.6, 119.7, 118.8, 42.1, 26.4, 25.9, 20.6, 18.0; HRMS (ESI+): Calcd for C17H21O3 
[M+H]+: 273.1491, Found: 273.1483. 
n  Representative Procedure for NHC–Catalyzed Enantioselective 
(Pinacolato)boron Conjugate Addition (Table 1.3, Entry 13): In a glove-box, an oven-
dried 1 dram vial equipped with a stir bar was charged with imidazolinium salt im-25 
(3.2 mg, 0.005 mmol), dbu (3.0 mg, 0.02 mmol) and thf (0.15 mL, 0.033 M solution of 
catalyst) for 30 min at 22 °C under a dry N2 atm. Bis(pinacolato)diboron (27.9 mg, 0.11 
mmol), 3-methyl-2-cyclohexen-1-one (11.0 mg, 0.10 mmol) and methanol (0.24 mL) 
were added to the vial (0.26 M solution of substrate), which was sealed with a cap before 
removal from the glove-box. The solution was allowed to stir at 22 °C for 14 h, after 
which the reaction was quenched by the addition of an aqueous solution of NH4Cl (0.5 
mL, 1.0 M) and the mixture was allowed to stir for an additional 20 min. The aqueous 
layer was washed with diethyl ether (3 x 2 mL). The combined organic layers were dried 
over anhydrous MgSO4 and filtered. The volatiles were removed under vacuum and the 
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resulting light yellow oil was purified by silica gel chromatography (hexanes:Et2O = 
10:1) to afford 21.4 mg (0.09 mmol, 90% yield) of 1.112. For the representative 
procedure carried out in a typical fume hood, see below. 
(S)-3-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-one 
(1.112): The spectroscopic data are consistent with those reported previously.67 1H NMR 
(400 MHz, CDCl3): δ 2.48 (1H, d, J = 13.6 Hz), 2.31–2.15 (2H, m), 2.01–1.90 (3H, m), 
1.82–1.71 (1H, m), 1.43–1.34 (1H, m), 1.19 (12H, s), 1.01 (3H, s). Specific Rotation: 
[α]D20 –11.5 (c 1.01, CHCl3) for an enantiomerically enriched sample of 96:4 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material (96:4 er shown; Chiraldex B-DM column, 15 psi, 100 °C). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 74.770 51.428 1 74.596 95.677 
2 78.790 48.573 2 78.882 4.323 
(S)-3-Butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-one (1.123): 
IR (neat): 2976 (m), 2960 (m), 2930 (s), 2873 (m), 1714 (s), 1409 (m), 1313 (s), 1144 (s) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 2.52 (1H, dt, J = 13.6, 1.5 Hz), 2.34–2.18 (2H, d, 
m), 2.01–1.92 (3H, m), 1.81–1.71 (1H, m), 1.48–1.21 (19H, m), 0.88 (3H, t, J = 7.0 Hz); 
13C NMR (100 MHz, CDCl3): δ 212.3, 83.7, 49.3, 41.5, 38.6, 32.9, 28.1, 25.0, 24.8, 24.2, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(67) Chen, I.–H.; Yin, L.; Itano, W.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 11664–11665. 
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23.5, 14.1; HRMS (ESI+): Calcd for C16H30B1O3 [M+H]+: 281.2288, Found: 281.2294. 
Specific Rotation: [α]D20 –9.1 (c 0.37, CHCl3) for an enantiomerically enriched sample of 
94:6 er. Enantiomeric purity is determined by GC analysis in comparison with authentic 
racemic material (94:6 er shown; Chiraldex B-DM column, 15 psi, 100 °C). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 335.743 51.669 1 331.702 93.890 
2 344.844 48.331 2 339.110 6.110 
(R)-3-Phenethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-one 
(1.124): Melting point: 90–91°C. IR (neat): 2977 (m), 2932 (m), 2866 (w), 1711 (s), 1454 
(m), 1383 (m), 1314 (m), 1143 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.29–7.24 (2H, 
m), 7.19–7.15 (3H, m), 2.63–2.49 (3H, m), 2.37–2.21 (2H, m), 2.09–1.96 (3H, m), 1.87–
1.62 (3H, m), 1.55–1.48 (1H, m), 1.25 (12H, s); 13C NMR (100 MHz, CDCl3): δ 211.8, 
142.3, 128.5, 128.4, 125.9, 83.8, 49.1, 41.5, 41.2, 32.8, 32.5, 25.0, 24.9, 24.1; HRMS 
(ESI+): Calcd for C20H30B1O3 [M+H]+: 329.2293, Found: 329.2288. Specific Rotation: 
[α]D20 –8.6 (c 1.20, CHCl3) for an enantiomerically enriched sample of 96:4 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (96:4 er shown; Chiralcel OD-H column, 99/1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 31.815 49.734 1 31.821 4.136 
2 35.116 50.266 2 34.916 95.864 
(S)-3-(Pent-4-yn-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-
one (1.144): IR (neat): 3283 (m), 2977 (m), 2933 (m), 2870 (m), 2116 (w), 1710 (s), 
1386 (m), 1312 (s), 1143 (s), 892 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 2.53 (1H, d, J 
= 14.0 Hz), 2.34–2.14 (4H, m), 2.02–1.93 (4H, m), 1.82–1.72 (1H, m), 1.54–1.42 (5H, 
m), 1.21 (12H, s); 13C NMR (100 MHz, CDCl3): δ 211.8, 84.4, 83.8, 68.6, 49.2, 41.5, 
38.0, 32.8, 25.0, 24.97, 24.9, 24.1, 19.2; HRMS (ESI+): Calcd for C17H28B1O3 [M+H]+: 
291.2132, Found: 291.2134. Specific Rotation: [α]D20 –10.6 (c 0.50, CHCl3) for an 
enantiomerically enriched sample of 94.5:5.5 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (94.5:5.5 er shown; 
Chiralcel OD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 300 nm). 
 
Peak # Time (mins) Area (%) Peak # Time (mins) Area (%) 
1 31.602 49.431 1 29.582 94.500 
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2 34.556 50.569 2 32.610 5.500 
(S)-3-(Hexa-4,5-dien-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)cyclohexan-1-one (1.145): IR (neat): 2976 (m), 2934 (m), 2871 (m), 1955 (m), 1703 
(m), 1665 (s), 1454 (s), 1327 (s), 1145 (s), 852 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
5.07 (1H, quin, J = 6.7 Hz), 4.66–4.63 (2H, m), 2.54 (1H, d, J = 13.6 Hz), 2.33–2.18 (2H, 
m), 2.01–1.92 (5H, m), 1.82–1.72 (1H, m), 1.49–1.34 (5H, m), 1.21 (12H, s); 13C NMR 
(100 MHz, CDCl3): δ 212.1, 208.7, 89.9, 83.7, 75.0, 49.3, 41.5, 38.4, 32.9, 28.9, 25.5, 
25.0, 24.9, 24.2; HRMS (ESI+): Calcd for C18H30B1O3 [M+H]+: 305.2301, Found: 
305.2288. Specific Rotation: [α]D20 –33.0 (c 0.50, CHCl3) for an enantiomerically 
enriched sample of 95:5 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (95:5 er shown; Chiralpak AS-H column, 
99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 38.999 48.502 1 38.054 5.321 
2 41.746 51.498 2 40.493 94.679 
(S)-3-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-one 
(1.117): The spectroscopic data match those reported previously.67 1H NMR (400 MHz, 
CDCl3): δ 7.32–7.28 (4H, m), 7.19–7.14 (1H, m), 2.87 (1H, d, J = 14.0 Hz), 2.59 (1H, d, 
J = 14.4 Hz), 2.40–2.24 (3H, m), 2.01–1.75 (3H, m) 1.15 (6H, s), 1.146 (6H, s); Specific 




Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (96:4 er shown; Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 26.048 49.830 1 27.150 95.722 
2 27.437 50.170 2 28.760 4.278 
(S)-3-(4-Methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-
1-one (1.118): The spectroscopic data match those reported previously.67 1H NMR (400 
MHz, CDCl3): δ 7.20 (2H, d, J = 8.8 Hz), 6.84 (2H, d, J = 8.8 Hz), 3.78 (3H, s), 2.84 
(1H, d, J = 14.4 Hz), 2.55 (1H, d, J = 14.0 Hz), 2.39–2.23 (3H, m), 1.96–1.87 (2H, m), 
1.84–1.73 (1H, m), 1.15 (6H, s), 1.14 (6H, s); Specific Rotation: [α]D20 +13.6 (c 1.01, 
CHCl3) for an enantiomerically enriched sample of 97:3 er. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (97:3 er 
shown; Chiraldex AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 45.310 48.898 1 47.240 97.333 
2 47.650 51.102 2 49.810 2.667 
(S)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(4-
(trifluoromethyl)phenyl)cyclohexan-1-one (1.120): IR (neat): 2956 (m), 2926 (s), 2855 
(m), 2853 (w), 1717 (m), 1326 (s), 1166 (m), 1126 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.55 (2H, d, J = 8.4 Hz), 7.40 (2H, d, J = 8.4 Hz), 2.88 (1H, d, J = 14.0 Hz), 
2.60 (1H, d, J = 14.0 Hz), 2.41–2.24 (3H, m), 2.04–1.79 (3H, m), 1.16 (6H, s), 1.15 (6H, 
s); 13C NMR (100 MHz, CDCl3): δ 210.7, 148.9, 128.1 (q, J = 31.9 Hz), 126.9, 125.5 (q, 
J = 3.8 Hz), 124.4 (q, J = 272.1 Hz), 84.3, 48.2, 41.2, 33.2, 25.0, 24.7, 24.5, 23.7; HRMS 
(ESI+): Calcd for C19H24B1F3NaO3 [M+Na]+: 391.1668, Found: 391.1672. Specific 
Rotation: [α]D20 +6.2 (c 0.63, CHCl3) for an enantiomerically enriched sample of 96:4 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (96:4 er shown; Chiralpak AS-H column, 99/1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 38.270 49.368 1 38.710 96.086 
2 43.560 50.632 2 44.690 3.914 
(S)-3-(3-Methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-
1-one (1.121): The spectroscopic data match those reported previously.67 1H NMR (400 
MHz, CDCl3): δ 7.21 (1H, t, J = 8.2 Hz), 6.88–6.84 (2H, m), 6.71 (1H, ddd, J = 8.5, 2.7, 
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0.9 Hz), 3.79 (3H, s), 2.85 (1H, dt, J = 14.0, 1.5 Hz), 2.57 (1H, d, J = 14.0 Hz), 2.39–2.24 
(3H, m), 2.00–1.89 (2H, m), 1.88–1.74 (1H, m), 1.16 (6H, s), 1.155 (6H, s); Specific 
Rotation: [α]D20 +15.9 (c 0.49, CHCl3) for an enantiomerically enriched sample of 93:7 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (93:7 er shown; Chiralcel OC-H column, 98/2 hexanes/i-PrOH, 0.3 
mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 46.789 49.065 1 47.971 7.035 
2 54.404 50.935 2 55.322 92.965 
(S)-3-(Naphthalen-2-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-
1-one (1.122): Melting point: 146–147°C. IR (neat): 2975 (m), 2929 (m), 2866 (w), 2853 
(w), 1712 (s), 1448 (w), 1370 (s), 1326 (s), 1142 (s), 856 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.81–7.77 (3H, m), 7.67 (1H, s), 7.48–7.40 (3H, m), 2.96 (1H, d, J = 14.0 Hz), 
2.72 (1H, d, J = 14.4 Hz), 2.47–2.27 (3H, m), 2.13–2.07 (1H, m), 1.93–1.81 (2H, m), 
1.16 (12H, s); 13C NMR (100 MHz, CDCl3): δ 211.4, 142.2, 133.8, 131.9, 128.1, 128.0, 
127.5, 126.1, 125.6, 125.5, 124.7, 84.1, 48.5, 41.4, 33.2, 24.7, 24.5, 23.8; HRMS (ESI+): 
Calcd for C22H28B1O3 [M+H]+: 351.2132, Found: 351.2136. Specific Rotation: [α]D20 
+32.9 (c 0.34, CHCl3) for an enantiomerically enriched sample of 96:4 er. Enantiomeric 
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purity was determined by HPLC analysis in comparison with authentic racemic material 
(96:4 er shown; Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 66.555 50.121 1 67.656 3.900 
2 71.445 51.094 2 72.684 96.100 
(S)-3-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopentan-1-one 
(1.113): The spectroscopic data match those reported previously.68 1H NMR (400 MHz, 
CDCl3): δ 2.42 (1H, d, J = 18.0 Hz), 2.32–2.11 (3H, m), 1.87 (1H, d, J = 18.0 Hz), 1.68–
1.60 (1H, m), 1.23 (12H, s), 1.12 (3H, s); Specific Rotation: [α]D20 –14.0 (c 0.20, CHCl3) 
for an enantiomerically enriched sample of >98:2 er. Enantiomeric purity was determined 
by GC analysis in comparison with authentic racemic material (>98:2 er shown; 
Chiraldex B-DM column, 15 psi, 100 °C).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 49.279 50.532 1 49.189 0.864 
2 51.730 49.468 2 50.785 99.136 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(68) Lee, K–s.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 7253–7255. 
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(S)-3-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopentan-1-one 
(1.114): The spectroscopic data match those reported previously.67 1H NMR (400 MHz, 
CDCl3): δ 7.33–7.16 (5H, m), 2.91 (1H, d, J = 18.0 Hz), 2.73–2.67 (1H, m), 2.42 (1H, d, 
J = 17.6 Hz), 2.37–2.18 (2H, m), 2.11–2.03 (1H, m), 1.14 (12H, s). Specific Rotation: 
[α]D20 –25.7 (c 0.80, CHCl3) for an enantiomerically enriched sample of 93:7 er. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material (93:7 er shown; Chiraldex B-DM column, 15 psi, 130 °C).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 184.965 49.799 1 180.227 93.026 
2 193.738 50.201 2 186.661 6.974 
(S)-3-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopentan-
1-one (1.115): Melting point: 106–108°C. IR (neat): 2980 (m), 2963 (m), 2928 (m), 2858 
(m), 1743 (s), 1507 (s), 1406 (s), 1374 (s), 1325 (s), 1221 (m), 1137 (s), 851 (m), 836 (m) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 7.22–7.17 (2H, m), 7.02–6.96 (2H, m), 2.89 (1H, d, 
J = 17.6 Hz), 2.71–2.65 (1H, m), 2.36 (1H, d, J = 18.4 Hz), 2.36–2.18 (2H, m), 2.06–1.99 
(1H, m), 1.34 (12H, s); 13C NMR (100 MHz, CDCl3): δ 218.6, 161.2 (d, J = 242.8 Hz), 
140.6 (d, J = 3.8 Hz), 128.0 (d, J = 7.6 Hz), 115.3 (d, J = 20.5 Hz), 84.3, 47.5, 38.3, 32.3, 
29.7, 24.6, 24.5; HRMS (ESI+): Calcd for C17H23B1F1O3 [M+H]+: 305.1724, Found: 
305.1720. Specific Rotation: [α]D20 –27.9 (c 0.60, CHCl3) for an enantiomerically 
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enriched sample of 95:5 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (95:5 er shown; Chiralpak AS-H column, 
99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 68.380 49.925 1 72.100 94.719 
2 131.38 50.075 2 135.55 5.282 
(S)-3-(3-Methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)cyclopentan-1-one (1.116): Melting point: 78–79 °C. IR (neat): 2976 (m), 2932 (m), 
1742 (s), 1600 (m), 1581 (s), 1352 (m), 1322 (m), 1139 (s) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.24–7.20 (1H, m), 6.84–6.79 (2H, m), 6.74–6.71 (1H, m), 3.80 (3H, s), 2.87 
(1H, d, J = 17.6 Hz), 2.69–2.63 (1H, m), 2.41 (1H, d, J = 18.0 Hz), 2.36–2.17 (2H, m), 
2.10–2.02 (1H, m), 1.15 (12H, s); 13C NMR (100 MHz, CDCl3): δ 218.9, 159.8, 146.6, 
129.5, 119.1, 112.8, 110.9, 84.2, 55.3, 47.4, 38.3, 32.1, 24.6, 24.5 HRMS (ESI+): Calcd 
for C18H26B1O4 [M+H]+: 317.1924, Found: 317.1931. Specific Rotation: [α]D20 –24.4 (c 
0.56, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (95:5 
er shown; Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 59.770 49.476 1 59.201 94.834 
2 72.253 53.302 2 72.006 5.166 
(S)-3-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cycloheptan-1-one 
(1.126): IR (neat): 2977 (m), 2926 (m), 2863 (m), 1698 (s), 1462 (m), 1371 (m), 1317 (s), 
1142 (s), 851 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 2.66 (1H, dd, J = 14.8, 1.2 Hz), 
2.46–2.42 (2H, m),  2.28 (1H, d, J = 14.8 Hz), 1.96–1.91 (1H, m), 1.84–1.73 (2H, m), 
1.68–1.54 (2H, m), 1.41–1.34 (1H, m), 1.22 (12H, s), 0.97 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 214.8, 83.6, 53.1, 44.6, 40.8, 27.7, 25.5, 24.8, 24.3; HRMS (ESI+): Calcd for 
C14H26B1O3 [M+H]+: 253.1984, Found: 253.1975. Specific Rotation: [α]D20 –31.1 (c 0.78, 
CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (95:5 er 
shown; Chiraldex B-DM column, 15 psi, 100 °C).  
	  
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 138.288 49.887 1 141.062 94.722 
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2 141.058 50.113 2 142.499 5.278 
(S)-3-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclooctan-1-one 
(1.127): IR (neat): 2975 (m), 2928 (m), 2855 (m), 1698 (s), 1468 (m), 1381 (m), 1371 
(m), 1313 (s), 1146 (s), 1113 (s), 844 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 2.64 (1H, 
d, J = 11.6 Hz), 2.32–2.28 (3H, m),  2.01–1.82 (2H, m), 1.74–1.68 (1H, m), 1.60–1.46 
(3H, m), 1.41–1.29 (1H, m), 1.26–1.24 (13H, m), 1.01 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 216.8, 83.4, 46.6, 45.4, 35.0, 29.3, 24.9, 24.7, 24.4, 23.0, 22.7; HRMS (ESI+): 
Calcd for C15H28B1O3 [M+H]+: 267.2132, Found: 267.2136. Specific Rotation: [α]D20 
+49.6 (c 1.00, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric 
purity was determined by GC analysis in comparison with authentic racemic material 
(95:5 er shown; Chiraldex B-DM column, 15 psi, 100 ºC).  
	  
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 201.869 50.161 1 206.896 95.376 
2 209.860 49.839 2 212.869 4.624 
(S)-4-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-one (1.130): 
The spectroscopic data match those reported previously.69 1H NMR (400 MHz, CDCl3): δ 
7.38–7.35 (2H, m), 7.30–7.26 (2H, m), 7.17–7.12 (1H, m), 3.18 (1H, d, J = 18.4 Hz), 
2.76 (1H, d, J = 18.0 Hz), 2.14 (3H, s), 1.34 (3H, s), 1.21 (6H, s), 1.19 (6H, s). Specific 
Rotation: [α]D20 –36.2 (c 0.60, CHCl3) for an enantiomerically enriched sample of 92:8 er. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(69) O’Brien, J. M.; Lee, K–s.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10630–10633. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (>99:1 er shown; Chiraldex AD-H column, 99/1 hexanes/i-PrOH, 0.3 
mL/min, 220 nm) 
 
Peak # Time (mins) Area (%) Peak # Time (mins) Area (%) 
1 9.930 48.156 1 9.907 99.712 
2 10.389 51.844 2 10.392 0.288 
(S)-4-(4-Methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-
one (1.129): Melting point: 82–83 °C. IR (neat): 2975 (m), 2927 (s), 2855 (m), 1715 (m), 
1511 (s), 1345 (s), 1464 (m), 1372 (m), 1348 (m), 1250 (s) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.30–7.60 (2H, m), 6.85–6.81 (2H, m), 3.78 (3H, s), 3.13 (1H, d, J = 18.0 Hz), 
2.72 (1H, d, J = 18.0 Hz), 2.12 (3H, s), 1.31 (3H, s), 1.21 (6H, s), 1.18 (6H, s); 13C NMR 
(100 MHz, CDCl3): δ 208.3, 157.5, 138.4, 127.6, 113.7, 83.5, 55.3, 54.5, 30.4, 24.8, 24.7, 
23.0; HRMS (ESI+): Calcd for C18H28B1O4 [M+H]+: 319.2081, Found: 319.2090. 
Specific Rotation: [α]D20 –32.3 (c 0.56, CHCl3) for an enantiomerically enriched sample 
of 91:9 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (99:1 er shown; Chiralcel OD-H column, 99.5/0.5 hexanes/i-
PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 23.958 50.846 1 22.371 98.697 
2 25.295 49.154 2 23.683 1.303 
(S)-4-(4-Fluorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-one 
(1.131): Melting point: 81–83 °C. IR (neat): 2976 (m), 2927 (m), 1715 (s), 1509 (s), 1372 
(m), 1347 (s), 1315 (s), 1228 (s), 1144 (s), 859 (m), 835 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.34–7.30 (2H, m), 6.98–6.94 (2H, m), 3.12 (1H, d, J = 18.0 Hz), 2.74 (1H, d, 
J = 18.0 Hz), 2.13 (3H, s), 1.32 (3H, s), 1.20 (6H, s), 1.18 (6H, s); 13C NMR (100 MHz, 
CDCl3): δ 208.0, 161.0 (d, J = 241.8 Hz), 142.0 (d, J = 3.0 Hz), 128.1 (d, J = 8.2 Hz), 
115.0 (d, J = 20.9 Hz), 83.6, 54.5, 30.3, 29.9, 24.7, 24.65, 23.1; HRMS (ESI+): Calcd for 
C17H25B1F1O3 [M+H]+: 307.1881, Found: 305.1881. Specific Rotation: [α]D20 –68.4 (c 
0.50, CHCl3) for an enantiomerically enriched sample of 92:8 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (92:8 
er shown; Chiralcel AZ-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 13.868 49.426 1 13.384 8.095 
2 14.595 50.574 2 13.870 91.905 
(S)-4-(4-Bromophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-one 
(1.132): Melting point: 125–127 °C. IR (neat): 2977 (m), 2928 (m), 1716 (s), 1490 (m), 
1371 (m), 1345 (s), 1316 (s), 1143 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.39 (2H, d, J 
= 8.8 Hz), 7.23 (2H, d, J = 8.8 Hz), 3.11 (1H, d, J = 18.0 Hz), 2.73 (1H, d, J = 18.4 Hz), 
2.14 (3H, s), 1.34 (3H, s), 1.20 (6H, s), 1.18 (6H, s); 13C NMR (100 MHz, CDCl3): δ 
207.9, 145.6, 131.3, 128.6, 119.4, 83.7, 54.2, 30.3, 24.7, 24.67, 22.8; HRMS (ESI+): 
Calcd for C17H25B1Br1O3 [M+H]+: 367.1080, Found: 367.1076. Specific Rotation: [α]D20 
–39.2 (c 0.65, CHCl3) for an enantiomerically enriched sample of 92:8 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(99:1 er shown; Chiralcel AZ-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm).  
	  
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 14.257 49.860 1 15.027 1.017 
2 15.085 50.140 2 15.956 98.983 
(S)-4-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-one (1.133): IR 
(neat): 2970 (m), 2936 (m), 1715 (s), 1347 (s), 1309 (s), 1316 (s), 1144 (s) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.31–7.25 (4H, m), 7.15–7.11 (1H, m), 3.04 (2H, s), 2.14 
(3H, s), 2.99–1.81 (2H, m), 1.22 (6H, s), 1.20 (6H, s), 0.57 (3H, t, J = 7.4  Hz); 13C NMR 
(100 MHz, CDCl3): δ 208.3, 144.3, 128.2, 127.4, 125.4, 83.4, 48.4, 30.5, 28.1, 24.8, 
24.78, 8.5; HRMS (ESI+): Calcd for C18H28B1O3 [M+H]+: 303.2132, Found: 303.2128. 
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Specific Rotation: [α]D20 –26.3 (c 0.22, CHCl3) for an enantiomerically enriched sample 
of 91:9 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (91:9 er shown; Chiralcel OD-H column, 100% hexanes, 0.3 
mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 26.212 50.172 1 25.513 8.591 
2 31.390 49.828 2 29.431 91.409 
(R)-8-Hydroxy-4-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octan-2-one 
(1.137): IR (neat): 3449 (br), 2975 (m), 2933 (m), 2867 (m), 1714 (s), 1469 (m), 1371 (s), 
1307 (s), 1145 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 3.63 (2H, q, J = 6.0 Hz), 2.62 
(1H, d, J = 18.0 Hz), 2.39 (1H, d, J = 18.0 Hz), 2.08 (3H, s), 1.54–1.46 (3H, m), 1.39–
1.28 (3H, m), 1.25 (6H, s), 1.23 (6H, s), 0.92 (3H, s); 13C NMR (100 MHz, CDCl3): δ 
208.9, 83.2, 62.8, 54.2, 38.1, 35.0, 33.4, 30.3, 24.93, 24.91, 21.5, 21.3; HRMS (ESI+): 
Calcd for C15H30B1O4 [M+H]+: 285.2237, Found: 285.2247. Specific Rotation: [α]D20 –
11.2 (c 0.30, CHCl3) for an enantiomerically enriched sample of 97:3 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(97:3 er shown; Chiralcel OJ-H column, 98/2 hexanes/i-PrOH, 0.3 mL/min, 300 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 28.257 50.953 1 28.236 3.428 
2 37.087 49.047 2 37.415 96.572 
(R)-5-(2-Methoxyphenyl)-4-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentan-2-one (1.136): IR (neat): 2974 (m), 2874 (m), 2835 (m) 1713 (s), 1492 (m), 
1460 (m), 1361 (s), 1305 (s), 1169 (s), 1146 (s), 1105 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 7.20–7.15 (1H, m), 7.05 (1H, dd, J = 7.2, 1.6 Hz), 6.88–6.83 (2H, m), 3.74 
(3H, s), 2.99 (1H, d, J = 13.2 Hz), 2.54 (1H, d, J = 13.2 Hz), 2.51 (1H, d, J = 18.8 Hz), 
2.27 (1H, d, J = 18.8 Hz), 2.05 (3H, s), 1.28 (12H, s), 0.87 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 208.6, 158.3, 133.0, 127.5, 127.5, 127.3, 120.0, 110.6, 103.9, 83.1, 55.3, 51.7, 
34.7, 29.7, 24.9, 24.8, 21.3; HRMS (ESI+): Calcd for C19H30B1O4 [M+H]+: 333.2237, 
Found: 333.2251. Specific Rotation: [α]D20 –16.8 (c 0.45, CHCl3) for an enantiomerically 
enriched sample of 93:7 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (93:7 er shown; Chiralcel OC-H column, 
99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 26.085 51.742 1 22.613 92.956 
2 35.151 48.258 2 32.533 7.044 
(S)-1,3-Diphenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-one (1.139): 
The spectroscopic data match those reported previously.10 Melting point: 89–91 °C.  1H 
NMR (400 MHz, CDCl3): δ 8.00–7.98 (2H, m), 7.57–7.53 (1H, m), 7.48–7.43 (4H, m), 
7.33–7.29 (2H, m), 7.19–7.15 (1H, m), 3.67 (1H, d, J = 18.4 Hz), 3.36 (1H, d, J = 18.0 
Hz), 1.43 (3H, s), 1.24 (6H, s), 1.20 (6H, s). Specific Rotation: [α]D20 –55.7 (c 0.69, 
CHCl3) for an enantiomerically enriched sample of 97:3 er. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (97:3 er 
shown; Chiralpak AD-H column, 100% hexanes, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 19.579 47.613 1 19.908 2.903 
2 21.136 52.387 2 21.394 97.097 
(S)-3-(4-Methoxyphenyl)-1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butan-1-one (1.138): IR (neat): 2977 (m), 1683 (s), 1511 (m), 1340 (m), 1307 (m), 
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1249 (s), 1144 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.99–7.97 (2H, m), 7.55–7.38 
(5H, m), 6.88–6.86 (2H, m), 3.80 (3H, s), 3.63 (1H, d, J = 18.0 Hz), 3.33 (1H, d, J = 18.4 
Hz), 1.42 (3H, s), 1.25 (6H, s), 1.21 (6H, s); 13C NMR (100 MHz, CDCl3): δ 199.4, 
157.5, 138.7, 137.3, 133.0, 128.6, 128.2, 127.8, 113.7, 83.4, 55.3, 50.1, 24.79, 24.77, 
23.3; HRMS (ESI+): Calcd for C23H30B1O4 [M+H]+: 381.2237, Found: 381.2236. 
Specific Rotation: [α]D20 –52.8 (c 0.36, CHCl3) for an enantiomerically enriched sample 
of 98:2 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (98:2 er shown; Chiraldex AD-H column, 99/1 hexanes/i-
PrOH, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 22.272 49.966 1 23.292 2.028 
2 30.826 50.034 2 31.774 97.972 
(S)-6-Methyl-2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptan-4-one 
(1.135): IR (neat): 2973 (m), 2957 (m), 2925 (m), 2871 (m), 1709 (m), 1465 (m), 1370 
(m), 1311 (s), 1310 (s), 1140 (s), 699 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.38–7.35 
(2H, m), 7.30–7.25 (2H, m), 7.16–7.12 (1H, m), 3.14 (1H, d, J = 18.4 Hz), 2.72 (1H, d, J 
= 18.4 Hz), 2.31–2.10 (3H, m), 1.34 (3H, s), 1.21 (6H, s), 1.18 (6H, s), 0.92 (6H, d, J = 
6.4 Hz); 13C NMR (100 MHz, CDCl3): δ 210.3, 146.6, 128.3, 126.7, 125.4, 83.4, 54.1, 
51.9, 29.8, 25.3, 24.8, 23.1, 22.7, 22.6; HRMS (ESI+): Calcd for C20H32B1O3 [M+H]+: 
 150	  
331.2445, Found: 331.2454. Specific Rotation: [α]D20 –38.7 (c 0.63, CHCl3) for an 
enantiomerically enriched sample of 95:5 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (95:5 er shown; Chiralcel 
OJ-H column, 100% hexanes, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 29.890 49.269 1 30.511 5.216 
2 61.372 50.731 2 61.773 94.784 
(S)-2-Methyl-5-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-one 
(1.134): IR (neat): 2973 (m), 2931 (m), 2873 (m), 1709 (s), 1466 (m), 1372 (s), 1346 (s), 
1310 (s), 1142 (s), 700 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.39–7.36 (2H, m), 
7.30–7.25 (2H, m), 7.16–7.12 (1H, m), 3.16 (1H, d, J = 18.0 Hz), 2.79 (1H, d, J = 17.6 
Hz), 2.58 (1H, sept, J = 5.9 Hz), 1.33 (3H, s), 1.21 (6H, s), 1.18 (6H, s), 1.10 (3H, d, J = 
2.4 Hz), 1.08 (3H, d, J = 2.0 Hz); 13C NMR (100 MHz, CDCl3): δ 214.2, 146.7, 128.3, 
126.7, 125.4, 83.4, 51.2, 40.7, 24.8, 24.7, 23.0, 18.4, 18.3; HRMS (ESI+): Calcd for 
C19H30B1O3 [M+H]+: 317.2288, Found: 317.2291. Specific Rotation: [α]D20 –32.5 (c 0.64, 
CHCl3) for an enantiomerically enriched sample of 96:4 er. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (96:4 er 




Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.695 51.341 1 15.462 4.300 
2 25.333 48.659 2 23.839 95.700 
(R)-3-Hydroxy-3-phenylbutanoic acid (1.142): IR (neat): 3409 (br), 2978 (m), 2931 
(m), 1705 (s), 1399 (m), 1208 (s), 700 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.45–
7.43 (2H, m), 7.37–7.33 (2H, m), 7.28–7.24 (1H, m), 3.03 (1H, d, J = 16.4 Hz), 2.85 (1H, 
d, J = 16.4 Hz), 1.57 (3H, s). 13C NMR (100 MHz, CDCl3): δ 177.0, 146.5, 128.6, 127.3, 
124.5, 72.9, 46.2, 30.8; HRMS (ESI+): Calcd for C10H16N1O3 [M+NH4]+: 198.1130, 
Found: 198.1130. Specific Rotation: [α]D20 –5.9 (c 0.28, EtOH) for an enantiomerically 
enriched sample of >99:1 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (>99:1 er shown; Chiralcel OD-H column, 
99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 32.561 48.105 1 32.042 0.065 
2 34.444 51.895 2 34.686 99.935 
!
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(R)-4-Hydroxy-4-phenylpentan-2-one (1.141): The spectroscopic data match those 
reported previously.70 1H NMR (400 MHz, CDCl3): δ 7.44–7.41 (2H, m), 7.35–7.31 (2H, 
m), 7.25–7.21 (1H, m), 4.50 (1H, s), 3.19 (1H, d, J = 16.8 Hz), 2.85 (1H, d, J = 17.2 Hz), 
2.08 (3H, s), 1.52 (3H, s). Specific Rotation: [α]D20 +25.1 (c 0.75, CHCl3) for an 
enantiomerically enriched sample of 99:1 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (99:1 er shown; Chiralcel 
OD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 55.999 49.829 1 52.663 98.644 
2 61.778 50.171 2 58.152 1.356 
(R)-3-(3,7-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oct-6-enoyl)-4-
hydroxybenzaldehyde (1.147): IR (neat): 2975 (m), 2926 (m), 2725 (w), 1699 (m), 1640 
(s), 1591 (m), 1482 (m), 1370 (s), 1310 (m), 1144 (s), 881 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 12.8 (1H, s), 9.90 (1H, s), 8.33 (1H, d, J = 2.0 Hz), 7.98 (1H, dd, J = 8.4, 1.6 
Hz), 7.09 (1H, d, J = 8.8 Hz), 5.09 (1H, t, J = 7.2 Hz), 3.29 (1H, d, J = 18.4 Hz), 3.06 
(1H, d, J = 18.4 Hz), 2.08–1.95 (2H, m), 1.66 (3H, s), 1.60 (3H, s), 1.54–1.36 (2H, m), 
1.27 (6H, s), 1.24 (6H, s), 1.06 (3H, s); 13C NMR (100 MHz, CDCl3): δ 206.5, 190.0, 
167.3, 145.5, 136.7, 133.3, 131.5, 128.3, 124.9, 119.6, 119.57, 83.4, 48.6, 39.0, 25.8, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(70) Kobayashi, S.; Xu, P.; Endo, T.; Ueno, M.; Kitanosono, T. Angew. Chem., Int. Ed. 2012, 51, 12763–
12766. 
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25.0, 24.9, 23.96, 21.7, 17.8; HRMS (ESI+): Calcd for C23H34B1O5 [M+H]+: 401.2499, 
Found: 401.2517. Specific Rotation: [α]D20 –20.3 (c 0.23 CHCl3) for an enantiomerically 
enriched sample of 95:5 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (95:5 er shown; Chiraldex AD-H column, 
99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm).  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 40.946 48.962 1 40.570 5.357 
2 43.008 51.038 2 42.637 94.643 
(S)-4-Hydroxy-3-(3-hydroxy-3,7-dimethyloct-6-enoyl)benzaldehyde (product after 
oxidation of 1.147): The spectroscopic data match those reported previously.71 1H NMR 
(400 MHz, CDCl3): δ 12.7 (1H, s), 9.91 (1H, s), 8.32 (1H, d, J = 1.6 Hz), 8.02 (1H, dd, J 
= 8.4, 1.6 Hz), 7.13 (1H, d, J = 9.2 Hz), 5.09 (1H, t, J = 7.2 Hz), 3.30 (1H, d, J = 16.4 
Hz), 3.27 (1H, s), 3.19 (1H, d, J = 16.8 Hz), 2.16–2.05 (2H, m), 1.74–1.57 (8H, m), 1.36 
(3H, s). Specific Rotation: [α]D20 –11.3 (c 0.21, CHCl3). 
n  Experimental Procedure for NHC–Catalyzed Enantioselective (Pinacolato)boron 
Conjugate Addition (performed in a typical fume hood): To a flame-dried 1 dram vial 
equipped with a stir bar was added imidazolinium salt  im-25 (3.2 mg, 0.005 mmol) and 
dbu (3.0 mg, 0.02 mmol). The vial was sealed with a cap with a septum and purged with 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(71) Chakor, J. N.; Merlini, L.; Dallavalle, S. Tetrahedron 2011, 67 , 6300–6307. 
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dry N2 for 20 min before addition of thf (0.15 mL) and the resulting mixture was allowed 
to stir for 30 min at 22 °C under a dry N2 atmosphere. Bis(pinacolato)diboron (27.9 mg, 
0.11 mmol) and 3-methyl-2-cyclohexen-1-one (11.0 mg, 0.10 mmol) were weighed into a 
separate flame-dried 1 dram vial. The vial was sealed with a cap with a septum and 
purged with dry N2 for 20 min before addition of methanol (0.24 mL) and the solution 
was transferred via syringe to the NHC solution (minimal addition of thf was used to 
ensure complete transfer). The mixture was allowed to stir at 22 °C for 14 h, after which 
the reaction was quenched upon addition of an aqueous solution of NH4Cl (0.5 mL, 1.0 
M) and the mixture was allowed to stir for an additional 20 min. The aqueous layer was 
washed with diethyl ether (3 x 2 mL). The combined organic layers were dried over 
anhydrous MgSO4 and filtered. The volatiles were removed under vacuum and the 
resulting light yellow oil was purified by silica gel chromatography (hexanes:Et2O = 
10:1) to afford 21.9 mg (0.09 mmol, 92% yield) of (S)-3-methyl-3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)cyclohexan-1-one (1.112). Enantiomeric purity was determined 
by GC analysis in comparison with authentic racemic material (95:5 er shown; Chiraldex 
B-DM column, 15 psi, 100 °C). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 74.770 51.428 1 74.324 94.906 
2 78.790 48.573 2 78.724 5.094 
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n  Experimental Procedures for Cu–Catalyzed Enantioselective (Pinacolato)boron 
Conjugate Additions with Previously Reported Catalyst Systems  
Reactions with (R,R)–QuinoxP* reported by Shibasaki (Scheme 1.34). Transformations 
were performed according to the reported procedure.68 Dimethyl sulfoxide (125 µL) was 
added to a mixture of bis(pinacolato)diboron (38.1 mg, 0.15 mmol), cyclic enone 
substrate (1.143: 16.2 mg, 0.10 mmol, for 1.145: 17.6 mg, 0.10 mmol), CuPF6(CH3CN)4 
(3.7 mg, 0.010 mmol), and QuinoxP* (4.0 mg, 0.012 mmol), and the mixture was stirred 
for 10 minutes at 22 ºC. A thf solution of 1 M lithium tert-butoxide (15 µL, 0.015 mmol) 
was then added, and the solution was allowed to stir for 12 hours. The reaction mixture 
was diluted with EtOAc (1 mL), water (1 mL) was added, and the mixture was allowed to 
stir for 5 minutes. The aqueous layer was then washed with EtOAc (2 x 1 mL). The 
combined organic layers were dried over Na2SO4, filter, and concentrated under reduce 
pressure. The resulting yellow oil was purified by silica gel column chromatography. 
Reactions with diamine–Cu reported by Shibasaki (Scheme 1.35). Transformations 
were performed according to the reported procedure.72 To a mixture of acyclic enone 
substrate (1.146: 31.6 mg, 0.1 mmol), bis(pinacolato)diboron (38.1 mg, 0.15 mmol), 
CuPF6(CH3CN)4 (3.7 mg, 0.010 mmol), and diamine catalyst (3.2 mg, 0.012 mmol), dme 
(33 µL) was added. The resulting solution was allowed to stir for 5 minutes at 22 ºC. 
Additional dme (167 µL) was then added, and the solution was allowed to stir for 5 min. 
Followed by adding a 1 M thf solution of lithium tert-butoxide (15 µL, 0.015 mmol) and 
isopropanol (15 µL, 0.2 mmol), the solution was stirred for 24 h. The solution was diluted 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(72) Chen, I.–H.; Kanai, M.; Shibasaki, M. Org. Lett. 2010, 12, 4098–4101. 
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with EtOAc (1 mL) and water (0.5 mL) was added. The aqueous layer was washed with 
EtOAc (2 x 1 mL). The combined organic layers were dried over Na2SO4, filter, and 
concentrated under reduce pressure. The resulting yellow oil was purified by silica gel 
column chromatography. 
Reactions with NHC–Cu reported by Hoveyda (Scheme 1.35). Transformations were 
performed according to the reported procedure.69 In an oven-dried 1 dram vial equipped 
with a stir bar, imidazolinium salt (3.3 mg, 0.005 mmol), NaOt-Bu (1.2 mg, 0.013 mmol), 
and CuCl (0.5 mg, 0.005 mmol) were placed and thf (0.5 mL) was added in the glove-box. 
After the solution was allowed to stir for two hours at 22 ºC, the resulting solution was 
charged with B2(pin)2 (27.9 mg , 0.11 mmol). The vessel was sealed with a cap with a 
septum, removed from the glovebox, placed in a fume hood and allowed to cool to –
30 °C. Acyclic enone substrate (1.146: 31.6 mg, 0.1 mmol), and MeOH (4.8 µL, 0.12 
mmol) were added and the mixture was allowed to stir for 24 hours at –30 °C, after 
which the reaction was quenched by the addition of 30% HCl in MeOH (0.5 mL). The 
resulting mixture was subsequently allowed to warm to 22 ºC, H2O (1 mL) was added, 
and the solution was neutralized through addition of a saturated solution of NaHCO3. The 
layers were separated, and the aqueous portion was washed with Et2O (3 x 1 mL). The 
combined organic layers were dried over Na2SO4 and filtered. The volatiles were 







n  Data for X-ray Crystallography of 1.124 
 
Table 1.  Crystal data and structure refinement for C20H29BO3 
Identification code  C20H29BO3 
Empirical formula  C20 H29 B O3 
Formula weight  328.24 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 6.1291(5) Å α= 90 º. 
 b = 9.8899(9) Å β= 90 º. 
 c = 29.990(3) Å γ = 90 º. 
Volume 1817.9(3) Å 3 
Z 4 
Density (calculated) 1.199 Mg/m3 
Absorption coefficient 0.610 mm-1 
F(000) 712 
Crystal size 0.400 x 0.150 x 0.080 mm3 
Theta range for data collection 2.947 to 70.063 º. 
Index ranges -5<=h<=7, -11<=k<=11, -36<=l<=36 
Reflections collected 22781 
Independent reflections 3393 [R(int) = 0.0317] 
Completeness to theta = 67.679 º 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.5897 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3393 / 0 / 217 





X-ray structure of 1.124
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Final R indices [I>2sigma(I)] R1 = 0.0282, wR2 = 0.0764 
R indices (all data) R1 = 0.0283, wR2 = 0.0765 
Absolute structure parameter 0.01(3) 
Extinction coefficient na 
Largest diff. peak and hole 0.188 and -0.149 e. Å -3 
 
Table 2. Atomic coordinates  (x 104) and equivalent  isotropic displacement 
parameters (Å2 x 103) for C20H29BO3.  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor 
________________________________________________________________________
_____ 
 x y z U(eq) 
________________________________________________________________________
______ 
O(1) 9129(2) 218(1) 1623(1) 27(1) 
O(2) 9235(2) 3770(1) 1679(1) 18(1) 
O(3) 6701(2) 5312(1) 1443(1) 20(1) 
B(1) 7547(3) 4040(2) 1395(1) 17(1) 
C(1) 7602(3) 815(2) 1456(1) 20(1) 
C(2) 5322(3) 705(2) 1640(1) 23(1) 
C(3) 4044(3) 2038(2) 1626(1) 21(1) 
C(4) 4214(3) 2707(2) 1167(1) 20(1) 
C(5) 6602(3) 3002(2) 1041(1) 18(1) 
C(6) 7880(3) 1652(2) 1036(1) 19(1) 
C(7) 6682(3) 3673(2) 576(1) 21(1) 
C(8) 9002(3) 3975(2) 414(1) 23(1) 
C(9) 9168(3) 4968(2) 30(1) 22(1) 
C(10) 10999(3) 5801(2) -6(1) 26(1) 
C(11) 11194(3) 6728(2) -351(1) 31(1) 
C(12) 9558(3) 6835(2) -670(1) 29(1) 
C(13) 7736(3) 6005(2) -640(1) 27(1) 
C(14) 7540(3) 5083(2) -292(1) 24(1) 
C(15) 9321(3) 4891(2) 2000(1) 18(1) 
C(16) 8197(3) 6057(2) 1735(1) 21(1) 
C(17) 8054(3) 4437(2) 2409(1) 24(1) 
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C(18) 11681(3) 5157(2) 2122(1) 23(1) 
C(19) 6893(3) 7033(2) 2020(1) 28(1) 
C(20) 9748(3) 6827(2) 1432(1) 28(1) 
_____________________________________________________  
 
Table 3. Bond lengths [Å] and angles [º] for C20H29BO3 
________________________________________________  
O(1)-C(1)  1.214(2) 
O(2)-B(1)  1.367(2) 
O(2)-C(15)  1.4692(17) 
O(3)-B(1)  1.368(2) 
O(3)-C(16)  1.4663(18) 
B(1)-C(5)  1.585(2) 
C(1)-C(2)  1.506(2) 
C(1)-C(6)  1.517(2) 
C(2)-C(3)  1.534(2) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.529(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.539(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(7)  1.545(2) 
C(5)-C(6)  1.548(2) 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.532(2) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.518(2) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(14)  1.392(2) 
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C(9)-C(10)  1.396(2) 
C(10)-C(11)  1.389(2) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.389(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.389(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.392(2) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(15)-C(18)  1.515(2) 
C(15)-C(17)  1.519(2) 
C(15)-C(16)  1.561(2) 
C(16)-C(19)  1.517(2) 
C(16)-C(20)  1.521(2) 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 














































































































Symmetry transformations used to generate equivalent atoms:  
 
Table 4. Anisotropic displacement parameters  (Å2 x 103) for sad.  The anisotropic 
displacement factor exponent takes the form:  –2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________
______  




O(1) 25(1)  24(1) 33(1)  4(1) -2(1)  3(1) 
O(2) 19(1)  16(1) 19(1)  -3(1) -2(1)  1(1) 
O(3) 21(1)  17(1) 23(1)  -2(1) -6(1)  1(1) 
B(1) 16(1)  17(1) 17(1)  2(1) 2(1)  -1(1) 
C(1) 24(1)  14(1) 22(1)  -3(1) -2(1)  0(1) 
C(2) 23(1)  20(1) 25(1)  2(1) 1(1)  -2(1) 
C(3) 19(1)  21(1) 24(1)  0(1) 2(1)  -2(1) 
C(4) 17(1)  20(1) 22(1)  -1(1) -3(1)  -1(1) 
C(5) 18(1)  18(1) 18(1)  -1(1) 0(1)  1(1) 
C(6) 21(1)  18(1) 19(1)  -3(1) 1(1)  0(1) 
C(7) 22(1)  22(1) 18(1)  -1(1) -2(1)  1(1) 
C(8) 24(1)  27(1) 19(1)  1(1) 1(1)  2(1) 
C(9) 26(1)  20(1) 18(1)  -4(1) 3(1)  2(1) 
C(10) 28(1)  27(1) 23(1)  -4(1) 0(1)  -1(1) 
C(11) 35(1)  25(1) 34(1)  -2(1) 7(1)  -6(1) 
C(12) 39(1)  23(1) 25(1)  4(1) 7(1)  4(1) 
C(13) 32(1)  28(1) 21(1)  2(1) -1(1)  6(1) 
C(14) 27(1)  23(1) 22(1)  -1(1) 2(1)  0(1) 
C(15) 19(1)  18(1) 19(1)  -4(1) 0(1)  -1(1) 
C(16) 21(1)  17(1) 23(1)  -2(1) -2(1)  -2(1) 
C(17) 23(1)  28(1) 20(1)  0(1) -1(1)  -3(1) 
C(18) 18(1)  24(1) 27(1)  -4(1) -3(1)  -1(1) 
C(19) 25(1)  20(1) 37(1)  -10(1) -2(1)  1(1) 
C(20) 32(1)  21(1) 30(1)  2(1) 1(1)  -5(1) 
________________________________________________________________________
______   
 









H(2A) 5403 390 1953 27 
H(2B) 4514 14 1467 27 
H(3A) 2492 1860 1695 25 
H(3B) 4624 2661 1855 25 
H(4A) 3379 3564 1169 24 
H(4B) 3559 2105 940 24 
H(6A) 7390 1109 777 23 
H(6B) 9450 1850 994 23 
H(7A) 5959 3070 358 25 
H(7B) 5847 4529 586 25 
H(8A) 9855 4334 668 28 
H(8B) 9688 3113 322 28 
H(10) 12129 5733 210 31 
H(11) 12449 7289 -370 37 
H(12) 9684 7471 -906 35 
H(13) 6618 6067 -858 33 
H(14) 6281 4525 -273 29 
H(17A) 6531 4268 2326 36 
H(17B) 8111 5146 2637 36 
H(17C) 8701 3605 2527 36 
H(18A) 12482 5450 1856 35 
H(18B) 12338 4327 2239 35 
H(18C) 11750 5867 2350 35 
H(19A) 5903 6523 2214 41 
H(19B) 6042 7634 1827 41 
H(19C) 7890 7572 2203 41 
H(20A) 10581 6185 1250 41 
H(20B) 10755 7366 1613 41 




























































Symmetry transformations used to generate equivalent atoms:  
 
n  Data for X-ray Crystallography of 1.129 
 
Table 1.  Crystal data and structure refinement for C18H27BO4 
Identification code  C18H27BO4 




X-ray structure of 1.129
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Formula weight  318.20 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 6.4661(3) Å α= 90 º. 
 b = 22.7367(11) Å β= 99.0710(10) º. 
 c = 12.2957(6) Å γ = 90 º. 
Volume 1785.08(15) Å3 
Z 4 
Density (calculated) 1.184 Mg/m3 
Absorption coefficient 0.648 mm-1 
F(000) 688 
Crystal size 0.600 x 0.160 x 0.100 mm3 
Theta range for data collection 3.640 to 70.154 º. 
Index ranges -7<=h<=7, 0<=k<=27, 0<=l<=14 
Reflections collected 6613 
Independent reflections 6613 [R(int) = ?] 
Completeness to theta = 67.679∞ 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.6403 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6613 / 1 / 420 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0291, wR2 = 0.0832 
R indices (all data) R1 = 0.0293, wR2 = 0.0833 
Absolute structure parameter 0.07(4) 
Extinction coefficient na 
Largest diff. peak and hole 0.256 and -0.166 e. Å-3 
 
Table 2. Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2 x 103) for C18H27BO4.  U(eq) is defined as one third of  the trace of 




 x y z U(eq) 
________________________________________________________________________
______ 
B(1) 5335(4) 1121(1) 418(2) 15(1) 
O(1) 3839(2) 808(1) -1666(1) 24(1) 
O(2) 4182(2) 1626(1) 312(1) 16(1) 
O(3) 7446(2) 1212(1) 541(1) 16(1) 
O(4) 3517(2) 380(1) 5139(1) 22(1) 
C(1) 394(4) 423(1) -2207(2) 27(1) 
C(2) 2301(3) 579(1) -1384(2) 18(1) 
C(3) 2193(3) 453(1) -191(2) 17(1) 
C(4) 4309(3) 498(1) 564(2) 15(1) 
C(5) 4069(3) 471(1) 1791(2) 14(1) 
C(6) 5851(3) 488(1) 2591(2) 18(1) 
C(7) 5753(3) 458(1) 3713(2) 18(1) 
C(8) 3818(3) 418(1) 4059(2) 17(1) 
C(9) 2015(3) 408(1) 3276(2) 20(1) 
C(10) 2136(3) 435(1) 2162(2) 18(1) 
C(11) 5651(3) 2114(1) 578(2) 16(1) 
C(12) 7772(3) 1840(1) 372(2) 17(1) 
C(13) 5619(3) 2271(1) 1781(2) 22(1) 
C(14) 4880(4) 2628(1) -167(2) 24(1) 
C(15) 8175(4) 1909(1) -808(2) 27(1) 
C(16) 9660(3) 2035(1) 1182(2) 25(1) 
C(17) 5750(3) -6(1) 310(2) 18(1) 
C(18) 5344(3) 374(1) 5956(2) 23(1) 
B(2) -298(3) 8107(1) 4778(2) 14(1) 
O(5) 864(2) 8425(1) 2948(1) 23(1) 
O(6) 858(2) 7600(1) 4832(1) 15(1) 
O(7) -2416(2) 8007(1) 4569(1) 16(1) 
O(8) 1646(2) 8885(1) 9797(1) 20(1) 
C(19) 4213(3) 8821(1) 2792(2) 20(1) 
C(20) 2461(3) 8659(1) 3403(2) 17(1) 
C(21) 2762(3) 8789(1) 4631(1) 16(1) 
C(22) 710(3) 8731(1) 5099(2) 16(1) 
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C(23) 1024(3) 8762(1) 6358(2) 15(1) 
C(24) -694(3) 8665(1) 6894(2) 18(1) 
C(25) -564(3) 8699(1) 8029(2) 18(1) 
C(26) 1339(3) 8835(1) 8672(2) 16(1) 
C(27) 3080(3) 8930(1) 8161(2) 18(1) 
C(28) 2922(3) 8892(1) 7023(2) 17(1) 
C(29) -577(3) 7123(1) 4430(2) 16(1) 
C(30) -2730(3) 7371(1) 4629(2) 15(1) 
C(31) -456(3) 7033(1) 3214(2) 21(1) 
C(32) 151(4) 6573(1) 5084(2) 23(1) 
C(33) -4575(3) 7205(1) 3755(2) 23(1) 
C(34) -3238(4) 7243(1) 5771(2) 24(1) 
C(35) -772(3) 9240(1) 4654(2) 19(1) 




Table 3. Bond lengths [Å] and angles [º] for C18H27BO4 
_____________________________________________________  
B(1)-O(2)  1.364(3) 
B(1)-O(3)  1.365(3) 
B(1)-C(4)  1.588(3) 
O(1)-C(2)  1.221(3) 
O(2)-C(11)  1.464(2) 
O(3)-C(12)  1.465(2) 
O(4)-C(8)  1.375(2) 
O(4)-C(18)  1.425(2) 
C(1)-C(2)  1.509(3) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-C(3)  1.507(3) 
C(3)-C(4)  1.531(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
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C(4)-C(17)  1.540(3) 
C(4)-C(5)  1.542(2) 
C(5)-C(6)  1.393(3) 
C(5)-C(10)  1.399(3) 
C(6)-C(7)  1.392(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.386(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.390(3) 
C(9)-C(10)  1.386(3) 
C(9)-H(9)  0.9500 
C(10)-H(10)  0.9500 
C(11)-C(14)  1.520(3) 
C(11)-C(13)  1.525(3) 
C(11)-C(12)  1.563(3) 
C(12)-C(16)  1.516(3) 
C(12)-C(15)  1.521(3) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
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B(2)-O(6)  1.370(3) 
B(2)-O(7)  1.372(3) 
B(2)-C(22)  1.586(3) 
O(5)-C(20)  1.216(2) 
O(6)-C(29)  1.461(2) 
O(7)-C(30)  1.464(2) 
O(8)-C(26)  1.370(2) 
O(8)-C(36)  1.424(3) 
C(19)-C(20)  1.501(3) 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-C(21)  1.520(2) 
C(21)-C(22)  1.534(3) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.530(2) 
C(22)-C(35)  1.546(3) 
C(23)-C(28)  1.394(3) 
C(23)-C(24)  1.395(3) 
C(24)-C(25)  1.388(3) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.388(3) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.389(3) 
C(27)-C(28)  1.390(3) 
C(27)-H(27)  0.9500 
C(28)-H(28)  0.9500 
C(29)-C(32)  1.520(3) 
C(29)-C(31)  1.524(3) 
C(29)-C(30)  1.556(3) 
C(30)-C(34)  1.521(2) 
C(30)-C(33)  1.521(3) 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
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C(31)-H(31C)  0.9800 
C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
C(32)-H(32C)  0.9800 
C(33)-H(33A)  0.9800 
C(33)-H(33B)  0.9800 
C(33)-H(33C)  0.9800 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-H(35A)  0.9800 
C(35)-H(35B)  0.9800 
C(35)-H(35C)  0.9800 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 






































































































































































































Table 4. Anisotropic displacement parameters  (Å2 x 103) for C18H27BO4.  The 
anisotropic 
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displacement factor exponent takes the form:  –2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________
______  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________
______  
B(1) 16(1)  17(1) 11(1)  -1(1) 2(1)  0(1) 
O(1) 27(1)  26(1) 19(1)  0(1) 4(1)  -2(1) 
O(2) 13(1)  14(1) 21(1)  -1(1) 3(1)  -2(1) 
O(3) 14(1)  14(1) 20(1)  1(1) 3(1)  0(1) 
O(4) 20(1)  30(1) 17(1)  -1(1) 4(1)  1(1) 
C(1) 31(1)  22(1) 24(1)  0(1) -8(1)  -2(1) 
C(2) 21(1)  14(1) 19(1)  -2(1) -1(1)  2(1) 
C(3) 16(1)  16(1) 18(1)  -1(1) 0(1)  -2(1) 
C(4) 15(1)  15(1) 15(1)  0(1) 2(1)  1(1) 
C(5) 15(1)  11(1) 17(1)  1(1) 2(1)  -1(1) 
C(6) 13(1)  19(1) 22(1)  1(1) 3(1)  -1(1) 
C(7) 15(1)  18(1) 18(1)  1(1) -1(1)  0(1) 
C(8) 21(1)  14(1) 16(1)  -1(1) 3(1)  1(1) 
C(9) 14(1)  24(1) 23(1)  1(1) 5(1)  0(1) 
C(10) 13(1)  20(1) 20(1)  1(1) -1(1)  0(1) 
C(11) 13(1)  15(1) 21(1)  -1(1) 3(1)  -3(1) 
C(12) 16(1)  14(1) 21(1)  -1(1) 6(1)  -1(1) 
C(13) 21(1)  23(1) 24(1)  -6(1) 8(1)  -2(1) 
C(14) 21(1)  16(1) 33(1)  2(1) 3(1)  1(1) 
C(15) 32(1)  24(1) 27(1)  3(1) 16(1)  0(1) 
C(16) 15(1)  24(1) 36(1)  -5(1) 4(1)  -4(1) 
C(17) 18(1)  17(1) 20(1)  -2(1) 1(1)  2(1) 
C(18) 23(1)  29(1) 17(1)  -1(1) 1(1)  2(1) 
B(2) 14(1)  18(1) 10(1)  0(1) 1(1)  1(1) 
O(5) 22(1)  28(1) 18(1)  0(1) 0(1)  -7(1) 
O(6) 12(1)  14(1) 17(1)  -2(1) 1(1)  0(1) 
O(7) 13(1)  15(1) 19(1)  0(1) 2(1)  -1(1) 
O(8) 21(1)  24(1) 15(1)  -1(1) 1(1)  0(1) 
C(19) 18(1)  24(1) 18(1)  2(1) 4(1)  0(1) 
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C(20) 16(1)  17(1) 18(1)  3(1) 2(1)  1(1) 
C(21) 18(1)  15(1) 16(1)  0(1) 3(1)  -1(1) 
C(22) 15(1)  15(1) 16(1)  0(1) 0(1)  -1(1) 
C(23) 16(1)  12(1) 17(1)  -1(1) 2(1)  1(1) 
C(24) 13(1)  20(1) 20(1)  -4(1) 0(1)  -1(1) 
C(25) 15(1)  18(1) 22(1)  -3(1) 5(1)  -2(1) 
C(26) 22(1)  11(1) 17(1)  -1(1) 2(1)  2(1) 
C(27) 15(1)  18(1) 20(1)  -2(1) -1(1)  0(1) 
C(28) 16(1)  15(1) 19(1)  -1(1) 3(1)  -1(1) 
C(29) 12(1)  16(1) 20(1)  -2(1) 2(1)  -3(1) 
C(30) 14(1)  15(1) 18(1)  -1(1) 5(1)  -2(1) 
C(31) 19(1)  24(1) 22(1)  -9(1) 7(1)  -5(1) 
C(32) 22(1)  16(1) 31(1)  1(1) 3(1)  1(1) 
C(33) 12(1)  25(1) 31(1)  -6(1) 2(1)  -4(1) 
C(34) 26(1)  25(1) 23(1)  3(1) 12(1)  2(1) 
C(35) 17(1)  17(1) 23(1)  2(1) 1(1)  1(1) 
C(36) 23(1)  43(1) 17(1)  0(1) 5(1)  1(1) 
________________________________________________________________________










 x  y  z  U(eq) 
________________________________________________________________________
______ 
H(1A) 556 578 -2933 40 
H(1B) -854 596 -1974 40 
H(1C) 242 -6 -2250 40 
H(3A) 1625 52 -131 21 
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H(3B) 1205 733 68 21 
H(6) 7183 522 2363 21 
H(7) 7001 465 4236 21 
H(9) 684 383 3507 24 
H(10) 884 428 1641 22 
H(13A) 6113 1935 2249 33 
H(13B) 4186 2371 1881 33 
H(13C) 6538 2610 1986 33 
H(14A) 4900 2519 -937 35 
H(14B) 5797 2968 24 35 
H(14C) 3448 2730 -70 35 
H(15A) 6936 1782 -1317 40 
H(15B) 9379 1668 -918 40 
H(15C) 8470 2323 -947 40 
H(16A) 9367 1988 1935 38 
H(16B) 9960 2450 1052 38 
H(16C) 10874 1795 1084 38 
H(17A) 5913 9 -469 28 
H(17B) 5130 -384 466 28 
H(17C) 7125 35 770 28 
H(18A) 6209 33 5838 35 
H(18B) 4932 348 6688 35 
H(18C) 6146 735 5903 35 
H(19A) 3898 8676 2033 30 
H(19B) 5521 8643 3158 30 
H(19C) 4366 9250 2785 30 
H(21A) 3314 9193 4763 19 
H(21B) 3809 8513 5021 19 
H(24) -2005 8571 6464 21 
H(25) -1769 8631 8364 22 
H(27) 4391 9021 8594 22 
H(28) 4133 8956 6690 20 
H(31A) -936 7390 2804 32 
H(31B) -1350 6702 2931 32 
H(31C) 995 6950 3125 32 
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H(32A) 67 6638 5864 35 
H(32B) 1602 6486 5001 35 
H(32C) -747 6241 4808 35 
H(33A) -4228 7289 3023 34 
H(33B) -5806 7435 3866 34 
H(33C) -4880 6785 3813 34 
H(34A) -2043 7353 6327 35 
H(34B) -3527 6822 5836 35 
H(34C) -4472 7470 5888 35 
H(35A) -1011 9230 3847 29 
H(35B) -132 9616 4908 29 
H(35C) -2110 9195 4923 29 
H(36A) -1222 9106 10012 41 
H(36B) 243 8895 11115 41 










































































































Symmetry transformations used to generate equivalent atoms:  
  








































































































































































































































































































Product after oxidation of 1.147
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Chapter 2 
Enantioselectivity Fluctuations in Phosphine–Cu-Catalyzed 




  There are many examples of catalytic additions of achiral organometallic 
nucleophiles to unsaturated organic molecules (e.g., alkenyl sites). Product enantiomeric 
purity is thus determined in the C–C bond forming step.73 There are also examples where 
a metal-substituted stereogenic carbon center reacts with an electrophile74 and either the 
chiral catalyst causes one of the rapidly interconverting stereoisomers to react 
(enantioselectivity by diastereoselective equilibration)75 or an isomer is transformed 
faster (kinetic resolution or dynamic enantioselective synthesis)76; whichever the case, 
manipulating the stereochemical identity of a metal-substituted stereogenic carbon center 
is key. A distinct category of transformations proceeds through enantioselective 
formation of metal-substituted stereogenic carbon center that then reacts in situ with an 
electrophile.	   Product enantiomeric purity is now determined when the organometallic 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(73) Ogasawara, M.; Hayashi, T. in Catalytic Asymmetric Synthesis (Ojima. I. Ed.), Wiley–VCH, 2000, 
651.	   
(74) Malinakova, H. C. Chem. Eur. J. 2004, 10, 2636–2646. 
(75) Beak, P.; Anderson, D. R.; Curtis, M. D.; Laumer, J. M.; Pippel, D. J.; Weisenburger, G. A.  Acc. 
Chem. Res. 2000, 33, 715–727. 
(76) (a) Cherney, A. H.; Kadunce, N. T.; Reisman, S. E.  Chem. Rev. 2015, 115, 9587–9652. (b) Jiang, X.; 
Kulbitski, K.; Nisnevich, G.; Gandelman, M. Chem. Sci. 2016, 7, 2762–2767. (c) Kainz, Q. M.; Matier, C. 
D.; Bartoszewicz, A.; Zultanski, S. L.; Peters, J. C.; Fu, G. C. Science 2016, 351, 681–684. 
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species is generated (vs when the C–C bond is formed) and kinetic stereoselectivity must 
be retained. In this chapter, the studies regarding what factors may cause the variations in 
enantioselectivity observed in the products despite the formation of organocopper 
intermediates being stereochemistry determining will be discussed. 
2.2. Background 
 In 2009, our laboratories reported an enantioselective proto-boration of β-
substituted aryl olefins.77 As illustrated in Scheme 2.1a, the reaction was shown to be 
site- and diastereoselective (>98% homobenzylic C–B and >98:2 dr). A stereochemistry-
determining step is likely to be at the Cu–B addition step. Later in 2015, Liao and co-
workers reported the use of a chiral Cu–B(pin) complex and an achiral palladium-based 
co-catalyst in reactions of aryl-olefins and allyl-tert-butyl carbonates (Scheme 2.1b).78 A 
very interesting observation but has not been discussed is that enantioselectivity of 
product 2.7 is dependent on electrophile identity despite the earlier step being 
stereochemistry-determining. When allylic carbonate 2.5 is used, 2.7 is formed in 
95.5:4.5 er; however, with an allylic electrophile is 2.6, the er value of 2.7 is obtained in 
98.5:1.5 er.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(77) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160–3161.  




Similar observations on enantioselectivity variation with different electrophiles 
were also found in hydroamination reactions. As shown in Scheme 2.2a, Buchwald and 
co-workers published an enantioselective phosphine–Cu–H addition to styrenes followed 
by amination reaction in the presence of an O-benzoylhydroxylamine.79 With 2.10, the 
product is generated with >99:1 er, while 2.11 leads to 95:5 er. In another example, 
Miura and co-workers reported hydroamination of an alkenyl–B(dan) (dan, 1,8-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(79) Zhu, S.; Niljianskul, N.; Buchwald, S. L. J. Am. Chem. Soc. 2013, 135, 15746–15749.  
Scheme 2.1. Intermediates with a Cu-substituted stereogenic carbon generated through copper–boryl additions




0.5 mol % NaOt-Bu, 2.0 equiv MeOD




















10 mol % CuOAc, 5.0 mol % Pd(dppf)Cl2
1.0 equiv KOH,1.5 equiv B2(pin)2,









76 % yield, 95.5:4.5 er

















diaminonaphthyl) compound with the same phosphine–Cu–H complex reported by 
Buchwald.80 Again O-benzoylhydroxylamine structure has an impact on stereoselectivity 
(97:3 vs 88:12 er, Scheme 2.2b).  We decided to investigate the above scenario while 
developing enantioselective multicomponent boron–allyl additions to aryl-olefins 
promoted by a chiral Cu complex without the need for a Pd-based co-catalyst (Section 
3.3).  
 
2.3. Phosphine–Cu-Catalyzed Enantioselective Boron-Allyl Addition to 
Aryl-Substituted Olefins 
2.3.1. Identification of an effective enantioselective Cu-based catalyst 
A mixture of styrene, allyl t-butylcarbonate (2.16) and B2(pin)2 in the absence of a 
ligand did not afford 2.18a (Table 2.1, entry 1), which is consistent with the previously 
disclosed where a Pd-based co-catalyst is needed to promote electrophile activation.3 In 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(80) Nishikawa, D.; Hirano, K.; Miura, M. J. Am. Chem. Soc. 2015, 137, 15620–15623.  









2.2 mol % Cu(OAc)2, 2.0 equiv (EtO)2MeSiH
thf, 40 ºC, 36 h
NR2
with
86 % yield, >99:1 er










10 mol % 2.8
10 mol % Cu(OAc)2, 3.0 equiv PMHS,






66 % yield, 97:3 er
























a) Hydroamination of aryl-olefins
b) Hydroamination of alkenyl–B(dan)
1.2 equiv
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contrast, with allylphosphate (2.17), under otherwise the same conditions (entry 2), there 
was 32% conversion to 2a [9% allyl–B(pin)]. With the NHC–Cu complex derived from 
im-1, there was minimal conversion with allylcarbonate 2.16 (entry 3), but with 
allylphosphate 2.17, 2.18a was isolated in 78% yield (entry 4). The catalyst derived from 
the more sizeable imidazolinium salt im-2 was much less effective (entry 5).	  Reactions 
with several chiral NHC–Cu catalysts were examined and found to be minimally 
enantioselective and at times inefficient due to allyl–B(pin) being formed predominantly, 
which is generally the reason for discrepancy between conversion and yield values 




We then turned to examining the possibility for a chiral phosphine being efficient 
and enantioselective (Table 2.2). Although we initially found that Ph3P–Cu complex 
produced 2.18a efficiently (76% conv, 69% yield), various chiral phosphine–Cu species 











































































5.5 mol % ligand,
5.0 mol % CuCl





2.16, R = CO2t-Bu





























im-1 Ar = 2,4,6-(Me)3C6H2









im-4 R = H
im-5 R = Me




































a Reactions were performed under N2 atmosphere. b Conversions of the limiting reagent (2.16, 2.17) were 
determined by analysis of 400 MHz 1H NMR spectra of unpurified mixtures. c Yield of isolated and purified product. 
d Determined by HPLC analysis.  e Only allyl–B(pin) detected . Mes = 2,4,6-(Me)3C6H2.
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dual-catalytic (Cu/Pd) protocol. Only a family of bis-phosphines derived from camphor 
(2.24a–c)81 delivered the desired product in appreciable yield and enantioselectivity. The 
complexes derived from 2.24a and 2.24b delivered 2.18a in ≥51% yield and ≥92:8 er 
(entries 8–9). With 2.24c, the enantioselectivity was reversed (62% yield, 20:80 er, entry 
10). 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




2.3.2. Scope of the bis-phosphine–Cu catalyzed boron–allyl addition to aryl-olefins 
Next, we investigated the scope of the reaction with different steric and electronic 
factors of the olefins (Scheme 2.3). ortho-Substituted products 2.18b-d as well as those 
PAr2
S PAr'2
2.24a Ar = Ph, Ar' = Ph
2.24b Ar = 3,5-(Me)2C6H3, Ar' = Ph










































Table 2.2. Examination of Different Types of Cu Complexesa
5.5 mol % ligand,
5.0 mol % CuCl



























































a See Table 2.1. b Only allyl–B(pin) detected
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containing a meta-methyl or meta-allyloxy group (2.18e–f) were formed with similar 
efficiency and enantioselectivity as 2.18a (93:7–97:3 er). In contrast, reaction with meta-
carboxylic ester styrene afforded 2.18g in somewhat lower enantioselectivity (82:18 er). 
Formation of para-MIDA boronate 2.18h (MIDA, N-methyliminodiacetic acid),82 para-
tolyl 2.18i and para-trimethylsilylphenyl 2.18j were again highly enantioselective (95:5–
96:4 er). The reaction leading to para-methoxyphenyl-substituted 2.18k was inefficient 
[28% yield; slow Cu–B(pin) addition] yet highly enantioselective (97:3 er); on the other 
hand, para-carboxylic ester containing 2.18l was generated in 14% yield (reduced 
organocopper nucleophilicity) and 51:49 er. Transformations affording heterocyclic 
2.18m–o proceed smoothly affording the corresponding products in 58–64% yield and 
90:10–98:2 er (<5% conv with unprotected indole). Reactions with aliphatic olefins were 
inefficient (<10% conv) probably because these more electron-rich substrates react much 
less efficiently with Cu–B(pin) and thus allyl–B(pin) is generated from reaction of Cu–
B(pin) with an allylic phosphate. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(82) Li, J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.; Palazzolo A. M. E.; Lehmann, J. W.; 
Morehouse, G. F.; Burke, M. D. Science 2015, 347, 1221–1226. 
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The lower er values for carboxylic ester 2.18g and 2.18l compared to a high er of 
2.18k could be due to a difference in the kinetic enantioselectivity in the copper–B(pin) 
addition step. Alternatively, it might be that a slower forming but more nucleophilic 
organocopper intermediate (affording 2.18k) can react rapidly with allylphosphate so that 
high enantioselectivity may be preserved. If lower nucleophilicity of the electron-
deficient alkenes, such as those with the meta-ester phenyl moiety in 2.18g, reduces the 
rate of allylic substitution such that there is diminution in organocopper enantiopurity 
prior to C–C bond formation, then increasing allylphosphate concentration should cause 
allylic substitution to occur faster and kinetic enantioselectivity should be better 
Scheme 2.3. Products of bis-phosphine–Cu-catalyzed multicomponent reactions (3:1 alkene:allyl phosphate)a
2.18d
































































>98% conv, 69% yield,
 82:18 er
B(pin)t-BuO2C
a See Table 2.2 for reaction conditions with ligand 2.24a.
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preserved. Indeed, whereas 2.18g was formed in 69% yield and 82:18 er with a 3:1 aryl 
olefin:2.17 ratio, reversing the ratio led to increase in enantioselectivity (95:5 er, 62% 
yield, Scheme 2.4). The same applies to para-bromophenyl-substituted 2.18p (90:10 vs 
84:16 er), para-B(pin)phenyl-substituted 2.18q (92:8 vs 82:18 er), meta-B(pin)phenyl-
substituted 2.18r (96.5:3.5 vs 83:17 er) and 2-naphthyl-substituted 2.18s (96:4 vs 89:11 
er). However, the same strategy did not result in any er enhancement for para-
esterphenyl-substituted 2.18l. Because product enantiomeric purity can be improved by 
adjustment of substrate concentration, we concluded that the differences in kinetic 
selectivity in the initial Cu–B(pin) addition step is not the main cause for er fluctuation. 
 
Scheme 2.4. Products of bis-phosphine–Cu-catalyzed multicomponent reactions (effect of higher allyl phosphate concentration)a
3:1 alkene:allylic phosphate:
45% conv, 29% yield,
90:10 er
1:6 alkene:allylic phosphate:




>98% conv, 60% yield,
90:10 er
1:3 alkene:allylic phosphate:




>98% conv, 71% yield,
95:5 er
1:3 alkene:allylic phosphate:






>98% conv, 63% yield,
95:5 er
1:3 alkene:allylic phosphate:




2.18t 2.18u 2.18v 2.18w
3:1 alkene:allylphosphate:
>98% conv, 65% yield,
89:11 er
1:3 alkene:allylphosphate:





75% conv, 57% yield,
84:16 er
1:3 alkene:allylphosphate:





>98% conv, 69% yield,
 82:18 er
1:3 alkene:allylphosphate:





>98% conv, 48% yield,
82:18 er
1:3 alkene:allylphosphate:





>98% conv, 44% yield,
 83:17 er
1:3 alkene:allylphosphate:





a See Table 2.2 for reaction conditions with ligand 2.24a, except 2.18t and 2.18u, ligand 2.24b was used.
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With a larger allylic phosphate, C–C bond formation might be slower, 
engendering lowering of er and thus higher allylic phosphate concentration could allow 
for better retention of kinetic stereoselectivity. This led us to find that 2.18t and 2.18u 
(Scheme 2.4), can be formed in higher enantioselectivity with 1:3 ratio of aryl 
olefin:allylic phosphate (96:4 vs 90:10 er and 95:5 vs 90:10 er, respectively). However, at 
this point we did not see much improvement for reactions to generate alkenylsilanes 
2.18v and 2.18w. 
Reactions with allylphenyl carbonate (2.25) were efficient but more 
enantioselective than when allylphosphate was employed. ortho- and para-Fluorophenyl-
containing 2.18x and 2.18y and ortho-, and para-trifluoromethylphenyl-substituted 2.18z 
and 2.18aa were isolated in 50–68% yield and 96:4–98:2 er (vs 81:19–92:8 er with 2.17). 
These findings expand the scope of the approach but were initially puzzling because 
allylphenyl carbonate is less electrophilic than allylphosphate as evidenced in lower 
conversion to the product in the absence of any ligand (e.g., ~40% vs ~10% conv to 
2.18a after 14 h). If slower C–C bond formation means loss of enantioselectivity, why 




2.3.3. Comparison of Cu versus Cu/Pd system  
As results in Scheme 2.6 indicate, under either set of conditions, products derived 
from strongly electron withdrawing para substituent were formed in low 
enantioselectivity (2.18l), indicating that this type of substituent is problematic with the 
two-catalyst method as well. While with a Pd-based co-catalyst,78 para-bromophenyl 
containing product 2.18p was formed in higher enantioselectivity (2:98 vs 90:10 er), 
reaction with allylphosphate and the bisphosphine ligand (2.24a) was more efficient 
(62% vs 43% yield). In some cases, one of approaches is superior. The single-catalyst 
conditions afforded para-methoxyphenyl-substituted product 2.18k in better yield (28% 
vs <5%) and in 97:3 er. MIDA boronates are insoluble in tert-butylmethyl ether, the 
optimal solvent for the two-catalyst strategy resulting in no conversion to 2.18h, while 
our procedure affords 2.18h in 59% yield and 95:5 er. As underscored by less efficient 
processes leading to 2.18r (24% vs 52% yield), the presence of the Pd complex may be 
Scheme 2.5. Products of bis-phosphine–Cu-catalyzed multicomponent reactions (effect of electrophile identity)a
B(pin)
2.18a
LG = OPO(OEt)2 (2.17):
>98% conv, 67% yield, 95:5 er
LG = OCO2Ph (2.25):
87% conv, 44% yield, 97:3 er
B(pin)
2.18x
LG = OPO(OEt)2 (2.17):
>98% conv, 54% yield, 89:11 er
LG = OCO2Ph (2.25):
79% conv, 64% yield, 96:4 er
F
2.18y
LG = OPO(OEt)2 (2.17):
>98% conv, 66% yield, 92:8 er
LG = OCO2Ph (2.25):):






LG = OPO(OEt)2 (2.17):
86% conv, 65% yield, 88:12 er
LG = OCO2Ph (2.25):
68% conv, 50% yield, 96:4 er
B(pin)
2.18aa
LG = OPO(OEt)2 (2.17):
83% conv, 53% yield, 74:26 er
LG = OCO2Ph (2.25):
>98% conv, 68% yield, 96:4 er
F3C
a See Table 2.2 for reaction conditions with ligand 2.24a; except 2.18z and 2.18aa, 1:3 alkene:allyl
electrophile was used
 239	  
incompatible with an aryl-boron substituent present. The transformation with the 2-
methyl-substituted allylic electrophiles was more efficient and enantioselective with the 
single-catalyst conditions (i.e., 2.18u in 84% yield, 95:5 er vs 19 % yield, 11:89 er). With 
the allylic electrophile derived from 2-butene-1-ol, the Cu/Pd combination afforded 
2.18ab in 76% yield, >98% E selectivity and 4.5:95.5 er; with the corresponding 
secondary allylic phosphate and the single-catalyst method, the process was fully SN2’-
selective (>98%), affording 2.18ab in 50% yield, 50:50 E:Z, 92:8 er (for either alkene 
isomer).  
 
2.3.4. Application in the synthesis of natural product 
The distinguishing attributes of the method are underscored in a formal enantioselective 
synthesis of heliespirones A and C (Scheme 2.7).83 Reaction with alkene 2.26, ligand 
2.24b and one gram of commercially available 2.17 afforded 2.27 in 64% yield and 97:3 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(83) (a) Huang, C.; Liu, B. Chem. Commun. 2010, 46, 5280–5282. (b) Bai, W.-J.; Green, J. C.; Pettus, T. R. 
R. J. Org. Chem. 2012, 77, 379–387. 




81% yield, 2.5:97.5 er
Condition B:




53% yield, 4.5: 95.5 er
Condition B:





43% yield, 2:98 er
Condition B:





19% yield, 11:89 er
Condition B:





56% yield, 33:67 er
Condition B:





76% yield, >98% E, >98% SN2, 4.5:95.5 er
Condition B:





24% yield, 2:98 er
Condition B:




















A (previous work, ref 78): alkene/allyl t-butylcarbonate (2.16): 1:1.5,
12 mol % 2.4, 10 mol % CuOAc, 5.0 mol % Pd(dppf)Cl2, 1.5 equiv B2(pin)2, 1.0 equiv KOH, t-BuOMe, 0 °C, 12 h
B (this work): alkene/allylic phosphate: 3:1 for 2.18a,i,k,h,u,ab; 1:3 otherwise
5.5 mol % 2.24a (for 2.18u & 2.18ab, 2.24b used) , 5.0 mol % CuCl, 1.1 equiv B2(pin)2, 1.5 equiv NaOt-Bu, thf, 22 °C, 14 h
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er; excess 2.26 can be recovered in 91% yield as part of purification by silica gel 
chromatography. With the two-catalyst protocol, 2.27 was isolated in similar yield (62%) 
but lower enantioselectivity (9:91 er). Cross-metathesis with 1.0 mol % 2.28 and 2-
methyl-2-butene gave 2.29, which was converted to 2.30 (92% after two steps).84 
Enantioselective epoxidation of 2.30 with 2.31,85 concomitant C–B oxidation, and acid-
catalyzed hydrolysis generated triol 2.33 in 46% yield and 89:11 dr. Triol 2.33 was 
previously employed to access heliespirones A and C.83a  
 
2.4. Mechanistic Investigation on Enantioselectivity Variations 
2.4.1. Enantioselectivity loss by epimerization 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(84) Sadhu, K. M.; Matteson, D. S. Organometallics 1985, 4, 1687–1689. 
(85) Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem. Soc. 1997, 119, 11224–11235. 
Scheme 2.7. Application to enantioselective synthesis of heliespirones A and C
1.0 equiv3.0 equiv
OPO(OEt)2
5.5 mol % 2.24b
5.0 mol % CuCl,
1.5 equiv NaOt-Bu,
1.1 equiv B2(pin)2, thf, 22 oC, 14 h
+
>98% conv, 64% yield,
97:3 er
(91% recovery of aryl olefin)



















































thf, –78 oC, 16 h92% yield
(two steps)
2.5 equiv Oxone, 5.8 equiv K2CO3,
4.0 mol % (n-Bu)4NHSO4,
MeCN, dimethoxymethane,
0.05 M Na2B4O7, –10 oC, 4 h















20 mol % H2SO4,
thf/H2O, 0–22 oC, 2 h









To probe the origins of enantioselectivity fluctuations, we first investigated the 
diastereoselectivity of reactions of E- and Z-β-deuterio-alkenes (2.34-E and 2.34-Z). As 
shown in Scheme 2.8, in the case of para-tert-butyl ester substituted styrene, regardless 
of the deuterated olefin isomer used, 2.35 was generated with minimal stereoselectivity 
(60:40–35:65 dr); the same was observed with the Cu/Pd system. Therefore, in this case 
there is facile epimerization at the copper-substituted stereogenic center. 
 
To probe whether epimerization at the Cu-substituted carbon center might occur 
by homolytic or heterolytic Cu–C bond rupture/re-formation, we investigated reactions 
with cyclopropenyl 2.36 (Table 2.3). With NHC–Cu complexes such as that derived 
imidazolinium salt im-2, only trisubstituted alkenyl–B(pin) compound 2.37 was 
generated (entry 1). With PPh3 (entry 2), sulfoxide-phosphine 2.4 (entry 3) or 
bisphosphine 2.24b, with or without a Pd complex (entries 4–5), cyclopropyl containing 
2.38 was formed exclusively.  
Scheme 2.8. Probing enantioselectivity loss by epimerization
1.0 equiv. KOH,
1.5 equiv B2(pin)2, t-BuOMe, 0 °C, 12 h
2.35
>98% conv, 52:48 dr
12 mol % 2.4,





5.0 mol % CuCl
1.5 equiv NaOt-Bu,
1.1 equiv B2(pin)2, thf, 22 oC, 14 h






























Although, NHC ligands can stabilize odd-electron intermediates86 but when diene 
2.39 was used with an NHC- or a bisphosphine-based complex (Scheme 2.9), none of the 
cyclopentenyl product 2.41 was observed. This signified that ionic pathways are involved 
with para-tert-butyl ester styrene and NHC– or phosphine–Cu complexes and 
cyclopropyl rupture in the NHC–Cu system is due to the stronger electron donating 
ability of the carbene ligands resulting in higher electron density at the benzylic carbon. 
Based on the above findings, it appears that a strongly electron withdrawing aryl unit can 
stabilize accumulation of electron density at the benzylic site, facilitating heterolytic 
cleavage/re-formation of the Cu–C bond. 
 
2.4.2. Fluctuation in enantioselectivity due to Cu–H elimination 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(86) Styra, S.; Melaimi, M.; Moore, C. E.; Rheingold, A. L.; Augenstein, T.; Breher, F.; Bertrand, G. Chem. 
Eur. J. 2015, 21, 8441–8446. 










2.16 R = CO2t-Bu






































condition A or B
1.1 equiv
a See Scheme 2.6 for conditions A and B.
Scheme 2.9. Examination the possibility of homolytic vs heterolytic Cu–C cleavage
5.5 mol % ligand,
5.0 mol % CuCl
1.5 equiv NaOt-Bu,
1.1 equiv B2(pin)2,
thf, 22 °C, 14 h
2.40a R = allyl









with  im-2: >98% conv, 58% 2.40a,b; <2% 2.41






Results were different with other deuterium-labeled alkenes (Scheme 2.10): anti- 
and syn-2.18g-d, 2.18aa-d and 2.18t-d were formed with >98% diastereospecificity (ds); 
the outcomes were the same under the two-catalyst conditions. These data showed that 
there is hardly or no epimerization at the Cu-substituted stereogenic center in these cases. 
Thus, there must be other mechanisms responsible for changes in er values. 
 
Two pathways may account for the er variability (other than epimerization): Cu–
B(pin) and Cu–H elimination/re-addition from the opposite face of the alkene. The Cu–
boryl elimination/re-addition possibility was ruled out because computational studies 
(DFT) performed by Dr. Sebastian Torker revealed that this would be energetically 
unfavorable; energy barrier for Cu–B elimination is ~30 kcal/mol (Scheme 2.11).  

























































R = H or Ph
(EtO)2OPO
R




Concerning the Cu–H elimination/re-addition possibility, alkenyl–B(pin) 
byproducts could be detected (~10% during synthesis of 2.18a with allylphenyl carbonate 
2.25). Moreover, syn-2.18aa-d and syn-2.18t-d were obtained with higher 
enantioselectivity compared to reactions with the non-labeled aryl olefins (75:25 vs 64:36 
er and 96:4 vs 88:12 er, respectively, Scheme 2.10). This is probably because, as 
illustrated in Scheme 2.12, Cu–D elimination to afford syn-2aa-d and syn-2t-d is slower. 
Cu–H elimination can have a significant impact on enantioselectivity when p-CF3 styrene 
is used due to much less nucleophilic organocopper to react with allyl electrophile or 
when the allylating agent is hindered (slower C–C bond formation).  
 
However, it does not appear to be the re-addition of Cu–H species causing the 
lower er because Cu–H adds to alkenyl–B(pin) with the opposite site selectivity (Scheme 



























































































































with (E)-!-deuterio-aryl olefins: with (Z)-!-deuterio-aryl olefins:
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2.13).87 It is more likely that loss in enantioselectivity comes from the major alkylcopper 
diastereomer undergoes Cu–H elimination faster. 
 
2.4.3. Competitive pathways via achiral Cu complexes 
 In addition to epimerization and Cu–H elimination, the presence of a Cu complex 
without a chiral phosphine on it could lead to formation of racemic product, which will 
lower the er values. As data in Scheme 2.14a indicate, reaction of 2.42 and 2.17-d2 
generates the product with lower SN2’ selectivity in the absence of a ligand (85% SN2’). 
When bis-phosphine 2.24b is present, 91% SN2’ is observed (with un-optimal 3:1 
alkene:allylphosphate). In contrast, with 2.24b or PPh3 present and optimal 1:3 
alkene:allylphosphate, the product is formed in >98% SN2’. This suggests that in an un-
optimal condition, there may be a reaction involving an achiral Cu complex. 
Furthermore, with larger amounts of the chiral ligand (2.24b), high enantioselectivity can 
be obtained even with an un-optimal alkene:allylphosphate ratio (3:1). As shown in 
Scheme 2.14b, with 20 mol % 2.24b, compound 2.18g was formed in 95:5 er, similar to 
the result with excess allylphosphate (optimal result; see Scheme 2.4). 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(87) Laitar, D. S.; Tsui, E. Y.; Sadighi, J. P. Organometallics 2006, 25, 2405–2408. 




5.5 mol % 2.24b
5.0 mol % CuCl
Ph
! B(pin)











 The most enantioselective pathway might begin with formation of alkylcopper S-
iii from addition of ii to olefin, eventually affording product vi in high SN2’ and 
enantioselectivity (Scheme 2.15). However, S-iii could undergo diastereoselective Cu–H 
elimination more facile compared R-iii leading to lower er, especially with an electron-
deficient aryl olefins (less nucleophilic alkylcopper) or at lower concentration and/or 
bulkier allylic electrophiles. 
 Metal alkoxide bridging to Cu centers can prevent phosphine chelation (vii).88 
With a more electrophilic olefin such as m-ester or p-CF3  styrene, additions can be facile 
with less reactive achiral Cu–B(pin) (ix via viii); as a result, lower SN2’ and er value were 
observed at higher concentration of olefin. Thus increasing the amount of the chiral bis-
phosphine ligand results in higher enantioselectivity (cf. Scheme 2.14b). 
 With a more reactive allylic phosphate, the achiral Cu–B(pin) viii is partially 
removed by conversion to allyl–B(pin). Thus at higher concentration of allylic phosphate 
there is some increase in er value. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(88) (a) Lemmen, T. H.; Goeden, G. V.; Huffman, J. C.; Geerts, R. L.; Caulton, K. G. Inorg. Chem. 1990, 
29, 3680–3685. (b) Dubinina, G. G.; Furutachi, H.; Vicic, D. A. J. Am. Chem. Soc. 2008, 130, 8600–8601. 
Scheme 2.14. Impact of bis-phosphine ligand
b)  Influence of ligand loading on er
0–5.5 mol % ligand, 5.0 mol % CuCl
1.1 equiv B2(pin)2,




no ligand: 85% SN2'







with 5.5 mol % 2.24b: >98% SN2'
with 5.5 mol % PPh3: >98% SN2'
5.5–20 mol % 2.24b,
5.0 mol % CuCl
1.1 equiv B2(pin)2,





5.5 mol % 2.24b: 86:14 er
10 mol % 2.24b: 90.5:9.5 er











 In the case of allylphenyl carbonate (2.25), although it is less reactive and should 
result in lower enantioselectivity of the product. However, we found that in the reaction 
with allylphenyl carbonate in the absence of phosphine ligand, there is significant amount 
of alkenyl–B(pin) formed. This implies that 2.25 does not react efficiently with ix to 
generate rac-vi. Cu–H elimination to form xiii serves as a corrective mechanism here. 
 















































































































2.4.4. Relevance to other catalytic processes 
The principles outlined above are applicable to catalytic hydroaminations. In the 
instances shown in Scheme 2.16, increasing the amount of the hydroxylamine improves 
enantioselectivity (93:7 to 96:4 er for 2.45 and 88:12 to 96:4 er for 2.46); this is despite 
the initially high selectivities and the narrow window for improvement in the former case 
(corresponding to DDG‡ = 0.35 and 0.70 kcal/mol, respectively). Excess bis-phosphine 
does not alter enantioselectivity of the reaction with the more electron rich 
dihydronaphthalene79 (93:7 er for 2.45 with 2.2 or 8.8 mol % 2.8), but the case of a more 
electrophilic alkenylboronate,80 higher er is obtained when 2.8 is used in larger amounts 
(97:3 and 88:12 er for 2.46 with 40 and 10 mol % 2.8, respectively). 
 
2.5. Conclusions 
We illustrate that catalytic allyl–boron additions can be performed without a co-
catalyst at ambient temperature efficiently and with high enantioselectivity. Rationally 
designed strategies, not applicable to processes where a C–C bond generating event is 
stereochemistry determining (vs C–metal bond formation), may be adopted for 
Scheme 2.16. Relevance to other catalytic systems
NBn2Ar = 3,5-(t-Bu)2,4-MeOC6H2
2.0 mol % Cu(OAc)2, 2.0 equiv (EtO)2MeSiH,
thf, 40 °C, 36 h
with 2.2 mol % 2.8:
1:1.2 alkene:amine–oxide:
87% yield, 93:7 er (ref 79);
1:3 alkene:amine–oxide:
75% yield, 96:4 er
with 8.8 mol % 2.8:
1:1.2 alkene:amine–oxide:














10 mol % Cu(OAc)2, 3.0 equiv PMHS,
4.0 equiv. LiOt-Bu, thf, 22 °C, 4 h
with 10 mol % 2.8:
1.2:1 alkene:amine–oxide:
57% yield, 88:12 er (ref 80);
1:3 alkene:amine–oxide:
43% yield, 96:4 er
with 40 mol % 2.8:
1.2:1 alkene:amine–oxide:
54% yield, 97:3 er








maximizing enantioselectivity. We show how the stereochemical integrity of 
organocopper intermediates depends on their steric and/or electronic attributes and in 
what ways enantioselectivity of the processes may vary according to the concentration of 
the alkene substrate and/or the allylic electrophile. The principles underscored by this 
investigation are expected to aid future endeavors regarding the development of 
enantioselective transformations catalyzed by organocopper entities. 
2.6. Experimental Section 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm-1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on Varian Unity INOVA 400 
(400 MHz), 500 (500 MHz), or 600 (600 MHz) spectrometers. Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, pent = pentet, m = multiplet, 
br = broad, app = apparent), and coupling constants (Hz). 13C NMR spectra were 
recorded on Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometers with complete proton decoupling. Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomeric 
ratios were determined by HPLC analysis (high-performance liquid chromatography) 
with a Shimadzu chromatograph [Chiral Technologies Chiralcel AZ-H (4.6 x 250 mm), 
Chiral Technologies Chiralcel OC-H (4.6 x 250 mm), Chiral Technologies Chiralcel OD-
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H (4.6 x 250 mm), Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral 
Technologies Chiralcel OZ-H (4.6 x 250 mm), or Chiral Technologies Chiralpak AD-H 
(4.6 x 250 mm)] in comparison with authentic racemic materials. Specific rotations were 
measured on a Rudolph Research Analytical Autopol IV Polarimeter. Melting points 
were measured on a Thomas Hoover capillary melting point apparatus and are 
uncorrected. X-ray structures were obtained, as described in the cif file, with a 
Microfocus sealed Cu tube from Incote. It is well established that that aforementioned 
detector allows for the determination of absolute configuration of molecules that do not 
have a heavy atom. 
Unless otherwise noted, reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 ºC) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Hexanes was purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system through 
a copper oxide and alumina column. Tetrahydrofuran (thf; Aldrich Chemical Co.) was 
purified by distillation from sodium benzophenone ketyl immediately prior to use. All 
work-up and purification procedures were carried out with reagent grade solvents 
(purchased from Fisher Scientific) under air. 
n  Reagents: 
Allyl phenyl carbonate (2.25): purchased from Aldrich and used as received. 
Allyl tert-butyl carbonate (2.16): prepared according to a previously reported 
procedure.89 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(89) Zhang, P.; Brozek, L. A.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 10686–10688. 
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Bis(pinacolato)diboron [B2(pin)2]: purchased from Frontier Scientific, Inc., 
recrystallized from pentane and dried under vacuum prior to use. 
n-Butyllithium (1.6 M in hexanes): purchased from Aldrich and used as received. 
Chlorotrimethylsilane: purchased from Acros and used as received. 
Copper(I) chloride: purchased from Strem and used as received. 
Deuterium oxide (D2O): purchased from Cambridge Isotope Laboratories and used as 
received. 
Diethyl allyl phosphate (2.17): purchased from Aldrich and used as received. 
Diisobutylaluminum hydride (dibal-H): purchased neat from Aldrich and used as 
received. 
Di-tert-butyl-dicarbonate (Boc2O): purchased from Advanced ChemTech and used as 
received. 
Hoveyda-Grubbs catalyst 2nd generation (2.28): purchased from Aldrich and used as 
received. 
Hydrogen peroxide (30 wt % in H2O): purchased from Aldrich and used as received. 
Imidazolinium salt im-1 and im-2: purchased from Aldrich and used as received. 
Imidazolinium salt im-3–im-7: prepared according to a previously reported procedure.90 
Imidazolinium salt im-9 and im-10: prepared according to a previously reported 
procedure.91 
Imidazolinium salt im-11: prepared according to a previously reported procedure.92 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(90) Lee, K-s.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455–4462. 
(91) (a) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 1097–
1100. (b) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7468–7472. 
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2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane [i-PrOB(pin)]: purchased from 
Aldrich and used as received. 
Oxone®, monopersulfate compound: purchased from Aldrich and used as received. 
Phosphine 2.4: prepared according to a previously reported procedure.93 
Phosphine ligands (2.8, 2.19–2.24a–c): purchased from Strem and used as received. 
Pyridinium dichromate (PDC): purchased from Aldrich and used as received. 
Sodium tert-butoxide: purchased from Strem and used as received. 
Sodium hydroxide (2 M): prepared from NaOH purchased from Fisher (used as 
received) and deionized water. 
Sulfuric acid: purchased from Fisher and used as received. 
Tetrabutylammonium fluoride (tbaf, 1.0 M in thf): purchased from Oakwood and 
used as received. 
Preparation of aryl or heteroaryl olefins: unless otherwise noted, olefins were 
purchased from Acros, Aldrich, Alfa Aesar, Combi-Blocks, Matrix Scientific, or TCI, 
and distilled over CaH2 under reduced pressure prior to use. 
The following olefins were synthesized from the corresponding aldehydes by Wittig 
olefination.94 
1,4-Dimethoxy-2-methyl-5-vinylbenzene (2.26): Melting point: 41–42°C. IR (neat): 
2995 (w), 2935 (w), 2830 (w), 1623 (w), 1501 (s), 1464 (m), 1416 (m), 1399 (m), 1207 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(92) Clavier, H.; Coutable, L.; Toupet, L.; Guillemin, J.-C.; Mauduit, M. J. Organomet. Chem. 2005, 690, 
5237–5254. 
(93) Jia, T.; Cao, P.; Wang, B.; Lou, Y.; Yin, X.; Wang, M.; Liao, J. J. Am. Chem. Soc. 2015, 137, 13760–
13763.  
(94) Cho, S. J.; Jensen, N. H.; Kurome, T.; Kadari, S.; Manzano, M. L.; Malberg, J. E.; Caldarone, B.; Roth, 
B. L.; Kozikowski, A. P. J. Med. Chem. 2009, 52, 1885–1902. 
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(s), 1182 (m), 1042 (s), 996 (m), 902 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.02 (1H, 
dd, J = 18.0, 11.2 Hz), 6.95 (1H, s), 6.70 (1H, s), 5.68 (1H, dd, J = 17.8, 1.4 Hz), 5.22 
(1H, dd, J = 11.2, 1.2 Hz), 3.82 (3H, s), 3.80 (3H, s), 2.23 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 152.0, 150.8, 131.7, 127.5, 124.5, 114.7, 113.3, 108.2, 56.4, 55.9, 16.4; HRMS 
(DART): Calcd for C11H15O2 [M+H]+: 179.1072, Found: 179.1069. 
1-(Allyloxy)-3-vinylbenzene (substrate for 2.18f and 2.18w): The spectroscopic data 
match those reported previously.95 1H NMR (400 MHz, CDCl3): δ 7.24 (1H, t, J = 8.0 
Hz), 7.03–6.96 (2H, m), 6.83 (1H, ddd, J = 8.2, 2.6, 0.9 Hz), 6.68 (1H, dd, J = 17.6, 10.8 
Hz), 6.07 (1H, ddt, J = 17.3, 10.6, 5.3 Hz), 5.73 (1H, dd, J = 17.6, 0.9 Hz), 5.43 (1H, dq, 
J = 17.3, 1.6 Hz), 5.29 (1H, dq, J = 10.5, 1.4 Hz), 5.25 (1H, dd, J = 10.9, 0.9 Hz), 4.56 
(2H, dt, J = 5.3, 1.5 Hz). 
tert-Butyl 5-vinyl-1H-indole-1-carboxylate (substrate for 2.18m): The spectroscopic 
data match those reported previously.96 1H NMR (400 MHz, CDCl3): δ 8.08 (1H, d, J= 
8.0 Hz), 7.58–7.57 (2H, m), 7.41 (1H, dd, J = 8.4, 1.2 Hz), 6.81 (1H, dd, J = 17.6, 10.8 
Hz), 6.55–6.54 (1H, m), 5.75 (1H, dd, J = 17.2, 1.2 Hz), 5.21 (1H, dd, J = 10.4, 0.8 Hz), 
1.68 (9H, s). 
2-Vinylbenzofuran (substrate for 2.18n): The spectroscopic data match those reported 
previously.97 1H NMR (400 MHz, CDCl3): δ 7.52 (1H, ddd, J = 7.6, 1.4, 0.7 Hz), 7.45 
(1H, dq, J =8.2, 0.9 Hz), 7.30–7.24 (2H, m), 6.64 (1H, dd, J = 17.5, 11.2 Hz), 6.60 (1H, 
s), 5.96 (1H, ddd, J = 17.4, 1.3, 0.6 Hz), 5.41 (1H, dd, J = 11.2, 1.2 Hz). 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(95) Paul, C. E.; Rajagopalan, A.; Lavandera, I.; Gotor-Fernández, V.; Kroutil, W.; Gotor V. Chem. 
Commun. 2012, 48, 3303–3305. 
(96) Molander, G. A.; Brown, A. R. J. Org. Chem. 2006, 71, 9681–9686. 
(97) (a) Brewer, J. D.; Elix, J. A. Aust. J. Chem. 1975, 28, 1059–1081, (b) Aitken, R. A.; Burns, G. J. Chem. 
Soc., Perkin Trans. 1 1994, 2455–2460. 
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The following olefins were synthesized from the corresponding aryl bromides by 
a two-step lithium halogen exchange/addition to TMSCl or i-PrOB(pin). To a flame-dried 
round bottom flask equipped with a stir bar was added 4-bromostyrene (0.71 mL, 5.5 
mmol) and thf (30 mL) under N2. The resulting solution was allowed to cool to –78 ºC 
(dry ice/acetone) and n-butyllithium (1.6 M in hexanes, 3.8 mL, 6.0 mmol) was added 
dropwise into the solution through syringe. The resulting light yellow solution was 
allowed to stir for 1 h at –78 ºC and then TMSCl (0.84 mL, 6.6 mmol) was added 
dropwise by syringe. The mixture was allowed to slowly warm up to 22 ºC. After 16 h, 
the reaction was quenched by the addition of H2O (10 mL) and a saturated solution of 
aqueous NH4Cl (10 mL). The layers were separated and the aqueous layer was washed 
with Et2O (3 x 20 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The resulting yellow oil was purified by silica gel 
chromatography (100% hexanes) to afford trimethyl(4-vinylphenyl)silane (substrate for 
2.18j) as colorless oil (876 mg, 5.0 mmol, 91%): IR (neat): 3063 (w), 3008 (w), 2956 
(m), 1629 (w), 1389 (m), 1248 (m), 1105 (m), 989 (m), 906 (m), 826 (s), 761 (m), 730 
(m), 692 (m), 642 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.51 (2H, d, J = 7.6 Hz), 
7.43 (2H, d, J = 8.0 Hz), 6.74 (1H, dd, J = 17.6, 10.9, Hz), 5.80 (1H, d, J = 17.6 Hz), 5.27 
(1H, d, J = 10.9 Hz), 0.29 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 140.3, 138.1, 137.0, 
133.7, 125.7, 114.2, –1.0; HRMS (DART): Calcd for C11H17Si [M+H]+: 177.1100, 
Found: 177.1101. 
4,4,5,5-Tetramethyl-2-(4-vinylphenyl)-1,3,2-dioxaborolane (substrate for 2.18q): 
Following the above procedure except i-PrOB(pin) was used instead of TMSCl, the 
product was obtained as colorless oil [purified by silica gel chromatography 
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(hexanes:Et2O = 25:1)] (1.0 g, 4.5 mmol, 82%). IR (neat): 2978 (m), 2930 (w), 1629 (m), 
1552 (w), 1397 (m), 1356 (s), 1322 (s), 1269 (m), 1213 (w), 1142 (s), 1088 (s), 1018 (m), 
990 (m), 962 (m), 830 (m), 758 (w), 682 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.82 
(2H, d, J = 8.0 Hz), 7.44 (2H, d, J = 8.0 Hz), 6.76 (1H, dd, J = 17.6, 10.8 Hz), 5.84 (1H, 
dd, J = 17.6, 1.2 Hz), 5.32 (1H, dd, J = 10.8, 0.8 Hz), 1.38 (12H, s); 13C NMR (CDCl3, 
100 MHz): δ 140.3, 137.0, 135.1, 125.6, 114.9, 83.8, 25.0, 24.9; HRMS (DART): Calcd 
for C14H20BO2 [M+H]+: 231.1556; Found: 231.1563. 
 4,4,5,5-Tetramethyl-2-(3-vinylphenyl)-1,3,2-dioxaborolane (substrate for 2.18r): 
Following the above except 3-bromostyrene and i-PrOB(pin) were used instead of 4-
bromostyrene and TMSCl, respectively, the product was obtained as colorless oil 
[purified by silica gel chromatography (hexanes:Et2O = 25:1)] (1.1 g, 4.7 mmol, 85%). 
IR (neat): 2978 (w), 2929 (m), 1380 (m), 1353 (s), 1319 (s), 1141 (s), 1079 (s), 990 (m), 
963 (m), 908 (m), 831 (m), 710 (w), 699 (s), 681 (m) cm−1; 1H NMR (CDCl3, 400 MHz): 
δ 7.87 (1H, s), 7.73 (1H, d, J = 7.3 Hz), 7.53 (1H, dt, J = 7.8, 1.6 Hz), 7.35 (1H, t, J = 7.5 
Hz), 6.75 (1H, dd, 17.6, 10.9 Hz), 5.81 (1H, dd, J = 17.6, 0.9 Hz), 5.26 (1H, dd, J = 10.9, 
0.9 Hz), 1.37 (12H, s); 13C NMR (CDCl3, 100 MHz): δ 137.0, 136.9, 134.3, 132.9, 129.0, 
128.0, 114.0, 83.9, 25.0, 24.9; HRMS (DART): Calcd for C14H20BO2 [M+H]+: 231.1556, 
Found: 231.1567. 
tert-Butyl 3-vinylbenzoate (substrate for 2.18g): Prepared according to the reported 
procedure.98 IR (neat): 2978 (w), 2932 (w), 1711 (s), 1367 (m), 1294 (s), 1271 (m), 1256 
(m), 1158 (s), 1113 (m), 1086 (m), 909 (m), 763 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(98) Miller, W. H.; Seefeld, M. A.; Newlander, K. A.; Uzinskas, I. N.; Burgess, W. J.; Heerding, D. A.; 
Yuan, C. C. K.; Head, M. S.; Payne, D. J.; Rittenhouse, S. F.; Moore, T. D.; Pearson, S. C.; Berry, V.; 
DeWolf, Jr. W. E.; Keller, P. M.; Polizzi, B. J.; Qiu, X.; Janson, C. A.; Huffman, W. F. J. Med. Chem. 2000, 
45, 3246–3256. 
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8.03 (1H, dd, J = 2.2, 1.0 Hz), 7.88 (1H, dt, J = 7.6, 1.2 Hz), 7.57–7.55 (1H, m), 7.37 
(1H, t, J = 7.8 Hz), 6.75 (1H, dd, J = 17.6, 10.8 Hz), 5.82 (1H, dd, J = 17.6, 0.4 Hz), 5.31 
(1H, dd, J = 11.0, 0.6 Hz), 1.61 (9H, s); 13C NMR (100 MHz, CDCl3): δ 165.8, 137.8, 
136.2, 132.4, 130.1, 128.8, 128.5, 127.3, 115.0, 81.2, 28.3, ; HRMS (DART): Calcd for 
C13H17O2 [M+H]+: 205.1229, Found: 205.1235.  
tert-Butyl 4-vinylbenzoate (substrate for 2.18l): Prepared according to the reported 
procedure.98 The spectroscopic data match those reported previously.99 1H NMR (400 
MHz, CDCl3): δ 7.94 (2H, d, J= 8.0 Hz), 7.44 (2H, d, J = 8.0 Hz), 6.75 (1H, dd, J = 17.6, 
10.8 Hz), 5.84 (1H, dd, J = 17.6, 1.2 Hz), 5.36 (1H, dd, J = 11.0, 0.2 Hz), 1.60 (9H, s). 
Preparation of allylic phosphates (substrates for 2.18t, 2.18v–w): Allylic alcohols 
were synthesized from the corresponding alkenyl bromides (purchased from Aldrich and 
used as received) by a two-step lithium halogen exchange/addition to formaldehyde 
sequence.100 Subsequently, allylic alcohols were converted to the corresponding allylic 
phosphates based on an established method.101  
Diethyl (2-phenylallyl) phosphate (substrates for 2.18t): IR (neat): 2983 (w), 2908 (w), 
1444 (w), 1262 (m), 1165 (w), 1016 (s), 975 (s), 778 (m), 707 (m) cm–1; 1H NMR (400 
MHz, CDCl3): δ 7.43–7.46 (2H, m), 7.28–7.37 (3H, m), 5.57 (1H, s), 5.44 (1H, s), 4.93 
(2H, d, J = 7.2 Hz), 4.11–4.03 (4H, m), 1.31–1.28 (6H, m); 13C NMR (100 MHz, CDCl3): 
δ 142.9 (d, J = 7.5 Hz), 137.7, 128.6, 128.2, 126.2, 115.4, 68.7 (d, J = 5.3 Hz), 63.9 (d, J 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(99) Mäsing, F.; Mardyukov, A.; Doerenkamp, C.; Eckert, H.; Malkus, U.; Nüsse, H.; Klingauf, J.; Studer, 
A. Angew. Chem. Int. Ed. 2015, 54, 12612–12617. 
(100) Amat, M.; Arioli, F.; Pérez, M.; Molins, E.; Bosch, J. Org. Lett. 2013, 15, 2470–2473. 
(101) Kacprzynski, M. A.; May, T. L.; Kazane, S. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 
4554–4558. 
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= 5.3 Hz), 16.2 (d, J = 6.8 Hz); HRMS (DART): Calcd for C13H20O4P1 [M+H]+: 
271.1099, Found: 271.1087.  
Diethyl (2-(trimethylsilyl)allyl) phosphate (substrate for 2.18v–w): IR (neat): 2982 
(w), 2957 (w), 2908 (m), 1394 (w), 1250 (m), 1167 (w), 1024 (s), 976 (m), 840 (s) cm–1; 
1H NMR (400 MHz, CDCl3): δ 5.85 (1H, s), 5.45 (1H, s), 4.65 (2H, d, J = 6.0 Hz), 4.15–
4.08 (4H, m), 1.33 (6H, t, J = 7.0 Hz), 0.13 (9H, s); 13C NMR (100 MHz, CDCl3): δ 
146.8 (d, J = 7.6 Hz), 125.1, 70.7 (d, J = 6.0 Hz), 63.9 (d, J = 6.1 Hz), 16.3 (d, J = 6.9 
Hz), –1.5; HRMS (DART): Calcd for C10H24O4P1Si1 [M+H]+: 267.1182, Found: 
267.1177. 
Preparation of an allylic phosphate for 2.18u: 2-Methyl-2-propen-1-ol (purchased 
from Aldrich and used as received) was converted to the corresponding allylic phosphate 
based on a previously disclosed method.101 
Diethyl (2-methylallyl) phosphate (substrate for 2.18u): IR (neat): 2983 (w), 2911 (w), 
1447 (w), 1264 (m), 1166 (w), 1008 (s), 973 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 
4.94 (1H, s), 4.83 (1H, s), 4.32 (2H, d, J = 7.2 Hz), 4.05–3.98 (4H, m), 1.67 (3H, s), 
1.26–1.21 (6H, m); 13C NMR (100 MHz, CDCl3): δ 140.0 (d, J = 6.8 Hz), 113.0, 70.5 (d, 
J = 6.1 Hz), 63.7 (d, J = 6.1 Hz), 18.9, 16.0 (d, J = 6.8 Hz); HRMS (DART): Calcd for 
C8H18O4P1 [M+H]+: 209.0943, Found: 209.0944. 
Preparation of allyl-1,1-d2-diethyl phosphate (2.17-d2): Allylic alcohol was 
synthesized from the reported procedure.102  Subsequently, allylic alcohol was converted 
to the corresponding allylic phosphates based on an established method.101 IR (neat): 
2984 (w), 2934 (w), 1265 (m), 1017(s), 976 (s), 801 (m) cm–1; 1H NMR (400 MHz, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(102) Schuetz, R. D.; Millard, F. W. J. Org. Chem. 1959, 24, 297–300. 
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CDCl3): δ 5.91 (1H, dd, J = 17.2, 10.4 Hz), 5.33 (1H, dt, J = 17.2, 1.5 Hz), 5.21 (1H, dt, 
J = 10.0, 1.4 Hz), 4.12–4.04 (4H, m), 1.32–1.28 (6H, m); 13C NMR (100 MHz, CDCl3): 
δ 135.6 (d, J = 6.8 Hz), 118.3, 63.8 (d, J = 6.1 Hz), 16.2 (d, J = 6.8 Hz); HRMS (DART): 
Calcd for C7H14D2O4P1 [M+H]+: 197.0912, Found: 197.0920. 
n  Representative Procedure for the Catalytic Enantioselective Boron-Allyl Addition 
to Aryl Alkenes 
In a N2-filled glove box, an oven-dried 1 dram vial equipped with a stir bar was 
charged with bisphosphine 2.24a (3.4 mg, 0.0055 mmol), NaOt-Bu (14 mg, 0.15 mmol), 
and CuCl (0.50 mg, 0.0050 mmol), and thf (1.0 mL). The mixture was allowed to stir for 
1 h under N2 at 22 °C; during this time the solution turned light-yellow. 
Bis(pinacolato)diboron (28 mg, 0.11 mmol) was added to the mixture, causing the 
solution to turn dark brown immediately. Styrene (31 mg, 0.30 mmol), allylphosphate 
(2.17) (19 mg, 0.10 mmol), and thf (0.50 mL) were added. The vial was sealed with a cap 
and electrical tape before removal from the glove box. The resulting mixture was allowed 
to stir at 22 °C for 14 h. The mixture was then passed through a short plug of silica gel (4 
x 1 cm) and eluted with Et2O. The organic layer was concentrated under reduced 
pressure, affording yellow oil, which was purified by silica gel chromatography (100% 
hexanes→hexanes:Et2O = 10:1) to afford 2.18a as colorless oil (18 mg, 0.067 mmol, 
67% yield). (R)-4,4,5,5-Tetramethyl-2-(2-phenylpent-4-en-1-yl)-1,3,2-dioxaborolane 
(2.18a). IR (neat): 3027 (w), 2977 (m), 2925 (w), 1452 (m), 1367 (s), 1319 (s), 1270 (w), 
12134(w), 1164 (m), 1143 (s), 968 (m), 911 (m), 847 (m), 756 (m), 699 (s) cm–1; 1H 
NMR (CDCl3, 400 MHz): δ 7.25–7.09 (5H, m), 5.68 (1H, ddt, J =17.2, 10.0, 7.2 Hz), 
4.96–4.88 (2H, m), 2.96–2.88 (1H, m), 2.40–2.27 (2H, m), 1.23 (1H, dd, J =15.4, 6.6 
 259	  
Hz), 1.14–1.08 (1H, m), 1.10 (6H, s), 1.09 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 146.9, 
137.3, 128.2, 127.6, 126.0, 116.1, 83.1, 43.9, 41.5, 24.83, 24.78; HRMS (DART): Calcd 
for C17H26B1O2 [M+H] +: 273.2026, Found: 273.2015. Specific rotation: [α]D20 +6.7 (c 
0.30, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (95:5 
er shown; Chiralcel OD–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   16.604	   50.067	   1	   17.223	   5.239	  2	   20.296	   49.933	   2	   20.890	   94.761	  
(R)-4,4,5,5-Tetramethyl-2-(2-(o-tolyl)pent-4-en-1-yl)-1,3,2-dioxaborolane (2.18b): IR 
(neat): 2977 (w), 2928 (w), 1365 (s), 1317 (s), 1144 (s), 968 (m), 911 (m), 846 (m), 758 
(m), 726 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.20 (1H, d, J = 8.0 Hz), 7.14 (1H, t, J 
= 7.2 Hz), 7.09–7.01 (2H, m), 5.74–5.63 (1H, m), 4.99–4.91 (2H, m), 3.23 (1H, app pent, 
J = 7.3 Hz), 2.38–2.24 (2H, m), 2.36 (3H, s), 1.23 (1H, dd, J = 14.6, 7.8 Hz), 1.12 (1H, 
dd, J = 16.0, 8.0 Hz), 1.05 (s, 6H), 1.03 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 145.1, 
137.3, 135.7, 130.0, 126.1, 125.6, 116.1, 83.0, 43.6, 36.0, 24.7, 20.0; HRMS (DART): 
Calcd for C18H28B1O2 [M+H]+: 287.2182, Found: 287.2177; Specific Rotation: [a]D20 
+8.8 (c 1.32, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric 
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purity was determined by HPLC analysis in comparison with authentic racemic material 
(95:5 er shown; Chiralcel OD–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   14.521	   48.770	   1	   14.419	   5.191	  2	   21.736	   51.230	   2	   20.205	   94.809	  
(R)-4,4,5,5-Tetramethyl-2-(2-(naphthalen-1-yl)pent-4-enyl)-1,3,2-dioxaborolane 
(2.18c): IR (neat): 2976 (w), 2975 (w), 1367 (s), 1312 (s), 1251 (w), 1142 (s), 967 (m), 
846 (m), 792 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.22 (1H, d, J = 8.1 Hz), 7.83 (1H, 
dd, J = 7.9, 1.6 Hz), 7.68 (1H, dd, J = 6.9, 2.5 Hz), 7.56–7.37 (4H, m), 5.75 (1H, ddt, J 
=17.2, 10.1, 7.0 Hz), 5.06–4.91 (2H, m), 3.90 (1H, app pent, J = 7.3 Hz), 2.66–2.53 (1H, 
m), 2.50–2.38 (1H, m), 1.47–1.35 (1H, m), 1.35–1.23 (1H, m), 1.04 (6H, s), 0.96 (6H, s); 
13C NMR (CDCl3, 100 MHz): δ 143.2, 137.2, 134.0, 131.8, 128.8, 126.4, 125.6, 125.6, 
125.3, 123.9, 123.4, 116.4, 83.1, 43.3, 35.0, 24.7; HRMS (DART): Calcd for C21H28B1O2 
[M+H]+: 323.2182, Found: 323.2185; Specific Rotation: [a]D20 +5.6 (c 1.08, CHCl3) for 
an enantiomerically enriched sample of 93:7 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (93:7 er shown; Chiralcel 
OJ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   21.777	   48.483	   1	   20.183	   93.067	  2	   24.906	   51.517	   2	   23.495	   6.933	  
(R)-2-(2-(2-Methoxyphenyl)pent-4-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18d): IR (neat): 2976 (w), 2929 (w), 2836 (w), 1599 (w), 1585 (w), 1491 (m), 1464 
(w), 1438 (w), 1368 (s), 1318 (s), 1215 (s), 1143 (s), 1101 (s), 1031 (m), 968 (m), 909 
(m), 885 (w), 749 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.17–7.10 (2H, m), 6.88 (1H, 
t, J = 7.4 Hz),  6.81 (1H, d, J = 8.4 Hz), 5.75–5.65 (1H, m), 4.96–4.88 (2H, m), 3.81 (3H, 
s), 3.42 (1H, app pent, J = 7.5 Hz),  2.44–2.26 (2H, m),  1.26–1.19 (1H, m), 1.16–1.08 
(1H, m), 1.11 (6H, s), 1.08 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 157.2, 137.8, 135.1, 
127.8, 126.7, 120.4, 115.7, 110.6, 82.9, 55.5, 42.3, 33.9, 24.80, 24.77; HRMS (DART): 
Calcd for C18H28B1O3 [M+H]+: 303.2132, Found: 303.2128; Specific Rotation: [a]D20 
+13.9 (c 1.61, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(95:5 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   23.978	   50.115	   1	   21.378	   95.065	  
 262	  
2	   32.136	   49.885	   2	   29.394	   4.935	  
(R)-4,4,5,5-Tetramethyl-2-(2-(m-tolyl)pent-4-en-1-yl)-1,3,2-dioxaborolane (2.18e): IR 
(neat): 2977 (w), 2922 (w), 1366 (s), 1319 (s), 1144 (s), 968 (m), 847 (m), 704 (m) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 7.15 (1H, dd, J = 9.0, 6.2 Hz), 7.00 (1H, s), 6.97–6.93 
(2H, m), 5.72–5.62 (1H, m), 4.98–4.89 (2H, m), 2.89 (1H, app pent, J = 7.6 Hz), 2.40–
2.26 (5H, m), 1.25–1.18 (1H, m), 1.11–1.03 (13H, m); 13C NMR (CDCl3, 100 MHz): δ 
146.9, 137.5, 137.46, 128.4, 128.1, 126.7, 124.5, 116.0, 83.1, 43.7, 41.4, 24.82, 24.79, 
21.6; HRMS (DART): Calcd for C18H28B1O2 [M+H]+: 287.2182, Found: 287.2188; 
Specific Rotation: [a]D20 +16.9 (c 0.98, CHCl3) for an enantiomerically enriched sample 
of 97:3 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (97:3 er shown; Chiralcel OD–H column, 100% hexanes, 0.3 
mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   14.537	   50.572	   1	   14.887	   3.297	  2	   16.483	   49.428	   2	   16.975	   96.703	  
(R)-2-(2-(3-(Allyloxy)phenyl)pent-4-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18f): IR (neat): 3076 (w), 2977 (w), 2925 (w), 1600 (m), 1583 (m), 1422 (s), 1366 (s), 
1265 (m), 1142 (s), 1034 (w), 913 (m), 846 (m), 776 (m), 699 (m) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.16 (1H, t, J = 7.9 Hz), 6.84–6.76 (2H, m), 6.71 (1H, ddd, J = 8.2, 
2.6, 0.9 Hz), 6.06 (1H, ddt J = 17.3, 10.6, 5.3 Hz), 5.67 (1H, dddd, J = 16.9, 10.1, 7.5, 6.6 
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Hz), 5.40 (1H, dd, J = 17.3, 1.6 Hz), 5.27 (1H, dd, J = 10.5, 1.5 Hz), 5.00–4.87 (2H, m), 
4.52 (2H, dt, J = 5.3, 1.5 Hz), 3.04–2.82 (1H, m), 2.43–2.26 (2H, m), 1.29–1.16 (2H, m), 
1.12 (6H, s), 1.11 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 158.6 148.7, 137.3, 133.7, 
129.1, 120.2, 117.6, 116.2, 114.2, 112.2, 83.1, 68.8, 43.7, 41.5, 24.85, 24.82; HRMS 
(DART): Calcd for C20H30B1O3 [M+H]+: 329.2288, Found: 329.2295; Specific Rotation: 
[a]D20 +6.4 (c 1.17, CHCl3) for an enantiomerically enriched sample of 95:5 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (95:5 er shown; Chiralcel OD–H column, 100% hexanes, 0.3 mL/min, 
220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   31.532	   49.049	   1	   32.064	   4.765	  2	   36.476	   50.951	   2	   36.398	   95.235	  
tert-Butyl (R)-3-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-
yl)benzoate (2.18g): Following the representative procedure except for 1:3 
alkene:phosphate used. IR (neat): 2977 (w), 2929 (w), 1713 (s), 1440 (w), 1390 (w), 1367 
(s), 1320 (m), 1294 (s), 1161 (s), 1144 (s), 1110 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.83 (1H, dd, J = 1.6, 1.2 Hz), 7.78 (1H, ddd, J = 7.7, 2.3, 1.1 Hz), 7.37 (1H, dd, J = 7.6, 
1.6 Hz), 7.30 (1H, t, J = 7.4 Hz), 5.66 (1H, ddt, J = 17.2, 10.0, 7.2 Hz), 4.98–4.91 (2H, 
m), 3.04–2.96 (1H, m), 2.44–2.32 (2H, m), 1.59 (9H, s), 1.25 (1H, dd, J = 15.8, 7.0 Hz), 
1.20–1.06 (13H, m); 13C NMR (100 MHz, CDCl3): δ 166.2, 147.1, 137.0, 131.9, 131.6, 
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128.8, 128.1, 127.2, 116.5, 83.2, 80.9, 43.4, 41.4, 28.4, 24.9, 24.8; HRMS (DART): 
Calcd for C22H34B1O4 [M+H]+: 373.2550, Found: 373.2565; Specific Rotation: [α]D20 
+4.9 (c 1.05, CHCl3) for an enantiomerically enriched sample of 94:6 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(94:6 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   17.885	   50.079	   1	   17.683	   93.933	  2	   20.783	   49.921	   2	   21.473	   6.067	  
tert-Butyl (R)-3-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl-5,5-
d2)benzoate [2.18g-d2 (SN2’)]: Following the representative procedure except 2.17-d2 
and 2.24b was used. IR (neat): 2977 (w), 2929 (w), 1713 (s), 1367 (s), 1320 (m), 1295 
(s), 1162 (s), 1145 (s), 1111 (m), 968 (m), 848 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.83 (1H, t, J = 1.6 Hz), 7.78 (1H, dt, J = 7.6, 1.6 Hz), 7.37 (1H, dt, J = 7.2, 1.6 Hz), 7.30 
(1H, t, J = 7.8 Hz), 5.65 (1H, t, J = 7.0 Hz, 3.04–2.96 (1H, m), 2.44–2.32 (2H, m), 1.59 
(9H, s), 1.25 (1H, dd, J = 15.2, 6.0 Hz) 1.11 (6H, s), 1.10 (6H, s), 1.12–1.06 (1H, m); 13C 
NMR (100 MHz, CDCl3): δ 166.2, 147.1, 136.8, 131.9, 131.6, 128.8, 128.1, 127.2, 83.2, 
80.9, 43.3, 41.4, 28.4, 24.9, 24.8; HRMS (DART): Calcd for C22H35D2B1N1O4 
[M+NH4]+: 392.2941, Found: 392.2954. 
(R)-6-Methyl-2-(4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-
yl)phenyl)-1,3,6,2-dioxazaborocane-4,8-dione (2.18h): IR (neat): 2977 (w), 2927 (w), 
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1765 (s), 1457 (w), 1370 (m), 1334 (m), 1293 (m), 1235 (m), 1145 (m), 1040 (m), 993 
(m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.40 (2H, d, J = 7.6 Hz), 7.23 (2H, d, J = 8.0 
Hz), 5.69–5.59 (1H, m), 4.96–4.88 (2H, m), 3.93 (2H, d, J = 16.4 Hz), 3.75 (2H, d, J = 
16.0 Hz), 2.95 (1H, app pent, J = 7.5 Hz), 2.51 (3H, s), 2.38–2.32 (2H, m), 1.23 (1H, dd, 
J = 15.2, 7.2 Hz),  1.12–1.06 (13H, m); 13C NMR (100 MHz, CDCl3): δ 167.5, 149.0, 
137.1, 132.2, 127.7, 116.3, 83.1, 61.8, 47.5, 43.6, 41.4, 24.9, 24.8; HRMS (DART): 
Calcd for C22H35B2N2O6 [M+NH4]+: 445.2681, Found: 445.2689. Specific Rotation: 
[α]D20 +6.4 (c 0.87, CHCl3) for an enantiomerically enriched sample of 95:5 er. 
Enantiomeric purity was determined by HPLC analysis of the product from 
oxidation/acetylation in comparison with authentic racemic material (95:5 er shown; 
Chiralcel OC–H column, 98% hexanes, 2% i-PrOH, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   148.992	   50.354	   1	   145.989	   95.214	  2	   163.447	   49.646	   2	   163.902	   4.786	  
(R)-4,4,5,5-Tetramethyl-2-(2-(p-tolyl)pent-4-en-1-yl)-1,3,2-dioxaborolane (2.18i): IR 
(neat): 2977 (m), 2924 (m), 1514 (w), 1368 (s), 1322 (s), 1145 (s), 968 (m), 911 (m), 846 
(m), 813 (m) cm−1; 1H NMR (CDCl3, 600 MHz): δ 7.09 (2H, d, J = 5.2 Hz), 7.06 (2H, d, 
J = 5.6 Hz), 5.71–5.64 (1H, m), 4.97–4.90 (2H, m), 2.91 (1H, app pent, J = 5.0 Hz), 
2.39–2.30 (5H, m), 1.21 (1H, dd, J = 9.8, 4.2 Hz), 1.12–1.06 (13H, m); 13C NMR 
(CDCl3, 150 MHz): δ 143.9, 137.5, 135.3, 128.9, 127.4, 116.0, 83.1, 43.8, 41.0, 24.84, 
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24.81, 21.1; HRMS (DART): Calcd for C18H28B1O2 [M+H]+: 287.2182, Found: 
287.2184; Specific Rotation: [a]D20 +8.6 (c 1.00, CHCl3) for an enantiomerically enriched 
sample of 95:5 er. Enantiomeric purity was determined by HPLC analysis in comparison 
with authentic racemic material (95:5 er shown; Chiralcel OD–H column, 100% hexanes, 
0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   14.002	   49.406	   1	   13.876	   4.731	  2	   14.488	   50.594	   2	   14.354	   95.269	  
(R)-Trimethyl(4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-
yl)phenyl)silane (2.18j): IR (neat): 3068 (w), 2977 (m), 2955 (m), 2926 (w), 1640 (w), 
1599 (w), 1365 (s), 1322 (s), 1164 (m), 1144 (s), 1110 (m), 997 (m), 968 (m), 911 (m), 
837 (s), 757 (m), 725 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.41 (2H, d, J = 8.1 Hz), 
7.23–7.17 (2H, m), 5.70 (1H, dddd, J = 16.8, 10.1, 7.6, 6.5 Hz), 4.98 (1H, ddt, J = 17.2, 
2.5, 1.4 Hz), 4.93 (1H, ddt, J = 10.1, 2.1, 1.0 Hz), 2.99–2.88 (1H, m), 2.46–2.26 (2H, m), 
1.29–1.20 (2H, m), 1.09 (6H, s), 1.08 (6H, s), 0.23 (9H, s); 13C NMR (CDCl3, 100 MHz): 
δ147.6, 137.5, 137.3, 133.2, 127.0, 116.1, 83.0, 43.5, 41.4, 24.8, 24.7, –0.8, –0.9; HRMS 
(DART): Calcd for C20H34BO2Si [M+H]+: 345.2421, Found: 345.2431; Specific 
Rotation: [a]D20 +8.2 (c 0.85, CHCl3) for an enantiomerically enriched sample of 96:4 er. 
Enantiomeric purity was determined by HPLC analysis of the alcohol product after 
 267	  
oxidation in comparison with authentic racemic material (96:4 er shown; Chiralcel AZ–H 
column, 99% hexanes, 1% i-PrOH, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   25.030	   49.887	   1	   24.263	   95.727	  2	   26.150	   50.113	   2	   25.372	   4.273	  
(R)-2-(2-(4-Methoxyphenyl)pent-4-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18k): IR (neat): 2976 (w), 2926 (w), 2834 (w), 1610 (w), 1511 (s), 1366 (s), 1319 (m), 
1244 (s), 1214 (w), 1177 (m), 1165 (s), 1143 (w), 1104 (m), 1037 (m), 967 (m), 910 (w), 
885 (w), 846 (m), 828 (m), 806 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.12 (2H, dd, J 
= 6.4, 2.0 Hz), 6.80 (2H, dd, J = 6.4, 2.0 Hz), 5.67 (1H, ddt, J = 17.2, 9.6, 7.2 Hz), 4.97–
4.90 (2H, m) 3.77 (3H, s), 2.94–2.86 (1H, m), 2.38–2.26 (2H, m), 1.25–1.18 (1H, m), 
1.11–1.04 (13H, m). 13C NMR (CDCl3, 100 MHz): δ 157.9, 139.1, 137.4, 128.4, 116.0, 
113.6, 83.1, 55.4, 44.1, 40.7, 24.9, 24.8; HRMS (DART): Calcd for C18H28BO3 [M+H]+: 
303.2132, Found: 303.2126; Specific Rotation: [a]D20 +9.8 (c 0.76, CHCl3) for an 
enantiomerically enriched sample of 97:3 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (97:3 er shown; Chiralcel 
OD–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   21.084	   49.788	   1	   20.993	   3.369	  2	   24.175	   50.212	   2	   23.315	   96.631	  
tert-Butyl (R)-4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-
yl)benzoate (2.18l): IR (neat): 2978 (m), 2930 (w), 1712 (s), 1609 (w), 1367 (s), 1312 
(m), 1290 (s), 1166 (s), 1145 (s), 1116 (s), 848 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.88 (2H, d, J = 8.0 Hz), 7.24 (2H, d, J = 8.0 Hz), 5.68–5.58 (1H, m), 4.96–4.90 (2H, m), 
3.00 (1H, app pent, J = 7.5 Hz), 2.35 (2H, t, J = 7.2 Hz), 1.58 (9H, s), 1.27–1.21 (1H, m), 
1.14–1.08, (1H, m) 1.12 (6H, s), 1.11 (6H, s); 13C NMR (100 MHz, CDCl3): δ 166.1, 
152.0, 136.8, 129.9, 129.5, 127.4, 116.5, 83.2, 80.8, 43.5, 41.5, 28.4, 24.9, 24.8; HRMS 
(DART): Calcd for C22H34B1O4 [M+H]+: 373.2550, Found: 373.2534; Specific Rotation: 
[α]D20 –3.0 (c 1.00, CHCl3) for an enantiomerically enriched sample of 67:33 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 







Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   14.638	   49.374	   1	   14.474	   48.271	  2	   17.479	   50.626	   2	   16.639	   51.729	  
tert-Butyl (R)-5-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl)-1H-
indole-1-carboxylate (2.18m): Following the representative procedure except for 6:1 
alkene:phosphate used. IR (neat): 2977 (m), 2927 (w), 1731 (s), 1469 (m), 1441 (w), 
1352 (s), 1318 (s), 1253 (m), 1162 (s), 1141 (s), 1081 (m), 1022 (m), 968 (w), 846 (w), 
766 (m), 725 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 8.00 (1H, d, J = 8 Hz), 7.54 (1H, 
d, J = 3.6 Hz), 7.38 (1H, d, J = 1.6 Hz), 7.17 (1H, dd, J = 8.8, 2.0 Hz), 6.50 (1H, d, J = 
3.6 Hz), 5.68 (1H, ddt, J = 17, 10.4, 6.4 Hz), 4.98–4.88 (2H, m), 3.04 (1H, app pent, J = 
7.0 Hz), 2.46–2.34 (2H, m), 1.66 (9H, s), 1.30–1.25 (1H, m), 1.19–1.13 (1H, m), 1.09 
(6H, s), 1.08 (6H, s); 13C NMR (100 MHz, CDCl3): δ 150.1, 141.4, 137.5, 133.8, 130.7, 
125.9, 124.1, 119.5, 116.0, 114.8, 107.5, 83.5, 83.1, 44.2, 41.4, 28.4, 24.9, 24.8; HRMS 
(DART): Calcd for C24H35B1N1O4 [M+H]+: 412.2659, Found: 412.2653; Specific 
Rotation: [a]D20 +17.1 (c 0.43, CHCl3) for an enantiomerically enriched sample of 98:2 
er. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (98:2 er shown; Chiralcel AD–H column, 100% hexanes, 0.3 mL/min, 
220 nm). 
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Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   22.469	   46.056	   1	   22.708	   1.990	  2	   25.810	   53.944	   2	   25.481	   98.010	  
(R)-2-(2-(Benzofuran-2-yl)pent-4-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18n) : IR (neat): 2977 (w), 2928 (w), 1584 (w), 1455 (m), 1370 (s), 1321 (s), 1253(w), 
1142 (s), 1006 (m), 912 (m), 846 (m), 796 (m), 749 (s), 738 (s), 671 (w) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.49–7.44 (1H, m), 7.42–7.38 (1H, m), 7.22–7.13 (2H, m), 6.38 
(1H, s), 5.76 (1H, ddt, J = 17.2, 10.1, 7.1 Hz), 5.08–4.96 (2H, m), 3.26–3.16 (1H, m), 
2.63–2.53 (1H, m), 2.49–2.38 (1H, m), 1.23 (2H, d, J = 7.7 Hz), 1.20 (6H, s), 1.18 (6H, 
s); 13C NMR (CDCl3, 100 MHz): δ 163.3, 154.7, 136.3, 129.0, 123.1, 122.4, 120.4, 117.0, 
110.9, 101.4,  83.3, 40.3, 35.0, 24.94, 24.88; HRMS (DART): Calcd for C19H26BO3 
[M+H]+: 313.1975, Found: 313.1987; Specific Rotation: [α]D20 +17.2 (c 1.67, CHCl3) for 
an enantiomerically enriched sample of 90:10 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (90:10 er shown; Chiralcel 
OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   19.923	   47.625	   1	   19.900	   90.179	  2	   21.690	   52.375	   2	   21.888	   9.821	  
(R)-2-(2-(Benzo[b]thiophen-5-yl)pent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.18o): Following the representative procedure except for 1:3 
alkene:phosphate used. IR (neat): 3073 (w), 2976 (w), 2924 (w), 1365 (s), 1319 (s), 
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11142 (s), 846 (m), 820 (m), 699 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.76 (1H, d, J 
= 8.4 Hz), 7.65 (1H, s), 7.38 (1H, dd, J = 5.4, 0.6 Hz), 7.27 (1H, d, J = 5.2 Hz), 7.22 (1H, 
d, J = 8.4 Hz), 5.74–5.64 (1H, m), 4.97 (1H, d, J = 17.2 Hz), 4.92 (1H, dd J = 10.4, 0.8 
Hz), 3.08 (1H, app pent, J = 7.5 Hz), 2.48–2.36 (2H, m), 1.30 (1H, dd, J = 15.8, 7.0 Hz), 
1.17 (1H, dd, J = 15.4, 9.0 Hz), 1.07 (12H, s); 13C NMR (CDCl3, 100 MHz): δ 152.3, 
140.0, 139.2, 136.4, 124.0, 123.4, 122.9, 122.3, 119.8, 116.9, 83.4, 43.8, 37.6, 24.9, 24.8; 
HRMS (DART): Calcd for C19H26B1O2S1 [M+H]+: 329.1747, Found: 329.1744; Specific 
Rotation: [a]D20 +18.0 (c 1.23, CHCl3) for an enantiomerically enriched sample of 95:5 
er. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (95:5 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 
220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   16.094	   49.409	   1	   16.643	   94.738	  2	   17.848	   50.591	   2	   18.783	   5.262	  
(R)-2-(2-(4-Bromophenyl)pent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18p): Following the representative procedure except for 1:3 alkene:phosphate used. IR 
(neat): 2977 (w), 2926 (w), 1488 (w), 1368 (s), 1320 (s), 1143 (s), 1073 (m), 1010 (m), 
968 (m), 913 (m), 846 (m), 820 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.37 (2H, d, J = 
6.4, Hz), 7.07 (2H, d, J = 7.6 Hz), 5.63 (1H, ddt, 17.2, 10.0, 7.2 Hz), 4.97–4.91 (2H, m), 
2.94–2.87 (1H, m), 2.32 (2H, t, J = 7.0 Hz), 1.21 (1H, dd, J = 15.4, 6.6 Hz),  1.12 (6H, s), 
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1.10 (6H, s), 1.09–1.03 (1H, m); 13C NMR (100 MHz, CDCl3): δ 145.9, 136.8, 131.2, 
129.4, 119.6, 116.5, 83.2, 43.6, 41.0, 24.9, 24.8; HRMS (DART): Calcd for 
C17H25B1Br1O2 [M+H]+: 351.1131, Found: 351.1141; Specific Rotation: [α]D20 +4.1 (c 
0.85, CHCl3) for an enantiomerically enriched sample of 90:10 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (90:10 
er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   15.188	   49.869	   1	   15.166	   89.619	  2	   17.236	   50.131	   2	   17.215	   10.381	  
(R)-4,4,5,5-Tetramethyl-2-(4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-
en-2-yl)phenyl)-1,3,2-dioxaborolane (2.18q): Following the representative procedure 
except for 1:3 alkene:phosphate used. IR (neat): 2977 (m), 2925 (m), 2041 (w), 2034 (w), 
2024 (w), 1611 (m), 1399 (m), 1360 (s), 1319 (m), 1271 (w), 1144 (m), 1090 (s), 964 
(w), 860 (w), 830 (w), 660 (m)cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.70 (2H, d, J= 8.0 
Hz), 7.21 (2H, d, J = 8.0 Hz), 5.73–5.57 (1H, m), 4.97–4.88 (2H, m), 3.01–2.90 (1H, m), 
2.43–2.28 (2H, m), 1.33 (12H, s), 1.28–1.16 (2H, m), 1.12 (6H, s), 1.11 (6H, s); 13C 
NMR (CDCl3, 100 MHz): δ 150.4, 137.2, 134.8, 127.0, 116.2, 83.6, 83.1, 43.5, 41.6, 
25.0, 24.8; HRMS (DART): Calcd for C23H40B2N1O4 [M+NH4]+: 416.3143, Found: 
416.3158; Specific Rotation: [a]D20 +9.1 (c 1.02, CHCl3) for an enantiomerically enriched 
sample of 92:8 er. Enantiomeric purity was determined by HPLC analysis in comparison 
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with authentic racemic material (92:8 er shown; Chiralcel AZ–H column, 99% hexanes, 
1% i-PrOH, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   15.733	   50.363	   1	   15.594	   92.237	  2	   16.969	   49.637	   2	   16.862	   7.763	  
(R)-4,4,5,5-Tetramethyl-2-(3-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-
en-2-yl)phenyl)-1,3,2-dioxaborolane (2.18r): Following the representative procedure 
except for 1:3 alkene:phosphate used. IR (neat): 2977 (m), 2926 (w), 2035 (w), 1611 (w), 
1457 (w), 1399 (m), 1360 (s), 1320 (m), 1271 (w), 1214 (w), 1144 (s), 1090 (m), 964 (w), 
860 (w), 829 (w), 659 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.66 (1H, s), 7.60 (1H, d, 
J = 7.1 Hz), 7.34–7.23 (2H, m), 5.68 (1H, ddt, J = 17.1, 10.1, 7.0 Hz), 4.97 (1H, dd, J = 
17.2, 1.9 Hz), 4.94–4.89 (1H, m), 3.03–2.91 (1H, m), 2.49–2.29 (2H, m), 1.34 (6H, s), 
1.33 (6H, s), 1.27–1.17 (2H, m), 1.10 (12H, s);13C NMR (CDCl3, 100 MHz): δ 146.2, 
137.5, 134.2, 132.5, 130.3, 127.6, 116.0, 83.7, 83.0, 43.3, 41.4, 25.0, 24.9, 24.8; HRMS 
(DART): Calcd for C23H37B2O4 [M+H]+: 399.2878, Found: 399.2887; Specific rotation: 
[a]D20 +5.8 (c 0.43, CHCl3) for an enantiomerically enriched sample of 96.5:3.5 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (96.5:3.5 er shown; Chiralcel OD–H column, 98% hexanes, 2% i-PrOH, 
0.3 mL/min, 220 nm). 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   27.908	   49.566	   1	   27.717	   3.516	  2	   29.493	   50.434	   2	   29.249	   96.484	  
(R)-4,4,5,5-Tetramethyl-2-(2-(naphthalen-2-yl)pent-4-en-1-yl)-1,3,2-dioxaborolane 
(2.18s): Following the representative procedure except for 1:3 alkene:phosphate used. IR 
(neat): 2976 (w), 2923 (s), 2853 (m), 1639 (w), 1362 (s), 1315 (s), 1143 (s), 968 (m), 911 
(m), 847 (s), 814 (s), 744 (s), 476 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.81–7.73 
(3H, m), 7.65–7.62 (1H, m), 7.46–7.35 (3H, m), 5.76–5.64 (1H, m), 5.01–4.89 (2H, m), 
3.19–3.08 (1H, m), 2.55–2.37 (2H, m), 1.28–1.17(2H, m), 1.06 (6H, s), 1.07 (6H, s); 13C 
NMR (CDCl3, 100 MHz): δ 144.5, 137.2, 133.6, 132.3, 127.82, 127.78, 127.74, 127.68, 
126.3, 125.81, 125.79, 125.1, 116.3, 83.1, 43.6, 41.6, 24.85, 24.77; HRMS (DART): 
Calcd for C21H28B1O2 [M+H]+: 323.2182, Found: 323.2194; Specific Rotation: [a]D20 
+16.4 (c 0.72, CHCl3) for an enantiomerically enriched sample of 96:4 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(96:4 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 254 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   16.181	   48.876	   1	   14.602	   96.000	  2	   18.684	   51.124	   2	   16.317	   4.000	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(R)-2-(2,4-Diphenylpent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.18t): 
Following the representative procedure except for 1:3 alkene:phosphate used. IR (neat): 
3027 (w), 2977 (w), 2929 (w), 1494 (m), 1452 (w), 1369 (s), 1320 (s), 1145 (s), 699 (s) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 7.39–7.36 (2H, m), 7.33–7.19 (5H, m), 7.14–7.09 
(3H, m), 5.15 (1H, d, J = 2.0 Hz), 4.83 (1H, d, J = 1.2 Hz), 2.96 (1H, app pent, J = 7.7 
Hz), 2.87 (1H, dd, J = 13.8, 7.0 Hz), 2.73 (1H, dd, J = 13.6, 8.0 Hz), 1.26 (1H, dd, J = 
15.6, 6.8 Hz), 1.13 (1H, dd, J = 15.6, 9.2 Hz), 1.07 (6H, s), 1.05 (6H, s); 13C NMR (100 
MHz, CDCl3): δ 146.9, 146.8, 141.2, 128.4, 128.1, 127.6, 127.4, 126.6, 125.9, 114.5, 
83.1, 45.7, 39.9, 24.8, 24.7; HRMS (DART): Calcd for C23H30B1O2 [M+H]+: 349.2339, 
Found: 349.2347; Specific Rotation: [α]20D –11.9 (c 0.50, CHCl3) for an enantiomerically 
enriched sample of 88:12 er. Enantiomeric purity was determined by HPLC analysis of 
the alcohol product after oxidation in comparison with authentic racemic material (96:4 
er shown; Chiralcel OD–H column, 99% hexanes, 1% i-PrOH,  0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   148.008	   48.370	   1	   146.542	   95.605	  2	   152.465	   51.630	   2	   152.058	   4.395	  
(R)-4,4,5,5-Tetramethyl-2-(4-methyl-2-phenylpent-4-en-1-yl)-1,3,2-dioxaborolane 
(2.18u): Following the representative procedure except for 1:6 alkene:phosphate used. IR 
(neat): 3028 (w), 2978 (m), 2929 (m), 1453 (w), 1369 (s), 1320 (m), 1145 (s), 968 (w), 
888 (w), 699 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.24–7.18 (4H, m), 7.13–7.10 
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(1H, m), 4.64 (1H, s), 4.56 (1H, s), 3.03 (1H, app pent, J = 7.7 Hz), 2.29 (2H, d, J = 7.6 
Hz), 1.65 (3H, s), 1.24–1.16 (1H, m), 1.09–1.03 (13H, m); 13C NMR (100 MHz, CDCl3): 
δ 147.2, 144.3, 128.1, 127.5, 125.9, 112.4, 83.0, 48.3, 39.8, 24.83, 24.75, 22.5; HRMS 
(DART): Calcd for C18H28B1O2 [M+H]+: 287.2182, Found: 287.2189; Specific Rotation: 
[α]D20 +5.7 (c 0.33, CHCl3) for an enantiomerically enriched sample of 90:10 er. 
Enantiomeric purity was determined by HPLC analysis of the alcohol product after 
oxidation in comparison with authentic racemic material (95:5 er shown; Chiralpak AD–
H column, 99% hexanes, 1% i-PrOH, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   57.500	   49.676	   1	   58.582	   94.890	  2	   64.003	   50.324	   2	   65.442	   5.110	  
(R)-Trimethyl(4-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-en-2-
yl)silane (2.18v): IR (neat): 2978 (w), 2955 (w), 1368 (s), 1319 (m), 1247 (m), 1145 (s), 
968 (w), 836 (s), 757 (m), 699 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.25–7.18 (4H, 
m), 7.15–7.10 (1H, m), 5.45–5.44 (1H, m), 5.31 (1H, d, J = 3.2 Hz), 3.06–2.98 (1H, m), 
2.49–2.35 (1H, m), 1.26–1.20 (1H, m), 1.09–1.01 (13H, m), 0.07 (9H, m); 13C NMR (100 
MHz, CDCl3): δ 150.3, 147.4, 128.1, 127.7, 126.5, 125.8, 83.0, 45.9, 40.7, 24.9, 24.8, –
1.2; HRMS (DART): Calcd for C20H34B1O2Si1 [M+H]+: 345.2421, Found: 345.2424. 
Specific Rotation: [α]D20 +7.9 (c 0.33, CHCl3) for an enantiomerically enriched sample of 
95:5 er. Enantiomeric purity was determined by HPLC analysis in comparison with 
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authentic racemic material (96:4 er shown; Chiralcel OD–H column, 100% hexanes, 0.3 
mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   19.960	   50.601	   1	   21.043	   4.340	  2	   28.623	   49.399	   2	   25.323	   95.660	  
(R)-(4-(3-(Allyloxy)phenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-
en-2-yl)trimethylsilane (2.18w): IR (neat): 2977 (w), 2954 (w), 1600 (w), 1584 (w), 
1366 (m), 1317 (m), 1247 (m), 1144 (s), 924 (m), 836 (s) cm–1; 1H NMR (500 MHz, 
CDCl3): δ 7.14 (1H, t, J = 6.2 Hz), 6.80–6.77 (2H, m), 6.69 (1H, dd, J = 6.4, 2.0 Hz), 
6.10–6.02 (1H, m), 5.45–5.38 (2H, m), 5.32–5.26 (2H, m), 4.52–4.51 (2H, m), 2.99 (1H, 
app pent, J = 6.1 Hz), 2.45 (1H, dd, J = 11.2, 6.0 Hz), 2.38 (1H, dd, J = 11.2, 6.0 Hz), 
1.21 (1H, dd, J = 14.0, 3.6 Hz), 1.11 (6H, s), 1.09 (6H, s), 1.02 (1H, dd, J = 12.2, 7.0 Hz), 
0.07 (9H, s); 13C NMR (125 MHz, CDCl3): δ 158.5, 150.3, 149.3, 133.8, 129.0, 126.5, 
120.4, 117.5, 114.3, 112.1, 83.0, 68.8, 45.7, 40.7, 24.9, 24.8, –1.2; HRMS (DART): 
Calcd for C23H38B1O3Si1 [M+H]+: 401.2683, Found: 401.2695; Specific Rotation: [α]D20 
+4.7 (c 0.88, CHCl3) for an enantiomerically enriched sample of 95:5 er. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(96:4 er shown; Chiralcel OD–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   18.411	   49.710	   1	   18.713	   3.920	  2	   21.443	   50.290	   2	   21.668	   96.080	  
(R)-2-(2-(2-Fluorophenyl)pent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18x): Following the representative procedure except 2.25 was used. IR (neat): 2978 
(w), 2931 (w), 1765 (s), 1490 (m), 1401 (s), 1369 (s), 1223 (m), 1144 (s), 968 (m), 913 
(m), 846 (m), 754 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.21 (1H, td, J = 7.6, 1.6 Hz), 
7.13–7.10 (1H, m), 7.09–7.02 (1H, m), 6.98–6.94 (1H, m), 5.68 (1H, ddt, J = 16.8, 10.4, 
6.8 Hz), 4.97–4.90 (2H, m), 3.35–3.27 (1H, m), 2.43–2.32 (2H, m), 1.28–1.22 (1H, m), 
1.19–1.08 (1H, m), 1.11 (6H, s), 1.08 (6H, s ); 13C NMR (100 MHz, CDCl3): δ 160.9 (d, 
J = 243.7 Hz), 136.9, 133.5 (d, J = 14.4 Hz), 128.8 (d, J = 5.3 Hz), 127.3 (d, J = 8.4 Hz), 
123.9 (d, J = 3.8 Hz), 116.4, 115.3 (d, J = 22.8 Hz), 83.1, 42.5, 34.3, 24.8, 24.7; HRMS 
(DART): Calcd for C17H25B1F1O2 [M+H]+: 291.1932, Found: 291.1937; Specific 
Rotation: [α]D20 +14.2 (c 0.87, CHCl3) for an enantiomerically enriched sample of 96:4 er. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 




Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   13.984	   48.955	   1	   13.782	   4.082	  2	   15.351	   51.045	   2	   14.947	   95.918	  
(R)-2-(2-(4-Fluorophenyl)pent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.18y): Following the representative procedure except 2.25 was used.  IR (neat): 2978 
(w), 2925 (w), 2855 (w), 1604 (w), 1509 (s), 1369 (s), 1322 (m), 1223 (m), 1144 (s), 968 
(w), 912 (w), 832 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.17–7.13 (2H, m), 6.98–
6.91 (2H, m), 5.65 (1H, ddt, J = 17.2, 10.0, 7.2 Hz), 4.96–4.91 (2H, m), 2.97–2.89 (1H, 
m), 2.36–2.27 (2H, m), 1.26–1.16 (1H, m), 1.09–1.04 (13H, m); 13C NMR (100 MHz, 
CDCl3): δ 161.4 (d, J = 241.3 Hz), 142.5 (d, J = 3.0 Hz), 137.0, 128.9 (d, J = 7.6 Hz), 
116.4, 114.9 (d, J = 20.5 Hz), 83.2, 44.0, 40.8, 24.8, 24.7; HRMS (DART): Calcd for 
C17H25B1F1O2 [M+H]+: 291.1932, Found: 291.1939; Specific Rotation: [α]D20 +14.9 (c 
1.20, CHCl3) for an enantiomerically enriched sample of 92:8 er. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (98:2 
er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   13.603	   50.944	   1	   13.798	   98.211	  2	   14.313	   49.056	   2	   14.657	   1.789	  
(R)-4,4,5,5-Tetramethyl-2-(2-(2-(trifluoromethyl)phenyl)pent-4-en-1-yl)-1,3,2-
dioxaborolane (2.18z): Following the representative procedure except 2.25 was used. IR 
(neat): 2979 (w), 2928 (w), 1363 (m), 1312 (s), 1145 (s), 1124 (s), 1036 (m), 768 (m) cm–
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1; 1H NMR (400 MHz, CDCl3): δ 7.58 (1H, d, J = 8.0 Hz), 7.50–7.43 (2H, m), 7.26–7.22 
(1H, m), 5.70 (1H, ddt, J = 18.0, 10.0, 7.2 Hz), 4.99–4.92 (2H, m), 3.42 (1H, app pent, J 
= 7.4 Hz), 2.45–2.25 (2H, m), 1.26 (1H, dd, J = 15.4, 7.0 Hz), 1.14 (1H, dd, J = 15.6, 8.4 
Hz), 1.08 (6H, s), 1.05 (6H, s); 13C NMR (100 MHz, CDCl3): δ 146.5, 136.7, 131.8, 
128.2 (q, J = 29.0 Hz), 128.18, 125.7, 125.6, 124.7 (q, J = 272.5 Hz), 116.6, 83.1, 43.9, 
36.0, 24.7, 18.6 (br, C–B); HRMS (DART): Calcd for C18H25B1F3O2 [M+H]+: 341.1900, 
Found: 341.1903; Specific Rotation: [α]D20 +11.9 (c 1.20, CHCl3) for an enantiomerically 
enriched sample of 88:12 er. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (96:4 er shown; Chiralcel OZ–H column, 
100% hexanes, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   12.811	   48.449	   1	   13.090	   96.273	  2	   13.878	   51.551	   2	   13.739	   3.727	  
(R)-4,4,5,5-Tetramethyl-2-(2-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl)-1,3,2-
dioxaborolane (2.18aa): Following the representative procedure except 2.25 was used. 
The spectroscopic data match those reported previously.93 1H NMR (400 MHz, CDCl3): δ 
7.58 (1H, d, J = 8.0 Hz), 7.50–7.43 (2H, m), 7.26–7.22 (1H, m), 5.70 (1H, ddt, J = 18.0, 
10.0, 7.2 Hz), 4.99–4.92 (2H, m), 3.42 (1H, app pent, J = 7.4 Hz), 2.45–2.25 (2H, m), 
1.26 (1H, dd, J = 15.4, 7.0 Hz), 1.14 (1H, dd, J = 15.6, 8.4 Hz), 1.08 (6H, s), 1.05 (6H, s). 
Specific Rotation: [α]D20 +6.1 (c 0.45, CHCl3) for an enantiomerically enriched sample of 
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96:4 er. Enantiomeric purity was determined by HPLC analysis of the alcohol product 
after oxidation in comparison with authentic racemic material (96:4 er shown; Chiralcel 
OZ–H column, 99% hexanes, 0.3 mL/min, 220 nm). 
 Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   66.741	   50.949	   1	   64.054	   4.220	  2	   73.532	   49.051	   2	   70.462	   95.780	  
(R)-4,4,5,5-Tetramethyl-2-(2-(o-tolyl)hex-4-en-1-yl)-1,3,2-dioxaborolane (2.18ab): 
Following the representative procedure except 2.24b was used. The spectroscopic data 
match those reported previously.93 1H NMR (400 MHz, CDCl3): δ 7.26–7.01 (8H, m, 
E/Z), 5.46–5.28 (4H, m, E/Z), 3.24–3.13 (2H, m, E/Z), 2.36 (3H, s, E) 2.35 (3H, s, Z), 
2.32–2.13 (4H, m, E/Z), 1.59 (3H, d, J = 5.6 Hz, E),  1.54 (3H, d, J = 6 Hz, Z), 1.23–1.10 
(4H, m, E/Z), 1.053 (6H, s, E), 1.045 (6H, s, E), 1.03 (6H, s, Z), 1.02 (6H, s, Z) Specific 
Rotation: [α]D20 +6.1 (c 0.45, CHCl3) for an enantiomerically enriched sample of 92:8 er. 
Enantiomeric purity was determined by HPLC analysis of the alcohol product after 
oxidation in comparison with authentic racemic material prepared according to the 
procedure reported previously obtaining rac-E-2ab.93  (92:8 er shown for E and Z; 
Chiralcel OJ–H column, 98% hexanes, 0.3 mL/min, 220 nm). 
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 Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	  (rac)	   39.389	   50.239	   1	  (E)	   37.848	   7.697	  2	  (rac)	   44.190	   49.761	   2	  (E)	   42.673	   92.303	  	   1	  (Z)	   54.599	   7.644	  2	  (Z)	   58.361	   92.356	  
 
n  Formal Synthesis of (+)-Heliespirone A and (–)-Heliespirone C 
(R)-2-(2-(2,5-Dimethoxy-4-methylphenyl)pent-4-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.27): In a N2-filled glove box, a flame-dried 100 mL round-bottom flask 
equipped with a stir bar was charged with bisphosphine 2.24b (188 mg, 0.28 mmol), 
NaOt-Bu (742 mg, 7.7 mmol), and CuCl (26 mg, 0.26 mmol). The flask was sealed with 
a septum and electrical tape before removal from the glove box. Tetrahydrofuran (20 mL) 
was added and the resulting yellow solution was allowed to stir for 1 h under N2 at 22 °C. 
A solution of B2(pin)2 (1.4 g, 5.7 mmol) in thf (15 mL) was added to the mixture at 0 °C, 
causing the solution to turn dark brown immediately. After 15 min, a solution of 2.26 
(2.75 g, 15.5 mmol) in thf (5 mL) and allylphosphate (2.17) [0.92 mL (1.0 g), 5.15 mmol] 







the mixture was passed through a short plug of silica gel  (4x4 cm) and eluted with Et2O. 
The organic layer was concentrated under reduced pressure, affording yellow oil, which 
was purified by silica gel chromatography (100% hexanes→hexanes:Et2O = 10:1) to 
afford 2.27 as colorless oil (1.1 g, 3.3 mmol, 64% yield) and recovered 2.26 (1.68 g, 9.4 
mmol, 91%). IR (neat): 2976 (w), 2931 (w), 2830 (w), 1506 (m), 1465 (m), 1398 (m), 
1369 (m), 1316 (m), 1207 (s), 1143 (s), 1046 (s), 968 (m), 846 (m), 802 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 6.68 (1H, s), 6.64 (1H, s), 5.71 (1H, ddt, J = 17.2, 9.8, 7.4 
Hz), 4.98–4.89 (2H, m), 3.78 (3H, s), 3.76 (3H, s), 3.36 (1H, app pent, J = 7.5 Hz), 2.43–
2.25 (2H, m), 2.18 (3H, s), 1.22 (1H, dd, J = 15.6, 7.6 Hz), 1.15–1.10 (1H, m), 1.13 (6H, 
s), 1.10 (6H, s); 13C NMR (100 MHz, CDCl3): δ 151.7, 151.0, 137.8, 133.2, 124.2, 115.7, 
114.4, 110.9, 82.9, 56.5, 56.2, 42.3, 34.2, 24.84, 24.81, 16.2; HRMS (DART): Calcd for 
C20H32B1O4 [M+H]+: 347.2394, Found: 347.2377; Specific Rotation: [α]D20 +36.6 (c 0.56, 
CHCl3) for an enantiomerically enriched sample of 97:3 er. Enantiomeric purity was 
determined by HPLC analysis of the alcohol product after oxidation in comparison with 
authentic racemic material (97:3 er shown; Chiralpak AD–H column, 99% hexanes, 1% i-
PrOH, 0.3 mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   100.356	   49.107	   1	   103.251	   3.364	  2	   116.048	   50.893	   2	   119.350	   96.636	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(R)-2-(3-(2,5-Dimethoxy-4-methylphenyl)-6-methylhept-5-en-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (2.30): Compound 2.27 was converted to 2.30 by a 
two step sequence olefin cross metathesis/homologation based on the reported procedures 
except Hoveyda-Grubbs catalyst 2nd generation was used in the cross metathesis.103 IR 
(neat): 2977 (w), 2931 (w), 2854 (w), 1504 (m), 1466 (m), 1398 (m), 1372 (m), 1317 (m), 
1208 (s), 1145 (m), 1049 (m), 968 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 6.65 (1H, s), 
6.62 (1H, s), 5.09–5.06 (1H, m), 3.77 (3H, s), 3.73 (3H, s), 3.02 (1H, app pent, J = 7.2 
Hz), 2.35–2.19 (2H, m), 1.81 (3H, s), 1.80–1.70 (1H, m), 1.68–1.56 (4H, m), 1.54 (3H, 
s), 1.21 (12H, s), 0.74–0.60 (2H, m); 13C NMR (100 MHz, CDCl3): δ 151.9, 151.7, 132.1, 
131.7, 124.2, 123.6, 114.5, 110.7, 82.9, 56.6, 56.2, 40.5, 33.8, 29.3, 25.9, 25.0, 24.9, 17.9, 
16.2; HRMS (DART): Calcd for C23H38B1O4 [M+H]+: 389.2863, Found: 389.2862; 
Specific Rotation: [α]D20 +18.0 (c 0.50, CHCl3). 
(3R,5R)-3-(2,5-Dimethoxy-4-methylphenyl)-6-methylheptane-1,5,6-triol (2.33): 
Compound 2.30 was converted to 2.33 by a two step sequence enantioselective 
epoxidation/hydrolysis based on the reported procedures except the oxidation was 
performed with 2.5 equiv of oxone.104 The spectroscopic data match those reported 
previously.105 1H NMR (400 MHz, CDCl3): δ 6.72 (1H, s), 6.66 (1H, s), 3.80 (3H, s), 
3.79 (3H, s), 3.58–3.53 (2H, m), 3.46–3.35 (2H, m), 2.20 (3H, s), 2.12–2.01 (1H, m), 
1.88–1.84 (1H, m), 1.74–1.59 (2H, m), 1.21 (3H, s), 1.15 (3H, s); HRMS (DART): Calcd 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(103) For cross-metathesis, see: Chatterjee, A. K.; Sanders, D. P.; Grubbs, R. H. Org. Lett. 2002, 4, 1939–
1942. For homologation, see: Kliman, L. T.; Mlynarski, S. N.; Morken, J. P. J. Am. Chem. Soc. 2009, 131, 
13210–13211. 
(104) Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem. Soc. 1997, 119, 11224–11235. 
(105) Huang, C.; Liu, B. Chem. Commun. 2010, 46, 5280–5282. 
 285	  
for C17H28O5 [M]+: 312.1937, Found: 312.1939. Specific Rotation: [α]D20 +23.4 (c 0.23, 
CHCl3). Literature precedence: [α]D13 +29.2 (c 0.10, CH2Cl2).105 
n  Study of the Possibility of Epimerization through Isotopic Labeling 
 
(Z)-(2-(4-Bromophenyl)vinyl-1-d)trimethylsilane (S1): To a flame-dried round bottom 
flask equipped with a stir bar was added hexanes (20 mL) under N2, after which dibal–H 
(8.6 mL, 48 mmol, USE WITH CAUTION, PYROPHORIC) was added by a gas-tight 
syringe. The resulting mixture was allowed to cool to 0 °C, and a solution of trimethyl(4-
bromophenylethynyl)silane (6.1 g, 24 mmol) in thf (4 mL) was added drop-wise by 
syringe. The mixture was allowed to stir for an additional 5 min at 0 °C and then warmed 
to 22 °C and allowed to stir for 23 h. The reaction was then quenched upon drop-wise 
addition of D2O (1.2 mL, 72 mmol) at 0 °C and allowed to stir for 1 h at 22 °C. The 
mixture was transferred to a separatory funnel and Rochelle’s salt (50 mL) and a 
saturated solution of aqueous ammonium chloride (40 mL) were added. The layers were 
separated, and the aqueous layer was washed with Et2O (3 x 20 mL). The combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The resulting yellow 
oil was purified by silica gel chromatography (100% pentane) and Kugelrohr distillation 
to afford S1. 
2.0 equiv. dibal–H
hexanes:thf (5:1),
22 °C, 18 h; D2O
D
SiMe3
1. 1.5 equiv. (n-Bu)4NF,
thf, 60 °C , 18 h D
D
2. 1.5 equiv. Mg(0),
1.2 equiv. Boc2O,














1. 1.5 equiv. (n-Bu)4NF,
thf, 60 °C , 18 h
2. 1.5 equiv. Mg(0),
1.2 equiv. Boc2O,





Scheme S1. Synthesis of E and Z Deuterium-Labeled Aryl Olefins
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(E)-(2-(4-Bromophenyl)vinyl-1-d)trimethylsilane (S2): This compound was prepared 
similarly to S1, except 100% hexanes (24 mL) was used for silica gel chromatography. 
tert-Butyl-(E)-4-(vinyl-2-d)benzoate (2.34-E): To a solution of S1 in thf (15 mL) was 
added tbaf (1.0 M in thf, 8.25 mL, 8.25 mmol) at 22 °C under N2. The mixture was 
allowed to stir at 60 °C for 18 hours after which it was transferred to a separatory funnel; 
water (25 mL) was added and the layers separated. The aqueous layer was washed with 
Et2O (3x20 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The resulting yellow oil was purified by Kugelrohr distillation to 
afford (E)-1-Bromo-4-(vinyl-2-d)benzene which was converted to 2.34-E following the 
previously reported procedure.98 The resulting colorless oil was purified by silica gel 
chromatography and Kugelrohr distillation to afford 2.34-E as colorless liquid (200 mg, 
>98% D,  >98% E).  IR (neat): 2979 (w), 1709 (s), 1608 (w), 1393 (m), 1291 (s), 1162 
(s), 1112 (s), 1066 (s), 1067 (m), 865 (s), 771 (s), 702 (m) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 7.97–7.94 (2H, m), 7.43 (2H, d, J = 8.4 Hz), 6.74 (1H, d, J = 17.6 Hz), 5.82 (1H, 
d, J = 17.6 Hz), 1.60 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 165.6, 141.5, 136.1, 131.3, 
129.8, 127.2, 126.0, 121.4, 115.9 (t, J = 24.3 Hz), 81.0, 28.3; HRMS (DART): Calcd for 
C13H16DO2 [M+H]+: 206.1291; Found: 206.1300. 
tert-Butyl-(Z)-4-(vinyl-2-d)benzoate (2.34-Z): To a solution of S2 in thf (15 mL) was 
added (nBu)4NF (1.0 M in thf, 8.25 mL, 8.25 mmol) at 22 °C under N2. The mixture was 
allowed to stir at 60 °C for 18 h after which it was transferred to a separatory funnel, 
water (25 mL) was added and the layers separated. The aqueous layer was washed with 
Et2O (3x20 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The resulting yellow oil was purified by Kugelrohr distillation to 
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afford (Z)-1-Bromo-4-(vinyl-2-d)benzene which was converted to 2.34-Z following the 
previously reported procedure.98 The product was purified by silica gel chromatography 
and Kugelrohr distillation to afford 2.34-Z as colorless liquid (199.4 mg, >98%D,  95:5 
Z:E). IR (neat): 2977 (w), 1707 (s), 1607 (w), 1367 (m), 1287 (s), 1161 (s), 1104 (s), 
1016 (m), 848 (s), 774 (s), 706 (s), 438 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.94 
(2H, d, J= 8.4 Hz), 7.43 (2H, d, J = 8.4 Hz), 6.75–6.79 (1H, m), 5.35 (1H, J = 10.4 Hz), 
1.60 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 165.7, 141.5, 136.2, 131.3, 129.8, 126.1, 
116.0 (t, J = 23.5 Hz), 81.0, 28.3 HRMS (DART): Calcd for C13H16DO2 [M+H]+: 
206.1291; Found: 206.1293 
tert-Butyl-4-((1S,2R)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl-
1-d)benzoate (2.35 from 2.34-E): Following the representative procedure except 2.24b 
and 1:3 alkene:phosphate used, 2.35 was obtained as colorless oil (60:40 dr, determined 
from 1H NMR of the product after oxidation). IR (neat): 2977 (w), 2929 (w), 1711 (s), 
1609 (w), 1391 (m), 1364 (s), 1312 (s), 1288 (s), 1255 (m), 1164 (s), 1143 (s), 1112 (s), 
850 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.88 (2H, d, J = 8.0 Hz), 7.24 (2H, d, J = 
8.0 Hz), 5.63 (1H, ddt, J = 17.2, 10.4, 6.8 Hz), 4.96–4.90 (2H, m), 2.99 (1H, app q, J = 
7.2 Hz), 2.35 (2H, t, J = 7.0 Hz), 1.58 (9H, s), 1.22 (1H, br s), 1.12 (6H, s), 1.11 (2.46H, 
s, minor), 1.10 (3.54H, s, major); 13C NMR (CDCl3, 150 MHz): δ 166.1, 151.95 (minor), 
151.93 (major), 136.8, 129.8, 129.5, 127.4, 116.5, 83.2, 80.8, 43.51 (major), 43.48 
(minor), 41.4, 28.4, 24.9, 24.80 (minor), 24.79 (major); HRMS (DART): Calcd for 
C22H33D1B1O4 [M+H]+: 374.2613; Found: 374.2620. 
tert-Butyl-4-((1R,2R)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl-
1-d)benzoate (2.35 from 2.34-Z): Following the representative procedure except 2.24b 
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and 1:3 alkene:phosphate used, 2.35 was obtained as colorless oil (35:65 dr, determined 
from 1H NMR of the product after oxidation). IR (neat): 2977 (w), 2929 (w), 1711 (s), 
1609 (w), 1391 (m), 1364 (s), 1312 (s), 1288 (s), 1255 (m), 1164 (s), 1143 (s), 1112 (s), 
850 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.88 (2H, d, J = 8.0 Hz), 7.24 (2H, d, J = 
8.0 Hz), 5.63 (1H, ddt, J = 17.2, 10.4, 6.8 Hz), 4.96–4.90 (2H, m), 2.99 (1H, app q, J = 
7.5 Hz), 2.35 (2H, t, J = 7.0 Hz), 1.58 (9H, s), 1.22 (1H, br s), 1.12 (6H, s), 1.11 (3.76H, 
s, major), 1.10 (2.24H, s, minor); 13C NMR (CDCl3, 150 MHz): δ 166.1, 151.95 (major), 
151.93 (minor), 136.8, 129.8, 129.5, 127.4, 116.5, 83.2, 80.8, 43.51 (minor), 43.48 
(major), 41.4, 28.4, 24.9, 24.80 (major), 24.79 (minor); HRMS (DART): Calcd for 
C22H33D1B1O4 [M+H]+: 374.2613; Found: 374.2620. 
tert-Butyl-(E)-3-(vinyl-2-d)benzoate (substrate for synthesis of anti-2.18g-d): 
Following the procedure for preparation of 2.34-E except trimethyl(3-
bromophenylethynyl)silane was used. The product was obtained as >98:2 E:Z. IR (neat): 
2977 (w), 1710 (s), 1367 (m), 1297 (s), 1254 (m), 1157 (s), 1079 (m), 1036 (m), 999 (m), 
883 (m), 785 (w), 753 (s), 408 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 8.02 (1H, s), 
7.87 (1H, dt, J = 7.6, 1.2 Hz), 7.56–7.55 (1H, m), 7.35 (1H, t, J = 7.2 Hz), 6.75 (1H, d, J 
= 17.6 Hz), 5.80 (1H, d, J = 17.6 Hz), 1.60 (9H, s); 13C NMR (100 MHz, CDCl3): δ 
165.7, 137.7, 136.1, 132.4, 130.1, 128.8, 128.5, 127.3, 114.7 (t, J = 24.3 Hz), 81.1, 28.3; 
HRMS (DART): Calcd for C13H16D1O2 [M+H]+: 206.1291, Found: 206.1297. 
tert-Butyl-(Z)-3-(vinyl-2-d)benzoate (substrate for synthesis of syn-2.18g-d): 
Following the procedure for preparation of 2.34-Z except trimethyl(3-
bromophenylethynyl)silane was used. The product was obtained as 90:10 Z:E. IR (neat): 
2977 (w), 1711 (s), 1367 (m), 1291 (s), 1277 (s), 1156 (s), 1109 (m), 1082 (m), 848 (m), 
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818 (m), 755 (m), 697 (m), 406 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 8.03 (1H, t, J = 
2 Hz), 7.88 (1H, dt, J = 7.6, 1.6 Hz), 7.57–7.55 (1H, m), 7.37 (1H, t, J = 7.6 Hz), 6.74 
(1H, dt, J = 10.8, 2.4 Hz), 5.29 (1H, d, J = 10.8 Hz), 1.61 (9H, s); 13C NMR (100 MHz, 
CDCl3): δ 165.7, 137.7, 136.1, 132.4, 130.1, 128.7, 128.5, 127.3, 114.6 (t, J = 23.5 Hz), 
81.1, 28.2; HRMS (DART): Calcd for C13H16D1O2 [M+H]+: 206.1291, Found: 206.1302. 
tert-Butyl-3-((1S,2R)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl-
1-d)benzoate (anti-2.18g-d): IR (neat): 2977 (m), 2927 (w), 1713 (s), 1479 (w), 1366 (s), 
1316 (s), 1295 (s), 1161 (s), 1145 (s), 1111 (m), 755 (m), 697 (w) cm–1; 1H NMR (400 
MHz, CDCl3): δ 7.83 (1H, t, J = 1.8 Hz), 7.78 (1H, dt, J = 8.0, 1.2 Hz), 7.37 (1H, dt, J = 
7.6, 1.2 Hz), 7.30 (1H, t, J = 7.6 Hz), 5.66 (1H, ddt, J = 17.0, 10.0, 7.2 Hz), 4.99–4.90 
(2H, m), 2.99 (1H, q, J = 7.2 Hz), 2.44–2.32 (2H, m), 1.59 (9H, s), 1.22 (1H, d, J = 7.6 
Hz), 1.11 (6H, s), 1.10 (6H, s); 13C NMR (100 MHz, CDCl3): δ 166.2, 147.1, 137.0, 
131.9, 131.6, 128.8, 128.1, 127.2, 116.4, 83.2, 80.9, 43.4, 41.3, 28.4, 24.9, 24.8; HRMS 
(DART): Calcd for C22H33D1B1O4 [M+H]+: 374.2613, Found: 374.2614. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(87:13 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   17.885	   50.079	   1	   18.855	   87.254	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2	   20.783	   49.921	   2	   23.306	   12.746	  
tert-Butyl-3-((1R,2R)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl-
1-d)benzoate (syn-2.18g-d): IR (neat): 2977 (m), 2927 (w), 1713 (s), 1479 (w), 1366 (s), 
1316 (s), 1295 (s), 1161 (s), 1145 (s), 1111 (m), 755 (m), 697 (w) cm–1; 1H NMR (400 
MHz, CDCl3): δ 7.83 (1H, t, J = 1.6 Hz), 7.78 (1H, dt, J = 7.6, 1.2 Hz), 7.37 (1H, dt, J = 
8, 1.6 Hz), 7.30 (1H, t, J = 7.6 Hz), 5.66 (1H, ddt, J = 17.0, 10.0, 7.2 Hz), 4.99–4.91 (2H, 
m), 2.99 (1H, q, J = 7.2 Hz), 2.44–2.32 (2H, m), 1.59 (9H, s), 1.11 (6H, s), 1.10 (6H, s), 
1.07 (1H, d, J = 9.2 Hz); 13C NMR (100 MHz, CDCl3): δ 166.2, 147.1, 137.0, 131.9, 
131.6, 128.8, 128.1, 127.2, 116.5, 83.2, 80.9, 43.4, 41.3, 28.4, 24.9, 24.8; HRMS 
(DART): Calcd for C22H33D1B1O4 [M+H]+: 374.2613, Found: 374.2614. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(87:13 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 mL/min, 220 nm). 
	  	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   17.885	   50.079	   1	   19.082	   87.184	  2	   20.783	   49.921	   2	   23.406	   12.816	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(Z)-Trimethyl(2-phenylvinyl-1-d)silane (S4): To a flame-dried round bottom flask 
equipped with a stir bar was added hexanes (20 mL) and thf (4 mL) under N2 after which 
dibal–H (8.6 mL, 48 mmol, USE CAUTION, PYROPHORIC) was added through a gas 
tight syringe. The mixture was allowed to cool to 0 °C (ice/water bath) and 
trimethyl(phenylethynyl)silane (4.8 mL, 24 mmol) was added by syringe drop-wise. The 
mixture was allowed to stir for an additional 5 min at 0 °C and then warm to 55 °C and 
stir for 23 h. The reaction was quenched upon drop-wise addition of D2O (0.8 mL, 48 
mmol) at 0 °C and stir for additional 1 h at 22 °C. The mixture was transferred to a 
separatory funnel, Rochelle’s salt (30 ml) and saturated aqueous solution of ammonium 
chloride (30 ml) were added to separate layers. The aqueous layer was washed with Et2O 
(3 x 20 mL). The combined organic layers were dried over Na2SO4 and concentrated. The 
resulting yellow oil was purified by silica gel chromatography (100% pentane) and 
Kugelrohr distillation to afford S4 as clear colorless liquid (4.0 g, 93%, >98% D). IR 
(neat): 2954 (w), 2897 (w), 1590 (w), 1569 (w), 1491 (w), 1247 (m), 1073 (w), 833 (s), 
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Scheme S2. Synthesis of E and Z Deuterium-Labeled Aryl Olefins
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(6H, m), 0.06 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 146.6, 128.4, 128.3, 128.0, 127.9, 
127.5, 0.3; HRMS (DART): Calcd for C11H15DSi [M+H]+: 177.1084; Found: 177.1097. 
(E)-Trimethyl(2-phenylvinyl-1-d)silane (S5): Prepared similarly to S4, 100% hexanes 
was used for silica gel chromatography to afford S5 (4.0 g, 93%, 96% D) as a colorless 
liquid. IR (neat): 3025 (w), 2954 (w), 1594 (w), 1570 (w), 1494 (w), 1297 (s), 1082 (m), 
922 (w), 834 (s), 754 (s), 692 (s), 485 (w) cm−1; 1H NMR (CDCl3, 400 MHz): 7.47–7.41 
(2H, m), 7.36–7.13 (3H, m), 6.89–6.85 (1H, m), 0.16 (9H, s); 13C NMR (CDCl3, 100 
MHz): δ 143.7, 128.7, 128.4, 128.1, 127.9, 126.5, 125.6, –1.1, –1.6; HRMS (DART): 
Calcd for C11H15DSi [M+H]+: 177.1084; Found: 177.1092. 
trans-Styrene-(β)-d (S6): To a solution of (Z)-trimethyl(2-phenylvinyl-1-d)silane (2.5 g, 
14 mmol) in thf (15 mL) was added (n-Bu)4NF (21 mL of 1M in thf) at 22 °C under N2. 
The mixture was allowed to stir at 60 °C for 3 h, after which it was transferred to a 
separatory funnel. Water (25 mL) was added and the layers separated. The aqueous layer 
was washed with Et2O (3 x 20 mL). The combined organic layers were dried over MgSO4 
and concentrated under house vacuum. The resulting yellow oil was purified by 
Kugelrohr distillation to afford the product (>98% E, >98% D) as colorless liquid. The 
spectroscopic data match those reported previously.106 1H NMR (CDCl3, 400 MHz): δ 
7.45–7.23 (5H, m), 6.73 (1H, dt, J = 17.6, 1.6 Hz) 5.74 (1H, d, J = 17.6 Hz) 
cis-Styrene-(β)-d (S7): This compound was prepared similarly to trans-Styrene-(β)-d, 
starting from (E)-trimethyl(2-phenylvinyl-1-d)silane (2.5 g, 14 mmol) and TBAF (56 mL 
of 1 M in thf) for 18 hours. The product was obtained as colorless liquid (96% Z, 95% D). 
The spectroscopic data match those reported previously.34  1H NMR (CDCl3, 400 MHz): δ 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(106) Kapeller, D.; Barth, R.; Mereiter, K.; Hammerschmidt, F. J. Am. Chem. Soc. 2007, 129, 914–923. 
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7.45–7.22 (5H, m), 6.72 (1H, dt, J = 10.9, 2.6 Hz), 5.23 (1H, d, J = 10.9 Hz) 
2-((1R,2R)-2,4-Diphenylpent-4-en-1-yl-1-d)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(anti-2.18t-d): IR (neat): 2923 (m), 2854 (w), 1453 (w), 1351 (m), 1314 (m), 1214 (w), 
1143 (s), 969 (m), 896 (w), 777 (m), 734 (m), 698 (s), 547 (w) cm−1; 1H NMR (CDCl3, 
600 MHz): δ 7.40–7.36 (2H, m), 7.33–7.29 (2H, m), 7.28–7.19 (3H, m), 7.15–7.09 (3H, 
m), 5.15 (1H, d, J = 1.8 Hz), 4.83 (1H, J = 1.2 Hz), 2.95 (1H, q, J = 6.6 Hz), 2.87 (1H, 
dd, J = 13.2, 6 Hz), 2.73 (1H, dd, J = 12.6 7.8 Hz), 1.23 (1H, d, J = 6), 1.07 (6H, s), 1.05 
(6H, s); 13C NMR (CDCl3, 150 MHz): δ 146.9, 146.8, 141.2, 128.4, 128.1, 127.6, 127.4, 
126.6, 125.9, 114.5, 83.0, 45.7, 39.9, 24.9, 24.7; HRMS (DART): Calcd for C22H27DBO2 
[M+H]+: 336.2245; Found: 336.2241. Enantiomeric purity was determined by HPLC 
analysis of the alcohol product after oxidation in comparison with authentic racemic 
material (89:11 er shown; Chiralcel OZ–H column, 99% hexanes, 1% i-PrOH, 0.3 
mL/min, 220 nm). 
	  	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   129.355	   49.803	   1	   131.578	   88.668	  2	   201.412	   50.197	   2	   210.567	   11.332	  
2-((1S,2R)-2,4-Diphenylpent-4-en-1-yl-1-d)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(syn-2.18t-d): IR (neat): 2977 (w), 2924 (m), 2854 (w), 1194 (w), 1389 (s), 1316 (s), 
1142 (s), 1110 (w), 970 (m), 895 (m), 859 (m), 777 (m), 697 (s), 521 (w) cm−1; 1H NMR 
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(CDCl3, 600 MHz): δ 7.42–7.35 (2H, m), 7.34–7.29 (2H, m), 7.28–7.19 (3H, m), 7.14–
7.09 (3H, m), 5.15 (1H, d, J =1.2 Hz), 4.83 (1H, s), 2.96 (1H, q, J = 8.4 Hz), 2.87 (1H, 
dd, J = 13.8, 6 Hz), 2.73 (1H, dd, J = 13.2, 7.8 Hz), 1.11 (1H, d, J = 9 Hz), 1.08 (6H, s), 
1.05 (6H, s); 13C NMR (CDCl3, 150 MHz): δ 146.9, 146.8, 141.2, 128.4, 128.1, 127.6, 
127.4, 126.7, 125.9, 114.5, 83.1, 45.6, 39.9, 24.9, 24.7; HRMS (DART): Calcd for 
C22H27BO2 [M+H]+: 336.2245; Found: 336.2245. Enantiomeric purity was determined by 
HPLC analysis of the alcohol product after oxidation in comparison with authentic 
racemic material (96:4 er shown; Chiralcel OZ–H column, 99% hexanes, 1% i-PrOH, 0.3 
mL/min, 220 nm). 
	  	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   129.355	   49.803	   1	   129.403	   95.564	  2	   201.412	   50.197	   2	   202.960	   4.436	  
(E)-1-(Trifluoromethyl)-4-(vinyl-2-d)benzene (substrate for synthesis of anti-2.18aa-
d): Following the procedure for preparation of S6 except 1-[(Trimethylsilyl)ethynyl]-4-
(trifluoromethyl)benzene was used. The product was obtained in 91:9 E:Z selectivity. The 
spectroscopic data match those reported previously.107 1H NMR (400 MHz, CDCl3): δ 
7.58 (2H, d, J = 8.4 Hz), 7.50 (2H, d, J = 8.4 Hz), 6.75 (1H, d, J = 17.6 Hz), 5.83 (1H, d, 
J = 17.6 Hz).  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(107) Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961–10963. 
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(Z)-1-(Trifluoromethyl)-4-(vinyl-2-d)benzene (substrate for synthesis of syn-2.18aa-
d): Following the procedure for preparation of S7 except 1-[(Trimethylsilyl)ethynyl]-4-
(trifluoromethyl)benzene was use. The product was obtained as a 90:10 ratio of Z:E 
isomers. IR (neat): 2954 (m), 2925 (m), 2854 (m), 1325 (s), 1168 (m), 1129 (m), 1068 
(m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.57 (2H, d, J = 8.4 Hz), 7.48 (2H, d, J = 8.4 
Hz), 6.72 (1H, dt, J = 11.2, 2.6 Hz), 5.36 (1H, d, J = 11.2 Hz); 13C NMR (100 MHz, 
CDCl3): δ 141.1, 135.7, 129.8 (q, J = 32.4 Hz), 126.5, 125.6, 124.3 (q, J = 270.2 Hz), 
116.3 (t, J = 23.6 Hz); HRMS (EI): Calcd for C9H7D1F3 [M]+: 173.0563, Found: 
173.0560. 
4,4,5,5-Tetramethyl-2-((1S,2R)-2-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl-1-d)-
1,3,2-dioxaborolane (anti-2.18aa-d): IR (neat): 2979 (w), 2926 (w), 1359 (m), 1322 (s), 
1162 (m), 1143 (m), 1120 (s), 1069 (m), 836 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.51 (2H, d, J = 8.0 Hz), 7.31 (2H, d, J = 8.4 Hz), 5.64 (1H, ddt, J = 17.0, 10.2, 7.0 Hz), 
4.98–4.92 (2H, m), 3.00 (1H, q, J = 7.1 Hz), 2.36 (2H, t, J = 7.2 Hz), 1.22 (1H, d, J = 1.2 
Hz), 1.10 (6H, s), 1.08 (6H, s); 13C NMR (100 MHz, CDCl3): δ 151.1, 136.5, 128.3 (q, J 
= 32.1 Hz), 127.9, 125.1 (q, J = 3.8 Hz), 124.5 (q, J = 270.4 Hz), 116.7, 83.3, 43.5, 41.4, 
24.8, 24.7; HRMS (DART): Calcd for C18H24D1B1F3O2 [M+H]+: 342.1963, Found: 
342.1961. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (60:40 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 
mL/min, 220 nm). 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   12.811	   48.458	   1	   14.097	   60.178	  2	   13.878	   51.542	   2	   15.594	   39.822	  
4,4,5,5-Tetramethyl-2-((1R,2R)-2-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl-1-d)-
1,3,2-dioxaborolane (syn-2.18aa-d): IR (neat): 2979 (w), 2926 (w), 1359 (m), 1322 (s), 
1162 (m), 1143 (m), 1120 (s), 1069 (m), 836 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.51 (2H, d, J = 8.4 Hz), 7.31 (2H, d, J = 8.4 Hz), 5.64 (1H, ddt, J = 17.2, 10.4, 6.8 Hz), 
4.98–4.91 (2H, m), 3.00 (1H, q, J = 7.9 Hz), 2.36 (2H, t, J = 7.2 Hz), 1.10 (6H, s), 1.09 
(6H, s), 1.10–1.09 (1H, m); 13C NMR (100 MHz, CDCl3): δ 151.1, 136.5, 128.3 (q, J = 
32.1 Hz), 127.9, 125.1 (q, J = 3.8 Hz), 124.5 (q, J = 270.2 Hz), 116.7, 83.3, 43.5, 41.4, 
24.8, 24.7; HRMS (DART): Calcd for C18H24D1B1F3O2 [M+H]+: 342.1963, Found: 
342.1961. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (74:26 er shown; Chiralcel OZ–H column, 100% hexanes, 0.3 
mL/min, 220 nm). 
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   12.811	   48.458	   1	   13.228	   74.379	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2	   13.878	   51.542	   2	   14.070	   25.621	  
 
n  Study of the Possibility of Homolytic versus Heterolytic Cu–C Bond Cleavage 
	  
1-Bromo-4-(cyclopropylidenemethyl)benzene (S9): Prepared from aldehyde S8 
(purchased from Aldrich and used as received) by formerly reported procedure.108  The 
spectroscopic data match those reported previously.109 1H NMR (400 MHz, CDCl3): δ 
7.46–7.42 (2H, m), 7.40–7.38 (2H, m), 6.70–6.68 (1H, m), 1.42–1.38 (2H, m), 1.20–1.16 
(2H, m). 
tert-Butyl-4-(cyclopropylidenemethyl)benzoate (2.36): Prepared from S9 according to 
the reported procedure.98 IR (neat): 2977 (w), 1706 (s), 1606 (m), 1367 (m), 1307 (s), 
1292 (s), 1254 (m), 1161 (s), 1107 (s), 1015 (m), 863 (m), 849 (m), 757 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.96 (2H, d, J = 8.4 Hz), 7.55 (2H, d, J = 8.4 Hz), 6.79–6.78 
(1H, m), 1.61 (9H, s), 1.48–1.42 (2H, m), 1.22–1.18 (2H, m); 13C NMR (100 MHz, 
CDCl3): δ 165.8, 142.3, 130.1, 129.7, 127.6, 126.3, 117.9, 80.8, 28.3, 4.5, 0.8; HRMS 
(DART): Calcd for C15H19O2 [M+H]+: 231.1391, Found: 231.1385. 
tert-Butyl-(S)-4-(1-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopropyl)but-
3-en-1-yl)benzoate (2.38): IR (neat): 2976 (w), 2932 (m), 1710 (s), 1640 (w), 1440 (m), 
1409 (m), 1290 (s), 1164 (s), 1140 (s), 1113 (s), 851 (s), 708 (m), 685 (m), 420 (w) cm–1; 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(108) Evans, P. A.; Inglesby, P. A.; Kilbride, K. Org. Lett. 2013, 15, 1798–1801. 












thf, 0–22 °C, 18 h
Scheme S3. Synthesis of Cyclopropane 2.36
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1H NMR (400 MHz, CDCl3): δ 7.88 (2H, d, J = 8), 7.38 (2H, d, J =8), 5.69 (1H, ddt, J = 
17.2, 9.6, 7.2), 5.00–4.95 (1H, m), 4.89–4.85 (1H, m), 2.75–2.71 (2H, m), 1.20 (1H, t, J 
=7.8), 1.58 (9H, s), 1.20 (12H, s), 0.74 (1H, ddd, J = 9.2, 5.6, 3.2), 0.66 (1H, ddd, J = 8, 
4.8, 2.8), 0.41 (1H, ddd, J =8.4, 5.2, 3.2), 0.35 (1H, ddd, J = 8.4, 5.2, 3.2); 13C NMR (100 
MHz, CDCl3): δ 166.1, 150.3, 138.1, 129.8, 129.2, 128.5, 115.5, 83.1, 80.7, 53.4, 38.8, 
28.4, 25.0, 24.5, 14.1, 10.2; HRMS (DART): Calcd for C24H36BO4 [M+H]+: 399.2707, 
Found: 399.2723. Enantiomeric purity was determined by HPLC analysis of the alcohol 
product after oxidation in comparison with authentic racemic material (54:46 er shown; 
Chiralcel OZ–H column, 99% hexanes, 1% i-PrOH, 0.3 mL/min, 220 nm).	  
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   104.145	   49.894	   1	   103.637	   46.394	  2	   112.153	   50.106	   2	   112.787	   53.606	  
	  
4-Bromo-2-chloro-1-vinylbenzene (S11): Prepared from aldehyde S10 (purchased from 
Combi-Blocks and used as received) following the previously reported procedure.22 IR 
(neat): 3089 (w), 3060 (w), 1579 (m), 1467 (s), 1371 (m), 1085 (m), 1049 (m), 985 (m), 
917 (s), 867 (m), 812 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.53 (1H, s), 7.42 (1H, d, J 
= 8.4 Hz), 7.36 (1H, dd, J = 8.4, 1.6 Hz), 7.02 (1H, dd, J = 17.4, 11.0 Hz), 5.74 (1H, d, J 








1.0 mol % Pd(OAc)2
1.1 mol % XPhos
2.2 equiv. CsF







thf, 0–22 °C, 18 h;
72% yield
 1.1 equiv. allyl–Sn(n-Bu)3
DME, 80 oC, 4 h;
74% yield
Scheme S4. Synthesis of Diene 2.39
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132.4, 132.3, 130.2, 127.7, 121.7, 117.3; HRMS (DART): Calcd for C8H7Br1Cl1 [M+H]+: 
216.9420, Found: 216.9427. 
tert-Butyl-3-chloro-4-vinylbenzoate (S12): Prepared from S11 according to the reported 
procedure.98 IR (neat): 2978 (w), 2933 (w), 1716 (s), 1392 (m), 1368 (m), 1298 (s), 1258 
(m), 1168 (s), 1118 (s), 773 (m), 849 cm–1; 1H NMR (400 MHz, CDCl3): δ 7.95 (1H, d, J 
= 1.6 Hz), 7.83 (1H, dd, J = 8.5, 2.1 Hz), 7.59 (1H, d, J = 8.0 Hz), 7.11 (1H, dd, J = 17.6, 
10.8 Hz), 5.82 (1H, dd, J = 17.4, 0.6 Hz), 5.48 (1H, dd, J = 11.0, 1.0 Hz), 1.59 (9H, s); 
13C NMR (100 MHz, CDCl3): δ 164.5, 139.5, 133.1, 132.7, 132.5, 130.8, 127.8, 126.3, 
118.6, 81.7, 28.3; HRMS (DART): Calcd for C13H16Cl1O2 [M+H]+: 239.0839, 
tert-Butyl-3-allyl-4-vinylbenzoate (2.39): Prepared from S12 according to the reported 
procedure.110  . IR (neat): 2977 (w), 2931 (w), 1709 (s), 1367 (m), 1293 (s), 1253 (s), 
1163 (s), 1118 (s), 989 (m), 914 (s), 849 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.82 
(1H, dd, J = 7.8, 1.4 Hz), 7.78 (1H, d, J = 1.6 Hz), 7.53 (1H, d, J = 8.4 Hz), 6.97 (1H, dd, 
J = 17.2, 11.2 Hz), 6.01–5.91 (1H, m), 5.73 (1H, dd, J = 17.4, 1.4 Hz), 5.39 (1H, dd, J = 
11.2, 1.2 Hz), 5.10–5.06 (1H, m), 5.00–4.94 (1H, m), 3.48 (2H, dt, J = 6.4, 1.6 Hz), 1.59 
(9H, s); 13C NMR (100 MHz, CDCl3): δ 165.8, 140.9, 137.1, 136.4, 134.1, 131.4, 131.0, 
127.8, 125.7, 117.5, 116.4, 81.0, 37.5, 28.3; HRMS (DART): Calcd for C16H21O2 
[M+H]+: 244.1463, Found: 244.1471. 
tert-Butyl-(R)-3-allyl-4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-
yl)benzoate (2.40a): IR (neat): 2977 (w), 2930 (w), 1711 (s), 1367 (s), 1298 (s), 1253 
(m), 1166 (s), 1143 (s), 1121 (m), 912 (m), 849 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 
7.78 (1H, dd, J = 8.0, 2.0 Hz), 7.75 (1H, d, J = 2.0 Hz), 7.27 (1H, d, J = 7.6 Hz), 6.00 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(110) Naber, J. R.; Buchwald, S. L. Adv. Synth. Catal. 2008, 350, 957–961. 
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(1H, ddt, J = 17.0, 10.2, 6.2 Hz), 5.70–5.60 (1H, m), 5.09–5.02 (2H, m), ), 4.99–4.91 
(2H, m), 3.59–3.45 (2H, m),  3.32–3.24 (1H, m), 2.36–2.23 (2H, m), 1.58 (9H, s), 1.26–
1.21 (1H, m), 1.08 (6H, s), 1.05 (6H, s), 1.12–1.05 (1H, m); 13C NMR (100 MHz, 
CDCl3): δ 166.2, 150.3, 137.6, 137.3, 136.8, 130.6, 129.5, 127.6, 126.4, 116.6, 116.1, 
83.2, 80.7, 43.5, 37.4, 35.6, 28.4, 24.8, 24.77; HRMS (DART): Calcd for C25H38B1O4 
[M+H]+: 413.2863, Found: 413.2858. 
n  Relevance to Catalytic Processes that Involve Cu–H Additions 
(S)-N,N-Dibutyl-1,2,3,4-tetrahydronaphthalen-1-amine (2.45): Following the 
previously reported procedure except 1:3 alkene:hydroxylamine was used. The 
spectroscopic data are consistent with those reported formerly.111 1H NMR (400 MHz, 
CDCl3): δ 8.07 (1H, dt, J = 7.8, 1.2 Hz), 7.53 (4H, d, J = 7.3 Hz), 7.38 (4H, dd, J = 8.2, 
6.9 Hz), 7.32–7.22 (3H, m), 7.17 (1H, tt, J = 7.3, 1.1 Hz), 7.09 (1H, d, J = 7.9 Hz), 4.00 
(1H, dd, J = 10.2, 5.7 Hz), 3.87 (2H, d, J = 13.6 Hz), 3.54 (2H, d, J = 13.6 Hz), 2.91–2.66 
(2H, m), 2.32–2.14 (1H, m), 2.06 (1H, dtt, J = 13.7, 5.6, 3.1 Hz), 1.85 (1H, tdd, J = 12.5, 
10.1, 2.8 Hz), 1.76–1.58 (1H, m); Specific Rotation: [α]D20 –62.0 (c 1.00, CHCl3) for an 
enantiomerically enriched sample of 97:3 er. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (97:3 er shown; Chiralcel 
OJ–H column, 97% hexanes, 3% i-PrOH, 0.8 mL/min, 220 nm).  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(111) Zhu, S.; Niljianskul, N.; Buchwald, S. L. J. Am. Chem. Soc. 2013, 135, 15746–15749. 
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  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  1	   6.131	   48.412	   1	   5.783	   96.880	  2	   8.210	   51.588	   2	   7.413	   3.120	  
(R)-2-(1-(3,4-Dihydroisoquinolin-2(1H)-yl)octyl)-2,3-dihydro-1H-naphtho[1,8-
de][1,3,2]diazaborinine (2.46): Following the previously reported procedure except 40 
mol % of 2.8 was used. The spectroscopic data match those reported previously.112 1H 
NMR (400 MHz, CDCl3): δ 7.10–7.01 (7H, m), 6.88 (1H, d, J = 6.8 Hz), 6.00 (2H, dd, 
6.8, 1.6 Hz), 5.66 (2H, bs), 3.81 (1H, d, J = 14.8 Hz), 3.55 (1H, d, J = 14.8 Hz), 2.86–
2.79 (1H, m), 2.73–2.55 (3H, m), 1.78 (1H, dd, J = 9.2, 4.4 Hz), 1.71–1.64 (1H, m), 
1.59–1.50 (1H, m), 1.46–1.37 (1H, m), 1.33–1.24 (9H, m), 0.89 (3H, t, J = 6.8 Hz); 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (97:3 er shown; Chiralcel OD–H column, 95% hexanes, 5% i-PrOH, 0.5 
mL/min, 330 nm).  
	  Peak	  #	   Time	  (min)	   Area	  (%)	   Peak	  #	   Time	  (min)	   Area	  (%)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(112) Nishikawa, D.; Hirano, K.; Miura, M. J. Am. Chem. Soc. 2015, 137, 15620–15623. 
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1	   14.988	   49.72	   1	   14.589	   2.99	  2	   17.587	   50.28	   2	   16.221	   97.01	  
 
n  Determination of Absolute Stereochemistry 
In addition to comparison of specific rotation of 2.33 to the reported values suggesting a 
(R) configuration of the products, we synthesized (R)-S14 and obtained the X-ray crystal 
structure to ascertain the absolute stereochemical identity of the products. 
 
Compound (R)-S14 was synthesized from enantiomerically enriched 2.18a (95:5 er), as 
illustrated in Scheme S5. (R)-4-Phenyldihydrofuran-2(3H)-one [(R)-S14]: The 
spectroscopic data match those reported previously.113 1H NMR (400 MHz, CDCl3): δ 
7.40–7.22 (5H, m), 4.67 (1H, dd, J = 8.8, 8.0 Hz), 4.28 (1H, dd, J = 9.0, 8.2 Hz), 3.79 
(1H, app pent, J = 8.5 Hz), 2.93 (1H, dd, J = 17.6 and 8.8 Hz), 2.68 (1H, dd, J = 17.6, 8.8 
Hz); Specific Rotation: [α]D20 –40.8 (c 0.50, CHCl3). The absolute configuration of (R)-
S14 was established by X-ray analysis, which was assigned to be (R). Compound 2.18a is 
thus assigned to possess the (R) configuration. The absolute stereochemistry for other 
enantiomerically enriched products has been assigned by inference. 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  






–78 oC, 1 min; Me2S
2. 1.5 equiv. PDC,
CH2Cl2, 22 °C, 3 h
H2O2, NaOH
2.18a








n  Data for X-ray Crystallography of (R)-S14 
	  
Table 1. Crystal data and structure refinement for C10H10O2 Identification	  code	  	   C10H10O2	  Empirical	  formula	  	   C10	  H10	  O2	  Formula	  weight	  	   162.18	  Temperature	  	   100(2)	  K	  Wavelength	  	   1.54178	  Å	  Crystal	  system	  	   Monoclinic	  Space	  group	  	   P21	  Unit	  cell	  dimensions	   a	  =	  6.1692(7)	  Å	   a=	  90∞.	  	   b	  =	  7.7518(8)	  Å	   b=	  93.023(5)∞.	  	   c	  =	  8.6969(9)	  Å	   g	  =	  90∞.	  Volume	   415.33(8)	  Å3	  Z	   2	  Density	  (calculated)	   1.297	  Mg/m3	  Absorption	  coefficient	   0.729	  mm-­‐1	  F(000)	   172	  Crystal	  size	   0.600	  x	  0.070	  x	  0.050	  mm3	  Theta	  range	  for	  data	  collection	   5.092	  to	  66.613°.	  Index	  ranges	   -­‐7<=h<=7,	  -­‐8<=k<=9,	  -­‐10<=l<=10	  Reflections	  collected	   4434	  Independent	  reflections	   1435	  [R(int)	  =	  0.0455]	  Completeness	  to	  theta	  =	  67.679°	   98.2	  %	  	  Absorption	  correction	   Semi-­‐empirical	  from	  equivalents	  Max.	  and	  min.	  transmission	   0.7528	  and	  0.5867	  Refinement	  method	   Full-­‐matrix	  least-­‐squares	  on	  F2	  Data	  /	  restraints	  /	  parameters	   1435	  /	  1	  /	  109	  Goodness-­‐of-­‐fit	  on	  F2	   1.091	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Final	  R	  indices	  [I>2sigma(I)]	   R1	  =	  0.0341,	  wR2	  =	  0.0848	  R	  indices	  (all	  data)	   R1	  =	  0.0346,	  wR2	  =	  0.0858	  Absolute	  structure	  parameter	   -­‐0.05(11)	  Extinction	  coefficient	   na	  Largest	  diff.	  peak	  and	  hole	   0.145	  and	  -­‐0.213	  e.	  Å-­‐3	  
	  
	  
Table	  2.	  Atomic	  coordinates	  	  (x104)	  and	  equivalent	  	  isotropic	  displacement	  
parameters	  (Å2	  x	  103)	  for	  C10H10O2.	  	  U(eq)	  is	  defined	  as	  one	  third	  of	  	  the	  trace	  
of	  the	  orthogonalized	  Uij	  tensor	  
________________________________________________________________________
______	  
 x y z U(eq) 
________________________________________________________________________
______ 
O(1) 4872(2) 3283(2) 344(2) 29(1) 
O(2) 8163(2) 4179(2) -234(2) 34(1) 
C(1) 6684(3) 4254(3) 609(2) 25(1) 
C(2) 6464(3) 5329(3) 2029(2) 23(1) 
C(3) 4017(3) 5331(3) 2238(2) 22(1) 
C(4) 3365(3) 3581(3) 1546(2) 26(1) 
C(5) 3258(3) 5568(2) 3851(2) 21(1) 
C(6) 4294(3) 4761(3) 5124(2) 26(1) 
C(7) 3475(4) 4930(3) 6572(2) 31(1) 
C(8) 1594(4) 5872(3) 6774(2) 32(1) 
C(9) 571(3) 6695(3) 5510(3) 31(1) 




Table	  3.	  Bond	  lengths	  [Å]	  and	  angles	  [°]	  for	  	  C10H10O2	  
________________________________________________________________________
______ O(1)-­‐C(1)	  	   1.357(3)	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O(1)-­‐C(4)	  	   1.453(2)	  O(2)-­‐C(1)	  	   1.202(3)	  C(1)-­‐C(2)	  	   1.502(3)	  C(2)-­‐C(3)	  	   1.530(3)	  C(2)-­‐H(2A)	  	   0.9900	  C(2)-­‐H(2B)	  	   0.9900	  C(3)-­‐C(5)	  	   1.513(3)	  C(3)-­‐C(4)	  	   1.530(3)	  C(3)-­‐H(3)	  	   1.0000	  C(4)-­‐H(4A)	  	   0.9900	  C(4)-­‐H(4B)	  	   0.9900	  C(5)-­‐C(10)	  	   1.392(3)	  C(5)-­‐C(6)	  	   1.396(3)	  C(6)-­‐C(7)	  	   1.388(3)	  C(6)-­‐H(6)	  	   0.9500	  C(7)-­‐C(8)	  	   1.390(3)	  C(7)-­‐H(7)	  	   0.9500	  C(8)-­‐C(9)	  	   1.393(3)	  C(8)-­‐H(8)	  	   0.9500	  C(9)-­‐C(10)	  	   1.384(3)	  C(9)-­‐H(9)	  	   0.9500	  C(10)-­‐H(10)	  	   0.9500	  C(1)-­‐O(1)-­‐C(4)	   110.01(15)	  O(2)-­‐C(1)-­‐O(1)	   120.97(19)	  O(2)-­‐C(1)-­‐C(2)	   129.3(2)	  O(1)-­‐C(1)-­‐C(2)	   109.77(17)	  C(1)-­‐C(2)-­‐C(3)	   103.33(16)	  C(1)-­‐C(2)-­‐H(2A)	   111.1	  C(3)-­‐C(2)-­‐H(2A)	   111.1	  C(1)-­‐C(2)-­‐H(2B)	   111.1	  C(3)-­‐C(2)-­‐H(2B)	   111.1	  H(2A)-­‐C(2)-­‐H(2B)	   109.1	  C(5)-­‐C(3)-­‐C(4)	   112.65(16)	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C(5)-­‐C(3)-­‐C(2)	   117.74(15)	  C(4)-­‐C(3)-­‐C(2)	   101.13(16)	  C(5)-­‐C(3)-­‐H(3)	   108.3	  C(4)-­‐C(3)-­‐H(3)	   108.3	  C(2)-­‐C(3)-­‐H(3)	   108.3	  O(1)-­‐C(4)-­‐C(3)	   105.02(16)	  O(1)-­‐C(4)-­‐H(4A)	   110.7	  C(3)-­‐C(4)-­‐H(4A)	   110.7	  O(1)-­‐C(4)-­‐H(4B)	   110.7	  C(3)-­‐C(4)-­‐H(4B)	   110.7	  H(4A)-­‐C(4)-­‐H(4B)	   108.8	  C(10)-­‐C(5)-­‐C(6)	   118.66(18)	  C(10)-­‐C(5)-­‐C(3)	   119.28(17)	  C(6)-­‐C(5)-­‐C(3)	   121.98(18)	  C(7)-­‐C(6)-­‐C(5)	   120.31(19)	  C(7)-­‐C(6)-­‐H(6)	   119.8	  C(5)-­‐C(6)-­‐H(6)	   119.8	  C(6)-­‐C(7)-­‐C(8)	   120.6(2)	  C(6)-­‐C(7)-­‐H(7)	   119.7	  C(8)-­‐C(7)-­‐H(7)	   119.7	  C(7)-­‐C(8)-­‐C(9)	   119.20(18)	  C(7)-­‐C(8)-­‐H(8)	   120.4	  C(9)-­‐C(8)-­‐H(8)	   120.4	  C(10)-­‐C(9)-­‐C(8)	   120.0(2)	  C(10)-­‐C(9)-­‐H(9)	   120.0	  C(8)-­‐C(9)-­‐H(9)	   120.0	  C(9)-­‐C(10)-­‐C(5)	   121.13(19)	  C(9)-­‐C(10)-­‐H(10)	   119.4	  C(5)-­‐C(10)-­‐H(10)	   119.4	  _____________________________________________________________	  	  Symmetry	  transformations	  used	  to	  generate	  equivalent	  atoms:	  	  	  
Table	  4.	  Anisotropic	  displacement	  parameters	  	  (Å2x103)	  for	  C10H10O2.	  	  The	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anisotropic	  




 U11 U22  U33 U23 U13 U12 
________________________________________________________________________
______  
O(1) 25(1)  38(1) 24(1)  -7(1) 4(1)  -6(1) 
O(2) 28(1)  46(1) 30(1)  -1(1) 8(1)  0(1) 
C(1) 24(1)  28(1) 23(1)  3(1) 0(1)  1(1) 
C(2) 20(1)  24(1) 25(1)  2(1) 0(1)  -1(1) 
C(3) 21(1)  24(1) 22(1)  3(1) 0(1)  1(1) 
C(4) 23(1)  34(1) 23(1)  -4(1) 3(1)  -3(1) 
C(5) 21(1)  18(1) 24(1)  -2(1) 1(1)  -3(1) 
C(6) 29(1)  23(1) 26(1)  1(1) 2(1)  2(1) 
C(7) 42(1)  24(1) 25(1)  0(1) -2(1)  -5(1) 
C(8) 40(1)  31(1) 27(1)  -9(1) 9(1)  -10(1) 
C(9) 25(1)  31(1) 37(1)  -11(1) 6(1)  0(1) 




Table	  5.	  Hydrogen	  coordinates	  (x104)	  and	  isotropic	  	  displacement	  parameters	  
(Å2	  x103)	  for	  C10H10O2	  
________________________________________________________________________
______ 
 x  y  z  U(eq) 
________________________________________________________________________
______ 
H(2A) 7011 6515 1879 28 
H(2B) 7263 4805 2930 28 
H(3) 3343 6256 1569 27 
H(4A) 3494 2663 2336 31 
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H(4B) 1850 3610 1109 31 
H(6) 5564 4094 4998 31 
H(7) 4208 4395 7435 37 
H(8) 1014 5954 7761 39 
H(9) -704 7357 5636 37 




Table	  6.	  Torsion	  angles	  [°]	  for	  C10H10O2	  _____________________________________________________________________________	  	  C(4)-­‐O(1)-­‐C(1)-­‐O(2)	   178.59(19)	  C(4)-­‐O(1)-­‐C(1)-­‐C(2)	   -­‐1.5(2)	  O(2)-­‐C(1)-­‐C(2)-­‐C(3)	   161.0(2)	  O(1)-­‐C(1)-­‐C(2)-­‐C(3)	   -­‐18.9(2)	  C(1)-­‐C(2)-­‐C(3)-­‐C(5)	   153.11(17)	  C(1)-­‐C(2)-­‐C(3)-­‐C(4)	   29.95(18)	  C(1)-­‐O(1)-­‐C(4)-­‐C(3)	   21.5(2)	  C(5)-­‐C(3)-­‐C(4)-­‐O(1)	   -­‐158.08(16)	  C(2)-­‐C(3)-­‐C(4)-­‐O(1)	   -­‐31.48(18)	  C(4)-­‐C(3)-­‐C(5)-­‐C(10)	   -­‐100.7(2)	  C(2)-­‐C(3)-­‐C(5)-­‐C(10)	   142.14(19)	  C(4)-­‐C(3)-­‐C(5)-­‐C(6)	   76.0(2)	  C(2)-­‐C(3)-­‐C(5)-­‐C(6)	   -­‐41.1(3)	  C(10)-­‐C(5)-­‐C(6)-­‐C(7)	   0.5(3)	  C(3)-­‐C(5)-­‐C(6)-­‐C(7)	   -­‐176.25(19)	  C(5)-­‐C(6)-­‐C(7)-­‐C(8)	   1.3(3)	  C(6)-­‐C(7)-­‐C(8)-­‐C(9)	   -­‐2.0(3)	  C(7)-­‐C(8)-­‐C(9)-­‐C(10)	   0.9(3)	  C(8)-­‐C(9)-­‐C(10)-­‐C(5)	   0.9(3)	  C(6)-­‐C(5)-­‐C(10)-­‐C(9)	   -­‐1.6(3)	  C(3)-­‐C(5)-­‐C(10)-­‐C(9)	   175.24(19)	  _____________________________________________________________________________	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Symmetry	  transformations	  used	  to	  generate	  equivalent	  atoms:	  	  
n  NMR	  Spectra	  











































































































































































































































































































































































































































oxidation product of 2.35
from E olefin
60:40 d.r.
















oxidation product of 2.35
from Z olefin
35:65 d.r.
 391	   
S9
Br
 392	   
2.36
t-BuO2C
 393	   
2.36
t-BuO2C








 396	   
S11
Br Cl
 397	   
S11
Br Cl
 398	   
S12
t-BuO2C Cl
 399	   
S12
t-BuO2C Cl
 400	   
2.39
t-BuO2C
 401	   
2.39
t-BuO2C
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oxidation product of syn-2.18g-d
89:11 dr 














 412	   
oxidation product of anti-2.18aa-d
92:8 dr














 415	   
oxidation product of syn-2.18aa-d
92:8 dr














 417	   
anti-2.18t-d
>98:2 dr




 418	    
syn-2.18t-d
>95:5 dr
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syn-2.18t-d
>95:5 dr
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NBn2
2.45










Synthesis of Vicinal Diboronate Compounds through Practical 
Phosphine–Copper Catalyzed Three-Component Processes 
 
3.1. Introduction  
 Organoboron compounds that contain one or more C–B(pin) (pin = pinacolato) 
bonds are of importance in chemical synthesis. Largely due to the pioneering 
investigations by the Morken group, it is widely appreciated that diboron additions of 
B2(pin)2 to alkenes may be catalyzed by Rh- or Pt-based complexes.114 More recently it 
has been demonstrated that alkoxides115 and carbohydrate-derived species116 can promote 
such transformations. 
Vicinal diboronates can be easily converted to the corresponding diols with 
complete retention of stereochemistry or more recent studies reveal that in the case of 
molecules containing a primary and a secondary C–B(pin) moiety, the former site can be 
site selectively induced to undergo cross-coupling reactions because of the activation by 
the latter.117 Thus, development of a practical method to access vicinal diboronate 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(114) For a representative report, see: (a) Kliman, L. T.; Mlynarski, S. N.; Morken, J. P. J. Am. Chem. Soc. 
2009, 131, 13210–13211. (b) Coombs, J. R.; Haeffner, F.; Kliman, L. T.; Morken, J. P. J. Am. Chem. Soc. 
2013, 135, 11222–11231. For processes promoted by Rh-based complexes, see: (c) Trudeau, S.; Morgan, J. 
B.; Shreshta, M.; Morken, J. P. J. Org. Chem. 2005, 70, 9538–9544. (d) Toribatake, K.; Nishiyama, H. 
Angew. Chem., Int. Ed. 2013, 52, 11011–11015.  
(115) (a) Bonet, A.; Pubill-Ulldemolins, C.; Bo, C.; Gulyás, H.; Fernández, E. Angew. Chem., Int. Ed. 2011, 
50, 7158–7161. (b) Blaisdell, T. P.; Caya, T. C.; Zhang, L.; Sanz-Marco, A.; Morken, J. P. J. Am. Chem. 
Soc. 2014, 136, 9264–9267. 
(116) Fang, L.; Yan, L.; Haeffner, F.; Morken, J.P. J. Am. Chem. Soc. 2016, 138, 2508–2511.  
(117) Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386–390. 
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compounds with differentiable C–B bonds is compelling especially ones that allow 
selective functionalization of a secondary C–B bond over a primary one. 
3.2. Background 
3.2.1. Synthesis of vicinal diboronate compounds through transition-metal catalysis 
 In 2009, our laboratories reported an alternative procedure to access vicinal 
diboronate compounds through a sequential addition reaction of a NHC–Cu–B(pin) 
complex and a terminal alkyne (Scheme 3.1a).118 In the first step, an alkenyl–B(pin) is 
generated from a site-selective proto-boryl addition of an alkyne. Then, the vicinal 
diboronate is obtained through a site- and enantioselective Cu–B(pin) addition to the in 
situ generated alkenyl–B(pin) followed by protonation (<2% germinal diboronate 
compound). The reactions provide access to a range of products including an alkyl- or 
aryl-substituent. 
 The Morken group showed that vicinal diboronate compounds can be obtained 
through the Pt-catalyzed enantioselective diboron addition to monosubstituted alkenes 
(Scheme 3.1b).114b Transformations are highly efficient with only 1.0 mol % of Pt-based 
complex, after 3 hours the diol products with an alkyl- or aryl-substituent (obtained after 
oxidation of diboronate compounds) are generated. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(118) (a) Lee, Y.; Jang, H.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 18234–18235. For an application 
in synthesis of a biologically active molecules, see: (b) Meek, S. J.; O’Brien, R. V.; Llaveria, J.; Schrock, R. 
R.; Hoveyda, A. H. Nature 2011, 471, 461–466. For a related study, see: (c) Jung, H.-Y.; Yun, J. Org. Lett. 
2012, 14, 2606–2609. 
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3.2.2. Synthesis of vicinal diboronate compounds through transition-metal free 
catalysis 
 In addition to reactions involving a transition-metal based catalyst to access 
vicinal diboronates, an alkoxide-catalyzed diboron addition to alkenes has been reported 
(Scheme 3.2a). Diboron addition of B2(pin)2 to alkenes occurs in the presence of 15 mol 
% Cs2CO3 and 5.0 equiv MeOH (A strategy related to Lewis-base catalyzed boryl 
conjugate additions discussed in Chapter 1). Alkyl- or aryl-substituted alkenes can be 
Scheme 3.1. Synthesis of vicinal diboronate compounds involving transition-metal complexes




5.0 mol % CuCl, 20 mol % NaOt-Bu
3.0 equiv MeOH























1.0 mol % Pt(dba)3





















91% yield, 95:5 er
OH
OH
81% yield, 96:4 er
Cy OH
OH








a) NHC–Cu–B(pin) addition to alkynes












used as substrates and proceed in the reaction to afford the diboron products with high 
selectivity (usually 99% diboronate vs monoboronate). It is worth to mention that 
compound 3.12 can be obtained from an internal alkene 3.13 in 69% yield with high syn 
selectivity (97%).115a 
 Recently, the Morken group reported a catalytic enantioselective diboron addition 
of alkenes with a carbohydrate-derived catalyst.116 As shown in Scheme 3.2b, this time 
B2(neo)2 (neo = neopentylglycolato) is needed for high efficiency of the reaction 
[reaction with B2(pin)2 results in lower yield]. The corresponding diol products with an 
alkyl-substituent can be synthesized in good yield and high enantioselectivity; however, 
reaction with styrene is challenging affording the desired product in lower 
enantioselectivity (3.11, 61:39 er). 
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3.2.3. Synthesis of vicinal diboronate compounds from unsymmetrical diboron 
reagent 
In 2010, the Suginome group introduced the use of an unsymmetrical diboron 
reagent [(dan)B–B(pin), (dan = naphthalene-1,8-diaminato)] in diboron addition reactions 
of alkynes.119 As shown in Scheme 3.3a, in the presence of 3.0 mol % Ir-based complex, 
phenyl acetylene (3.19) proceeds to afford the diboron product 3.20 in 85% yield with 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(119) (a) Iwadate, N.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 2548–2549. For representative 
subsequent studies involving the use of (dan)B–B(pin), see: (b) Sake, R.; Hirano, K.; Miura, M. J. Am. 
Chem. Soc. 2015, 137, 6460–6463. (c) Guo, X.; Nelson, A. K.; Slebodnick, C.; Santos, W. L. ACS Catal. 
2015, 5, 2172–2176. 
 
Scheme 3.2. Synthesis of vicinal diboronate compounds by transition-metal free catalysis
a) Methoxide-catalyzed diboron addition to alkenes
b) Carbohydrate-catalyzed enantioselective diboron addition to alkenes
C6H13
98% conv, 71% yield
B2(pin)2+
1.1 equiv
15 mol % Cs2CO3
5.0 equiv MeOH,























68% yield, 97:3 er
B2(neo)2+













74% yield, 96:4 er
HO
OHBnO
72% yield, 97:3 er
HO
OHMeO2C









high regioselectivity where the B(pin) unit is at the internal position. Substrates bearing 
heteroaryl- or alkyl-substituent are also suitable generating the products in 64–74% yield 
with 93–99% selectivity. 
 A report involving an alkoxide-promoted diboron addition of alkenes with 
(dan)B–B(pin) was subsequently reported in 2015.120 In the presence of 30 mol % 
Cs2CO3 and MeOH as solvent, products are obtained in moderate yields with the B(pin) 
group is at the external position. In contrast to reactions with B2(pin)2 shown in Scheme 
3.2a, reaction with styrene did not proceed to afford the diboron compounds. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




3.3. Synthesis of Vicinal Diboronate Compounds through Phosphine–Cu 
Catalyzed Boron–Allyl Addition to Alkenylboron Compounds 
3.3.1. Reaction conditions optimization and ligand screen 
As illustrated in Scheme 3.4, we envisioned the reaction of an alkenyl–B(pin) 
with B2(pin)2 and an allylic phosphate, in the presence of a Cu-based catalyst would 
Scheme 3.3. Synthesis of diboronate compounds with (dan)B–B(pin)
a) Ir-catalyzed diboron addition to alkynes
b) Alkoxide-catalyzed diboron addition to alkenes
1.5 equiv
(dan)B–B(pin)+ (pin)B
B(dan)1.5 mol % [IrCl(cod)2]2

























30 mol % Cs2CO3


















afford a product that contains a readily functionalizable alkene.121,122 We viewed this as 
highly advantageous for synthesizing a number of otherwise difficult-to-access and 
desirable products. 
The multicomponent strategy may have several distinct advantages, one of which 
would be the possibility of utilizing (dan)B–B(pin). We surmised that, as depicted in 
Scheme 3.4, the intermediate copper-alkoxide would favor interaction with the more 
Lewis acidic B(pin) unit, leading to the formation of the Cu–B(dan) complex (v), which 
would then generate a product with a terminal B(dan) and an internal B(pin) group (viii). 
As such, a sequence involving an alkenyl–B(dan) substrate and B2(pin)2 would furnish 
the alternative diboron isomer [i.e., primary C–B(pin) and secondary C–B(dan)]. Because 
differentiation of these two types of boronate groups is much more straightforward than 
that of two B(pin) groups, the resulting product would offer a distinct advantage 
regarding subsequent functionalization. This would be especially the case when selective 
reaction at the typically less reactive secondary C–B bond is desired. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(121) For related processes involing aryl olefins and promoted by a combination of a chiral bis-phosphine–
Cu and an achiral bis-phosphine–Pd co-catalyst, see: a) Jia, T.; Cao, P.; Wang, B.; Lou, Y.; Yin, X.; Wang, 
M.; Liao, J. J. Am. Chem. Soc. 2015, 137, 13760–13763. For transformations that commence with an 
enantioselective Cu–H addition, see: b) Wang, Y.-M.; Buchwald, S. L. J. Am. Chem. Soc. 2016, 138, 5024–
5027; c) Han, J. T.; Jang, W. J.; Kim, N.; Yun, J. J. Am. Chem. Soc. 2016, 138, 15146–15149. 
(122) For hydroamination of alkenylboron compounds, see: a) Nishikawa, D.; Hirano, K.; Miura, M. J. Am. 
Chem. Soc. 2015, 137, 15620–15623. For aminoboration of alkenylboron compounds, see: b) Nishikawa, 





We began by investigating the possibility of a three-component process with 
vinyl–B(pin), allylphosphate  and B2(pin)2 (Table 3.1). Reaction in the presence of 10 
mol % Cu–PPh3 and NaOt-Bu as a base, vicinal diboronate 3.28 was isolated in 81% 
yield (entry 1).  However, in the absence of a ligand there was 90% conv of the limiting 
reagent [(vinyl–B(pin)] but 3.28 was obtained in only 13% yield indicating an important 
of the role of the ligand on Cu (entry 2). Evaluation of other metal alkoxides indicated 
that LiOt-Bu is the optimal generating the product in 92% yield after 2 hours (entries 3).  
Scheme 3.4. The key objectives of the study
















































We then examined several mono- and bidentate phosphines (Scheme 3.5). It was 
found that use of PCy3 is optimal affording the product in 92% yield after 1 hour. 
Reaction with NHC–Cu proved to be much less efficient (im-1, 17% yield). The 
diminished efficiency with the more Lewis basic ligand systems probably arises from a 
more nucleophilic Cu–B(pin) complex and thus a more competitive reaction with 
allylphosphate, leading to the generation of allyl–B(pin).123 Thus, it appears that certain 
phosphine ligands (e.g., PPh3 or PCy3) offer sufficient catalyst activation to engender 




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(123) a) Ito, H.; Ito, S.; Sasaki, Y.; Matsuura, K.; Sawamura, M. J. Am. Chem. Soc. 2007, 129, 14856–
14857; b) Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634–10637. 
 
 





B(pin)11 mol % PPh3, 10 mol % CuCl
1.5 equiv Base,
thf, 22 oC, 2 h1.5 equiv1.0 equiv
3.28

















a All reactions were performed under N2 atm. b Determined by analysis of 400 MHz 1H NMR
spectra of unpurified mixtures. c Yields of purified products.
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3.3.2. Scope of the three-component processes to access vicinal diboronate 
compounds 
Reactions with a variety of 2-substituted allylic phosphates promoted by a catalyst 
derived from PCy3 and CuCl are shown in Scheme 3.6. Reactions with electrophiles 
bearing an alkyl (3.29–3.30), aryl (3.31), heteroaryl (3.32), silyl (3.33) substituent 
proceed to afford products in 61–92% yield. It is noteworthy that products containing a 
functionalizable carboxylic ester (3.34) or an alkenyl chloride or bromide (3.35–3.36) can 
be obtained in 56–85% yield; interference by the carbon–halogen bond is minimal. The 
transformations are highly site-selective as the formation of the geminal diboronate 
isomer is not observed. 
 









B(pin)11 mol % PPh3, 10 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 2 h1.5 equiv1.0 equiv
80% conv, 16% yield >98% conv, 91% yield96% conv, 58% yield
91% conv, 53% yield
>98% conv, 92% yield
1 h
96% conv, 85% yield












>98% conv, 92% yield
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We then turned to exploring the possibility of site-selective generation of 
differentiated diboronate compounds through the use of (dan)B–B(pin). As illustrated in 
Scheme 3.7, the transformations afford products that contain a primary C–B(dan) and a 
secondary C–B(pin) moiety with complete selectivity (<2% of the alternative isomer 
detected by 1H NMR of the unpurified mixture). Similar to the reactions with B2(pin)2 
(Scheme 3.6), an assortment of allylic phosphates may be employed. It is interesting that 
transformation to produce 3.44 is not efficient generating the product in only 27% yield 
[vs 78% yield with B2(pin)2]. It might be because Cu–Ot-Bu reacts with (dan)B–B(pin) 
less efficiently making side-reactions more competitive with Br-substituted allylic 
phosphate. We were also able to obtain the X-ray structures of vicinal diboronates 3.40 
and 3.41 to ascertain the identity of the products.    
 
Scheme 3.6. Products with vicinal B(pin) units from reactions with various allylic phosphates
OPO(OEt)2+ B2(pin)2+
1.1 equiv
(pin)B11 mol % PCy3, 10 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 1 h1.5 equiv1.0 equiv
>98% conv, 92% yield
3.28
>98% conv, 88% yield
>98% conv, 85% yield 90% conv, 78% yield
89% conv, 61% yield>98% conv, 92% yield
>98% conv, 84% yield
91% conv, 72% yield
90% conv, 56% yield
(1.5:1 vinylB(pin):phosphate)
3.29 3.30 3.31 3.32




















Another key advantage of the multicomponent approach is that it can allow access 
to vicinal diboronate products with a boron-substituted quaternary carbon center. These 
entities cannot be accessed efficiently through catalytic diboron additions to 1,1-
disubstituted olefins or alkynes. The examples provided in Scheme 3.8 are illustrative 
(3.46–3.52). It is again noteworthy that products with an alkenyl halide group are 
tolerated (3.51–3.52). Furthermore, despite the increased steric hindrance of the substrate 
(3.45), reactions proceeded to completion within two hours under similar conditions as 
used for transformations involving vinyl–B(pin), except slightly excess of 3.45 is 
required for higher yields of the products. 
 
Scheme 3.7. Products containing a secondary C–B(pin) and a primary C–B(dan)
OPO(OEt)2+ (dan)B–B(pin)+
1.1 equiv
(pin)B11 mol % PCy3, 10 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 2 h1.5 equiv
1.0 equiv
>98% conv, 84% yield
3.37
95% conv, 81% yield
92% conv, 60% yield 92% conv, 27% yield
>98% conv, 60% yield88% conv, 61% yield



















X-ray structure of 3.41
X-ray structure of 3.40
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The catalytic transformations presented in Scheme 3.9 further underline the broad 
scope of the method. Differentiable vicinal organoboron products that contain a (pin)B-
substituted carbon center can be prepared easily through the use of the appropriate 
alkenyl–B(pin) as the substrate and (dan)B–B(pin) as the reagent; thus compound 3.53 
could be obtained in 68% yield after 4 hours at ambient temperature. Similarly 
noteworthy is the transformation with vinyl–B(dan), obtained easily from vinyl–B(pin) 
(single step), leading to the efficient formation (>98% conv, 1 h) of the diboronate 
product 3.55 in 88% yield, the identity of which was confirmed by X-ray crystallography 
(Scheme 3.9). 
 




(pin)B11 mol % PCy3, 10 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 2 h1.0 equiv1.5 equiv >98% conv, 67% yield
3.46
>98 conv, 79% yield
79% conv, 62% yield 77% conv, 48% yield
>98% conv, 54% yield>98% conv, 95% yield






















The multicomponent reactions are scalable and can be performed with reduced 
catalyst loading; two illustrative cases are shown in Scheme 3.10. These transformations 
were performed with 2.5 mol % of the PCy3–Cu complex, although longer reaction time 
required (12 h). Diboron products 3.37 and 3.46 were obtained in 91% and 78% yield, 
respectively. 
 
3.3.3. Functionalizations of the vicinal diboronate compounds 
The C–B(pin) bond of the diboronate products can be site selectively oxidized to 
afford the corresponding alcohols containing C–B(dan) unit with high efficiency and 
selectivity (3.56 and 3.57, Scheme 3.11). The remaining C–B(dan) moiety can be 




(pin)B11 mol % PCy3, 10 mol % CuCl
1.5 equiv LiOt-Bu,









(dan)B11 mol % PCy3, 10 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 1 h1.5 equiv1.0 equiv
>98% conv, 88% yield
3.55
(dan)B B(pin)B2(pin)2
X-ray structure of 3.55
Scheme 3.10. Reactions performed on a larger scale with reduced catalyst loading
OPO(OEt)2+ +
1.1 equiv
(pin)B2.75 mol % PCy3, 2.5 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 12 h1.5 equiv1.0 equiv






(pin)B2.75 mol % PCy3, 2.5 mol % CuCl
1.5 equiv LiOt-Bu,
thf, 22 oC, 12 h1.0 equiv1.5 equiv








subsequently converted to a C–B(pin) and then used for C–C by a reported method,124 
leading to the formation of silyl ethers 3.59 and 3.61. The state-of-the-art pertaining to 
direct conversion of a C–B(dan) to a C–C bond by means of catalytic cross-coupling is 
less advanced compared to those containing a C–B(pin). Thus, future developments in 
this key area will further enhance the utility of the present approach. 
 
Another set of important functionalizations of products involves recently 
developed catalyst-controlled stereoselective cross-metathesis approaches for accessing 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(124) Odachowski, M.; Bonet, A.; Essafi, S.; Conti-Ramsden, P.; Harvey, J. N.; Leonori, D.; Aggarwal, V. 




thf/H2O (1:1), pH = 7 buffer,















no purification (3 steps)
1. 5.0 equiv pinacol,
2 M H2SO4, 0–22 °C, 6 h
2. TBSCl, imdazole,
0–22 °C, 12 h
1.5 equiv furan, 1.5 equiv n-BuLi,
thf, –78 °C, 1h;











alkenyl halide compounds (Scheme 3.12).125 With 5.0 mol % Mo-1, Z-alkenyl chlorides 
3.62 and 3.64 were obtained in exceptionally high Z selectivity (>98:2 Z:E) and in 62% 
and 86% yield, respectively. Switching the cross partner to Z-1-bromo-2-fluoroethene, Z-
alkenyl fluoride 3.63 and 3.65 can be synthesized with >98% Z selectivity, but with 
moderate F:Br ratios due to the unhindered nature of the olefin. 
 
3.4. Conclusions 
We have developed a practical and general catalytic multicomponent processes to 
access a variety of vicinal diboronate compounds. The transformations are promoted 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(125) a) Koh, M. J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; Hoveyda, A. H. Nature 2016, 531, 459–464. 
For the corresponding kinetically E-selective cross-metathesis reactions, see: b) Nguyen, T. T.; Koh, M. J.; 
Shen, X.; Romiti, F.; Schrock, R. R.; Hoveyda, A. H. Science 2016, 352, 569–575. 
 
 
Scheme 3.12. Catalytic Z-selective cross-metathesis
3.55
B(pin)(dan)B
















































simply by a Cu complex derived from PCy3 and CuCl and with commercially available 
diboron reagents [B2(pin)2 or (dan)B–B(pin)]. The ability for facile access to either 
regioisomeric products with a C–B(pin) and an adjacent C–B(dan) bond that can be site 
selectively modified is a particularly noteworthy feature of the new approach. 
3.5. Experimental Section 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm-1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on Varian Unity INOVA 400 
(400 MHz), 500 (500 MHz), or 600 (600 MHz) spectrometers. Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, pent = pentet, m = multiplet, 
br = broad, app = apparent), and coupling constants (Hz). 13C NMR spectra were 
recorded on Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometers with complete proton decoupling. Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Melting 
points were measured on a Thomas Hoover capillary melting point apparatus and are 
uncorrected. X-ray structures were obtained, as described in the cif file, with a 
Microfocus sealed Cu tube from Incote. It is well established that that aforementioned 
detector allows for the determination of absolute configuration of molecules that do not 
have a heavy atom. 
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Unless otherwise noted, reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 ºC) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Hexanes was purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system through 
a copper oxide and alumina column. Tetrahydrofuran (thf; Aldrich Chemical Co.) was 
purified by distillation from sodium benzophenone ketyl immediately prior to use. All 
work-up and purification procedures were carried out with reagent grade solvents 
(purchased from Fisher Scientific) under air. 
n  Reagents: 
Bis(pinacolato)diboron [B2(pin)2]: purchased from Frontier Scientific, Inc., 
recrystallized from pentane and dried under vacuum prior to use. 
n-Butyllithium (1.6 M in hexanes): purchased from Aldrich and used as received. 
Copper(I) chloride: purchased from Strem and used as received. 
Diethyl allyl phosphate: purchased from Aldrich and used as received. 
Imidazolinium salt im-1: purchased from Aldrich and used as received. 
Isopropenylboronic acid pinacol ester (3.45): purchased from Aldrich and used as 
received. 
Lithium tert-butoxide: purchased from Strem and used as received. 
Phosphine ligands: purchased from Strem and used as received. 
Potassium tert-butoxide: purchased from Strem and used as received. 




de][1,3,2]diazaborinine [(dan)B–B(pin)]: purchased from AKSci and used as 
received. 
Vinylboronic acid pinacol ester [vinyl–B(pin)]: purchased from Combi-Blocks and 
distilled over CaH2 prior to used. 
Vinyl–B(dan) (3.54): prepared from vinyl–B(pin) according to a previously reported 
procedure.126 
n  Representative Procedure for the Catalytic Cu–B(pin) Addition to Vinyl–B(pin) 
Followed by Allylic Substitution Reaction (Scheme 3.6) 
In a N2-filled glove box, an oven-dried 1 dram vial equipped with a stir bar was 
charged with PCy3 (3.1 mg, 0.0055 mmol), LiOt-Bu (12 mg, 0.15 mmol), CuCl (0.50 mg, 
0.0050 mmol), and thf (1.0 mL). The mixture was allowed to stir for 15 min at 22 °C; 
during this time the solution turned light-yellow. Bis(pinacolato)diboron (28 mg, 0.11 
mmol) was added to the mixture, causing the solution to turn dark brown immediately. 
Vinyl–B(pin) (15.4 mg, 0.10 mmol), allylphosphate (29.1 mg, 0.15 mmol), and thf (0.50 
mL) were added. The vial was sealed with a cap and electrical tape before removal from 
the glove box. The resulting mixture was allowed to stir at 22 °C for 1 h. The mixture 
was then passed through a short plug of silica gel (4 x 1 cm) and eluted with Et2O. The 
organic layer was concentrated under reduced pressure, affording yellow oil, which was 
purified by silica gel chromatography (100% hexanes→hexanes:Et2O = 10:1) to afford 
3.28 as colorless oil (29.6 mg, 0.092 mmol, 92% yield). 2,2'-(Pent-4-ene-1,2-
diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (3.28): IR (neat): 2978 (m), 2927 (w), 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(126) Iannazzo, L.; Vollhardt, K. P. C.; Malacria, M.; Aubert, C.; Gandon, V. Eur. J. Org. Chem. 2011, 
3238–3292. 
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1371 (s), 1314 (s), 1143 (s), 968 (w) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.84–5.74 
(1H, m), 5.00–4.90 (2H, m), 2.25–2.18 (1H, m), 2.11–2.04 (1H, m), 1.22 (12H, s), 1.21 
(12H, s), 1.27–1.21 (1H, m), 0.90–0.78 (2H, m); 13C NMR (100 MHz, CDCl3): δ 138.8, 
115.1, 83.0, 82.96, 38.0, 25.0, 24.99, 24.93, 24.91; HRMS (DART): Calcd for 
C17H33B2O4 [M+H]+: 323.2565, Found: 323.2575. 
2,2'-(4-Methylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.29): IR (neat): 2978 (m), 2928 (w), 1370 (s), 1314 (s), 1143 (s), 968 (w) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 4.68 (1H, d, J = 1.6 Hz), 4.66 (1H, d, J = 0.8 Hz), 2.20 (1H, 
dd, J = 14.0, 7.2 Hz), 2.00 (1H, dd, J = 14.2, 8.6 Hz), 1.58 (3H, s), 1.35–1.27 (1H, m), 
1.22 (12H, s), 1.217 (12H, s), 0.85–0.74 (2H, m); 13C NMR (100 MHz, CDCl3): δ 135.2, 
117.2, 83.3, 83.1, 44.6, 25.0, 24.97, 24.9; HRMS (DART): Calcd for C18H35B2O4 
[M+H]+: 337.2721, Found: 337.2722.  
tert-Butyldimethyl((2-methylene-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentyl)oxy)silane (3.30): IR (neat): 2977 (w), 2929 (w), 2856 (w), 1370 (s), 1313 (s), 
1252 (m), 1142 (s), 1101 (m), 968 (m), 836 (s), 776 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 5.05–5.04 (1H, m), 4.83–4.81 (1H, m), 4.05 (2H, s), 2.19 (1H, dd, J = 14.6, 7.4 
Hz), 1.98 (1H, dd, J = 14.4, 8.4 Hz), 1.33–1.19 (1H, m), 1.22 (12H, s), 1.21 (12H, s), 
0.90 (9H, s), 0.88–0.74 (2H, m), 0.05 (6H, s); 13C NMR (100 MHz, CDCl3): δ 148.0, 
108.9, 83.0, 82.99, 65.7, 36.7, 26.1, 25.0, 24.97, 24.9, 18.6, –5.2; HRMS (DART): Calcd 
for C24H52B2N1O5Si1 [M+NH4]+: 484.3801, Found: 484.3795.  
2,2'-(4-Phenylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.31): IR (neat): 2977 (m), 2927 (w), 1370 (s), 1313 (s), 1142 (s), 968 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.43–7.41 (2H, m), 7.30–7.22 (3H, m), 5.25 (1H, d, J = 2.0 
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Hz), 5.06 (1H, d, J = 1.2 Hz), 2.73 (1H, dd, J = 13.6, 7.6 Hz), 2.48 (1H, dd, J = 14.6, 7.8 
Hz), 1.34–1.27 (1H, m), 1.22 (12H, s), 1.21 (12H, s), 0.88–0.79 (2H, m); 13C NMR (100 
MHz, CDCl3): δ 148.4, 141.6, 128.2, 127.2, 126.5, 113.2, 83.0, 82.99, 39.0, 25.0, 24.99, 
24.96, 24.92; HRMS (DART): Calcd for C23H40B2N1O4 [M+NH4]+: 416.3143, Found: 
416.3127.  
2,2'-(4-(Furan-3-yl)pent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.32): IR (neat): 2977 (m), 2928 (w), 1369 (s), 1312 (s), 1140 (s), 968 (m), 872 (m) cm–
1; 1H NMR (400 MHz, CDCl3): δ 7.54 (1H, s), 7.32 (1H, t, J = 1.6 Hz), 6.51 (1H, dd, J = 
1.8, 1.0 Hz), 5.20 (1H, d, J = 1.2 Hz), 4.93 (1H, d, J = 1.6 Hz), 2.54 (1H, ddd, J = 14.1, 
7.9, 0.9 Hz), 2.30 (1H, dd, J = 14.0, 7.6 Hz), 1.46–1.37 (1H, m), 1.23 (12H, s), 1.21 (12H, 
s), 0.90–0.81 (2H, m); 13C NMR (100 MHz, CDCl3): δ 142.9, 139.5, 139.3, 126.8, 110.9, 
108.5, 83.1, 83.0, 38.7, 25.03, 25.01, 24.96, 24.94; HRMS (DART): Calcd for 
C21H35B2O5 [M+H]+: 389.2671, Found: 389.2667.  
(4,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-en-2-yl)trimethylsilane 
(3.33): IR (neat): 2977 (m), 1370 (s), 1313 (s), 1247 (m), 1142 (s), 968 (m), 836 (s) cm–1; 
1H NMR (400 MHz, CDCl3): δ 5.57–5.56 (1H, m), 5.31–5.30 (1H, m), 2.38–2.32 (1H, m), 
2.08 (1H, dd, J = 14.6, 8.2 Hz), 1.37–1.29 (1H, m), 1.22 (12H, s), 1.20 (12H, s), 0.86–
0.73 (2H, m), 0.07 (9H, s); 13C NMR (100 MHz, CDCl3): δ 152.0, 124.4, 82.9, 82.87, 
39.7, 25.0, 24.96, 24.9, –1.2; HRMS (DART): Calcd for C20H44B2N1O4Si1 [M+NH4]+: 
412.3226, Found: 412.3222.  
Methyl 2-methylene-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanoate 
(3.34): IR (neat): 2978 (m), 2928 (w), 1722 (m), 1629 (w), 1370 (s), 1315 (s), 1141 (s), 
968 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 6.14 (1H, d, J = 1.2 Hz), 5.53 (1H, dd, J = 
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2.8, 1.2 Hz), 3.72 (3H, s), 2.54 (1H, ddd, J = 14.6, 7.4, 0.8 Hz), 2.26 (1H, dd, J = 14.5, 
7.7 Hz), 1.40–1.33 (1H, m), 1.22 (24H, s), 0.83 (2H, d, J = 7.6 Hz); 13C NMR (100 MHz, 
CDCl3): δ 168.0, 140.4, 125.5, 83.1, 83.06, 51.8, 35.4, 30.5, 25.0, 24.98, 24.9; HRMS 
(DART): Calcd for C19H35B2O6 [M+H]+: 381.2620, Found: 381.2635.  
2,2'-(4-Chloropent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.35): IR (neat): 2979 (m), 2929 (w), 1633 (w), 1371 (s), 1317 (s), 1142 (s), 968 (w) cm–
1; 1H NMR (400 MHz, CDCl3): δ 5.13 (1H, d, J = 0.8 Hz), 5.10 (1H, d, J = 1.2 Hz), 2.52 
(1H, ddd, J = 14.7, 6.5, 0.9 Hz), 2.35 (1H, ddd, J = 14.8, 8.8, 0.4 Hz), 1.53–1.42 (1H, m), 
1.22 (24H, s), 0.90–0.79 (2H, m); 13C NMR (100 MHz, CDCl3): δ 143.0, 112.7, 83.3, 
83.1, 42.4, 25.0, 24.97, 24.93, 24.92; HRMS (DART): Calcd for C17H32B2Cl1O4 [M+H]+: 
357.2175, Found: 357.2179.  
2,2'-(4-Bromopent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.36): IR (neat): 2977 (m), 2928 (w), 1627 (w), 1369 (s), 1313 (s), 1139 (s), 967 (m), 
882 (m), 856 (m), 844 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.54 (1H, d, J = 1.2 Hz), 
5.38 (1H, d, J = 1.2 Hz), 2.61 (1H, dd, J = 14.2, 5.8 Hz), 2.43 (1H, dd, J = 15.0, 9.0 Hz), 
1.54–1.46 (1H, m), 1.23 (24H, s), 0.91–0.78 (2H, m); 13C NMR (100 MHz, CDCl3): δ 
135.2, 117.2, 83.3, 83.1, 44.6, 25.0, 24.97, 24.9; HRMS (DART): Calcd for 
C17H32B2Br1O4 [M+H]+: 401.1670, Found: 401.1684.  
n  Representative Procedure for the Catalytic Cu–B(dan) Addition to Vinyl–B(pin) 
Followed by Allylic Substitution Reaction (Scheme 3.7) 
In a N2-filled glove box, an oven-dried 1 dram vial equipped with a stir bar was 
charged with PCy3 (3.1 mg, 0.0055 mmol), LiOt-Bu (12 mg, 0.15 mmol), CuCl (0.50 mg, 
0.0050 mmol), and thf (1.0 mL). The mixture was allowed to stir for 15 min at 22 °C; 
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during this time the solution turned light-yellow. (dan)B–B(pin) (31.2 mg, 0.11 mmol) 
was added to the mixture, causing the solution to turn dark brown immediately. Vinyl–
B(pin) (15.4 mg, 0.10 mmol), allylphosphate (29.1 mg, 0.15 mmol), and thf (0.50 mL) 
were added. The vial was sealed with a cap and electrical tape before removal from the 
glove box. The resulting mixture was allowed to stir at 22 °C for 2 h. The mixture was 
then passed through a short plug of celite and neutral alumina (4 x 1 cm) and eluted with 
Et2O. The organic layer was concentrated under reduced pressure, affording brown oil, 
which was purified by neutralized silica gel chromatography (pre-treated with Et3N, 
100% hexanes→hexanes:Et2O = 10:1) to afford 3.37 as off-white solid (30.4 mg, 0.084 
mmol, 84% yield). 2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-
2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.37): Melting point: 104–105 
ºC. IR (neat): 3399 (br), 2976 (w), 2899 (w), 1600 (s), 1510 (m), 1411 (m), 1373 (m), 
1318 (m), 1139 (m), 820 (m), 763 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.09 (2H, dd, 
J = 8.2, 7.4 Hz), 6.99 (2H, dd, J = 8.4, 0.8 Hz), 6.26 (2H, dd, J = 7.2, 0.8 Hz), 6.01 (2H, 
br s), 5.83 (1H, ddt, J = 17.2, 10.0, 6.8 Hz), 5.08–4.98 (2H, m), 2.34–2.27 (1H, m), 2.13 
(1H, app pent, J = 7.0 Hz), 1.32–1.22 (1H, m), 1.27 (12H, s), 0.98 (2H, d, J = 8.0 Hz); 
13C NMR (100 MHz, CDCl3): δ 141.5, 138.6, 136.5, 127.7, 119.7, 117.2, 115.4, 105.4, 
83.5, 38.3, 25.01, 25.0; HRMS (DART): Calcd for C21H29B2N2O2 [M+H]+: 363.2415, 
Found: 363.2430. 
2-(4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.38): IR (neat): 3395 (br), 2976 (w), 
2919 (w), 1599 (s), 1510 (m), 1411 (s), 1372 (s), 1317 (m), 1139 (s), 820 (m), 763 (s) 
cm–1; 1H NMR (400 MHz, CDCl3): δ 7.09 (2H, dd, J = 8.2, 7.4 Hz), 6.99 (2H, dd, J = 8.4, 
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0.8 Hz), 6.27 (2H, dd, J = 7.2, 0.8 Hz), 6.03 (2H, br s), 4.76 (1H, s), 4.73 (1H, s), 2.29 
(1H, dd, J = 14.0, 8.0 Hz), 2.05 (1H, dd, J = 14.2, 8.2 Hz), 1.73 (3H, s), 1.43–1.35 (1H, 
m), 1.27 (12H, s), 1.01–0.88 (2H, m); 13C NMR (100 MHz, CDCl3): δ 145.6, 141.6, 
136.5, 127.7, 119.7, 117.2, 111.0, 105.4, 83.5, 41.9, 25.0, 24.96, 22.4; HRMS (DART): 
Calcd for C22H31B2N2O2 [M+H]+: 377.2572, Found: 377.2574.  
2-(4-(((tert-Butyldimethylsilyl)oxy)methyl)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-dihydro-1H-naphtho[1,8-
de][1,3,2]diazaborinine (3.39): IR (neat): 3398 (br), 2976 (w), 2955 (w), 2928 (w), 2891 
(w), 2856 (w), 1601 (s), 1511 (m), 1411 (m), 1373 (m), 1320 (m), 1252 (m), 1141 (m), 
1103 (m), 836 (m), 763 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.08 (2H, dd, J = 8.0, 
7.2 Hz), 6.98 (2H, dd, J = 8.6, 1.0 Hz), 6.26 (2H, dd, J = 7.6, 0.8 Hz), 6.03 (2H, br s), 
5.09 (1H, d, J = 2.0 Hz), 4.87 (1H, d, J = 2.0 Hz), 4.08 (2H, s), 2.26 (1H, dd, J = 14.8, 8.0 
Hz), 2.03 (1H, dd, J = 14.6, 7.8 Hz), 1.41–1.28 (1H, m), 1.25 (12H, s), 1.03–0.91 (2H, m), 
0.92 (9H, s), 0.07 (6H, s); 13C NMR (100 MHz, CDCl3): δ 148.2, 141.5, 136.5, 127.7, 
119.7, 117.2, 109.0, 105.4, 83.6, 65.8, 37.0, 26.1, 25.0, 24.97, 18.6, –5.19, –5.17; HRMS 
(DART): Calcd for C28H45B2N2O3Si1 [M+H]+: 507.3386, Found: 507.3396.  
2-(4-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.40): Melting point: 128–130 ºC. 
IR (neat): 3401 (br), 2976 (w), 2925 (w), 1627 (w), 1599 (s), 1411 (m), 1372 (m), 1318 
(m), 1140 (m), 820 (m), 764 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.42–7.40 (2H, m), 
7.35–7.25 (3H, m), 7.07 (2H, dd, J = 8.4, 7.2 Hz), 6.97 (2H, dd, J = 8.2, 1.0 Hz), 6.22 
(2H, dd, J = 7.2, 1.2 Hz), 5.91 (2H, br s), 5.28 (1H, d, J = 1.6 Hz), 5.11 (1H, d, J = 1.2 
Hz), 2.81 (1H, dd, J = 14.5, 7.9 Hz), 2.48 (1H, dd, J = 14.1, 7.5 Hz), 1.37–1.31 (1H, m), 
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1.24 (12H, s), 1.02–0.89 (2H, m); 13C NMR (100 MHz, CDCl3): δ 148.6, 141.53, 141.5, 
136.5, 128.4, 127.7, 127.5, 126.5, 119.7, 117.2, 113.4, 105.4, 83.5, 39.4, 25.0, 24.96; 
HRMS (DART): Calcd for C27H33B2N2O2 [M+H]+: 439.2728, Found: 439.2724.  
2-(4-(Furan-3-yl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.41): Melting point: 139–140 ºC. 
IR (neat): 3396 (br), 2974 (w), 2926 (w), 1629 (w), 1600 (s), 1511 (m), 1411 (m), 1372 
(m), 1317 (m), 1165 (m), 1139 (m), 765 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.48 
(1H, d, J = 1.2 Hz), 7.36 (1H, t, J = 1.6 Hz), 7.08 (2H, dd, J = 8.2, 8.4 Hz), 6.98 (2H, dd, 
J = 8.2, 1.0 Hz), 6.52 (1H, dd, J = 2.2, 1.0 Hz), 5.99 (2H, br s), 5.25 (1H, d, J = 1.2 Hz), 
4.98 (1H, d, J = 1.2 Hz), 2.63 (1H, dd, J = 13.8, 7.8 Hz), 2.30 (1H, dd, J = 14.2, 7.4 Hz), 
1.50–1.40 (1H, m), 1.24 (12H, s), 1.08–0.89 (2H, m); 13C NMR (100 MHz, CDCl3): δ 
143.2, 141.5, 139.24, 139.2, 136.5, 127.7, 126.8, 119.7, 117.3, 111.0, 108.5, 105.4, 83.6, 
39.0, 25.0, 24.9; HRMS (DART): Calcd for C25H31B2N2O3 [M+H]+: 429.2521, Found: 
429.2507. 
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trimethylsilyl)pent-4-en-1-yl)-
2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.42): IR (neat): 3386 (br), 2976 
(w), 2897 (w), 1628 (w), 1601 (s), 1513 (m), 1411 (m), 1372 (s), 1317 (m), 1247 (m), 
1141 (s), 836 (s), 820 (m), 763 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.09 (2H, t, J = 
7.8 Hz), 6.98 (2H, d, J = 8.4 Hz), 6.27 (2H, dd, J = 7.4, 1.0 Hz), 6.04 (2H, br s), 5.63 (1H, 
s), 5.37 (1H, s), 2.44 (1H, dd, J = 15.0, 8.6 Hz), 2.13 (1H, dd, J = 14.8, 7.6 Hz), 1.44–
1.38 (1H, m), 1.25 (12H, s), 1.03–0.89 (2H, m), 0.10 (9H, s); 13C NMR (100 MHz, 
CDCl3): δ 152.1, 141.6, 136.5, 127.7, 124.3, 119.7, 117.2, 105.4, 83.4, 40.1, 25.0, 24.97, 
–1.2; HRMS (DART): Calcd for C24H37B2N2O2Si1 [M+H]+: 435.2810, Found: 435.2826.  
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2-(4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.43): IR (neat): 3397 (br), 2977 (w), 
2928 (w), 1630 (w), 1600 (s), 1511 (m), 1411 (m), 1372 (m), 1320 (m), 1139 (m), 820 
(m), 764 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.08 (2H, dd, J = 8.4, 7.2 Hz), 6.99 
(2H, dd, J = 8.0, 0.8 Hz), 6.27 (2H, dd, J = 7.2, 1.2 Hz), 6.03 (2H, br s), 5.20 (1H, d, J = 
0.8 Hz), 5.17 (1H, d, J = 1.2 Hz), 2.60 (1H, dd, J = 14.2, 7.0 Hz), 2.35 (1H, dd, J = 14.4, 
8.0 Hz), 1.61–1.53 (1H, m), 1.27 (12H, s), 1.03–0.89 (2H, m); 13C NMR (100 MHz, 
CDCl3): δ 142.8, 141.5, 136.5, 127.7, 119.8, 117.3, 113.1, 105.5, 83.8, 42.9, 25.0; HRMS 
(DART): Calcd for C21H28B2Cl1N2O2 [M+H]+: 397.2025, Found: 397.2043.  
2-(4-Bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.44): Melting point: 111–112 ºC. 
IR (neat): 3400 (br), 2976 (w), 2923 (w), 1628 (w), 1600 (s), 1512 (m), 1412 (m), 1373 
(m), 1320 (m), 1140 (m), 820 (m), 764 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.08 
(2H, dd, J = 8.2, 7.4 Hz), 6.98 (2H, dd, J = 8.4, 0.8 Hz), 6.27 (2H, dd, J = 7.4, 1.0 Hz), 
6.04 (2H, br s), 5.62 (1H, d, J = 1.2 Hz), 5.45 (1H, d, J = 1.6 Hz), 2.68 (1H, dd, J = 14.8, 
6.8 Hz), 2.41 (1H, dd, J = 15.0, 8.2 Hz), 1.61–1.54 (1H, m), 1.27 (12H, s), 1.00 (1H, dd, 
J = 15.6, 4.8 Hz), 0.91 (1H, dd, J = 15.8, 10.6 Hz); 13C NMR (100 MHz, CDCl3): δ 141.5, 
136.5, 135.0, 127.7, 119.8, 117.6, 117.3, 105.5, 102.0, 83.8, 45.0, 25.0; HRMS (DART): 
Calcd for C21H28B2Br1N2O2 [M+H]+: 441.1520, Found: 441.1509. 
2-(2-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.53): IR (neat): 3399 (br), 2976 (w), 
1627 (w), 1600 (s), 1509 (m), 1411 (m), 1372 (m), 1140 (m), 820 (m), 764 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.08 (2H, dd, J = 8.2, 7.4 Hz), 6.98 (2H, dd, J = 8.2, 1.0 Hz), 
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6.25 (2H, dd, J = 7.2, 1.2 Hz), 6.17 (2H, br s), 5.85 (1H, ddt, J = 16.8, 10.0, 7.4 Hz), 
5.07–5.00 (1H, m), 2.19–2.10 (2H, m), 1.32 (6H, s), 1.29 (6H, s), 1.08 (1H, d, J = 14.8 
Hz), 1.02 (3H, s), 0.73 (1H, d, J = 14.4 Hz); 13C NMR (100 MHz, CDCl3): δ 141.7, 136.7, 
136.5, 127.7, 119.8, 117.1, 116.7, 105.3, 83.7, 46.9, 25.2, 25.0; HRMS (DART): Calcd 
for C22H31B2N2O2 [M+H]+: 377.2572, Found: 377.2571. 
2-(1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl)-2,3-dihydro-1H-
naphtho[1,8-de][1,3,2]diazaborinine (3.55): Melting point: 70–71 ºC. IR (neat): 3380 
(br), 2975 (w), 2902 (w), 1628 (w), 1598 (s), 1509 (m), 1410 (m), 1370 (m), 1312 (m), 
1139 (s), 966 (m), 845 (m),  819 (m), 762 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.08 
(2H, t, J = 7.8 Hz), 6.98 (2H, d, J = 8.0 Hz), 6.27 (2H, dd, J = 7.2, 0.8 Hz), 5.98 (2H, br 
s), 5.84 (1H, ddt, J = 17.2, 10.0, 7.0 Hz), 5.08–4.99 (1H, m), 2.29 (1H, app pent, J = 6.9 
Hz), 2.15 (1H, app pent, J = 7.2 Hz), 1.32–1.20 (1H, m), 1.26 (12H, s), 1.01–0.86 (2H, 
m); 13C NMR (100 MHz, CDCl3): δ 141.5, 138.7, 136.5, 127.7, 119.8, 117.3, 115.8, 
105.5, 83.5, 38.7, 25.1, 25.0; HRMS (DART): Calcd for C21H29B2N2O2 [M+H]+: 
363.2415, Found: 363.2430. 
n  Representative Procedure for the Catalytic Cu–B(pin) Addition to Isopropenyl–
B(pin) (3.45) Followed by Allylic Substitution Reaction (Scheme 3.8) 
In a N2-filled glove box, an oven-dried 1 dram vial equipped with a stir bar was 
charged with PCy3 (3.1 mg, 0.0055 mmol), LiOt-Bu (12 mg, 0.15 mmol), CuCl (0.50 mg, 
0.0050 mmol), and thf (1.0 mL). The mixture was allowed to stir for 15 min at 22 °C; 
during this time the solution turned light-yellow. Bis(pinacolato)diboron (28 mg, 0.11 
mmol) was added to the mixture, causing the solution to turn dark brown immediately. 
Isopronenyl–B(pin) (3.45) (25.2 mg, 0.15 mmol), allylphosphate (19.4 mg, 0.10 mmol), 
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and thf (0.50 mL) were added. The vial was sealed with a cap and electrical tape before 
removal from the glove box. The resulting mixture was allowed to stir at 22 °C for 2 h. 
The mixture was then passed through a short plug of silica gel (4 x 1 cm) and eluted with 
Et2O. The organic layer was concentrated under reduced pressure, affording yellow oil, 
which was purified by silica gel chromatography (100% hexanes→hexanes:Et2O = 10:1) 
to afford 3.46 as colorless oil (22.5 mg, 0.067 mmol, 67% yield). 2,2'-(2-Methylpent-4-
ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (3.46): IR (neat): 2977 (m), 
2930 (w), 1360 (s), 1307 (s), 1139 (s), 969 (m), 845 (m) cm–1; 1H NMR (400 MHz, 
CDCl3): δ 5.82 (1H, ddt, J = 17.0, 10.2, 7.4 Hz), 2.13 (1H, dd, J = 14.2, 7.2 Hz), 2.05 (1H, 
dd, J = 14.2, 7.0 Hz), 1.23 (12H, s), 1.21 (12H, s), 0.96 (3H, s), 0.94 (1H, d, J = 15.2 Hz), 
0.70 (1H, d, J = 16.0 Hz); 13C NMR (100 MHz, CDCl3): δ 136.9, 116.2, 83.1, 82.9, 46.0, 
25.1, 25.0, 24.9, 24.89, 24.0; HRMS (DART): Calcd for C18H35B2O4 [M+H]+: 337.2721, 
Found: 337.2738. 
2,2'-(2,4-Dimethylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.47): IR (neat): 2977 (m), 2929 (w), 1461 (m), 1370 (s), 1359 (s), 1307 (s), 1213 (m), 
1142 (s), 969 (m), 848 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 4.74–4.72 (1H, m), 4.66 
(1H, s), 2.18 (1H, d, J = 13.6 Hz), 2.06 (1H, d, J = 13.6 Hz), 1.72, (3H, s), 1.23 (12H, s), 
1.22 (12H, s), 0.99 (3H, s), 0.96 (1H, d, J = 16.0 Hz), 0.73 (1H, d, J = 15.6 Hz); 13C 
NMR (100 MHz, CDCl3): δ 144.8, 112.8, 83.2, 82.9, 49.1, 25.1, 25.06, 24.9, 24.7, 24.3; 
HRMS (DART): Calcd for C19H37B2O4 [M+H]+: 351.2878, Found: 351.2892.  
tert-Butyldimethyl((4-methyl-2-methylene-4,5-bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pentyl)oxy)silane (3.48): IR (neat): 2977 (m), 2929 (m), 2857 (m), 
1462 (m), 1370 (s), 1360 (s), 1309 (s), 1253 (m), 1213 (m), 1142 (s), 1109 (s), 970 (m), 
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836 (s), 775 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.14–5.12 (1H, m), 4.86 (1H, s), 
4.03 (2H, s), 2.13 (1H, d, J = 14.0 Hz), 2.02 (1H, d, J = 14.4 Hz), 1.23 (12H, s), 1.22 
(12H, s), 0.98 (3H, s), 0.94 (1H, d, J = 15.6 Hz), 0.90 (9H, s), 0.75 (1H, d, J = 15.6 Hz), 
0.04 (6H, s); 13C NMR (100 MHz, CDCl3): δ 146.9, 110.6, 83.2, 82.9, 66.9, 43.7, 26.1, 
25.1, 25.07, 25.0, 24.9, 24.4, 18.5, –5.2; HRMS (DART): Calcd for C25H54B2N1O5Si1 
[M+NH4]+: 498.3967, Found: 498.3969. 
2,2'-(2-Methyl-4-phenylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (3.49): IR (neat): 2977 (m), 2928 (w), 1463 (w), 1369 (s), 1359 (s), 1310 
(s), 1213 (m), 1143 (s), 970 (m), 700 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.40–7.38 
(2H, m), 7.28–7.18 (3H, m), 5.20 (1H, d, J = 2.0 Hz), 5.07 (1H, s), 2.72 (1H, d, J = 14.0 
Hz), 2.57 (1H, d, J = 14.0 Hz), 1.21 (6H, s), 1.207 (6H, s), 1.14 (12H, s), 0.95 (1H, d, J = 
15.6 Hz), 0.86 (3H, s), 0.72 (1H, d, J = 15.6 Hz); 13C NMR (100 MHz, CDCl3): δ 147.8, 
143.9, 128.1, 127.0, 126.9, 116.1, 83.1, 82.9, 45.7, 25.1, 25.05, 24.94, 24.9; HRMS 
(DART): Calcd for C24H42B2N1O4 [M+NH4]+: 430.3300, Found: 430.3287.  
Trimethyl(4-methyl-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-en-2-
yl)silane (3.50): IR (neat): 2977 (m), 1465 (w), 1378 (s), 1370 (s), 1359 (s), 1310 (s), 
1248 (m), 1143 (s), 970 (m), 837 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.67–5.65 (1H, 
m), 5.41–5.40 (1H, m), 2.32 (1H, dt, J = 15.6, 1.4 Hz), 2.12 (1H, dd, J = 15.6, 1.2 Hz), 
1.23 (24H, s), 1.01 (3H, s), 0.99 (1H, d, J = 14.4 Hz), 0.74 (1H, d, J = 15.2 Hz), 0.06 (9H, 
s); 13C NMR (100 MHz, CDCl3): δ 150.8, 125.4, 83.1, 82.9, 45.5, 25.2, 25.1, 24.9, 24.0, –
1.1; HRMS (DART): Calcd for C121H43B2O4Si1 [M+H]+: 409.3117, Found: 409.3119.  
2,2'-(4-Chloro-2-methylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (3.51): IR (neat): 2977 (m), 2929 (w), 1629 (w), 1461 (w), 1369 (s), 
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1311 (s), 1138 (s), 969 (m), 845 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.17 (1H, d, J 
= 1.2 Hz), 5.11 (1H, d, J = 1.2 Hz), 2.54 (1H, d, J = 14.4 Hz), 2.45 (1H, d, J = 14.8 Hz), 
1.24 (12H, s), 1.22 (12H, s), 1.05 (3H, s), 1.02 (1H, d, J = 15.6 Hz), 0.80 (1H, d, J = 16.0 
Hz); 13C NMR (100 MHz, CDCl3): δ 141.5, 114.4, 83.4, 83.0, 49.4, 25.1, 25.03, 25.0, 
24.9, 23.8; HRMS (DART): Calcd for C18 H34B2Cl1O4 [M+H]+: 371.2332, Found: 
371.2323. 
2,2'-(4-Bromo-2-methylpent-4-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (3.52): IR (neat): 2977 (m), 2929 (w), 1623 (w), 1462 (m), 1369 (s), 
1313 (s), 1140 (s), 969 (m), 845 (m) cm–1; 1H NMR (400 MHz, CDCl3): δ 5.57 (1H, d, J 
= 1.2 Hz), 5.45 (1H, d, J = 1.6 Hz), 2.67 (1H, d, J = 14.8 Hz), 2.58 (1H, d, J = 14.8 Hz), 
1.25 (12H, s), 1.23 (12H, s), 1.07 (3H, s), 1.04 (1H, d, J = 16.0 Hz), 0.83 (1H, d, J = 15.6 
Hz); 13C NMR (100 MHz, CDCl3): δ 132.4, 119.0, 83.4, 83.0, 51.2, 25.1, 25.0, 24.97, 
23.8; HRMS (DART): Calcd for C18 H34B2Br1O4 [M+H]+: 415.1827, Found: 415.1843.  
2-(2-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)-2,3-
dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine (3.53): IR (neat): 3399 (br), 2976 (w), 
1627 (w), 1600 (s), 1509 (m), 1411 (m), 1372 (m), 1140 (m), 820 (m), 764 (m) cm–1; 1H 
NMR (400 MHz, CDCl3): δ 7.08 (2H, dd, J = 8.2, 7.4 Hz), 6.98 (2H, dd, J = 8.2, 1.0 Hz), 
6.25 (2H, dd, J = 7.2, 1.2 Hz), 6.17 (2H, br s), 5.85 (1H, ddt, J = 16.8, 10.0, 7.4 Hz), 
5.07–5.00 (1H, m), 2.19–2.10 (2H, m), 1.32 (6H, s), 1.29 (6H, s), 1.08 (1H, d, J = 14.8 
Hz), 1.02 (3H, s), 0.73 (1H, d, J = 14.4 Hz); 13C NMR (100 MHz, CDCl3): δ 141.7, 
136.7, 136.5, 127.7, 119.8, 117.1, 116.7, 105.3, 83.7, 46.9, 25.2, 25.0; HRMS (DART): 
Calcd for C22H31B2N2O2 [M+H]+: 377.2572, Found: 377.2571. 
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2-(1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl)-2,3-dihydro-1H-
naphtho[1,8-de][1,3,2]diazaborinine (3.55): Melting point: 70–71 ºC. IR (neat): 3380 
(br), 2975 (w), 2902 (w), 1628 (w), 1598 (s), 1509 (m), 1410 (m), 1370 (m), 1312 (m), 
1139 (s), 966 (m), 845 (m),  819 (m), 762 (s) cm–1; 1H NMR (400 MHz, CDCl3): δ 7.08 
(2H, t, J = 7.8 Hz), 6.98 (2H, d, J = 8.0 Hz), 6.27 (2H, dd, J = 7.2, 0.8 Hz), 5.98 (2H, br s), 
5.84 (1H, ddt, J = 17.2, 10.0, 7.0 Hz), 5.08–4.99 (1H, m), 2.29 (1H, app pent, J = 6.9 Hz), 
2.15 (1H, app pent, J = 7.2 Hz), 1.32–1.20 (1H, m), 1.26 (12H, s), 1.01–0.86 (2H, m); 
13C NMR (100 MHz, CDCl3): δ 141.5, 138.7, 136.5, 127.7, 119.8, 117.3, 115.8, 105.5, 
83.5, 38.7, 25.1, 25.0; HRMS (DART): Calcd for C21H29B2N2O2 [M+H]+: 363.2415, 
Found: 363.2430. 
n  Data for X-ray Crystallography of 3.40 
 
 
Table 1.  Crystal data and structure refinement for C27H32B2N2O2. 
Identification code  C27H32B2N2O2 
Empirical formula  C27 H32 B2 N2 O2 
Formula weight  438.16 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.7928(4) Å a= 90º. 
 b = 9.8354(4) Å b= 95.934(3)º. 
 c = 20.6121(8) Å g = 90º. 
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Volume 2377.92(16) Å3 
Z 4 
Density (calculated) 1.224 Mg/m3 
Absorption coefficient 0.586 mm-1 
F(000) 936 
Crystal size 0.200 x 0.200 x 0.080 mm3 
Theta range for data collection 4.144 to 69.789º. 
Index ranges -14<=h<=13, -11<=k<=9, -24<=l<=24 
Reflections collected 11807 
Independent reflections 4197 [R(int) = 0.0410] 
Completeness to theta = 66.500º 97.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.6540 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4197 / 0 / 324 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0489, wR2 = 0.1220 
R indices (all data) R1 = 0.0724, wR2 = 0.1361 
Extinction coefficient n/a 
Largest diff. peak and hole 0.247 and -0.222 e. Å -3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for C27H32B2N2O2.  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
O(1) 3349(1) 5792(2) 5712(1) 38(1) 
O(2) 3952(1) 6823(2) 6673(1) 42(1) 
N(1) 6786(1) 6903(2) 6488(1) 34(1) 
N(2) 7137(1) 5288(2) 5663(1) 32(1) 
B(1) 6521(2) 6431(2) 5838(1) 30(1) 
B(2) 3961(2) 6847(2) 6011(1) 28(1) 
C(1) 2750(2) 9637(3) 5920(1) 45(1) 
C(2) 2890(2) 9456(2) 5294(1) 30(1) 
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C(3) 3844(2) 8597(2) 5078(1) 28(1) 
C(4) 4623(2) 7894(2) 5624(1) 28(1) 
C(5) 5605(2) 7140(2) 5333(1) 31(1) 
C(6) 7666(2) 6371(2) 6922(1) 32(1) 
C(7) 7965(2) 6926(2) 7531(1) 39(1) 
C(8) 8870(2) 6368(3) 7939(1) 43(1) 
C(9) 9453(2) 5258(2) 7757(1) 42(1) 
C(10) 9162(2) 4641(2) 7139(1) 35(1) 
C(11) 9725(2) 3477(2) 6932(1) 43(1) 
C(12) 9441(2) 2955(2) 6323(1) 45(1) 
C(13) 8590(2) 3552(2) 5887(1) 40(1) 
C(14) 7999(2) 4668(2) 6075(1) 32(1) 
C(15) 8268(2) 5229(2) 6711(1) 30(1) 
C(16) 2104(2) 10109(2) 4775(1) 30(1) 
C(17) 2199(2) 9898(2) 4118(1) 40(1) 
C(18) 1470(2) 10514(2) 3633(1) 40(1) 
C(19) 635(2) 11367(3) 3788(1) 47(1) 
C(20) 655(8) 11816(12) 4419(4) 53(2) 
C(21) 1355(7) 11184(11) 4901(2) 43(2) 
C(20X) 348(11) 11257(16) 4447(5) 43(3) 
C(21X) 1095(7) 10655(12) 4933(3) 32(2) 
C(22) 2708(2) 5148(2) 6207(1) 37(1) 
C(23) 3464(2) 5513(2) 6838(1) 44(1) 
C(24) 1552(2) 5821(3) 6140(2) 65(1) 
C(25) 2588(2) 3658(3) 6065(1) 57(1) 
C(26) 4463(2) 4551(4) 6987(2) 86(1) 
C(27) 2815(3) 5711(4) 7429(1) 90(1) 
________________________________________________________________________
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Table 3. Bond lengths [Å] and angles [º] for  C27H32B2N2O2. 
_____________________________________________________  
O(1)-B(2)  1.373(3) 
O(1)-C(22)  1.474(2) 
O(2)-B(2)  1.365(2) 
O(2)-C(23)  1.466(3) 
N(1)-C(6)  1.400(2) 
N(1)-B(1)  1.422(3) 
N(1)-H(1N)  0.87(2) 
N(2)-C(14)  1.396(2) 
N(2)-B(1)  1.406(3) 
N(2)-H(2N)  0.87(2) 
B(1)-C(5)  1.582(3) 
B(2)-C(4)  1.560(3) 
C(1)-C(2)  1.331(3) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(16)  1.487(3) 
C(2)-C(3)  1.510(3) 
C(3)-C(4)  1.541(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.548(2) 
C(4)-H(4)  1.0000 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.379(3) 
C(6)-C(15)  1.421(3) 
C(7)-C(8)  1.402(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.364(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.421(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.411(3) 
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C(10)-C(15)  1.426(3) 
C(11)-C(12)  1.365(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.405(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.377(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.427(3) 
C(16)-C(21X)  1.375(7) 
C(16)-C(17)  1.386(3) 
C(16)-C(21)  1.418(5) 
C(17)-C(18)  1.389(3) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.357(3) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.372(8) 
C(19)-C(20X)  1.438(11) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.373(8) 
C(20)-H(20)  0.9500 
C(21)-H(21)  0.9500 
C(20X)-C(21X)  1.395(12) 
C(20X)-H(20X)  0.9500 
C(21X)-H(21X)  0.9500 
C(22)-C(25)  1.499(3) 
C(22)-C(24)  1.509(3) 
C(22)-C(23)  1.540(3) 
C(23)-C(26)  1.518(4) 
C(23)-C(27)  1.518(3) 
C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-H(25A)  0.9800 
C(25)-H(25B)  0.9800 
C(25)-H(25C)  0.9800 
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C(26)-H(26A)  0.9800 
C(26)-H(26B)  0.9800 
C(26)-H(26C)  0.9800 
C(27)-H(27A)  0.9800 
C(27)-H(27B)  0.9800 









































































































































Symmetry transformations used to generate equivalent atoms:  
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Table 4. Anisotropic displacement parameters  (Å2x 103) for C27H32B2N2O2.  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h 
k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 48(1)  40(1) 27(1)  3(1) 9(1)  -11(1) 
O(2) 53(1)  49(1) 24(1)  3(1) 3(1)  -14(1) 
N(1) 28(1)  36(1) 37(1)  1(1) 3(1)  7(1) 
N(2) 31(1)  32(1) 31(1)  2(1) 2(1)  -1(1) 
B(1) 25(1)  32(1) 34(1)  4(1) 5(1)  -5(1) 
B(2) 22(1)  36(1) 27(1)  0(1) -1(1)  4(1) 
C(1) 48(1)  56(2) 31(1)  -2(1) 0(1)  20(1) 
C(2) 30(1)  30(1) 28(1)  -4(1) -1(1)  -2(1) 
C(3) 27(1)  31(1) 25(1)  2(1) 0(1)  -2(1) 
C(4) 27(1)  31(1) 25(1)  -2(1) -1(1)  2(1) 
C(5) 29(1)  34(1) 29(1)  1(1) 4(1)  -2(1) 
C(6) 26(1)  37(1) 32(1)  9(1) 6(1)  0(1) 
C(7) 35(1)  48(1) 35(1)  4(1) 6(1)  3(1) 
C(8) 38(1)  62(2) 30(1)  7(1) 6(1)  -3(1) 
C(9) 30(1)  61(2) 36(1)  23(1) 1(1)  1(1) 
C(10) 25(1)  39(1) 43(1)  17(1) 8(1)  -2(1) 
C(11) 29(1)  40(1) 61(1)  22(1) 8(1)  4(1) 
C(12) 34(1)  32(1) 70(2)  10(1) 13(1)  5(1) 
C(13) 35(1)  33(1) 51(1)  1(1) 9(1)  -2(1) 
C(14) 24(1)  31(1) 40(1)  9(1) 5(1)  -4(1) 
C(15) 24(1)  31(1) 35(1)  11(1) 8(1)  -2(1) 
C(16) 29(1)  29(1) 30(1)  -4(1) -3(1)  -2(1) 
C(17) 46(1)  41(1) 32(1)  4(1) 4(1)  14(1) 
C(18) 49(1)  39(1) 32(1)  5(1) -3(1)  5(1) 
C(19) 37(1)  58(2) 44(1)  2(1) -9(1)  10(1) 
C(20) 43(4)  53(5) 61(3)  -3(4) -6(3)  20(3) 
C(21) 47(3)  40(4) 39(2)  -11(2) -3(2)  10(3) 
C(20X) 34(4)  52(7) 43(4)  0(4) -1(3)  12(4) 
C(22) 38(1)  41(1) 32(1)  9(1) 9(1)  -4(1) 
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C(23) 56(1)  49(2) 28(1)  10(1) 3(1)  -13(1) 
C(24) 33(1)  62(2) 99(2)  33(2) 11(1)  -2(1) 
C(25) 78(2)  46(2) 50(1)  0(1) 21(1)  -16(1) 
C(26) 62(2)  92(2) 99(2)  65(2) -20(2)  -5(2) 
C(27) 144(3)  91(2) 42(2)  -11(2) 45(2)  -58(2) 
________________________________________________________________________ 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for C27H32B2N2O2. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1N) 6450(20) 7600(30) 6640(11) 45(7) 
H(2N) 6986(19) 4950(20) 5276(12) 44(7) 
H(1A) 2143 10188 6039 54 
H(1B) 3256 9216 6248 54 
H(3A) 4324 9181 4827 34 
H(3B) 3504 7887 4778 34 
H(4) 4958 8604 5934 34 
H(5A) 6005 7800 5075 37 
H(5B) 5267 6437 5028 37 
H(7) 7557 7686 7672 47 
H(8) 9082 6773 8353 52 
H(9) 10057 4894 8046 51 
H(11) 10304 3055 7217 52 
H(12) 9828 2171 6191 54 
H(13) 8423 3186 5461 47 
H(17) 2782 9313 3996 47 
H(18) 1557 10336 3187 48 
H(19) 47 11647 3466 57 
H(20) 190 12558 4522 64 
H(21) 1337 11480 5339 51 
H(20X) -363 11600 4554 52 
H(21X) 907 10623 5370 38 
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H(24A) 1643 6800 6219 97 
H(24B) 1084 5430 6460 97 
H(24C) 1178 5670 5699 97 
H(25A) 2138 3528 5643 85 
H(25B) 2201 3218 6408 85 
H(25C) 3345 3254 6052 85 
H(26A) 4864 4441 6598 129 
H(26B) 4182 3665 7119 129 
H(26C) 4987 4926 7343 129 
H(27A) 3353 5922 7811 135 
H(27B) 2400 4875 7511 135 
H(27C) 2273 6462 7348 135 
________________________________________________________________________
























































































Symmetry transformations used to generate equivalent atoms:  
  
Table 7.  Hydrogen bonds for C27H32B2N2O2  [Å and º]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
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 N(2)-H(2N)...O(1)#1 0.87(2) 2.16(3) 3.026(2) 177(2) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       	  
n  Data for X-ray Crystallography of 3.41	  
 
Table 1.  Crystal data and structure refinement for C25H30B2N2O3. 
Identification code  C25H30B2N2O3 
Empirical formula  C25 H30 B2 N2 O3 
Formula weight  428.13 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.4630(2) Å a= 90º. 
 b = 9.8897(2) Å b= 98.190(2)º. 
 c = 20.2832(4) Å g = 90º. 
Volume 2275.97(8) Å3 
Z 4 
Density (calculated) 1.249 Mg/m3 
Absorption coefficient 0.634 mm-1 
F(000) 912 
Crystal size 0.180 x 0.120 x 0.110 mm3 
Theta range for data collection 4.194 to 70.315∞. 
Index ranges -13<=h<=13, -11<=k<=11, -24<=l<=18 
Reflections collected 9224 
Independent reflections 4102 [R(int) = 0.0431] 
Completeness to theta = 67.679º 97.1 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 0.7533 and 0.6406 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4102 / 2 / 299 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0463, wR2 = 0.1142 
R indices (all data) R1 = 0.0620, wR2 = 0.1228 
Extinction coefficient n/a 
Largest diff. peak and hole 0.243 and -0.272 e. Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for C25H30B2N2O3.  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
O(1) 8811(1) -457(1) 6521(1) 32(1) 
O(2) 6287(1) 2950(1) 3410(1) 26(1) 
O(3) 6699(1) 4158(1) 4371(1) 24(1) 
N(1) 3143(1) 2780(2) 3502(1) 23(1) 
N(2) 2878(1) 4569(1) 4269(1) 22(1) 
B(1) 3473(2) 3365(2) 4143(1) 21(1) 
B(2) 6169(2) 3030(2) 4066(1) 21(1) 
C(1) 7503(2) 212(2) 4259(1) 29(1) 
C(2) 7284(1) 472(2) 4873(1) 23(1) 
C(3) 6252(1) 1315(2) 5031(1) 22(1) 
C(4) 5472(1) 1979(2) 4443(1) 20(1) 
C(5) 4420(1) 2716(2) 4691(1) 21(1) 
C(6) 1990(1) 5153(2) 3817(1) 21(1) 
C(7) 1424(2) 6325(2) 3958(1) 25(1) 
C(8) 544(2) 6888(2) 3483(1) 30(1) 
C(9) 207(2) 6277(2) 2885(1) 29(1) 
C(10) 746(1) 5052(2) 2723(1) 24(1) 
C(11) 400(2) 4350(2) 2116(1) 29(1) 
C(12) 958(2) 3176(2) 1983(1) 31(1) 
C(13) 1887(2) 2642(2) 2434(1) 28(1) 
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C(14) 2241(1) 3286(2) 3029(1) 22(1) 
C(15) 1664(1) 4493(2) 3193(1) 21(1) 
C(16) 8043(1) -71(2) 5458(1) 24(1) 
C(17) 9014(2) -1007(2) 5481(1) 38(1) 
C(18) 9422(2) -1190(2) 6124(1) 38(1) 
C(19) 7973(2) 207(2) 6100(1) 27(1) 
C(20) 6760(2) 4247(2) 3226(1) 26(1) 
C(21) 5699(2) 5102(2) 2951(1) 44(1) 
C(22) 7541(2) 3997(2) 2693(1) 42(1) 
C(23) 7412(2) 4762(2) 3899(1) 23(1) 
C(24) 7432(2) 6286(2) 3983(1) 37(1) 
C(25) 8645(2) 4176(2) 4078(1) 34(1) 
________________________________________________________________________ 
Table 3.   Bond lengths [Å] and angles [º] for  C25H30B2N2O3. 
_____________________________________________________  
O(1)-C(18)  1.350(2) 
O(1)-C(19)  1.360(2) 
O(2)-B(2)  1.359(2) 
O(2)-C(20)  1.463(2) 
O(3)-B(2)  1.374(2) 
O(3)-C(23)  1.471(2) 
N(1)-C(14)  1.398(2) 
N(1)-B(1)  1.424(3) 
N(1)-H(1N)  0.890(15) 
N(2)-C(6)  1.395(2) 
N(2)-B(1)  1.414(2) 
N(2)-H(2N)  0.863(15) 
B(1)-C(5)  1.575(2) 
B(2)-C(4)  1.573(2) 
C(1)-C(2)  1.330(3) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(16)  1.469(3) 
C(2)-C(3)  1.517(2) 
C(3)-C(4)  1.533(2) 
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C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.553(2) 
C(4)-H(4)  1.0000 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.379(2) 
C(6)-C(15)  1.425(3) 
C(7)-C(8)  1.406(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.362(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.420(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.418(3) 
C(10)-C(15)  1.426(2) 
C(11)-C(12)  1.371(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.404(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.375(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.427(2) 
C(16)-C(19)  1.345(3) 
C(16)-C(17)  1.443(2) 
C(17)-C(18)  1.334(3) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-C(22)  1.519(3) 
C(20)-C(21)  1.520(3) 
C(20)-C(23)  1.546(3) 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
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C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-C(24)  1.517(2) 
C(23)-C(25)  1.523(2) 
C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-H(25A)  0.9800 
C(25)-H(25B)  0.9800 



























































































































Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for C25H30B2N2O3.  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h 
k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 31(1)  30(1) 31(1)  6(1) -4(1)  2(1) 
O(2) 29(1)  27(1) 21(1)  -1(1) 2(1)  -8(1) 
O(3) 28(1)  26(1) 19(1)  0(1) 5(1)  -7(1) 
N(1) 21(1)  24(1) 25(1)  0(1) 2(1)  4(1) 
N(2) 21(1)  23(1) 19(1)  0(1) -2(1)  0(1) 
B(1) 18(1)  22(1) 24(1)  3(1) 4(1)  -4(1) 
B(2) 16(1)  23(1) 22(1)  -1(1) -2(1)  2(1) 
C(1) 27(1)  29(1) 30(1)  0(1) 2(1)  2(1) 
C(2) 21(1)  20(1) 29(1)  1(1) 1(1)  -3(1) 
C(3) 20(1)  23(1) 23(1)  2(1) 1(1)  -2(1) 
C(4) 19(1)  20(1) 20(1)  -2(1) -1(1)  0(1) 
C(5) 19(1)  23(1) 22(1)  1(1) 3(1)  -1(1) 
C(6) 17(1)  21(1) 25(1)  7(1) 2(1)  -3(1) 
C(7) 25(1)  20(1) 30(1)  2(1) 1(1)  -3(1) 
C(8) 24(1)  20(1) 44(1)  7(1) 3(1)  1(1) 
C(9) 21(1)  29(1) 35(1)  14(1) 0(1)  0(1) 
C(10) 18(1)  29(1) 25(1)  11(1) 2(1)  -4(1) 
C(11) 21(1)  42(1) 23(1)  11(1) -2(1)  -3(1) 
C(12) 29(1)  44(1) 19(1)  0(1) 2(1)  -7(1) 
C(13) 26(1)  33(1) 24(1)  -2(1) 5(1)  0(1) 
C(14) 18(1)  27(1) 21(1)  5(1) 4(1)  -2(1) 
C(15) 18(1)  23(1) 22(1)  7(1) 3(1)  -4(1) 
C(16) 20(1)  21(1) 31(1)  2(1) 3(1)  -1(1) 
C(17) 33(1)  42(1) 39(1)  2(1) 6(1)  14(1) 
C(18) 29(1)  42(1) 42(1)  8(1) 2(1)  14(1) 
C(19) 25(1)  23(1) 31(1)  2(1) -2(1)  2(1) 
C(20) 29(1)  25(1) 22(1)  3(1) 2(1)  -6(1) 
C(21) 37(1)  44(1) 46(1)  22(1) -7(1)  -3(1) 
C(22) 54(1)  46(1) 26(1)  -6(1) 14(1)  -18(1) 
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C(23) 26(1)  24(1) 21(1)  1(1) 5(1)  -5(1) 
C(24) 48(1)  26(1) 39(1)  -2(1) 18(1)  -9(1) 
C(25) 22(1)  40(1) 39(1)  10(1) 1(1)  -7(1) 
________________________________________________________________________
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3) for C25H30B2N2O3. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1N) 3456(18) 2014(17) 3379(10) 28 
H(2N) 3036(18) 4980(20) 4646(8) 26 
H(1A) 8160 -332 4193 35 
H(1B) 7003 571 3886 35 
H(3A) 6566 2038 5344 26 
H(3B) 5746 730 5267 26 
H(4) 5154 1257 4121 24 
H(5A) 4741 3441 5002 26 
H(5B) 4013 2062 4949 26 
H(7) 1628 6754 4378 30 
H(8) 178 7711 3582 36 
H(9) -393 6674 2573 34 
H(11) -220 4696 1801 35 
H(12) 710 2713 1577 37 
H(13) 2271 1836 2327 34 
H(17) 9305 -1411 5112 45 
H(18) 10064 -1767 6284 45 
H(19) 7405 797 6243 32 
H(21A) 5229 4620 2583 66 
H(21B) 5969 5965 2789 66 
H(21C) 5216 5272 3304 66 
H(22A) 8138 3317 2852 62 
H(22B) 7931 4842 2598 62 
H(22C) 7059 3670 2287 62 
H(24A) 6622 6630 3931 55 
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H(24B) 7850 6696 3644 55 
H(24C) 7836 6519 4427 55 
H(25A) 8962 4431 4535 52 
H(25B) 9158 4531 3771 52 
H(25C) 8608 3188 4041 52 
________________________________________________________________________















































































Symmetry transformations used to generate equivalent atoms:  
  
Table 7.  Hydrogen bonds for C25H30B2N2O3  [Å and º]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 N(2)-H(2N)...O(3)#1 0.863(15) 2.150(16) 3.0082(19) 173.5(19) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       
 
n  Data for X-ray Crystallography of 3.55 
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Table 1.  Crystal data and structure refinement for C21H28B2N2O2. 
Identification code  C21H28B2N2O2 
Empirical formula  C21 H28 B2 N2 O2 
Formula weight  362.07 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.9787(12) Å α= 100.956(8)º. 
 b = 10.6797(13) Å β= 114.093(7)º. 
 c = 11.8681(15) Å γ= 100.609(8)º. 
Volume 1084.2(2) Å3 
Z 2 
Density (calculated) 1.109 Mg/m3 
Absorption coefficient 0.543 mm-1 
F(000) 388 
Crystal size 0.250 x 0.170 x 0.120 mm3 
Theta range for data collection 4.271 to 66.697. 
Index ranges -10<=h<=11, -12<=k<=12, -14<=l<=14 
Reflections collected 9561 
Independent reflections 3784 [R(int) = 0.0269] 
Completeness to theta = 66.697º 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.6548 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3784 / 339 / 339 
Goodness-of-fit on F2 1.035 
Final R indices [I>2sigma(I)] R1 = 0.0521, wR2 = 0.1394 
R indices (all data) R1 = 0.0794, wR2 = 0.1586 
Extinction coefficient n/a 
Largest diff. peak and hole 0.155 and -0.158 e. Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for C21H28B2N2O2.  U(eq) is defined as one third of  the trace 
of the orthogonalized Uij tensor. 
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________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________ 
O(1) 3515(2) 1845(1) 5296(1) 68(1) 
N(1) 7339(2) 1370(2) 5886(2) 60(1) 
N(2) 7489(2) 3651(2) 5950(2) 61(1) 
B(1) 6735(3) 2284(2) 5258(2) 56(1) 
B(2) 3587(2) 2765(2) 4654(2) 56(1) 
C(1) 4721(8) 1701(8) 609(5) 163(3) 
C(2) 4792(6) 1117(6) 1472(4) 102(2) 
C(3) 5989(4) 1731(3) 2882(3) 61(1) 
C(1X) 3370(40) 70(50) 90(30) 330(20) 
C(2X) 3810(30) 130(30) 1250(20) 160(8) 
C(3X) 5330(30) 1300(30) 2250(20) 145(8) 
C(4) 5349(2) 1803(2) 3858(2) 62(1) 
C(5) 8599(2) 1749(2) 7107(2) 63(1) 
C(6) 9126(3) 830(3) 7711(2) 82(1) 
C(7) 10415(3) 1256(3) 8918(3) 101(1) 
C(8) 11169(3) 2566(4) 9520(3) 98(1) 
C(9) 10672(3) 3551(3) 8943(2) 79(1) 
C(10) 11408(3) 4933(3) 9528(3) 97(1) 
C(11) 10857(3) 5842(3) 8968(3) 96(1) 
C(12) 9538(3) 5440(2) 7776(2) 78(1) 
C(13) 8795(2) 4102(2) 7151(2) 62(1) 
C(14) 9346(2) 3131(2) 7724(2) 62(1) 
C(15) 4243(2) 2675(2) 3673(2) 64(1) 
O(2) 2962(3) 3729(3) 4934(3) 70(1) 
C(16) 3122(4) 2406(4) 6314(5) 70(1) 
C(17) 2251(4) 3333(3) 5724(4) 76(1) 
C(18) 2264(6) 1316(5) 6612(5) 95(2) 
C(19) 4657(4) 3174(5) 7521(3) 117(2) 
C(20) 2329(6) 4555(3) 6625(5) 111(1) 
C(21) 536(3) 2562(5) 4773(4) 108(1) 
O(2X) 3610(20) 4020(20) 5420(20) 70(5) 
C(16X) 3130(30) 2280(20) 6250(40) 86(5) 
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C(17X) 2930(30) 3640(20) 6220(20) 98(5) 
C(18X) 1850(30) 1140(30) 6070(30) 73(7) 
C(19X) 4640(30) 2320(40) 7410(30) 122(9) 
C(20X) 3540(50) 4700(20) 7430(30) 127(8) 
C(21X) 1170(30) 3520(30) 5430(30) 111(1) 
 
Table 3. Bond lengths [Å] and angles [º] for  C21H28B2N2O2. 
________________________________________________________________________  
O(1)-B(2)  1.362(2) 
O(1)-C(16)  1.473(5) 
N(1)-C(5)  1.395(3) 
N(1)-B(1)  1.412(3) 
N(1)-H(1N)  0.86(2) 
N(2)-C(13)  1.398(3) 
N(2)-B(1)  1.417(3) 
N(2)-H(2N)  0.83(2) 
B(1)-C(4)  1.574(3) 
B(2)-O(2)  1.355(3) 
B(2)-C(15)  1.548(3) 
C(1)-C(2)  1.281(6) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(3)  1.523(5) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.530(4) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(15)  1.547(3) 
C(4)-H(4)  1.03(2) 
C(5)-C(6)  1.379(3) 
C(5)-C(14)  1.418(3) 
C(6)-C(7)  1.395(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.352(4) 
C(7)-H(7)  0.9500 
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C(8)-C(9)  1.417(4) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.412(4) 
C(9)-C(14)  1.420(3) 
C(10)-C(11)  1.354(4) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.400(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.379(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.418(3) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
O(2)-C(17)  1.465(3) 
C(16)-C(18)  1.500(4) 
C(16)-C(17)  1.520(4) 
C(16)-C(19)  1.539(4) 
C(17)-C(20)  1.488(4) 
C(17)-C(21)  1.559(4) 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 














































































































Symmetry transformations used to generate equivalent atoms:  
  
Table 4. Anisotropic displacement parameters  (Å 2x 103) for C21H28B2N2O2.  The 
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anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 
h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 81(1)  58(1) 81(1)  28(1) 48(1)  29(1) 
N(1) 62(1)  55(1) 67(1)  22(1) 31(1)  19(1) 
N(2) 67(1)  57(1) 69(1)  24(1) 35(1)  25(1) 
B(1) 57(1)  58(1) 69(1)  24(1) 40(1)  22(1) 
B(2) 48(1)  54(1) 68(1)  23(1) 25(1)  17(1) 
C(1) 190(6)  250(7) 83(3)  51(4) 67(3)  125(5) 
C(2) 111(3)  141(4) 49(2)  13(2) 33(2)  48(3) 
C(3) 70(2)  67(2) 54(2)  17(1) 30(2)  32(1) 
C(1X) 280(30)  490(50) 178(13)  66(15) 87(14)  80(30) 
C(2X) 152(15)  209(19) 144(11)  20(11) 79(10)  112(13) 
C(3X) 165(16)  206(18) 119(9)  54(9) 85(10)  126(13) 
C(4) 63(1)  61(1) 71(1)  24(1) 35(1)  26(1) 
C(5) 63(1)  73(1) 66(1)  29(1) 37(1)  26(1) 
C(6) 88(2)  88(2) 84(2)  45(1) 40(1)  36(1) 
C(7) 106(2)  123(2) 89(2)  57(2) 40(2)  54(2) 
C(8) 90(2)  134(2) 70(2)  36(2) 28(1)  44(2) 
C(9) 73(1)  100(2) 62(1)  18(1) 31(1)  25(1) 
C(10) 82(2)  112(2) 72(2)  5(2) 28(1)  16(2) 
C(11) 95(2)  85(2) 86(2)  -4(1) 44(2)  6(2) 
C(12) 87(2)  67(1) 82(2)  11(1) 47(1)  17(1) 
C(13) 65(1)  65(1) 64(1)  16(1) 39(1)  19(1) 
C(14) 62(1)  74(1) 61(1)  21(1) 36(1)  23(1) 
C(15) 63(1)  69(1) 71(1)  29(1) 34(1)  29(1) 
O(2) 80(2)  65(1) 107(2)  45(1) 64(2)  39(1) 
C(16) 84(2)  65(2) 76(2)  24(2) 49(2)  23(2) 
C(17) 89(2)  70(2) 113(2)  43(2) 74(2)  40(2) 
C(18) 133(4)  81(2) 106(4)  45(2) 78(3)  34(2) 
C(19) 101(2)  147(4) 76(2)  15(2) 31(2)  21(2) 
C(20) 158(4)  74(2) 164(4)  40(2) 125(3)  48(2) 
C(21) 62(2)  152(4) 135(3)  68(3) 56(2)  38(2) 
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O(2X) 83(12)  58(6) 90(9)  28(5) 55(9)  26(6) 
C(16X) 124(12)  64(9) 102(8)  27(7) 81(8)  27(8) 
C(17X) 149(10)  74(9) 129(9)  43(6) 108(7)  42(7) 
C(18X) 89(12)  75(11) 96(18)  53(11) 63(11)  43(8) 
C(19X) 135(13)  140(20) 104(10)  38(11) 69(9)  43(12) 
C(20X) 210(20)  71(11) 133(10)  29(8) 113(10)  40(12) 
C(21X) 158(4)  74(2) 164(4)  40(2) 125(3)  48(2) 
________________________________________________________________________ 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for C21H28B2N2O2. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H(1N) 6940(20) 530(20) 5500(20) 72 
H(2N) 7240(20) 4240(20) 5610(20) 73 
H(1A) 5429 2546 840 196 
H(1B) 3959 1288 -262 196 
H(2) 4075 272 1223 123 
H(3A) 6560 2645 2994 74 
H(3B) 6730 1205 3085 74 
H(1X1) 3924 703 -143 398 
H(1X2) 2471 -605 -553 398 
H(2X) 3285 -489 1513 192 
H(3X1) 5385 2078 1918 174 
H(3X2) 6244 997 2357 174 
H(4) 4740(20) 820(20) 3622(19) 74 
H(6) 8609 -95 7304 98 
H(7) 10770 614 9324 121 
H(8) 12044 2831 10341 118 
H(10) 12311 5231 10334 116 
H(11) 11373 6766 9389 115 
H(12) 9155 6088 7397 94 
H(15A) 3380 2303 2787 77 
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H(15B) 4795 3586 3757 77 
H(18A) 2014 1708 7290 143 
H(18B) 1315 792 5831 143 
H(18C) 2903 735 6909 143 
H(19A) 4458 3570 8231 175 
H(19B) 5265 2560 7772 175 
H(19C) 5225 3882 7327 175 
H(20A) 1855 4300 7159 166 
H(20B) 3404 5077 7183 166 
H(20C) 1778 5092 6127 166 
H(21A) 9 2275 5260 162 
H(21B) 41 3147 4309 162 
H(21C) 480 1779 4152 162 
H(18D) 1524 1391 6737 109 
H(18E) 987 939 5216 109 
H(18F) 2215 355 6153 109 
H(19D) 4586 2616 8219 182 
H(19E) 4778 1425 7308 182 
H(19F) 5512 2939 7430 182 
H(20D) 3064 4419 7957 191 
H(20E) 4656 4866 7907 191 
H(20F) 3317 5514 7254 191 
H(21D) 629 3268 5913 166 
H(21E) 1067 4382 5290 166 
H(21F) 736 2841 4591 166 
________________________________________________________________________ 
  



































































Symmetry transformations used to generate equivalent atoms:  
  
Table 7. Hydrogen bonds for C21H28B2N2O2  [Å and º]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 N(1)-H(1N)...O(1)#1 0.86(2) 2.42(2) 3.256(2) 165.4(19) 
 N(2)-H(2N)...O(2)#2 0.83(2) 2.40(2) 3.213(3) 167(2) 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y,-z+1    #2 -x+1,-y+1,-z+1       
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